|
Name |
Accession |
Description |
Interval |
E-value |
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
575-2027 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 994.67 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLAA 654
Cdd:PRK12467 659 AYVIYTSGSTGQPKGVAISHGALANYVCVIAERLQLAADDSMLMVSTFAFDLGVTELFGALASGATLHLLPPDCARDAEA 738
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 655 LVDDLVARETTIVDLPTAVWQLLCADGDAIdaiGRSRLRQIVIGGEAIRCSAVDKWLEsaASQGISLLSSYGPTEATVVA 734
Cdd:PRK12467 739 FAALMADQGVTVLKIVPSHLQALLQASRVA---LPRPQRALVCGGEALQVDLLARVRA--LGPGARLINHYGPTETTVGV 813
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 735 TFLPivCDQTTMDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYLGIDG--------DGFGtvtaAD 795
Cdd:PRK12467 814 STYE--LSDEERDFGNVPIGQPLANLGLYIldhylnpvpvgVVGELYIGGAGLARGYHRRPAltaerfvpDPFG----AD 887
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 796 GSRrrAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGS----LGVWFKSQRTRE 871
Cdd:PRK12467 888 GGR--LYRTGDLARYRADGVIEYLGRMDHQVKIRGFRIELGEIEARLLAQPGVREAVVLAQPGDaglqLVAYLVPAAVAD 965
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 872 GEQDAAAATRIRLVLVSL----GVSSFFVVgVPNIPRKPNGKIDSDNLPRLPQWSAAGLNTAETGQRAAGLSQIWSRQLG 947
Cdd:PRK12467 966 GAEHQATRDELKAQLRQVlpdyMVPAHLLL-LDSLPLTPNGKLDRKALPKPDASAVQATFVAPQTELEKRLAAIWADVLK 1044
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 948 -RAIGPDSSLLGEGIGSLDLIRILPETRRYLGWRLSLLDLIGADTAANLADyAPTPDAPTgedRFRPLVAAQRPAAIPLS 1026
Cdd:PRK12467 1045 vERVGLTDNFFELGGHSLLATQVISRVRQRLGIQVPLRTLFEHQTLAGFAQ-AVAAQQQG---AQPALPDVDRDQPLPLS 1120
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1027 FAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADLGCDIVDA 1106
Cdd:PRK12467 1121 YAQERQWFLWQLEPGSAAYHIPQALRLKGPLDIEALERSFDALVARHESLRTTFVQEDGRTRQVIHPVGSLTLEEPLLLA 1200
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1107 TAWPADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAPDWAP 1186
Cdd:PRK12467 1201 ADKDEAQLKVYVEAEARQPFDLEQGPLLRVGLLRLAADEHVLVLTLHHIVSDGWSMQVLVDELVALYAAYSQGQSLQLPA 1280
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1187 LPVQYVDYTLWQREILGDLDDsdspiAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQVRRIAR 1266
Cdd:PRK12467 1281 LPIQYADYAVWQRQWMDAGER-----ARQLAYWKAQLGGEQPVLELPTDRPRPAVQSHRGARLAFELPPALAEGLRALAR 1355
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1267 QHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRARSLAAYE 1346
Cdd:PRK12467 1356 REGVTLFMLLLASFQTLLHRYSGQDDIRVGVPIANRNRAETEGLIGFFVNTQVLRAEVDGQASFQQLLQQVKQAALEAQA 1435
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1347 NQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQ-DNPVGQLNLGDLQATPMPIDTRTARMDLVFSLAErfsegsEPAGIGG 1425
Cdd:PRK12467 1436 HQDLPFEQLVEALQPERSLSHSPLFQVMFNHQrDDHQAQAQLPGLSVESLSWESQTAQFDLTLDTYE------SSEGLQA 1509
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1426 AVEYRTDVFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARLDEWGNRAvlTAPAPTPVSIPQMLAAQVARI 1505
Cdd:PRK12467 1510 SLTYATDLFEASTIERLAGHWLNLLQGLVADPERRLGELDLLDEAERRQILEGWNAT--HTGYPLARLVHQLIEDQAAAT 1587
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML 1585
Cdd:PRK12467 1588 PEAVALVFGEQELTYGELNRRANRLAHRLIALGVGPEVLVGIAVERSLEMVVGLLAILKAGGAYVPLDPEYPRERLAYMI 1667
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1586 GDAVPVAAVTTAGLRSRL-AGHDLPIIdVVDA----LAAYPGTPPPM-PAAVNLAYILYTSGTTGEPKGVGITHRNVTRL 1659
Cdd:PRK12467 1668 EDSGIELLLTQSHLQARLpLPDGLRSL-VLDQeddwLEGYSDSNPAVnLAPQNLAYVIYTSGSTGRPKGAGNRHGALVNR 1746
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1660 FASLPAR--LSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAMLpTQ 1737
Cdd:PRK12467 1747 LCATQEAyqLSAADVVLQFTSFAFDVSVWELFWPLINGARLVIAPPGAHRDPEQLIQLIERQQVTTLHFVPSMLQQL-LQ 1825
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1738 GLESVA-------LVVAGEACPAALVDRW---APGRVMLNAYGPTETTICAA---ISAPLRPGSGMPPIGVPVSGAALFV 1804
Cdd:PRK12467 1826 MDEQVEhplslrrVVCGGEALEVEALRPWlerLPDTGLFNLYGPTETAVDVThwtCRRKDLEGRDSVPIGQPIANLSTYI 1905
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1805 LDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGY 1884
Cdd:PRK12467 1906 LDASLNPVPIGVAGELYLGGVGLARGYLNRPALTAERFVADPFGTVGSRLYRTGDLARYRADGVIEYLGRIDHQVKIRGF 1985
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1885 RIELGEVATALAELAGVGQAVVIAREDRPGdKRLVGYATEIAPGAVDPAG--------LRAQLAQRLPGYLVPAAVVVID 1956
Cdd:PRK12467 1986 RIELGEIEARLREQGGVREAVVIAQDGANG-KQLVAYVVPTDPGLVDDDEaqvalraiLKNHLKASLPEYMVPAHLVFLA 2064
|
1450 1460 1470 1480 1490 1500 1510
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 1957 ALPLTVNGKLDHRALPAPEYGD-TNGYRAPAGPVEKTVAGIFARVLGLERVGVDDSFFELGGDSLAAMRVIA 2027
Cdd:PRK12467 2065 RMPLTPNGKLDRKALPAPDASElQQAYVAPQSELEQRLAAIWQDVLGLEQVGLHDNFFELGGDSIISIQVVS 2136
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
1006-2210 |
0e+00 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 975.49 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1006 TGEDRFRPLVAAQRPAAIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDG 1085
Cdd:COG1020 1 AAAAAAAALPPAAAAAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAG 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1086 VPRQLVIEARRADLG--CDIVDATAWPADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVA 1163
Cdd:COG1020 81 RPVQVIQPVVAAPLPvvVLLVDLEALAEAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGLSDG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1164 PLTADLSAAYASRCAGRAPDWAPLPVQYVDYTLWQREilgdlDDSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVAD 1243
Cdd:COG1020 161 LLLAELLRLYLAAYAGAPLPLPPLPIQYADYALWQRE-----WLQGEELARQLAYWRQQLAGLPPLLELPTDRPRPAVQS 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1244 QRGASLVVDWPASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVN 1323
Cdd:COG1020 236 YRGARVSFRLPAELTAALRALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRPRPELEGLVGFFVNTLPLRVD 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1324 LAGDPSFAELLGQVRARSLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQLNLGDLQATPMPIDTRTAR 1403
Cdd:COG1020 316 LSGDPSFAELLARVRETLLAAYAHQDLPFERLVEELQPERDLSRNPLFQVMFVLQNAPADELELPGLTLEPLELDSGTAK 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1404 MDLVFSLAERfsegsePAGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARLDEWGNRAv 1483
Cdd:COG1020 396 FDLTLTVVET------GDGLRLTLEYNTDLFDAATIERMAGHLVTLLEALAADPDQPLGDLPLLTAAERQQLLAEWNAT- 468
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1484 lTAPAPTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVL 1563
Cdd:COG1020 469 -AAPYPADATLHELFEAQAARTPDAVAVVFGDQSLTYAELNARANRLAHHLRALGVGPGDLVGVCLERSLEMVVALLAVL 547
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1564 KTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLRSRLAGHDLPIIDV-VDALAAYPGTPPPMPAAV-NLAYILYTSG 1641
Cdd:COG1020 548 KAGAAYVPLDPAYPAERLAYMLEDAGARLVLTQSALAARLPELGVPVLALdALALAAEPATNPPVPVTPdDLAYVIYTSG 627
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1642 TTGEPKGVGITHRNVTRLFASLPAR--LSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAE 1719
Cdd:COG1020 628 STGRPKGVMVEHRALVNLLAWMQRRygLGPGDRVLQFASLSFDASVWEIFGALLSGATLVLAPPEARRDPAALAELLARH 707
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1720 HVSVLTQTPAAVAMLPTQGLESVA----LVVAGEACPAALVDRWA---PGRVMLNAYGPTETTICAAIS--APLRPGSGM 1790
Cdd:COG1020 708 RVTVLNLTPSLLRALLDAAPEALPslrlVLVGGEALPPELVRRWRarlPGARLVNLYGPTETTVDSTYYevTPPDADGGS 787
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1791 PPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMYRTGDLVCWRADGQLE 1870
Cdd:COG1020 788 VPIGRPIANTRVYVLDAHLQPVPVGVPGELYIGGAGLARGYLNRPELTAERFVADPFGFPGARLYRTGDLARWLPDGNLE 867
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1871 FLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPA 1950
Cdd:COG1020 868 FLGRADDQVKIRGFRIELGEIEAALLQHPGVREAVVVAREDAPGDKRLVAYVVPEAGAAAAAALLRLALALLLPPYMVPA 947
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1951 AVVVIDALPLTVNGKLDHRALPAPEYGDTNGYRAPAGPVEKTVAGIFARVLGLERVGVDDSFFELGGDSLAAMRVIAAIN 2030
Cdd:COG1020 948 AVVLLLPLPLTGNGKLDRLALPAPAAAAAAAAAAPPAEEEEEEAALALLLLLVVVVGDDDFFFFGGGLGLLLLLALARAA 1027
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2031 TTLNADLPVRALLHASSTRGLSQLLGRDARPTSDPRLVSVHGDNPTEVHASDLTLDRFIDADTLATAVNLPGPSPELRTV 2110
Cdd:COG1020 1028 RLLLLLLLLLLLFLAAAAAAAAAAAAAAAAAAAAPLAAAAAPLPLPPLLLSLLALLLALLLLLALLALLALLLLLLLLLL 1107
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2111 LLTGATGFLGRYLVLELLRRLDVDGRLICLVRAESDEDARRRLEKTFDSGDPELLRHFKELAADRLEVVAGDKSEPDLGL 2190
Cdd:COG1020 1108 LLALLLLLALLLALLAALRARRAVRQEGPRLRLLVALAAALALAALLALLLAAAAAAAELLAAAALLLLLALLLLALLLL 1187
|
1210 1220
....*....|....*....|
gi 489495878 2191 DQPMWRRLAETVDLIVDSAA 2210
Cdd:COG1020 1188 LLLLLLLLLLLLLLLLLLLL 1207
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1020-2075 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 851.37 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1020 PAAIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADL 1099
Cdd:PRK12467 47 FERIPLSYAQERQWFLWQLDPDSAAYNIPTALRLRGELDVSALRRAFDALVARHESLRTRFVQDEEGFRQVIDASLSLTI 126
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1100 GCDIVDATAwPADR---LQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASR 1176
Cdd:PRK12467 127 PLDDLANEQ-GRAResqIEAYINEEVARPFDLANGPLLRVRLLRLADDEHVLVVTLHHIISDGWSMRVLVEELVQLYSAY 205
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1177 CAGRAPDWAPLPVQYVDYTLWQREILgdlddSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPAS 1256
Cdd:PRK12467 206 SQGREPSLPALPIQYADYAIWQRSWL-----EAGERERQLAYWQEQLGGEHTVLELPTDRPRPAVPSYRGARLRVDLPQA 280
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1257 VQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQ 1336
Cdd:PRK12467 281 LSAGLKALAQREGVTLFMVLLASFQTLLHRYSGQSDIRIGVPNANRNRVETERLIGFFVNTQVLKAEVDPQASFLELLQQ 360
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1337 VRARSLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQLN-----LGDLQATPMPIDTRTARMDLVFSLA 1411
Cdd:PRK12467 361 VKRTALGAQAHQDLPFEQLVEALQPERSLSHSPLFQVMFNHQNTATGGRDregaqLPGLTVEELSWARHTAQFDLALDTY 440
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1412 ErfsegsEPAGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARLDEWGNravLTAPAPTP 1491
Cdd:PRK12467 441 E------SAQGLWAAFTYATDLFEATTIERLATHWRNLLEAIVAEPRRRLGELPLLDAEERARELVRWN---APATEYAP 511
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1492 VSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLP 1571
Cdd:PRK12467 512 DCVHQLIEAQARQHPERPALVFGEQVLSYAELNRQANRLAHVLIAAGVGPDVLVGIAVERSIEMVVGLLAVLKAGGAYVP 591
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1572 IDPANPPPRVAFMLGDAVPVAAVTTAGLRSRLAGHD----LPIIDVVDALAAYPGTPPPMPAAV-NLAYILYTSGTTGEP 1646
Cdd:PRK12467 592 LDPEYPQDRLAYMLDDSGVRLLLTQSHLLAQLPVPAglrsLCLDEPADLLCGYSGHNPEVALDPdNLAYVIYTSGSTGQP 671
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1647 KGVGITHRNVTRLFASLPAR--LSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVL 1724
Cdd:PRK12467 672 KGVAISHGALANYVCVIAERlqLAADDSMLMVSTFAFDLGVTELFGALASGATLHLLPPDCARDAEAFAALMADQGVTVL 751
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1725 TQTPAAVAML-----PTQGLESVALVVAGEACPAALVDRW---APGRVMLNAYGPTETTICAA---ISAPLRPgSGMPPI 1793
Cdd:PRK12467 752 KIVPSHLQALlqasrVALPRPQRALVCGGEALQVDLLARVralGPGARLINHYGPTETTVGVStyeLSDEERD-FGNVPI 830
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1794 GVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMYRTGDLVCWRADGQLEFLG 1873
Cdd:PRK12467 831 GQPLANLGLYILDHYLNPVPVGVVGELYIGGAGLARGYHRRPALTAERFVPDPFGADGGRLYRTGDLARYRADGVIEYLG 910
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1874 RTDDQVKIRGYRIELGEVATALAELAGVGQAVVIArEDRPGDKRLVGY-----ATEIAPGAVDPAGLRAQLAQRLPGYLV 1948
Cdd:PRK12467 911 RMDHQVKIRGFRIELGEIEARLLAQPGVREAVVLA-QPGDAGLQLVAYlvpaaVADGAEHQATRDELKAQLRQVLPDYMV 989
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1949 PAAVVVIDALPLTVNGKLDHRALPAPE-YGDTNGYRAPAGPVEKTVAGIFARVLGLERVGVDDSFFELGGDSLAAMRVIA 2027
Cdd:PRK12467 990 PAHLLLLDSLPLTPNGKLDRKALPKPDaSAVQATFVAPQTELEKRLAAIWADVLKVERVGLTDNFFELGGHSLLATQVIS 1069
|
1050 1060 1070 1080
....*....|....*....|....*....|....*....|....*...
gi 489495878 2028 AINTTLNADLPVRALLHASSTRGLSQLLGRDArPTSDPRLVSVHGDNP 2075
Cdd:PRK12467 1070 RVRQRLGIQVPLRTLFEHQTLAGFAQAVAAQQ-QGAQPALPDVDRDQP 1116
|
|
| carboxyl_red |
NF041592 |
carboxylic acid reductase; |
1519-2512 |
0e+00 |
|
carboxylic acid reductase;
Pssm-ID: 469476 [Multi-domain] Cd Length: 1161 Bit Score: 835.37 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPP-----------PRV----AF 1583
Cdd:NF041592 79 TYRELWDRVGAVAAALAGDPVRPGDRVAVLGFTSVDYTTIDLALIRLGAVAVPLQTSAPVaqlrpivaetePRVlaasVD 158
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1584 MLGDAVPVAAVTT---------------------AGLRSRLAGHDL----PIIDVVDALAAYPGTPPPMPAAVN-LAYIL 1637
Cdd:NF041592 159 LLDDAVELVLTGPaprrlvvfdyhpevddhrealEAARARLADAGPvvveTLAEVLERGRALPAAPPPASDDDDpLALLI 238
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1638 YTSGTTGEPKGVGITHRNVTRLFaslpaRLSAAQVWSQC-------------HSYGFDAsaweIWGALLGGGRLVIVPES 1704
Cdd:NF041592 239 YTSGSTGAPKGAMYTERLVANMW-----RGSARAGWGPRavpsitlnfmpmsHVMGRGT----LYGTLARGGTAYFAARS 309
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1705 vaaspnDFHGLLvaEHVSVLTQT-----PAAVAML--------PTQGLESVALVVAGEACPAALVDRWAPGRVMlnaygp 1771
Cdd:NF041592 310 ------DLSTLL--EDLALVRPTelnfvPRVWDMLfqeyqselDRRAADGADRAAAEAAVKAELREDLLGGRFV------ 375
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1772 TETTICAAISAPLRPGS----GMPPI---GVPVSGAALF--------VLDSWL------------RPVPAGvagELYIAG 1824
Cdd:NF041592 376 SAMTGSAPISAEMKAFVesllDLHLHdgyGSTEAGGVFIdgrvrrppVLDYKLvdvpelgyfgtdRPHPRG---ELLVKT 452
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1825 AGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCWRADGQLEFLGRTDDQVKI-RGYRIELGEVATALAELAGVGQ 1903
Cdd:NF041592 453 TTMFPGYYKRPEVTAEVFDEDGF-------YRTGDIVAELGPDQLVYVDRRNNVLKLsQGEFVTVSKLEAVFGDSPLVRQ 525
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1904 AVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQ---------RLPGYLVPAAVVvIDALPLTV-NGKL-DHRALP 1972
Cdd:NF041592 526 IYVYGNSARAYLLAVVVPTEEALARHGDAAELKALIAEslqrvareaGLQSYEIPRDFL-IETTPFTLeNGLLtGIRKLA 604
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1973 APE----YGD-------------TNGYRA-----PAGPVEKTVAGIFARVLGLERVGV--DDSFFELGGDSLAAMRVIAA 2028
Cdd:NF041592 605 RPKlkerYGErleqlytelaagqADELRAlrrsgADRPVLETVGRAAAALLGAAAADLrpDAHFTDLGGDSLSALTFSNL 684
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2029 INTTLNADLPVRALLH-ASSTRGL-----SQLLGRDARPTSDprlvSVHGDNPTEVHASDLTLDRFIDADTLATAVNLPG 2102
Cdd:NF041592 685 LHEIFGVEVPVGVIVSpATDLRALadyieAERASGAKRPTFA----SVHGRDATEVRAADLTLDKFIDAATLAAAPSLPG 760
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2103 PSPELRTVLLTGATGFLGRYLVLELLRRLD-VDGRLICLVRAESDEDARRRLEKTFDSGDPELLRHFKELAADRLEVVAG 2181
Cdd:NF041592 761 PSGEVRTVLLTGATGFLGRYLALEWLERLAlVGGTLICLVRAKDDAAARARLDATFDSGDPELLAHYRELAADHLEVLAG 840
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2182 DKSEPDLGLDQPMWRRLAETVDLIVDSAAMVN-AFPYHELFGPNVAGTAELIRIALTTKLKPFTYVSTADVGAAIEPSAF 2260
Cdd:NF041592 841 DKGEPDLGLDRATWQRLADTVDLIVDPAALVNhVLPYSQLFGPNVVGTAELIRLALTTRLKPFTYLSTIGVGAQIEPGAF 920
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2261 TEDADIRVISPTRTVDGGWAGGYGTSKWAGEVLLREANDLCALPVAVFRCGMILADTSYAGQLNMSDWVTRMVLSLMATG 2340
Cdd:NF041592 921 TEDADIREISPVRAIDDSYANGYGNSKWAGEVLLREAHDLCGLPVAVFRCDMILADTRYAGQLNLPDMFTRLMLSLVATG 1000
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2341 IAPRSFYEPDSEGNRQRAHFDGLPVTFVAEAIAVLGARVAgsslAGFATYHVMNPHDDGIGLDEYVDWLIEAGYPIRRID 2420
Cdd:NF041592 1001 IAPGSFYELDADGNRQRAHYDGLPVDFIAEAIATLGARVT----DGFETYHVMNPHDDGIGLDEFVDWLIEAGHPIQRID 1076
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2421 DFAEWLQRFEASLGALPDRQRRHSVLPMLLASNsqrlQPLKPTRGCSAPTDRFRAAVRAAKVGSDKdnpDIPHVSAPTII 2500
Cdd:NF041592 1077 DYADWLQRFETALRALPERQRQASLLPLLHNYR----RPAPPIRGSIAPTDRFRAAVQEAKIGPDK---DIPHLTPALIV 1149
|
1130
....*....|..
gi 489495878 2501 NYVTNLQLLGLL 2512
Cdd:NF041592 1150 KYVTDLRLLGLL 1161
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
372-2027 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 821.13 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 372 SVLDEEQRTLNLAIWNRADLPAcKTHPKVAERIAAALesmaamwdrpiamivndwfgigpdgtrcqgdwpARQPSTPAWF 451
Cdd:PRK12316 1978 ALLDAGERQRILADWDRTPEAY-PRGPGVHQRIAEQA---------------------------------ARAPEAIAVV 2023
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 452 LDSARGVHQFLGRR--RFVYPwvawLVQRGAAPGDVLVFTDDDTDKTIDLLIACHLAGCGYSVCDTADEISVRTNAITEH 529
Cdd:PRK12316 2024 FGDQHLSYAELDSRanRLAHR----LRARGVGPEVRVAIAAERSFELVVALLAVLKAGGAYVPLDPNYPAERLAYMLEDS 2099
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 530 GDGILVTVVDVAA--------TQLAVVGHDELRKVVDERVTQVTHDALLAtktaYIMPTSGTTGQPKLVRISHGSLAVFC 601
Cdd:PRK12316 2100 GAALLLTQRHLLErlplpagvARLPLDRDAEWADYPDTAPAVQLAGENLA----YVIYTSGSTGLPKGVAVSHGALVAHC 2175
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 602 DAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGAR-LVRSAAMKTGDlaALVDDLVARETTIVDLPTAVWQLLcAD 680
Cdd:PRK12316 2176 QAAGERYELSPADCELQFMSFSFDGAHEQWFHPLLNGARvLIRDDELWDPE--QLYDEMERHGVTILDFPPVYLQQL-AE 2252
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 681 GDAIDAiGRSRLRQIVIGGEAIRCSAVDKWLESAasQGISLLSSYGPTEATVVATfLPIVCDQTTMDGALLRLGRPILPN 760
Cdd:PRK12316 2253 HAERDG-RPPAVRVYCFGGEAVPAASLRLAWEAL--RPVYLFNGYGPTEAVVTPL-LWKCRPQDPCGAAYVPIGRALGNR 2328
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 761 TVFL-----------AFGEVVIVGDLVADGYLGIDG--------DGFGTVTAadgsrrRAFATGDRVTVDAEGFPVFSGR 821
Cdd:PRK12316 2329 RAYIldadlnllapgMAGELYLGGEGLARGYLNRPGltaerfvpDPFSASGE------RLYRTGDLARYRADGVVEYLGR 2402
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 822 KDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLG---VWFKSQRTREGEQDAAAATRIRLVLVSLGVSSFFVVg 898
Cdd:PRK12316 2403 IDHQVKIRGFRIELGEIEARLQAHPAVREAVVVAQDGASGkqlVAYVVPDDAAEDLLAELRAWLAARLPAYMVPAHWVV- 2481
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 899 VPNIPRKPNGKIDSDNLPRLPQWSAAGLNTAETGQRAAGLSQIWSRQLG-RAIGPDSSLLGEGIGSLDLIRILPETRRYL 977
Cdd:PRK12316 2482 LERLPLNPNGKLDRKALPKPDVSQLRQAYVAPQEGLEQRLAAIWQAVLKvEQVGLDDHFFELGGHSLLATQVVSRVRQDL 2561
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 978 GWRLSLLDLIGADTAANLADYAPTPDAPtgedRFRPLVAAQRPAAIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYL 1057
Cdd:PRK12316 2562 GLEVPLRILFERPTLAAFAASLESGQTS----RAPVLQKVTRVQPLPLSHAQQRQWFLWQLEPESAAYHLPSALHLRGVL 2637
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1058 DTEALGAAVADVVGRHESLRTVFPAVDGVPRQlVIEARRAdLGCDIVDATAWPADRLQRAIEEAARHSFDLATEIPLRTW 1137
Cdd:PRK12316 2638 DQAALEQAFDALVLRHETLRTRFVEVGEQTRQ-VILPNMS-LRIVLEDCAGVADAAIRQRVAEEIQRPFDLARGPLLRVR 2715
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1138 LFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAPDWAPLPVQYVDYTLWQREILgdlddSDSPIAAQLA 1217
Cdd:PRK12316 2716 LLALDGQEHVLVITQHHIVSDGWSMQVMVDELVQAYAGARRGEQPTLPPLPLQYADYAAWQRAWM-----DSGEGARQLD 2790
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1218 YWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGF 1297
Cdd:PRK12316 2791 YWRERLGGEQPVLELPLDRPRPALQSHRGARLDVALDVALSRELLALARREGVTLFMLLLASFQVLLHRYSGQSDIRVGV 2870
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1298 PIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRARSLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAW 1377
Cdd:PRK12316 2871 PIANRNRAETERLIGFFVNTQVLRAQVDAQLAFRDLLGQVKEQALGAQAHQDLPFEQLVEALQPERSLSHSPLFQVMYNH 2950
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1378 QDNPVGQLNLGDLQATPMPIDTRTARMDLVFSLAErfsegsEPAGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAP 1457
Cdd:PRK12316 2951 QSGERAAAQLPGLHIESFAWDGAATQFDLALDTWE------SAEGLGASLTYATDLFDARTVERLARHWQNLLRGMVENP 3024
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1458 ERTVSSIDALDGTERARLDEWGNRAvlTAPAPTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGC 1537
Cdd:PRK12316 3025 QRSVDELAMLDAEERGQLLEAWNAT--AAEYPLERGVHRLFEEQVERTPDAVALAFGEQRLSYAELNRRANRLAHRLIER 3102
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1538 GAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLRSRLAGHDLPIIDVVDAL 1617
Cdd:PRK12316 3103 GVGPDVLVGVAVERSLEMVVGLLAILKAGGAYVPLDPEYPEERLAYMLEDSGAQLLLSQSHLRLPLAQGVQVLDLDRGDE 3182
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1618 AAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPA--RLSAAQVWSQCHSYGFDASAWEIWGALLGG 1695
Cdd:PRK12316 3183 NYAEANPAIRTMPENLAYVIYTSGSTGKPKGVGIRHSALSNHLCWMQQayGLGVGDRVLQFTTFSFDVFVEELFWPLMSG 3262
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1696 GRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAML----PTQGLESVALVVA-GEACPAALVDRWAPGRVMLNAYG 1770
Cdd:PRK12316 3263 ARVVLAGPEDWRDPALLVELINSEGVDVLHAYPSMLQAFleeeDAHRCTSLKRIVCgGEALPADLQQQVFAGLPLYNLYG 3342
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1771 PTETTICAAISAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFgGS 1850
Cdd:PRK12316 3343 PTEATITVTHWQCVEEGKDAVPIGRPIANRACYILDGSLEPVPVGALGELYLGGEGLARGYHNRPGLTAERFVPDPF-VP 3421
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1851 GARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRpgdkRLVGYATEIAPGAV 1930
Cdd:PRK12316 3422 GERLYRTGDLARYRADGVIEYIGRVDHQVKIRGFRIELGEIEARLLEHPWVREAVVLAVDGR----QLVAYVVPEDEAGD 3497
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1931 DPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAPEYGDT-NGYRAPAGPVEKTVAGIFARVLGLERVGVD 2009
Cdd:PRK12316 3498 LREALKAHLKASLPEYMVPAHLLFLERMPLTPNGKLDRKALPRPDAALLqQDYVAPVNELERRLAAIWADVLKLEQVGLT 3577
|
1690
....*....|....*...
gi 489495878 2010 DSFFELGGDSLAAMRVIA 2027
Cdd:PRK12316 3578 DNFFELGGDSIISLQVVS 3595
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1013-2027 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 789.92 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1013 PLVAAQRPAA-IPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLV 1091
Cdd:PRK12316 39 PIPAGVSSAErDRLSYAQQRMWFLWQLEPQSGAYNLPSAVRLNGPLDRQALERAFASLVQRHETLRTVFPRGADDSLAQV 118
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1092 IEARraDLGCDIVDATAWP-ADRLQRAIEEAARHS---FDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTA 1167
Cdd:PRK12316 119 PLDR--PLEVEFEDCSGLPeAEQEARLRDEAQRESlqpFDLCEGPLLRVRLLRLGEEEHVLLLTLHHIVSDGWSMNVLIE 196
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1168 DLSAAYASRCAGRAPDWAPLPVQYVDYTLWQREILgdlddSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGA 1247
Cdd:PRK12316 197 EFSRFYSAYATGAEPGLPALPIQYADYALWQRSWL-----EAGEQERQLEYWRAQLGEEHPVLELPTDHPRPAVPSYRGS 271
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1248 SLVVDWPASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGD 1327
Cdd:PRK12316 272 RYEFSIDPALAEALRGTARRQGLTLFMLLLGAFNVLLHRYSGQTDIRVGVPIANRNRAEVEGLIGFFVNTQVLRSVFDGR 351
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1328 PSFAELLGQVRARSLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQ---LNLGDLQATPMPIDTRTARM 1404
Cdd:PRK12316 352 TRVATLLAGVKDTVLGAQAHQDLPFERLVEALKVERSLSHSPLFQVMYNHQPLVADIealDTVAGLEFGQLEWKSRTTQF 431
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1405 DLVFSLAERfsegsePAGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARLDEWGNRAvl 1484
Cdd:PRK12316 432 DLTLDTYEK------GGRLHAALTYATDLFEARTVERMARHWQNLLRGMVENPQARVDELPMLDAEERGQLVEGWNAT-- 503
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1485 TAPAPTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLK 1564
Cdd:PRK12316 504 AAEYPLQRGVHRLFEEQVERTPEAPALAFGEETLDYAELNRRANRLAHALIERGVGPDVLVGVAMERSIEMVVALLAILK 583
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1565 TGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLRSRL---AGHDLPIIDVVDA-LAAYPGTPPPMPA-AVNLAYILYT 1639
Cdd:PRK12316 584 AGGAYVPLDPEYPAERLAYMLEDSGVQLLLSQSHLGRKLplaAGVQVLDLDRPAAwLEGYSEENPGTELnPENLAYVIYT 663
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1640 SGTTGEPKGVGITHRN-VTRLFASLPA-RLSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLV 1717
Cdd:PRK12316 664 SGSTGKPKGAGNRHRAlSNRLCWMQQAyGLGVGDTVLQKTPFSFDVSVWEFFWPLMSGARLVVAAPGDHRDPAKLVELIN 743
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1718 AEHVSVLTQTPAAV-AMLPTQGLESVA----LVVAGEACPAALVDRW---APGRVMLNAYGPTETTICAAISAPLRPGSG 1789
Cdd:PRK12316 744 REGVDTLHFVPSMLqAFLQDEDVASCTslrrIVCSGEALPADAQEQVfakLPQAGLYNLYGPTEAAIDVTHWTCVEEGGD 823
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1790 MPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFgGSGARMYRTGDLVCWRADGQL 1869
Cdd:PRK12316 824 SVPIGRPIANLACYILDANLEPVPVGVLGELYLAGRGLARGYHGRPGLTAERFVPSPF-VAGERMYRTGDLARYRADGVI 902
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1870 EFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREdrpgDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVP 1949
Cdd:PRK12316 903 EYAGRIDHQVKLRGLRIELGEIEARLLEHPWVREAAVLAVD----GKQLVGYVVLESEGGDWREALKAHLAASLPEYMVP 978
|
970 980 990 1000 1010 1020 1030
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1950 AAVVVIDALPLTVNGKLDHRALPAPEYGDTN-GYRAPAGPVEKTVAGIFARVLGLERVGVDDSFFELGGDSLAAMRVIA 2027
Cdd:PRK12316 979 AQWLALERLPLTPNGKLDRKALPAPEASVAQqGYVAPRNALERTLAAIWQDVLGVERVGLDDNFFELGGDSIVSIQVVS 1057
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
575-2027 |
0e+00 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 769.33 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLAA 654
Cdd:PRK05691 1276 AYVIYTSGSTGQPKGVGNTHAALAERLQWMQATYALDDSDVLMQKAPISFDVSVWECFWPLITGCRLVLAGPGEHRDPQR 1355
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 655 LVDDLVARETTIVDLPTAVWQLLCadgDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLESAAsqGISLLSSYGPTEATVVA 734
Cdd:PRK05691 1356 IAELVQQYGVTTLHFVPPLLQLFI---DEPLAAACTSLRRLFSGGEALPAELRNRVLQRLP--QVQLHNRYGPTETAINV 1430
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 735 TFLPIVCDqttmDGALLRLGRPiLPNTVFLAF------------GEVVIVGDLVADGYLGIDG--------DGFGTVTAa 794
Cdd:PRK05691 1431 THWQCQAE----DGERSPIGRP-LGNVLCRVLdaelnllppgvaGELCIGGAGLARGYLGRPAltaerfvpDPLGEDGA- 1504
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 795 dgsrrRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGVWFKSQRTREGEQ 874
Cdd:PRK05691 1505 -----RLYRTGDRARWNADGALEYLGRLDQQVKLRGFRVEPEEIQARLLAQPGVAQAAVLVREGAAGAQLVGYYTGEAGQ 1579
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 875 DAAAAtRIRLVLvSLGVSSFFV----VGVPNIPRKPNGKIDSDNLPrLPQWSAaGLNTAETGQRAAGLSQIWSRQLG-RA 949
Cdd:PRK05691 1580 EAEAE-RLKAAL-AAELPEYMVpaqlIRLDQMPLGPSGKLDRRALP-EPVWQQ-REHVEPRTELQQQIAAIWREVLGlPR 1655
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 950 IGPDSSLLGEGIGSLDLIRILPETRRYLGWRLSLLDLIGADTAANLADYAPTPDAPTGEDRFRPLVAAQRPAAIPLSFAQ 1029
Cdd:PRK05691 1656 VGLRDDFFALGGHSLLATQIVSRTRQACDVELPLRALFEASELGAFAEQVARIQAAGERNSQGAIARVDRSQPVPLSYSQ 1735
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1030 RRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVieARRADLGCDIVDATAW 1109
Cdd:PRK05691 1736 QRMWFLWQMEPDSPAYNVGGMARLSGVLDVDRFEAALQALILRHETLRTTFPSVDGVPVQQV--AEDSGLRMDWQDFSAL 1813
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1110 PAD----RLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAPDWA 1185
Cdd:PRK05691 1814 PADarqqRLQQLADSEAHQPFDLERGPLLRACLVKAAEREHYFVLTLHHIVTEGWAMDIFARELGALYEAFLDDRESPLE 1893
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1186 PLPVQYVDYTLWQREILgdlddSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQVRRIA 1265
Cdd:PRK05691 1894 PLPVQYLDYSVWQRQWL-----ESGERQRQLDYWKAQLGNEHPLLELPADRPRPPVQSHRGELYRFDLSPELAARVRAFN 1968
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1266 RQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRARSLAAY 1345
Cdd:PRK05691 1969 AQRGLTLFMTMTATLAALLYRYSGQRDLRIGAPVANRIRPESEGLIGAFLNTQVLRCQLDGQMSVSELLEQVRQTVIEGQ 2048
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1346 ENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQL-NLGDLQATPMPIDTRTARMDL---VFSLAERfsegsepa 1421
Cdd:PRK05691 2049 SHQDLPFDHLVEALQPPRSAAYNPLFQVMCNVQRWEFQQSrQLAGMTVEYLVNDARATKFDLnleVTDLDGR-------- 2120
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1422 gIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARLdeWGNRAVLTAPAPTPVSIPQMLAAQ 1501
Cdd:PRK05691 2121 -LGCCLTYSRDLFDEPRIARMAEHWQNLLEALLGDPQQRLAELPLLAAAEQQQL--LDSLAGEAGEARLDQTLHGLFAAQ 2197
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1502 VARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRV 1581
Cdd:PRK05691 2198 AARTPQAPALTFAGQTLSYAELDARANRLARALRERGVGPQVRVGLALERSLEMVVGLLAILKAGGAYVPLDPEYPLERL 2277
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1582 AFMLGDAVPVAAVTTAGLRSRLAghDLP-------IIDVVDALAAYPGTPPP-MPAAVNLAYILYTSGTTGEPKGVGITH 1653
Cdd:PRK05691 2278 HYMIEDSGIGLLLSDRALFEALG--ELPagvarwcLEDDAAALAAYSDAPLPfLSLPQHQAYLIYTSGSTGKPKGVVVSH 2355
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1654 RNVTRLFASLPARLSAAQVWSQCHSYG--FDASAWEIWGALLGGGRLVIVPESVAASpNDFHGLLVAEHVSVLTQTPAAV 1731
Cdd:PRK05691 2356 GEIAMHCQAVIERFGMRADDCELHFYSinFDAASERLLVPLLCGARVVLRAQGQWGA-EEICQLIREQQVSILGFTPSYG 2434
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1732 AMLP----TQGLE-SVALVV-AGEACPAALVDR----WAPgRVMLNAYGPTETTICA-AISAP--LRPGSGMPPIGVPVS 1798
Cdd:PRK05691 2435 SQLAqwlaGQGEQlPVRMCItGGEALTGEHLQRirqaFAP-QLFFNAYGPTETVVMPlACLAPeqLEEGAASVPIGRVVG 2513
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1799 GAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQ 1878
Cdd:PRK05691 2514 ARVAYILDADLALVPQGATGELYVGGAGLAQGYHDRPGLTAERFVADPFAADGGRLYRTGDLVRLRADGLVEYVGRIDHQ 2593
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1879 VKIRGYRIELGEVATALAELAGVGQAVVIAReDRPGDKRLVGY-ATEIAPG-----AVDPAGLRAQLAQRLPGYLVPAAV 1952
Cdd:PRK05691 2594 VKIRGFRIELGEIESRLLEHPAVREAVVLAL-DTPSGKQLAGYlVSAVAGQddeaqAALREALKAHLKQQLPDYMVPAHL 2672
|
1450 1460 1470 1480 1490 1500 1510
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 1953 VVIDALPLTVNGKLDHRALPAPEYG-DTNGYRAPAGPVEKTVAGIFARVLGLERVGVDDSFFELGGDSLAAMRVIA 2027
Cdd:PRK05691 2673 ILLDSLPLTANGKLDRRALPAPDPElNRQAYQAPRSELEQQLAQIWREVLNVERVGLGDNFFELGGDSILSIQVVS 2748
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
568-2057 |
0e+00 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 730.43 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 568 ALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYG--WGAHDTVLQCAPLTSDISV-----EEIFGGAACgar 640
Cdd:PRK05691 162 ALQPDDIAFLQYTSGSTALPKGVQVSHGNLVANEQLIRHGFGidLNPDDVIVSWLPLYHDMGLiggllQPIFSGVPC--- 238
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 641 LVRSAAMKTGDLAALVDDLVARETTIVDLPTAVWQLlCADGDAIDAIGR---SRLRQIVIGGEAIRCSAVDKWLESAASQ 717
Cdd:PRK05691 239 VLMSPAYFLERPLRWLEAISEYGGTISGGPDFAYRL-CSERVSESALERldlSRWRVAYSGSEPIRQDSLERFAEKFAAC 317
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 718 GI---SLLSSYGPTEATVVATF---------------------------LPIVCDQTTMDGALLRLGRP----ILPNTVF 763
Cdd:PRK05691 318 GFdpdSFFASYGLAEATLFVSGgrrgqgipaleldaealarnraepgtgSVLMSCGRSQPGHAVLIVDPqsleVLGDNRV 397
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 764 lafGEVVIVGDLVADGYLGIDGDGFGTVTAADGsrRRAFATGDrVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIA 843
Cdd:PRK05691 398 ---GEIWASGPSIAHGYWRNPEASAKTFVEHDG--RTWLRTGD-LGFLRDGELFVTGRLKDMLIVRGHNLYPQDIEKTVE 471
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 844 EDPA------VSDVAVElHSGSLGVWFKSQRTREGEQDAAAAT---RIRLVLVSLGVSSFFVVGVPN---IPRKPNGKID 911
Cdd:PRK05691 472 REVEvvrkgrVAAFAVN-HQGEEGIGIAAEISRSVQKILPPQAlikSIRQAVAEACQEAPSVVLLLNpgaLPKTSSGKLQ 550
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 912 S------------DNLPRLPQWSAAGLNTAETG--QRAAGLSQIWSRQLG-RAIGPDSSLLGEGIGSLDLIRILPETRRY 976
Cdd:PRK05691 551 RsacrlrladgslDSYALFPALQAVEAAQTAASgdELQARIAAIWCEQLKvEQVAADDHFFLLGGNSIAATQVVARLRDE 630
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 977 LGWRLSL--------LDLIGADTAANLADYAPTPDAptgedrfrpLVAAQRPAAIPLSFAQRRLWFLDQLQRPAPVYNMA 1048
Cdd:PRK05691 631 LGIDLNLrqlfeaptLAAFSAAVARQLAGGGAAQAA---------IARLPRGQALPQSLAQNRLWLLWQLDPQSAAYNIP 701
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1049 VALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEArrADLGCDIVDATAWPAD----RLQRAIEEAARH 1124
Cdd:PRK05691 702 GGLHLRGELDEAALRASFQRLVERHESLRTRFYERDGVALQRIDAQ--GEFALQRIDLSDLPEAereaRAAQIREEEARQ 779
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1125 SFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAPDWAPLPVQYVDYTLWQREILgd 1204
Cdd:PRK05691 780 PFDLEKGPLLRVTLVRLDDEEHQLLVTLHHIVADGWSLNILLDEFSRLYAAACQGQTAELAPLPLGYADYGAWQRQWL-- 857
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1205 lddSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQVRRIARQHNATSFMVVAAGLAVLL 1284
Cdd:PRK05691 858 ---AQGEAARQLAYWKAQLGDEQPVLELATDHPRSARQAHSAARYSLRVDASLSEALRGLAQAHQATLFMVLLAAFQALL 934
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1285 SKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRARSLAAYENQDVPFEVLVDRLKPTRa 1364
Cdd:PRK05691 935 HRYSGQGDIRIGVPNANRPRLETQGLVGFFINTQVLRAQLDGRLPFTALLAQVRQATLGAQAHQDLPFEQLVEALPQAR- 1013
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1365 ltHHPLIQVMLAWQDNPVGQL-NLGDLQATPMPIDTRTARMDLvfslaERFSEGSEPAGIGGAVEYRTDVFEAQAIDVLI 1443
Cdd:PRK05691 1014 --EQGLFQVMFNHQQRDLSALrRLPGLLAEELPWHSREAKFDL-----QLHSEEDRNGRLTLSFDYAAELFDAATIERLA 1086
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1444 ERLRKVLVAVAAAPERTVSSIDALDGTERARLDEWGnravlTAP-APTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRE 1522
Cdd:PRK05691 1087 EHFLALLEQVCEDPQRALGDVQLLDAAERAQLAQWG-----QAPcAPAQAWLPELLNEQARQTPERIALVWDGGSLDYAE 1161
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1523 LDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLRSR 1602
Cdd:PRK05691 1162 LHAQANRLAHYLRDKGVGPDVCVAIAAERSPQLLVGLLAILKAGGAYVPLDPDYPAERLAYMLADSGVELLLTQSHLLER 1241
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1603 LAGHDLPIIDVVDAL--AAYPGTPPPMP-AAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPA--RLSAAQVWSQCH 1677
Cdd:PRK05691 1242 LPQAEGVSAIALDSLhlDSWPSQAPGLHlHGDNLAYVIYTSGSTGQPKGVGNTHAALAERLQWMQAtyALDDSDVLMQKA 1321
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1678 SYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVA-----LVVAGEACP 1752
Cdd:PRK05691 1322 PISFDVSVWECFWPLITGCRLVLAGPGEHRDPQRIAELVQQYGVTTLHFVPPLLQLFIDEPLAAACtslrrLFSGGEALP 1401
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1753 AALVDR---WAPGRVMLNAYGPTETTICAAISAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGV 1829
Cdd:PRK05691 1402 AELRNRvlqRLPQVQLHNRYGPTETAINVTHWQCQAEDGERSPIGRPLGNVLCRVLDAELNLLPPGVAGELCIGGAGLAR 1481
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1830 GYWRRAGLTASRFVACPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAR 1909
Cdd:PRK05691 1482 GYLGRPALTAERFVPDPLGEDGARLYRTGDRARWNADGALEYLGRLDQQVKLRGFRVEPEEIQARLLAQPGVAQAAVLVR 1561
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1910 EDRPGdKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAPEYgDTNGYRAPAGPV 1989
Cdd:PRK05691 1562 EGAAG-AQLVGYYTGEAGQEAEAERLKAALAAELPEYMVPAQLIRLDQMPLGPSGKLDRRALPEPVW-QQREHVEPRTEL 1639
|
1530 1540 1550 1560 1570 1580
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1990 EKTVAGIFARVLGLERVGVDDSFFELGGDSLAAMRVIAAINTTLNADLPVRALLHASSTRGLSQLLGR 2057
Cdd:PRK05691 1640 QQQIAAIWREVLGLPRVGLRDDFFALGGHSLLATQIVSRTRQACDVELPLRALFEASELGAFAEQVAR 1707
|
|
| LCL_NRPS-like |
cd19540 |
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ... |
1023-1457 |
0e+00 |
|
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380463 [Multi-domain] Cd Length: 433 Bit Score: 660.66 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1023 IPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADLGCD 1102
Cdd:cd19540 2 IPLSFAQQRLWFLNRLDGPSAAYNIPLALRLTGALDVDALRAALADVVARHESLRTVFPEDDGGPYQVVLPAAEARPDLT 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1103 IVDATAwpaDRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAP 1182
Cdd:cd19540 82 VVDVTE---DELAARLAEAARRGFDLTAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLARDLATAYAARRAGRAP 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1183 DWAPLPVQYVDYTLWQREILGDLDDSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQVR 1262
Cdd:cd19540 159 DWAPLPVQYADYALWQRELLGDEDDPDSLAARQLAYWRETLAGLPEELELPTDRPRPAVASYRGGTVEFTIDAELHARLA 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1263 RIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRARSL 1342
Cdd:cd19540 239 ALAREHGATLFMVLHAALAVLLSRLGAGDDIPIGTPVAGRGDEALDDLVGMFVNTLVLRTDVSGDPTFAELLARVRETDL 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1343 AAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQLNLGDLQATPMPIDTRTARMDLVFSLAERFSEGSEPAG 1422
Cdd:cd19540 319 AAFAHQDVPFERLVEALNPPRSTARHPLFQVMLAFQNTAAATLELPGLTVEPVPVDTGVAKFDLSFTLTERRDADGAPAG 398
|
410 420 430
....*....|....*....|....*....|....*
gi 489495878 1423 IGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAP 1457
Cdd:cd19540 399 LTGELEYATDLFDRSTAERLADRFVRVLEAVVADP 433
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
1506-1972 |
0e+00 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 612.34 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML 1585
Cdd:cd17652 1 PDAPAVVFGDETLTYAELNARANRLARLLAARGVGPERLVALALPRSAELVVAILAVLKAGAAYLPLDPAYPAERIAYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1586 GDAVPVAAVTTAGlrsrlaghdlpiidvvdalaaypgtpppmpaavNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPA 1665
Cdd:cd17652 81 ADARPALLLTTPD---------------------------------NLAYVIYTSGSTGRPKGVVVTHRGLANLAAAQIA 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1666 RLS--AAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLES-V 1742
Cdd:cd17652 128 AFDvgPGSRVLQFASPSFDASVWELLMALLAGATLVLAPAEELLPGEPLADLLREHRITHVTLPPAALAALPPDDLPDlR 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1743 ALVVAGEACPAALVDRWAPGRVMLNAYGPTETTICAAISAPLrPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYI 1822
Cdd:cd17652 208 TLVVAGEACPAELVDRWAPGRRMINAYGPTETTVCATMAGPL-PGGGVPPIGRPVPGTRVYVLDARLRPVPPGVPGELYI 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1823 AGAGVGVGYWRRAGLTASRFVACPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVG 1902
Cdd:cd17652 287 AGAGLARGYLNRPGLTAERFVADPFGAPGSRMYRTGDLARWRADGQLEFLGRADDQVKIRGFRIELGEVEAALTEHPGVA 366
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1903 QAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALP 1972
Cdd:cd17652 367 EAVVVVRDDRPGDKRLVAYVVPAPGAAPTAAELRAHLAERLPGYMVPAAFVVLDALPLTPNGKLDRRALP 436
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
1022-1457 |
3.20e-176 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 546.95 E-value: 3.20e-176
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1022 AIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADLgc 1101
Cdd:cd19531 1 PLPLSFAQQRLWFLDQLEPGSAAYNIPGALRLRGPLDVAALERALNELVARHEALRTTFVEVDGEPVQVILPPLPLPL-- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1102 DIVDATAWPAD----RLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRC 1177
Cdd:cd19531 79 PVVDLSGLPEAereaEAQRLAREEARRPFDLARGPLLRATLLRLGEDEHVLLLTMHHIVSDGWSMGVLLRELAALYAAFL 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1178 AGRAPDWAPLPVQYVDYTLWQREILgdlddSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASV 1257
Cdd:cd19531 159 AGRPSPLPPLPIQYADYAVWQREWL-----QGEVLERQLAYWREQLAGAPPVLELPTDRPRPAVQSFRGARVRFTLPAEL 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1258 QQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQV 1337
Cdd:cd19531 234 TAALRALARREGATLFMTLLAAFQVLLHRYSGQDDIVVGTPVAGRNRAELEGLIGFFVNTLVLRTDLSGDPTFRELLARV 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1338 RARSLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQLNLGDLQATPMPIDTRTARMDLVFSLAERfseg 1417
Cdd:cd19531 314 RETALEAYAHQDLPFEKLVEALQPERDLSRSPLFQVMFVLQNAPAAALELPGLTVEPLEVDSGTAKFDLTLSLTET---- 389
|
410 420 430 440
....*....|....*....|....*....|....*....|
gi 489495878 1418 sePAGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAP 1457
Cdd:cd19531 390 --DGGLRGSLEYNTDLFDAATIERMAGHFQTLLEAIVADP 427
|
|
| LCL_NRPS |
cd19538 |
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ... |
1023-1457 |
4.68e-173 |
|
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380461 [Multi-domain] Cd Length: 432 Bit Score: 538.39 E-value: 4.68e-173
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1023 IPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADLGCD 1102
Cdd:cd19538 2 IPLSFAQRRLWFLHQLEGPSATYNIPLVIKLKGKLDVQALQQALYDVVERHESLRTVFPEEDGVPYQLILEEDEATPKLE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1103 IVDAtawPADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAP 1182
Cdd:cd19538 82 IKEV---DEEELESEINEAVRYPFDLSEEPPFRATLFELGENEHVLLLLLHHIAADGWSLAPLTRDLSKAYRARCKGEAP 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1183 DWAPLPVQYVDYTLWQREILGDLDDSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQVR 1262
Cdd:cd19538 159 ELAPLPVQYADYALWQQELLGDESDPDSLIARQLAYWKKQLAGLPDEIELPTDYPRPAESSYEGGTLTFEIDSELHQQLL 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1263 RIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRARSL 1342
Cdd:cd19538 239 QLAKDNNVTLFMVLQAGFAALLTRLGAGTDIPIGSPVAGRNDDSLEDLVGFFVNTLVLRTDTSGNPSFRELLERVKETNL 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1343 AAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQLNLGDLQATPMPIDTRTARMDLVFSLAERFSEGSePAG 1422
Cdd:cd19538 319 EAYEHQDIPFERLVEALNPTRSRSRHPLFQIMLALQNTPQPSLDLPGLEAKLELRTVGSAKFDLTFELREQYNDGT-PNG 397
|
410 420 430
....*....|....*....|....*....|....*
gi 489495878 1423 IGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAP 1457
Cdd:cd19538 398 IEGFIEYRTDLFDHETIEALAQRYLLLLESAVENP 432
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
1021-2076 |
5.88e-172 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 566.98 E-value: 5.88e-172
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1021 AAIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQlVIEARRADLG 1100
Cdd:PRK10252 6 QHLPLVAAQPGIWMAEKLSPLPSAWSVAHYVELTGELDAPLLARAVVAGLAEADTLRMRFTEDNGEVWQ-WVDPALTFPL 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1101 CDIVD--ATAWPADRLQRAIEEAARHSFDLATEIPL-RTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRC 1177
Cdd:PRK10252 85 PEIIDlrTQPDPHAAAQALMQADLQQDLRVDSGKPLvFHQLIQLGDNRWYWYQRYHHLLVDGFSFPAITRRIAAIYCAWL 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1178 AGRAPDWAPLPVQ------YVDY---TLWQREilgdlddsdspiaaqLAYWENALAGMPERLRLPTARPYPPVADQRGAS 1248
Cdd:PRK10252 165 RGEPTPASPFTPFadvveeYQRYrasEAWQRD---------------AAFWAEQRRQLPPPASLSPAPLPGRSASADILR 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1249 LVVDWPASVQQQVRRIARQHNATSfmVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDP 1328
Cdd:PRK10252 230 LKLEFTDGAFRQLAAQASGVQRPD--LALALVALWLGRLCGRMDYAAGFIFMRRLGSAALTATGPVLNVLPLRVHIAAQE 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1329 SFAELLGQVRARSLAAYENQDVPFEVLV---DRLKPTRALtHHPLIQVMLAWQdnpvgQLNLGDLQATPMPIDTRTARmD 1405
Cdd:PRK10252 308 TLPELATRLAAQLKKMRRHQRYDAEQIVrdsGRAAGDEPL-FGPVLNIKVFDY-----QLDFPGVQAQTHTLATGPVN-D 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1406 LVFSLAerfseGSEPAGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARLDEWGNRAVlt 1485
Cdd:PRK10252 381 LELALF-----PDEHGGLSIEILANPQRYDEATLIAHAERLKALIAQFAADPALLCGDVDILLPGEYAQLAQVNATAV-- 453
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1486 aPAPtPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKT 1565
Cdd:PRK10252 454 -EIP-ETTLSALVAQQAAKTPDAPALADARYQFSYREMREQVVALANLLRERGVKPGDSVAVALPRSVFLTLALHAIVEA 531
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1566 GAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLRSRLAGHDLPIIDVVDALAAYPGTPP-PMPAAVNLAYILYTSGTTG 1644
Cdd:PRK10252 532 GAAWLPLDTGYPDDRLKMMLEDARPSLLITTADQLPRFADVPDLTSLCYNAPLAPQGAAPlQLSQPHHTAYIIFTSGSTG 611
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1645 EPKGVGITHRN-VTRLF---ASLParLSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEH 1720
Cdd:PRK10252 612 RPKGVMVGQTAiVNRLLwmqNHYP--LTADDVVLQKTPCSFDVSVWEFFWPFIAGAKLVMAEPEAHRDPLAMQQFFAEYG 689
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1721 VSVLTQTP----AAVAMLPTQGLESVALVVA-----GEACPAALVDRW-----APgrvMLNAYGPTEtticAAISAPLRP 1786
Cdd:PRK10252 690 VTTTHFVPsmlaAFVASLTPEGARQSCASLRqvfcsGEALPADLCREWqqltgAP---LHNLYGPTE----AAVDVSWYP 762
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1787 GSGMP---------PIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGgSGARMYRT 1857
Cdd:PRK10252 763 AFGEElaavrgssvPIGYPVWNTGLRILDARMRPVPPGVAGDLYLTGIQLAQGYLGRPDLTASRFIADPFA-PGERMYRT 841
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1858 GDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAR-----EDRPGD-KRLVGYATEIAPGAVD 1931
Cdd:PRK10252 842 GDVARWLDDGAVEYLGRSDDQLKIRGQRIELGEIDRAMQALPDVEQAVTHACvinqaAATGGDaRQLVGYLVSQSGLPLD 921
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1932 PAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAPEYGDTNGYRAPAGPVEKTVAGIFARVLGLERVGVDDS 2011
Cdd:PRK10252 922 TSALQAQLRERLPPHMVPVVLLQLDQLPLSANGKLDRKALPLPELKAQVPGRAPKTGTETIIAAAFSSLLGCDVVDADAD 1001
|
1050 1060 1070 1080 1090 1100
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 2012 FFELGGDSLAAMRVIAAINTTLNADLPVRALLHASSTRGLSQLLG----RDARPTSDPRLVSVHGDNPT 2076
Cdd:PRK10252 1002 FFALGGHSLLAMKLAAQLSRQFARQVTPGQVMVASTVAKLATLLDaeedESRRLGFGTILPLREGDGPT 1070
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1013-2052 |
8.72e-172 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 593.68 E-value: 8.72e-172
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1013 PLVAAQRPAAIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGyLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVI 1092
Cdd:PRK12467 2637 PVAVGDIEDIYPLSPMQQGMLFHTLYEGGAGDYINQMRVDVEG-LDVERFRTAWQAVIDRHEILRSGFLWDGELEEPLQV 2715
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1093 EARRADLGCDIVDATAWP--ADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLS 1170
Cdd:PRK12467 2716 VYKQARLPFSRLDWRDRAdlEQALDALAAADRQQGFDLLSAPLLRLTLVRTGEDRHHLIYTNHHILMDGWSGSQLLGEVL 2795
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1171 AAYAsrcaGRAPdwAPLPVQYVDYTLW-QREilgdlddsdsPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRG-AS 1248
Cdd:PRK12467 2796 QRYF----GQPP--PAREGRYRDYIAWlQAQ----------DAEASEAFWKEQLAALEEPTRLARALYPAPAEAVAGhGA 2859
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1249 LVVDWPASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRsdPA----LDNLVGFFVNTLVLRVNL 1324
Cdd:PRK12467 2860 HYLHLDATQTRQLIEFARRHRVTLNTLVQGAWLLLLQRFTGQDTVCFGATVAGR--PAqlrgAEQQLGLFINTLPVIASP 2937
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1325 AGDPSFAELLGQVRARSLAAYENQDVP-FEVLVDRLKPTRALthhplIQVMLAWQDNPVGQlNLGDLQATPMPIDTRTAR 1403
Cdd:PRK12467 2938 RAEQTVSDWLQQVQAQNLALREFEHTPlADIQRWAGQGGEAL-----FDSILVFENYPISE-ALKQGAPSGLRFGAVSSR 3011
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1404 ------MDLVFSLAERFSegsepagiggaVEYRTD--VFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARL 1475
Cdd:PRK12467 3012 eqtnypLTLAVGLGDTLE-----------LEFSYDrqHFDAAAIERLAESFDRLLQAMLNNPAARLGELPTLAAHERRQV 3080
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1476 DEWGNRAVLTAPAPTPVSipQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPA 1555
Cdd:PRK12467 3081 LHAWNATAAAYPSERLVH--QLIEAQVARTPEAPALVFGDQQLSYAELNRRANRLAHRLIAIGVGPDVLVGVAVERSVEM 3158
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1556 VVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLRSRL--AGHDLPIIDVVDALAAYP-GTPPPMPAAVN 1632
Cdd:PRK12467 3159 IVALLAVLKAGGAYVPLDPEYPRERLAYMIEDSGVKLLLTQAHLLEQLpaPAGDTALTLDRLDLNGYSeNNPSTRVMGEN 3238
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1633 LAYILYTSGTTGEPKGVGITHRNVTRLFASLPA--RLSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAaSPN 1710
Cdd:PRK12467 3239 LAYVIYTSGSTGKPKGVGVRHGALANHLCWIAEayELDANDRVLLFMSFSFDGAQERFLWTLICGGCLVVRDNDLW-DPE 3317
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1711 DFHGLLVAEHVSVLTQTPAAV-AMLPTQGLESVA----LVVAGEACPAA---LVDRWAPGRVMLNAYGPTETTICA---A 1779
Cdd:PRK12467 3318 ELWQAIHAHRISIACFPPAYLqQFAEDAGGADCAsldiYVFGGEAVPPAafeQVKRKLKPRGLTNGYGPTEAVVTVtlwK 3397
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1780 ISAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMYRTGD 1859
Cdd:PRK12467 3398 CGGDAVCEAPYAPIGRPVAGRSIYVLDGQLNPVPVGVAGELYIGGVGLARGYHQRPSLTAERFVADPFSGSGGRLYRTGD 3477
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1860 LVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAReDRPGDKRLVGYATEIAPGAVDPAGLRAQL 1939
Cdd:PRK12467 3478 LARYRADGVIEYLGRIDHQVKIRGFRIELGEIEARLLQHPSVREAVVLAR-DGAGGKQLVAYVVPADPQGDWRETLRDHL 3556
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1940 AQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAPEYGDTNGYRAPAGPVEKTVAGIFARVLGLERVGVDDSFFELGGDS 2019
Cdd:PRK12467 3557 AASLPDYMVPAQLLVLAAMPLGPNGKVDRKALPDPDAKGSREYVAPRSEVEQQLAAIWADVLGVEQVGVTDNFFELGGDS 3636
|
1050 1060 1070
....*....|....*....|....*....|...
gi 489495878 2020 LAAMRVIAAINTTLNADLPVRALLHASSTRGLS 2052
Cdd:PRK12467 3637 LLALQVLSRIRQSLGLKLSLRDLMSAPTIAELA 3669
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1013-2055 |
2.89e-171 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 592.70 E-value: 2.89e-171
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1013 PLVAAQRPAAIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGyLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVI 1092
Cdd:PRK12316 4093 PLPLGEIEDIYPLSPMQQGMLFHSLYEQEAGDYINQMRVDVQG-LDVERFRAAWQAALDRHDVLRSGFVWQGELGRPLQV 4171
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1093 EARRADLGCDIVDATAWPadRLQRAIEEAA----RHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTAD 1168
Cdd:PRK12316 4172 VHKQVSLPFAELDWRGRA--DLQAALDALAaaerERGFDLQRAPLLRLVLVRTAEGRHHLIYTNHHILMDGWSNSQLLGE 4249
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1169 LSAAYAsrcaGRAPdwAPLPVQYVDYTLWqreilgdLDDSDSpiAAQLAYWENALAGMPERLRLPTARPYPPVADQRG-A 1247
Cdd:PRK12316 4250 VLERYS----GRPP--AQPGGRYRDYIAW-------LQRQDA--AASEAFWREQLAALDEPTRLAQAIARADLRSANGyG 4314
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1248 SLVVDWPASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSD--PALDNLVGFFVNTLVLRVNLA 1325
Cdd:PRK12316 4315 EHVRELDATATARLREFARTQRVTLNTLVQAAWLLLLQRYTGQDTVAFGATVAGRPAelPGIEGQIGLFINTLPVIATPR 4394
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1326 GDPSFAELLGQVRARSLAAYENQDVPFEvlvdRLKPTRALTHHPLIQVMLAWQDNPVGQLnlgdLQatpmpidtRTARMD 1405
Cdd:PRK12316 4395 AQQSVVEWLQQVQRQNLALREHEHTPLY----EIQRWAGQGGEALFDSLLVFENYPVSEA----LQ--------QGAPGG 4458
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1406 LVFSLAERFSEGSEP----AGIGGAVE----YRTDVFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARLDE 1477
Cdd:PRK12316 4459 LRFGEVTNHEQTNYPltlaVGLGETLSlqfsYDRGHFDAATIERLARHLTNLLEAMAEDPQRRLGELQLLEKAEQQRIVA 4538
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1478 WGNRAvlTAPAPTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVV 1557
Cdd:PRK12316 4539 LWNRT--DAGYPATRCVHQLVAERARMTPDAVAVVFDEEKLTYAELNRRANRLAHALIARGVGPEVLVGIAMERSAEMMV 4616
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1558 AMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLRSRL---AGHDLPIIDVVDALAAYPGTPPPMPAAV-NL 1633
Cdd:PRK12316 4617 GLLAVLKAGGAYVPLDPEYPRERLAYMMEDSGAALLLTQSHLLQRLpipDGLASLALDRDEDWEGFPAHDPAVRLHPdNL 4696
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1634 AYILYTSGTTGEPKGVGITHRNVTRLFASLPAR--LSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESvAASPND 1711
Cdd:PRK12316 4697 AYVIYTSGSTGRPKGVAVSHGSLVNHLHATGERyeLTPDDRVLQFMSFSFDGSHEGLYHPLINGASVVIRDDS-LWDPER 4775
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1712 FHGLLVAEHVSVLTQTPAAVAML---PTQGLESVALVVA---GEACPAALVDRW---APGRVMLNAYGPTETTI---CAA 1779
Cdd:PRK12316 4776 LYAEIHEHRVTVLVFPPVYLQQLaehAERDGEPPSLRVYcfgGEAVAQASYDLAwraLKPVYLFNGYGPTETTVtvlLWK 4855
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1780 ISAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMYRTGD 1859
Cdd:PRK12316 4856 ARDGDACGAAYMPIGTPLGNRSGYVLDGQLNPLPVGVAGELYLGGEGVARGYLERPALTAERFVPDPFGAPGGRLYRTGD 4935
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1860 LVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDrPGDKRLVGY----ATEIAPGAVDPAGL 1935
Cdd:PRK12316 4936 LARYRADGVIDYLGRVDHQVKIRGFRIELGEIEARLREHPAVREAVVIAQEG-AVGKQLVGYvvpqDPALADADEAQAEL 5014
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1936 RAQ----LAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAPEYG-DTNGYRAPAGPVEKTVAGIFARVLGLERVGVDD 2010
Cdd:PRK12316 5015 RDElkaaLRERLPEYMVPAHLVFLARMPLTPNGKLDRKALPQPDASlLQQAYVAPRSELEQQVAAIWAEVLQLERVGLDD 5094
|
1050 1060 1070 1080
....*....|....*....|....*....|....*....|....*
gi 489495878 2011 SFFELGGDSLAAMRVIAAINTTLNADLPVRALLHASSTRGLSQLL 2055
Cdd:PRK12316 5095 NFFELGGHSLLAIQVTSRIQLELGLELPLRELFQTPTLAAFVELA 5139
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
1506-1971 |
2.50e-165 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 517.47 E-value: 2.50e-165
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML 1585
Cdd:cd05930 1 PDAVAVVDGDQSLTYAELDARANRLARYLRERGVGPGDLVAVLLERSLEMVVAILAVLKAGAAYVPLDPSYPAERLAYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1586 GDAVPVAAVTTAGlrsrlaghdlpiidvvdalaaypgtpppmpaavNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPA 1665
Cdd:cd05930 81 EDSGAKLVLTDPD---------------------------------DLAYVIYTSGSTGKPKGVMVEHRGLVNLLLWMQE 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1666 R--LSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVA 1743
Cdd:cd05930 128 AypLTPGDRVLQFTSFSFDVSVWEIFGALLAGATLVVLPEEVRKDPEALADLLAEEGITVLHLTPSLLRLLLQELELAAL 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1744 -----LVVAGEACPAALVDRWA---PGRVMLNAYGPTETTICAAI--SAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVP 1813
Cdd:cd05930 208 pslrlVLVGGEALPPDLVRRWRellPGARLVNLYGPTEATVDATYyrVPPDDEEDGRVPIGRPIPNTRVYVLDENLRPVP 287
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1814 AGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGsGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVAT 1893
Cdd:cd05930 288 PGVPGELYIGGAGLARGYLNRPELTAERFVPNPFGP-GERMYRTGDLVRWLPDGNLEFLGRIDDQVKIRGYRIELGEIEA 366
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1894 ALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05930 367 ALLAHPGVREAAVVAREDGDGEKRLVAYVVPDEGGELDEEELRAHLAERLPDYMVPSAFVVLDALPLTPNGKVDRKAL 444
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1013-2075 |
2.16e-159 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 554.95 E-value: 2.16e-159
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1013 PLVAAQRPAAIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGyLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVI 1092
Cdd:PRK12316 1547 PLPAGEIADIYPLSPMQQGMLFHSLYEQEAGDYINQLRVDVQG-LDPDRFRAAWQATVDRHEILRSGFLWQDGLEQPLQV 1625
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1093 EARRADLGCDIVDATAWP--ADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLS 1170
Cdd:PRK12316 1626 IHKQVELPFAELDWRGREdlGQALDALAQAERQKGFDLTRAPLLRLVLVRTGEGRHHLIYTNHHILMDGWSNAQLLGEVL 1705
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1171 AAYAsrcaGRAPdwAPLPVQYVDYTLWqreilgdLDDSDSpiAAQLAYWENALAG--MPERLRLPTARPYPPVAdqrGAS 1248
Cdd:PRK12316 1706 QRYA----GQPV--AAPGGRYRDYIAW-------LQRQDA--AASEAFWKEQLAAleEPTRLAQAARTEDGQVG---YGD 1767
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1249 LVVDWPASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSD--PALDNLVGFFVNTLVLRVNLAG 1326
Cdd:PRK12316 1768 HQQLLDPAQTRALAEFARAQKVTLNTLVQAAWLLLLQRYTGQETVAFGATVAGRPAelPGIEQQIGLFINTLPVIAAPRP 1847
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1327 DPSFAELLGQVRARSLAAYENQDVP-FEVlvdrlKPTRALTHHPLIQVMLAWQDNPVGQ-LNLGdlqatpmpidtrtARM 1404
Cdd:PRK12316 1848 DQSVADWLQEVQALNLALREHEHTPlYDI-----QRWAGQGGEALFDSLLVFENYPVAEaLKQG-------------APA 1909
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1405 DLVFSLAERFSEGSEPAGIGG------AVEYRTD--VFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARLD 1476
Cdd:PRK12316 1910 GLVFGRVSNHEQTNYPLTLAVtlgetlSLQYSYDrgHFDAAAIERLDRHLLHLLEQMAEDAQAALGELALLDAGERQRIL 1989
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1477 EWGNRAvlTAPAPTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAV 1556
Cdd:PRK12316 1990 ADWDRT--PEAYPRGPGVHQRIAEQAARAPEAIAVVFGDQHLSYAELDSRANRLAHRLRARGVGPEVRVAIAAERSFELV 2067
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1557 VAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLRSRL---AGHDLPIIDVVDALAAYPGT-PPPMPAAVN 1632
Cdd:PRK12316 2068 VALLAVLKAGGAYVPLDPNYPAERLAYMLEDSGAALLLTQRHLLERLplpAGVARLPLDRDAEWADYPDTaPAVQLAGEN 2147
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1633 LAYILYTSGTTGEPKGVGITHrnvTRLFASLPA-----RLSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVI------V 1701
Cdd:PRK12316 2148 LAYVIYTSGSTGLPKGVAVSH---GALVAHCQAageryELSPADCELQFMSFSFDGAHEQWFHPLLNGARVLIrddelwD 2224
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1702 PESVAASPNDfHGLLVAEHVSVLTQTPAAVAMLPTQGLESVALVVAGEACPAALVDRWA---PGRVMLNAYGPTETTICA 1778
Cdd:PRK12316 2225 PEQLYDEMER-HGVTILDFPPVYLQQLAEHAERDGRPPAVRVYCFGGEAVPAASLRLAWealRPVYLFNGYGPTEAVVTP 2303
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1779 AI--SAPLRP-GSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMY 1855
Cdd:PRK12316 2304 LLwkCRPQDPcGAAYVPIGRALGNRRAYILDADLNLLAPGMAGELYLGGEGLARGYLNRPGLTAERFVPDPFSASGERLY 2383
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1856 RTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAReDRPGDKRLVGYATEIAPGAVDPAGL 1935
Cdd:PRK12316 2384 RTGDLARYRADGVVEYLGRIDHQVKIRGFRIELGEIEARLQAHPAVREAVVVAQ-DGASGKQLVAYVVPDDAAEDLLAEL 2462
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1936 RAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAPEYGDT-NGYRAPAGPVEKTVAGIFARVLGLERVGVDDSFFE 2014
Cdd:PRK12316 2463 RAWLAARLPAYMVPAHWVVLERLPLNPNGKLDRKALPKPDVSQLrQAYVAPQEGLEQRLAAIWQAVLKVEQVGLDDHFFE 2542
|
1050 1060 1070 1080 1090 1100
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 489495878 2015 LGGDSLAAMRVIAAINTTLNADLPVRALLHASSTRGLSQLLGRDARPTSdPRLVSVHGDNP 2075
Cdd:PRK12316 2543 LGGHSLLATQVVSRVRQDLGLEVPLRILFERPTLAAFAASLESGQTSRA-PVLQKVTRVQP 2602
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
1496-1971 |
2.16e-156 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 493.64 E-value: 2.16e-156
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1496 QMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPA 1575
Cdd:cd12117 1 ELFEEQAARTPDAVAVVYGDRSLTYAELNERANRLARRLRAAGVGPGDVVGVLAERSPELVVALLAVLKAGAAYVPLDPE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1576 NPPPRVAFMLGDAVPVAAVTTAGLRSRLAGhDLPIIDVVDALAAYPGTPPPMPA-AVNLAYILYTSGTTGEPKGVGITHR 1654
Cdd:cd12117 81 LPAERLAFMLADAGAKVLLTDRSLAGRAGG-LEVAVVIDEALDAGPAGNPAVPVsPDDLAYVMYTSGSTGRPKGVAVTHR 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1655 NVTRLFASLP-ARLSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAM 1733
Cdd:cd12117 160 GVVRLVKNTNyVTLGPDDRVLQTSPLAFDASTFEIWGALLNGARLVLAPKGTLLDPDALGALIAEEGVTVLWLTAALFNQ 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1734 LPTQGLESVA----LVVAGEACPAALVDRW---APGRVMLNAYGPTETTICAA--ISAPLRPGSGMPPIGVPVSGAALFV 1804
Cdd:cd12117 240 LADEDPECFAglreLLTGGEVVSPPHVRRVlaaCPGLRLVNGYGPTENTTFTTshVVTELDEVAGSIPIGRPIANTRVYV 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1805 LDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGsGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGY 1884
Cdd:cd12117 320 LDEDGRPVPPGVPGELYVGGDGLALGYLNRPALTAERFVADPFGP-GERLYRTGDLARWLPDGRLEFLGRIDDQVKIRGF 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1885 RIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATeiAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNG 1964
Cdd:cd12117 399 RIELGEIEAALRAHPGVREAVVVVREDAGGDKRLVAYVV--AEGALDAAELRAFLRERLPAYMVPAAFVVLDELPLTANG 476
|
....*..
gi 489495878 1965 KLDHRAL 1971
Cdd:cd12117 477 KVDRRAL 483
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
1506-1971 |
6.22e-155 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 487.97 E-value: 6.22e-155
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML 1585
Cdd:cd17643 1 PEAVAVVDEDRRLTYGELDARANRLARTLRAEGVGPGDRVALALPRSAELIVALLAILKAGGAYVPIDPAYPVERIAFIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1586 GDAVPVAAVTTAGlrsrlaghdlpiidvvdalaaypgtpppmpaavNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPA 1665
Cdd:cd17643 81 ADSGPSLLLTDPD---------------------------------DLAYVIYTSGSTGRPKGVVVSHANVLALFAATQR 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1666 --RLSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAA------VAMLPTQ 1737
Cdd:cd17643 128 wfGFNEDDVWTLFHSYAFDFSVWEIWGALLHGGRLVVVPYEVARSPEDFARLLRDEGVTVLNQTPSAfyqlveAADRDGR 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1738 GLESVALVV-AGEACPAALVDRWA-----PGRVMLNAYGPTETTICA---AISAPLRPGSGMPPIGVPVSGAALFVLDSW 1808
Cdd:cd17643 208 DPLALRYVIfGGEALEAAMLRPWAgrfglDRPQLVNMYGITETTVHVtfrPLDAADLPAAAASPIGRPLPGLRVYVLDAD 287
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1809 LRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIEL 1888
Cdd:cd17643 288 GRPVPPGVVGELYVSGAGVARGYLGRPELTAERFVANPFGGPGSRMYRTGDLARRLPDGELEYLGRADEQVKIRGFRIEL 367
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1889 GEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDH 1968
Cdd:cd17643 368 GEIEAALATHPSVRDAAVIVREDEPGDTRLVAYVVADDGAAADIAELRALLKELLPDYMVPARYVPLDALPLTVNGKLDR 447
|
...
gi 489495878 1969 RAL 1971
Cdd:cd17643 448 AAL 450
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
1506-1971 |
1.44e-146 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 465.23 E-value: 1.44e-146
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML 1585
Cdd:cd12116 1 PDATAVRDDDRSLSYAELDERANRLAARLRARGVGPGDRVAVYLPRSARLVAAMLAVLKAGAAYVPLDPDYPADRLRYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1586 GDAVPVAAVTTAGLRSRLAGHDLPIIDVVDALAAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPA 1665
Cdd:cd12116 81 EDAEPALVLTDDALPDRLPAGLPVLLLALAAAAAAPAAPRTPVSPDDLAYVIYTSGSTGRPKGVVVSHRNLVNFLHSMRE 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1666 RLS--AAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPT---QGLE 1740
Cdd:cd12116 161 RLGlgPGDRLLAVTTYAFDISLLELLLPLLAGARVVIAPRETQRDPEALARLIEAHSITVMQATPATWRMLLDagwQGRA 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1741 SVALVVAGEACPAALVDRW-APGRVMLNAYGPTETTICAAIsAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGE 1819
Cdd:cd12116 241 GLTALCGGEALPPDLAARLlSRVGSLWNLYGPTETTIWSTA-ARVTAAAGPIPIGRPLANTQVYVLDAALRPVPPGVPGE 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1820 LYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELA 1899
Cdd:cd12116 320 LYIGGDGVAQGYLGRPALTAERFVPDPFAGPGSRLYRTGDLVRRRADGRLEYLGRADGQVKIRGHRIELGEIEAALAAHP 399
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 1900 GVGQAVVIAREDRpGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd12116 400 GVAQAAVVVREDG-GDRRLVAYVVLKAGAAPDAAALRAHLRATLPAYMVPSAFVRLDALPLTANGKLDRKAL 470
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
1498-1972 |
3.46e-146 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 464.89 E-value: 3.46e-146
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1498 LAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANP 1577
Cdd:cd17651 1 FERQAARTPDAPALVAEGRRLTYAELDRRANRLAHRLRARGVGPGDLVALCARRSAELVVALLAILKAGAAYVPLDPAYP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1578 PPRVAFMLGDAVPVAAVTTAGLRSRLAGHDLPIIDVVDALAAYPGTPPPMPA--AVNLAYILYTSGTTGEPKGVGITHRN 1655
Cdd:cd17651 81 AERLAFMLADAGPVLVLTHPALAGELAVELVAVTLLDQPGAAAGADAEPDPAldADDLAYVIYTSGSTGRPKGVVMPHRS 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1656 VTRLFASLPARLSAAQ--VWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVS-VLTQTPAAVA 1732
Cdd:cd17651 161 LANLVAWQARASSLGPgaRTLQFAGLGFDVSVQEIFSTLCAGATLVLPPEEVRTDPPALAAWLDEQRISrVFLPTVALRA 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1733 MLPTQGLESVA------LVVAGEACP-AALVDRWA---PGRVMLNAYGPTETTICAAISAPLRPGSGM--PPIGVPVSGA 1800
Cdd:cd17651 241 LAEHGRPLGVRlaalryLLTGGEQLVlTEDLREFCaglPGLRLHNHYGPTETHVVTALSLPGDPAAWPapPPIGRPIDNT 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1801 ALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGsGARMYRTGDLVCWRADGQLEFLGRTDDQVK 1880
Cdd:cd17651 321 RVYVLDAALRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPDPFVP-GARMYRTGDLARWLPDGELEFLGRADDQVK 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1881 IRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPL 1960
Cdd:cd17651 400 IRGFRIELGEIEAALARHPGVREAVVLAREDRPGEKRLVAYVVGDPEAPVDAAELRAALATHLPEYMVPSAFVLLDALPL 479
|
490
....*....|..
gi 489495878 1961 TVNGKLDHRALP 1972
Cdd:cd17651 480 TPNGKLDRRALP 491
|
|
| AA-adenyl-dom |
TIGR01733 |
amino acid adenylation domain; This model represents a domain responsible for the specific ... |
1519-1906 |
6.06e-146 |
|
amino acid adenylation domain; This model represents a domain responsible for the specific recognition of amino acids and activation as adenylyl amino acids. The reaction catalyzed is aa + ATP -> aa-AMP + PPi. These domains are usually found as components of multi-domain non-ribosomal peptide synthetases and are usually called "A-domains" in that context. A-domains are almost invariably followed by "T-domains" (thiolation domains, pfam00550) to which the amino acid adenylate is transferred as a thiol-ester to a bound pantetheine cofactor with the release of AMP (these are also called peptide carrier proteins, or PCPs. When the A-domain does not represent the first module (corresponding to the first amino acid in the product molecule) it is usually preceded by a "C-domain" (condensation domain, pfam00668) which catalyzes the ligation of two amino acid thiol-esters from neighboring modules. This domain is a subset of the AMP-binding domain found in Pfam (pfam00501) which also hits substrate--CoA ligases and luciferases. Sequences scoring in between trusted and noise for this model may be ambiguous as to whether they activate amino acids or other molecules lacking an alpha amino group.
Pssm-ID: 273779 [Multi-domain] Cd Length: 409 Bit Score: 460.58 E-value: 6.06e-146
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRL-AGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTA 1597
Cdd:TIGR01733 1 TYRELDERANRLARHLrAAGGVGPGDRVAVLLERSAELVVAILAVLKAGAAYVPLDPAYPAERLAFILEDAGARLLLTDS 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1598 GLRSRLAGHDLPIIDVVDAL------AAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPAR--LSA 1669
Cdd:TIGR01733 81 ALASRLAGLVLPVILLDPLElaalddAPAPPPPDAPSGPDDLAYVIYTSGSTGRPKGVVVTHRSLVNLLAWLARRygLDP 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1670 AQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEH-VSVLTQTPAAVAMLPTQGLESVA----L 1744
Cdd:TIGR01733 161 DDRVLQFASLSFDASVEEIFGALLAGATLVVPPEDEERDDAALLAALIAEHpVTVLNLTPSLLALLAAALPPALAslrlV 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1745 VVAGEACPAALVDRWA---PGRVMLNAYGPTETTICAA---ISAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAG 1818
Cdd:TIGR01733 241 ILGGEALTPALVDRWRargPGARLINLYGPTETTVWSTatlVDPDDAPRESPVPIGRPLANTRLYVLDDDLRPVPVGVVG 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1819 ELYIAGAGVGVGYWRRAGLTASRFVACPF-GGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAE 1897
Cdd:TIGR01733 321 ELYIGGPGVARGYLNRPELTAERFVPDPFaGGDGARLYRTGDLVRYLPDGNLEFLGRIDDQVKIRGYRIELGEIEAALLR 400
|
....*....
gi 489495878 1898 LAGVGQAVV 1906
Cdd:TIGR01733 401 HPGVREAVV 409
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
1495-1971 |
1.85e-141 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 451.34 E-value: 1.85e-141
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1495 PQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDP 1574
Cdd:cd17646 1 HALVAEQAARTPDAPAVVDEGRTLTYRELDERANRLAHLLRARGVGPEDRVAVLLPRSADLVVALLAVLKAGAAYLPLDP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1575 ANPPPRVAFMLGDAVPVAAVTTAGLRSRLAGHDLPIIDVVDALAAYPGTPP-PMPAAVNLAYILYTSGTTGEPKGVGITH 1653
Cdd:cd17646 81 GYPADRLAYMLADAGPAVVLTTADLAARLPAGGDVALLGDEALAAPPATPPlVPPRPDNLAYVIYTSGSTGRPKGVMVTH 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1654 RNVTRLFASLPAR--LSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTP--- 1728
Cdd:cd17646 161 AGIVNRLLWMQDEypLGPGDRVLQKTPLSFDVSVWELFWPLVAGARLVVARPGGHRDPAYLAALIREHGVTTCHFVPsml 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1729 -AAVAMLPTQGLESVALVV-AGEACPAALVDRWA--PGRVMLNAYGPTETTIcAAISAPLRPGSGMP--PIGVPVSGAAL 1802
Cdd:cd17646 241 rVFLAEPAAGSCASLRRVFcSGEALPPELAARFLalPGAELHNLYGPTEAAI-DVTHWPVRGPAETPsvPIGRPVPNTRL 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1803 FVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFgGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIR 1882
Cdd:cd17646 320 YVLDDALRPVPVGVPGELYLGGVQLARGYLGRPALTAERFVPDPF-GPGSRMYRTGDLARWRPDGALEFLGRSDDQVKIR 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1883 GYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGA-VDPAGLRAQLAQRLPGYLVPAAVVVIDALPLT 1961
Cdd:cd17646 399 GFRVEPGEIEAALAAHPAVTHAVVVARAAPAGAARLVGYVVPAAGAAgPDTAALRAHLAERLPEYMVPAAFVVLDALPLT 478
|
490
....*....|
gi 489495878 1962 VNGKLDHRAL 1971
Cdd:cd17646 479 ANGKLDRAAL 488
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
1496-1975 |
1.02e-134 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 432.14 E-value: 1.02e-134
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1496 QMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPA 1575
Cdd:cd17655 1 ELFEEQAEKTPDHTAVVFEDQTLTYRELNERANQLARTLREKGVGPDTIVGIMAERSLEMIVGILGILKAGGAYLPIDPD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1576 NPPPRVAFMLGDAVPVAAVTTAGLRSRLAGHDLPIIDVVDALAAYPGTP-PPMPAAVNLAYILYTSGTTGEPKGVGITHR 1654
Cdd:cd17655 81 YPEERIQYILEDSGADILLTQSHLQPPIAFIGLIDLLDEDTIYHEESENlEPVSKSDDLAYVIYTSGSTGKPKGVMIEHR 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1655 NVTRLFASLPARLSAAQV--WSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVA 1732
Cdd:cd17655 161 GVVNLVEWANKVIYQGEHlrVALFASISFDASVTEIFASLLSGNTLYIVRKETVLDGQALTQYIRQNRITIIDLTPAHLK 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1733 MLP----TQGLESVALVVAGEACPAALVDRW----APGRVMLNAYGPTETTICAAI--SAPLRPGSGMPPIGVPVSGAAL 1802
Cdd:cd17655 241 LLDaaddSEGLSLKHLIVGGEALSTELAKKIielfGTNPTITNAYGPTETTVDASIyqYEPETDQQVSVPIGKPLGNTRI 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1803 FVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGgSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIR 1882
Cdd:cd17655 321 YILDQYGRPQPVGVAGELYIGGEGVARGYLNRPELTAEKFVDDPFV-PGERMYRTGDLARWLPDGNIEFLGRIDHQVKIR 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1883 GYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPgaVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTV 1962
Cdd:cd17655 400 GYRIELGEIEARLLQHPDIKEAVVIARKDEQGQNYLCAYIVSEKE--LPVAQLREFLARELPDYMIPSYFIKLDEIPLTP 477
|
490
....*....|...
gi 489495878 1963 NGKLDHRALPAPE 1975
Cdd:cd17655 478 NGKVDRKALPEPD 490
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1013-2055 |
6.17e-133 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 470.03 E-value: 6.17e-133
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1013 PLVAAQRPAAIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVI 1092
Cdd:PRK05691 3248 PVPAAEIEDVYPLTPMQEGLLLHTLLEPGTGLYYMQDRYRINSALDPERFAQAWQAVVARHEALRASFSWNAGETMLQVI 3327
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1093 EaRRADLGCDIVDATAWPAD----RLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTAD 1168
Cdd:PRK05691 3328 H-KPGRTPIDYLDWRGLPEDgqeqRLQALHKQEREAGFDLLNQPPFHLRLIRVDEARYWFMMSNHHILIDAWCRSLLMND 3406
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1169 LSAAYASRCAGRAPDWAPLPvQYVDYTLW-QREilgDLDDSDspiaaqlAYWENALAGMPERLRLPTARPY-PPVADQRG 1246
Cdd:PRK05691 3407 FFEIYTALGEGREAQLPVPP-RYRDYIGWlQRQ---DLAQAR-------QWWQDNLRGFERPTPIPSDRPFlREHAGDSG 3475
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1247 ASLVVD----WPASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGR--SDPALDNLVGFFVNTLVL 1320
Cdd:PRK05691 3476 GMVVGDcytrLDAADGARLRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAGRpvSMPQMQRTVGLFINSIAL 3555
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1321 RVNLAGDP---SFAELLGQVRARSLAAYENQDVPfevLVDRLKPTRALTHHPLIQVMLAWQDNPVGQLNLGDLQATPMPI 1397
Cdd:PRK05691 3556 RVQLPAAGqrcSVRQWLQGLLDSNMELREYEYLP---LVAIQECSELPKGQPLFDSLFVFENAPVEVSVLDRAQSLNASS 3632
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1398 DTrtARMDLVFSLAERFSEGSEpagIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARLDE 1477
Cdd:PRK05691 3633 DS--GRTHTNFPLTAVCYPGDD---LGLHLSYDQRYFDAPTVERLLGEFKRLLLALVQGFHGDLSELPLLGEQERDFLLD 3707
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1478 WGNRAvlTAPAPTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVV 1557
Cdd:PRK05691 3708 GCNRS--ERDYPLEQSYVRLFEAQVAAHPQRIAASCLDQQWSYAELNRAANRLGHALRAAGVGVDQPVALLAERGLDLLG 3785
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1558 AMVAVLKTGAAYLPIDPANPPPRVAFMLG-DAVPVAAVTTA------GLRSRLAGHDLPIIDV---VDALAAYPGTPPPM 1627
Cdd:PRK05691 3786 MIVGSFKAGAGYLPLDPGLPAQRLQRIIElSRTPVLVCSAAcreqarALLDELGCANRPRLLVweeVQAGEVASHNPGIY 3865
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1628 PAAVNLAYILYTSGTTGEPKGVGITHRN-VTRLFASLP-ARLSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESV 1705
Cdd:PRK05691 3866 SGPDNLAYVIYTSGSTGLPKGVMVEQRGmLNNQLSKVPyLALSEADVIAQTASQSFDISVWQFLAAPLFGARVEIVPNAI 3945
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1706 AASPNDFHGLLVAEHVSVLTQTPAAV-AML--PTQGLESVA-LVVAGEACPAALVDRWA---PGRVMLNAYGPTETTICA 1778
Cdd:PRK05691 3946 AHDPQGLLAHVQAQGITVLESVPSLIqGMLaeDRQALDGLRwMLPTGEAMPPELARQWLqryPQIGLVNAYGPAECSDDV 4025
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1779 A---ISAPLRPGSGMPpIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMY 1855
Cdd:PRK05691 4026 AffrVDLASTRGSYLP-IGSPTDNNRLYLLDEALELVPLGAVGELCVAGTGVGRGYVGDPLRTALAFVPHPFGAPGERLY 4104
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1856 RTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREdRPGDKRLVGYATEiAPGAVDPAGL 1935
Cdd:PRK05691 4105 RTGDLARRRSDGVLEYVGRIDHQVKIRGYRIELGEIEARLHEQAEVREAAVAVQE-GVNGKHLVGYLVP-HQTVLAQGAL 4182
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1936 RAQLAQR----LPGYLVPAAVVVIDALPLTVNGKLDHRALPAPEYGDTNG--YRAPAGPVEKTVAGIFARVLGLERVGVD 2009
Cdd:PRK05691 4183 LERIKQRlraeLPDYMVPLHWLWLDRLPLNANGKLDRKALPALDIGQLQSqaYLAPRNELEQTLATIWADVLKVERVGVH 4262
|
1050 1060 1070 1080
....*....|....*....|....*....|....*....|....*.
gi 489495878 2010 DSFFELGGDSLAAMRVIAAINTTLNADLPVRALLHASSTRGLSQLL 2055
Cdd:PRK05691 4263 DNFFELGGHSLLATQIASRVQKALQRNVPLRAMFECSTVEELAEYI 4308
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
1496-1971 |
4.29e-129 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 414.02 E-value: 4.29e-129
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1496 QMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPA 1575
Cdd:cd12115 3 DLVEAQAARTPDAIALVCGDESLTYAELNRRANRLAARLRAAGVGPESRVGVCLERTPDLVVALLAVLKAGAAYVPLDPA 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1576 NPPPRVAFMLGDAVPVAAVTTAGlrsrlaghdlpiidvvdalaaypgtpppmpaavNLAYILYTSGTTGEPKGVGITHRN 1655
Cdd:cd12115 83 YPPERLRFILEDAQARLVLTDPD---------------------------------DLAYVIYTSGSTGRPKGVAIEHRN 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1656 -VTRLFASlpARLSAAQVWSQ---CHSYGFDASAWEIWGALLGGGRLVIVpESVAASPNdfhgLLVAEHVSVLTQTPAAV 1731
Cdd:cd12115 130 aAAFLQWA--AAAFSAEELAGvlaSTSICFDLSVFELFGPLATGGKVVLA-DNVLALPD----LPAAAEVTLINTVPSAA 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1732 AMLPTQGL--ESVALV-VAGEACPAALVDRW---APGRVMLNAYGPTETTICAAISAPLRPGSGMPPIGVPVSGAALFVL 1805
Cdd:cd12115 203 AELLRHDAlpASVRVVnLAGEPLPRDLVQRLyarLQVERVVNLYGPSEDTTYSTVAPVPPGASGEVSIGRPLANTQAYVL 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1806 DSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGsGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYR 1885
Cdd:cd12115 283 DRALQPVPLGVPGELYIGGAGVARGYLGRPGLTAERFLPDPFGP-GARLYRTGDLVRWRPDGLLEFLGRADNQVKVRGFR 361
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1886 IELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGK 1965
Cdd:cd12115 362 IELGEIEAALRSIPGVREAVVVAIGDAAGERRLVAYIVAEPGAAGLVEDLRRHLGTRLPAYMVPSRFVRLDALPLTPNGK 441
|
....*.
gi 489495878 1966 LDHRAL 1971
Cdd:cd12115 442 IDRSAL 447
|
|
| Thioester-redct |
TIGR01746 |
thioester reductase domain; This model includes the terminal domain from the fungal alpha ... |
2109-2511 |
8.77e-122 |
|
thioester reductase domain; This model includes the terminal domain from the fungal alpha aminoadipate reductase enzyme (also known as aminoadipate semialdehyde dehydrogenase) which is involved in the biosynthesis of lysine, as well as the reductase-containing component of the myxochelin biosynthetic gene cluster, MxcG. The mechanism of reduction involves activation of the substrate by adenylation and transfer to a covalently-linked pantetheine cofactor as a thioester. This thioester is then reduced to give an aldehyde (thus releasing the product) and a regenerated pantetheine thiol. (In myxochelin biosynthesis this aldehyde is further reduced to an alcohol or converted to an amine by an aminotransferase.) This is a fundamentally different reaction than beta-ketoreductase domains of polyketide synthases which act at a carbonyl two carbons removed from the thioester and forms an alcohol as a product. This domain is invariably found at the C-terminus of the proteins which contain it (presumably because it results in the release of the product). The majority of hits to this model are non-ribosomal peptide synthetases in which this domain is similarly located proximal to a thiolation domain (pfam00550). In some cases this domain is found at the end of a polyketide synthetase enzyme, but is unlike ketoreductase domains which are found before the thiolase domains. Exceptions to this observed relationship with the thiolase domain include three proteins which consist of stand-alone reductase domains (GP|466833 from M. leprae, GP|435954 from Anabaena and OMNI|NTL02SC1199 from Strep. coelicolor) and one protein (OMNI|NTL01NS2636 from Nostoc) which contains N-terminal homology with a small group of hypothetical proteins but no evidence of a thiolation domain next to the putative reductase domain. Below the noise cutoff to this model are proteins containing more distantly related ketoreductase and dehydratase/epimerase domains. It has been suggested that a NADP-binding motif can be found in the N-terminal portion of this domain that may form a Rossman-type fold.
Pssm-ID: 273787 [Multi-domain] Cd Length: 367 Bit Score: 389.85 E-value: 8.77e-122
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2109 TVLLTGATGFLGRYLVLELLRRLdVDGRLICLVRAESDEDARRRLEKTFDSgdpELLRHFkELAADRLEVVAGDKSEPDL 2188
Cdd:TIGR01746 1 TVLLTGATGFLGAYLLEELLRRS-TRAKVICLVRADSEEHAMERLREALRS---YRLWHE-NLAMERIEVVAGDLSKPRL 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2189 GLDQPMWRRLAETVDLIVDSAAMVN-AFPYHELFGPNVAGTAELIRIALTTKLKPFTYVSTADVGAAIEPSAFtedadIR 2267
Cdd:TIGR01746 76 GLSDAEWERLAENVDTIVHNGALVNhVYPYSELRGANVLGTVEVLRLAASGRAKPLHYVSTISVGAAIDLSTG-----VT 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2268 VISPTRTVDGGWAGGYGTSKWAGEVLLREANDLcALPVAVFRCGMILADtSYAGQLNMSDWVTRMVLSLMATGIAprsfy 2347
Cdd:TIGR01746 151 EDDATVTPYPGLAGGYTQSKWVAELLVREASDR-GLPVTIVRPGRILGD-SYTGAWNSSDILWRMVKGCLALGAY----- 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2348 ePDSEGNrqraHFDGLPVTFVAEAIAVLGARVAGSslAGFATYHVMNPhdDGIGLDEYVDWLIEAGYPIrRIDDFAEWLQ 2427
Cdd:TIGR01746 224 -PQSPEL----TEDLTPVDFVARAIVALSSRPAAS--AGGIVFHVVNP--NPVPLDEFLEWLERAGYNL-RLVSFDEWLQ 293
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2428 RFEASLGALPDRqRRHSVLPMLLASNSQRLQPlkptrgcsaPTDRFRAAVRAAKVGSDKDNPDIPHVSAPTIINYVTNLQ 2507
Cdd:TIGR01746 294 RLEDSDTAKRDS-RRYPLLPLLHFTGDAFESD---------ETDTRNLDSRSTAEALEGDGIREPSITAPLLHLYLQYLK 363
|
....
gi 489495878 2508 LLGL 2511
Cdd:TIGR01746 364 EIGF 367
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
1500-1971 |
6.97e-118 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 381.27 E-value: 6.97e-118
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1500 AQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPP 1579
Cdd:cd17653 5 RIAAAHPDAVAVESLGGSLTYGELDAASNALANRLLQLGVVPGDVVPLLSDRSLEMLVAILAILKAGAAYVPLDAKLPSA 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1580 RVAFMLGDAVPVAAVTTAglrsrlAGHDlpiidvvdalaaypgtpppmpaavnLAYILYTSGTTGEPKGVGITHRNVTRL 1659
Cdd:cd17653 85 RIQAILRTSGATLLLTTD------SPDD-------------------------LAYIIFTSGSTGIPKGVMVPHRGVLNY 133
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1660 FASLPARLSA------AQVWsqchSYGFDASAWEIWGALLGGGRLVIvpesvAASPNDF-HgllVAEHVSVLTQTPAAVA 1732
Cdd:cd17653 134 VSQPPARLDVgpgsrvAQVL----SIAFDACIGEIFSTLCNGGTLVL-----ADPSDPFaH---VARTVDALMSTPSILS 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1733 MLPTQGLESVALV-VAGEACPAALVDRWAPGRVMLNAYGPTETTICAAISApLRPGSGMpPIGVPVSGAALFVLDSWLRP 1811
Cdd:cd17653 202 TLSPQDFPNLKTIfLGGEAVPPSLLDRWSPGRRLYNAYGPTECTISSTMTE-LLPGQPV-TIGKPIPNSTCYILDADLQP 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1812 VPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFgGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGE- 1890
Cdd:cd17653 280 VPEGVVGEICISGVQVARGYLGNPALTASKFVPDPF-WPGSRMYRTGDYGRWTEDGGLEFLGREDNQVKVRGFRINLEEi 358
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1891 VATALAELAGVGQAVVIAREDrpgdkRLVGYATeiaPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRA 1970
Cdd:cd17653 359 EEVVLQSQPEVTQAAAIVVNG-----RLVAFVT---PETVDVDGLRSELAKHLPSYAVPDRIIALDSFPLTANGKVDRKA 430
|
.
gi 489495878 1971 L 1971
Cdd:cd17653 431 L 431
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
1506-1972 |
1.12e-117 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 381.33 E-value: 1.12e-117
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML 1585
Cdd:cd17649 1 PDAVALVFGDQSLSYAELDARANRLAHRLRALGVGPEVRVGIALERSLEMVVALLAILKAGGAYVPLDPEYPAERLRYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1586 GDAvpvaavttaGLRSRLAGHdlpiidvvdalaaypgtpppmPAavNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPA 1665
Cdd:cd17649 81 EDS---------GAGLLLTHH---------------------PR--QLAYVIYTSGSTGTPKGVAVSHGPLAAHCQATAE 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1666 --RLSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPA--------AVAMLP 1735
Cdd:cd17649 129 ryGLTPGDRELQFASFNFDGAHEQLLPPLICGACVVLRPDELWASADELAEMVRELGVTVLDLPPAylqqlaeeADRTGD 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1736 TQGLESVALVVAGEACPAALVDRWAPGRVML-NAYGPTETTICAA---ISAPLRPGSGMPPIGVPVSGAALFVLDSWLRP 1811
Cdd:cd17649 209 GRPPSLRLYIFGGEALSPELLRRWLKAPVRLfNAYGPTEATVTPLvwkCEAGAARAGASMPIGRPLGGRSAYILDADLNP 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1812 VPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEV 1891
Cdd:cd17649 289 VPVGVTGELYIGGEGLARGYLGRPELTAERFVPDPFGAPGSRLYRTGDLARWRDDGVIEYLGRVDHQVKIRGFRIELGEI 368
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1892 ATALAELAGVGQAVVIAReDRPGDKRLVGY--ATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHR 1969
Cdd:cd17649 369 EAALLEHPGVREAAVVAL-DGAGGKQLVAYvvLRAAAAQPELRAQLRTALRASLPDYMVPAHLVFLARLPLTPNGKLDRK 447
|
...
gi 489495878 1970 ALP 1972
Cdd:cd17649 448 ALP 450
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
1506-1971 |
3.45e-117 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 379.89 E-value: 3.45e-117
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML 1585
Cdd:cd17650 1 PDAIAVSDATRQLTYRELNERANQLARTLRGLGVAPGSVVGVCADRSLDAIVGLLAVLKAGGAYVPIDPDYPAERLQYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1586 GDAvpvaavttaglrsrlaGHDLPIIDvvdalaayPGtpppmpaavNLAYILYTSGTTGEPKGVGITHRNVTRL------ 1659
Cdd:cd17650 81 EDS----------------GAKLLLTQ--------PE---------DLAYVIYTSGTTGKPKGVMVEHRNVAHAahawrr 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1660 ---FASLPARLSaaqvwsQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPA----AVA 1732
Cdd:cd17650 128 eyeLDSFPVRLL------QMASFSFDVFAGDFARSLLNGGTLVICPDEVKLDPAALYDLILKSRITLMESTPAlirpVMA 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1733 MLPTQGLESVA---LVVAGEACPAA----LVDRWAPGRVMLNAYGPTETTICAAI---SAPLRPGSGMPPIGVPVSGAAL 1802
Cdd:cd17650 202 YVYRNGLDLSAmrlLIVGSDGCKAQdfktLAARFGQGMRIINSYGVTEATIDSTYyeeGRDPLGDSANVPIGRPLPNTAM 281
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1803 FVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGgSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIR 1882
Cdd:cd17650 282 YVLDERLQPQPVGVAGELYIGGAGVARGYLNRPELTAERFVENPFA-PGERMYRTGDLARWRADGNVELLGRVDHQVKIR 360
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1883 GYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYAteIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTV 1962
Cdd:cd17650 361 GFRIELGEIESQLARHPAIDEAVVAVREDKGGEARLCAYV--VAAATLNTAELRAFLAKELPSYMIPSYYVQLDALPLTP 438
|
....*....
gi 489495878 1963 NGKLDHRAL 1971
Cdd:cd17650 439 NGKVDRRAL 447
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
1493-1972 |
1.05e-116 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 379.09 E-value: 1.05e-116
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1493 SIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPI 1572
Cdd:cd17644 1 CIHQLFEEQVERTPDAVAVVFEDQQLTYEELNTKANQLAHYLQSLGVKSESLVGICVERSLEMIIGLLAILKAGGAYVPL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1573 DPANPPPRVAFMLGDAVpvaavttaglrsrlaghdlpiidvVDALAAYPGtpppmpaavNLAYILYTSGTTGEPKGVGIT 1652
Cdd:cd17644 81 DPNYPQERLTYILEDAQ------------------------ISVLLTQPE---------NLAYVIYTSGSTGKPKGVMIE 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1653 HRNVTRLFASLPARL---SAAQVwSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPA 1729
Cdd:cd17644 128 HQSLVNLSHGLIKEYgitSSDRV-LQFASIAFDVAAEEIYVTLLSGATLVLRPEEMRSSLEDFVQYIQQWQLTVLSLPPA 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1730 AVAMLPTQGLESVA--------LVVAGEACPAALVDRWA----PGRVMLNAYGPTETTICAAISAPLRPGSGM---PPIG 1794
Cdd:cd17644 207 YWHLLVLELLLSTIdlpsslrlVIVGGEAVQPELVRQWQknvgNFIQLINVYGPTEATIAATVCRLTQLTERNitsVPIG 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1795 VPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGS-GARMYRTGDLVCWRADGQLEFLG 1873
Cdd:cd17644 287 RPIANTQVYILDENLQPVPVGVPGELHIGGVGLARGYLNRPELTAEKFISHPFNSSeSERLYKTGDLARYLPDGNIEYLG 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1874 RTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVV 1953
Cdd:cd17644 367 RIDNQVKIRGFRIELGEIEAVLSQHNDVKTAVVIVREDQPGNKRLVAYIVPHYEESPSTVELRQFLKAKLPDYMIPSAFV 446
|
490
....*....|....*....
gi 489495878 1954 VIDALPLTVNGKLDHRALP 1972
Cdd:cd17644 447 VLEELPLTPNGKIDRRALP 465
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
1506-1972 |
6.06e-109 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 356.32 E-value: 6.06e-109
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAG-PGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFM 1584
Cdd:cd17648 1 PDRVAVVYGDKRLTYRELNERANRLAHYLLSVAEIrPDDLVGLVLDKSELMIIAILAVWKAGAAYVPIDPSYPDERIQFI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1585 LGDAVPVAAVTTAglrsrlaghdlpiidvvdalaaypgtpppmpaaVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLP 1664
Cdd:cd17648 81 LEDTGARVVITNS---------------------------------TDLAYAIYTSGTTGKPKGVLVEHGSVVNLRTSLS 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1665 ARL----SAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLE 1740
Cdd:cd17648 128 ERYfgrdNGDEAVLFFSNYVFDFFVEQMTLALLNGQKLVVPPDEMRFDPDRFYAYINREKVTYLSGTPSVLQQYDLARLP 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1741 SVALV-VAGEACPAALVDRWA---PGRVmLNAYGPTETTICAAIsaplRPGSGMPP----IGVPVSGAALFVLDSWLRPV 1812
Cdd:cd17648 208 HLKRVdAAGEEFTAPVFEKLRsrfAGLI-INAYGPTETTVTNHK----RFFPGDQRfdksLGRPVRNTKCYVLNDAMKRV 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1813 PAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFG-------GSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYR 1885
Cdd:cd17648 283 PVGAVGELYLGGDGVARGYLNRPELTAERFLPNPFQteqerarGRNARLYKTGDLVRWLPSGELEYLGRNDFQVKIRGQR 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1886 IELGEVATALAELAGVGQAVVIARED-----RPGDKRLVGYATeIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPL 1960
Cdd:cd17648 363 IEPGEVEAALASYPGVRECAVVAKEDasqaqSRIQKYLVGYYL-PEPGHVPESDLLSFLRAKLPRYMVPARLVRLEGIPV 441
|
490
....*....|..
gi 489495878 1961 TVNGKLDHRALP 1972
Cdd:cd17648 442 TINGKLDVRALP 453
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
1494-1971 |
3.06e-105 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 346.84 E-value: 3.06e-105
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1494 IPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPID 1573
Cdd:cd05918 1 VHDLIEERARSQPDAPAVCAWDGSLTYAELDRLSSRLAHHLRSLGVGPGVFVPLCFEKSKWAVVAMLAVLKAGGAFVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1574 PANPPPRVAFMLGDavpvaavTTAGLrsrlaghdlpiidvvdALAAYPGtpppmpaavNLAYILYTSGTTGEPKGVGITH 1653
Cdd:cd05918 81 PSHPLQRLQEILQD-------TGAKV----------------VLTSSPS---------DAAYVIFTSGSTGKPKGVVIEH 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1654 RNV-TRLFASLPA-RLSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESvaASPNDFHGLLVAEHVSVLTQTPAAV 1731
Cdd:cd05918 129 RALsTSALAHGRAlGLTSESRVLQFASYTFDVSILEIFTTLAAGGCLCIPSEE--DRLNDLAGFINRLRVTWAFLTPSVA 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1732 AMLPTQGLESV-ALVVAGEACPAALVDRWAPGRVMLNAYGPTETTICAAISAPLRPGSGmPPIGVPVsGAALFVLD--SW 1808
Cdd:cd05918 207 RLLDPEDVPSLrTLVLGGEALTQSDVDTWADRVRLINAYGPAECTIAATVSPVVPSTDP-RNIGRPL-GATCWVVDpdNH 284
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1809 LRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPF------GGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIR 1882
Cdd:cd05918 285 DRLVPIGAVGELLIEGPILARGYLNDPEKTAAAFIEDPAwlkqegSGRGRRLYRTGDLVRYNPDGSLEYVGRKDTQVKIR 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1883 GYRIELGEVATALAE-LAGVGQAVV--IAREDRPGDKRLVG--YATEIAPGAVDP---------------AGLRAQLAQR 1942
Cdd:cd05918 365 GQRVELGEIEHHLRQsLPGAKEVVVevVKPKDGSSSPQLVAfvVLDGSSSGSGDGdslflepsdefralvAELRSKLRQR 444
|
490 500
....*....|....*....|....*....
gi 489495878 1943 LPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05918 445 LPSYMVPSVFLPLSHLPLTASGKIDRRAL 473
|
|
| X-Domain_NRPS |
cd19546 |
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to ... |
1019-1457 |
3.54e-104 |
|
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to the non-ribosomal peptide synthetase (NRPS); The X-domain is a catalytically inactive member of the Condensation (C) domain family of non-ribosomal peptide synthetase (NRPS). It has been shown to recruit oxygenases to the NRPS to perform side-chain crosslinking in the production of glycopeptide antibiotics. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as this X-domain, the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, and dual E/C (epimerization and condensation) domains. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity; members of this X-domain subfamily lack the second H of this motif.
Pssm-ID: 380468 [Multi-domain] Cd Length: 440 Bit Score: 342.15 E-value: 3.54e-104
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1019 RPAAIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRAD 1098
Cdd:cd19546 1 RPDEVPATAGQLRTWLLARLDEETRGRHLSVALRLRGRLDRDALEAALGDVAARHEILRTTFPGDGGDVHQRILDADAAR 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1099 LGCDIVDATAwpaDRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCA 1178
Cdd:cd19546 81 PELPVVPATE---EELPALLADRAAHLFDLTRETPWRCTLFALSDTEHVLLLVVHRIAADDESLDVLVRDLAAAYGARRE 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1179 GRAPDWAPLPVQYVDYTLWQREILGDLDDSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQ 1258
Cdd:cd19546 158 GRAPERAPLPLQFADYALWERELLAGEDDRDSLIGDQIAYWRDALAGAPDELELPTDRPRPVLPSRRAGAVPLRLDAEVH 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1259 QQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDP-ALDNLVGFFVNTLVLRVNLAGDPSFAELLGQV 1337
Cdd:cd19546 238 ARLMEAAESAGATMFTVVQAALAMLLTRLGAGTDVTVGTVLPRDDEEgDLEGMVGPFARPLALRTDLSGDPTFRELLGRV 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1338 RARSLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQLN---LGDLQATPMPIDTRTARMDLVFSLAERF 1414
Cdd:cd19546 318 REAVREARRHQDVPFERLAELLALPPSADRHPVFQVALDVRDDDNDPWDapeLPGLRTSPVPLGTEAMELDLSLALTERR 397
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 489495878 1415 SEGSEPAGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAP 1457
Cdd:cd19546 398 NDDGDPDGLDGSLRYAADLFDRATAAALARRLVRVLEQVAADP 440
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
1506-1971 |
2.13e-103 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 341.17 E-value: 2.13e-103
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML 1585
Cdd:cd12114 1 PDATAVICGDGTLTYGELAERARRVAGALKAAGVRPGDLVAVTLPKGPEQVVAVLGILAAGAAYVPVDIDQPAARREAIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1586 GDAVPVAAVTTAGLRSRLAGHDLPIIDVVDALAAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPA 1665
Cdd:cd12114 81 ADAGARLVLTDGPDAQLDVAVFDVLILDLDALAAPAPPPPVDVAPDDLAYVIFTSGSTGTPKGVMISHRAALNTILDINR 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1666 R--LSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAML------PTQ 1737
Cdd:cd12114 161 RfaVGPDDRVLALSSLSFDLSVYDIFGALSAGATLVLPDEARRRDPAHWAELIERHGVTLWNSVPALLEMLldvleaAQA 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1738 GLESVALV-VAGEACPAALVDRW---APGRVMLNAYGPTETTICAAIS--APLRPGSGMPPIGVPVSGAALFVLDSWLRP 1811
Cdd:cd12114 241 LLPSLRLVlLSGDWIPLDLPARLralAPDARLISLGGATEASIWSIYHpiDEVPPDWRSIPYGRPLANQRYRVLDPRGRD 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1812 VPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGsgaRMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEV 1891
Cdd:cd12114 321 CPDWVPGELWIGGRGVALGYLGDPELTAARFVTHPDGE---RLYRTGDLGRYRPDGTLEFLGRRDGQVKVRGYRIELGEI 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1892 ATALAELAGVGQAVVIAReDRPGDKRLVGYATEIAPGA-VDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRA 1970
Cdd:cd12114 398 EAALQAHPGVARAVVVVL-GDPGGKRLAAFVVPDNDGTpIAPDALRAFLAQTLPAYMIPSRVIALEALPLTANGKVDRAA 476
|
.
gi 489495878 1971 L 1971
Cdd:cd12114 477 L 477
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
1023-1457 |
4.11e-102 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 335.50 E-value: 4.11e-102
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1023 IPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVD-GVPRQLVIEARRADLGC 1101
Cdd:cd19539 2 IPLSFAQERLWFIDQGEDGGPAYNIPGAWRLTGPLDVEALREALRDVVARHEALRTLLVRDDgGVPRQEILPPGPAPLEV 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1102 -DIVDATAWPADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGR 1180
Cdd:cd19539 82 rDLSDPDSDRERRLEELLRERESRGFDLDEEPPIRAVLGRFDPDDHVLVLVAHHTAFDAWSLDVFARDLAALYAARRKGP 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1181 APDWAPLPVQYVDYTLWQREILGDlddsdSPIAAQLAYWENALAGMpERLRLPTARPYPPVADQRGASLVVDWPASVQQQ 1260
Cdd:cd19539 162 AAPLPELRQQYKEYAAWQREALAA-----PRAAELLDFWRRRLRGA-EPTALPTDRPRPAGFPYPGADLRFELDAELVAA 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1261 VRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRAR 1340
Cdd:cd19539 236 LRELAKRARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGRNHPRFESTVGFFVNLLPLRVDVSDCATFRDLIARVRKA 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1341 SLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQLNL-GDLQATPMPIDTRTARMDLVFSLAErfsegsE 1419
Cdd:cd19539 316 LVDAQRHQELPFQQLVAELPVDRDAGRHPLVQIVFQVTNAPAGELELaGGLSYTEGSDIPDGAKFDLNLTVTE------E 389
|
410 420 430
....*....|....*....|....*....|....*...
gi 489495878 1420 PAGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAP 1457
Cdd:cd19539 390 GTGLRGSLGYATSLFDEETIQGFLADYLQVLRQLLANP 427
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
1502-1971 |
1.61e-101 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 334.60 E-value: 1.61e-101
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1502 VARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRV 1581
Cdd:cd05945 1 AAANPDRPAVVEGGRTLTYRELKERADALAAALASLGLDAGDPVVVYGHKSPDAIAAFLAALKAGHAYVPLDASSPAERI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1582 AFMLGDAVPVAAVTtaglrsrlAGHDLpiidvvdalaaypgtpppmpaavnlAYILYTSGTTGEPKGVGITHRNVTRLFA 1661
Cdd:cd05945 81 REILDAAKPALLIA--------DGDDN-------------------------AYIIFTSGSTGRPKGVQISHDNLVSFTN 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1662 SLPAR--LSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPT--- 1736
Cdd:cd05945 128 WMLSDfpLGPGDVFLNQAPFSFDLSVMDLYPALASGATLVPVPRDATADPKQLFRFLAEHGITVWVSTPSFAAMCLLspt 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1737 ---QGLESVALVV-AGEACPAALVDRW---APGRVMLNAYGPTETTI-CAAISAPLRPGSGMP--PIGVPVSGAALFVLD 1806
Cdd:cd05945 208 ftpESLPSLRHFLfCGEVLPHKTARALqqrFPDARIYNTYGPTEATVaVTYIEVTPEVLDGYDrlPIGYAKPGAKLVILD 287
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1807 SWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFvacpFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRI 1886
Cdd:cd05945 288 EDGRPVPPGEKGELVISGPSVSKGYLNNPEKTAAAF----FPDEGQRAYRTGDLVRLEADGLLFYRGRLDFQVKLNGYRI 363
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1887 ELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPG-AVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGK 1965
Cdd:cd05945 364 ELEEIEAALRQVPGVKEAVVVPKYKGEKVTELIAFVVPKPGAeAGLTKAIKAELAERLPPYMIPRRFVYLDELPLNANGK 443
|
....*.
gi 489495878 1966 LDHRAL 1971
Cdd:cd05945 444 IDRKAL 449
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
1496-1972 |
3.20e-100 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 330.67 E-value: 3.20e-100
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1496 QMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPA 1575
Cdd:cd17645 2 QLFEEQVERTPDHVAVVDRGQSLTYKQLNEKANQLARHLRGKGVKPDDQVGIMLDKSLDMIAAILGVLKAGGAYVPIDPD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1576 NPPPRVAFMLGDAVPVAAVTTAGlrsrlaghdlpiidvvdalaaypgtpppmpaavNLAYILYTSGTTGEPKGVGITHRN 1655
Cdd:cd17645 82 YPGERIAYMLADSSAKILLTNPD---------------------------------DLAYVIYTSGSTGLPKGVMIEHHN 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1656 VTRL-------FASLPARLSAaqVWSqchSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVltqtp 1728
Cdd:cd17645 129 LVNLcewhrpyFGVTPADKSL--VYA---SFSFDASAWEIFPHLTAGAALHVVPSERRLDLDALNDYFNQEGITI----- 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1729 aavAMLPTQGLE--------SVALVVAGEACPAALVDRwapGRVMLNAYGPTETTICAAiSAPLRPGSGMPPIGVPVSGA 1800
Cdd:cd17645 199 ---SFLPTGAAEqfmqldnqSLRVLLTGGDKLKKIERK---GYKLVNNYGPTENTVVAT-SFEIDKPYANIPIGKPIDNT 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1801 ALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGgSGARMYRTGDLVCWRADGQLEFLGRTDDQVK 1880
Cdd:cd17645 272 RVYILDEALQLQPIGVAGELCIAGEGLARGYLNRPELTAEKFIVHPFV-PGERMYRTGDLAKFLPDGNIEFLGRLDQQVK 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1881 IRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATeiAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPL 1960
Cdd:cd17645 351 IRGYRIEPGEIEPFLMNHPLIELAAVLAKEDADGRKYLVAYVT--APEEIPHEELREWLKNDLPDYMIPTYFVHLKALPL 428
|
490
....*....|..
gi 489495878 1961 TVNGKLDHRALP 1972
Cdd:cd17645 429 TANGKVDRKALP 440
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
1228-2449 |
4.54e-100 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 355.53 E-value: 4.54e-100
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1228 ERLRLPTARPYP-----PVADQrgaslVVDWPASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGR 1302
Cdd:TIGR03443 4 ERLDNPTLSVLPhdylrPANNR-----LVEATYSLQLPSAEVTAGGGSTPFIILLAAFAALVYRLTGDEDIVLGTSSNKS 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1303 SDPaldnlvgffvntLVLRVNLAGDPSFAELLGQVRARSLAAYENQDVPFEVLVDRLKPTRALTHHPLIqVMLAWQDNPV 1382
Cdd:TIGR03443 79 GRP------------FVLRLNITPELSFLQLYAKVSEEEKEGASDIGVPFDELSEHIQAAKKLERTPPL-FRLAFQDAPD 145
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1383 GQlnlgdlQATPMPIDTRtarmDLVFSLAerfseGSEPAGIGGAVeYRTDVFEAQAIDVLIERLRKVLVAVAAAPERTVS 1462
Cdd:TIGR03443 146 NQ------QTTYSTGSTT----DLTVFLT-----PSSPELELSIY-YNSLLFSSDRITIVADQLAQLLSAASSNPDEPIG 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1463 SIDALDGTERARLdewgnravltaPAPTPV--------SIPQMLAAQVARIP------EAEAVCCGDA---SMTYRELDE 1525
Cdd:TIGR03443 210 KVSLITPSQKSLL-----------PDPTKDldwsgfrgAIHDIFADNAEKHPdrtcvvETPSFLDPSSktrSFTYKQINE 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1526 ASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVT--TAG----- 1598
Cdd:TIGR03443 279 ASNILAHYLLKTGIKRGDVVMIYAYRGVDLVVAVMGVLKAGATFSVIDPAYPPARQTIYLSVAKPRALIVieKAGtldql 358
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1599 ----------LRSR-----------LAGHDLPIiDVVDALAAY-------------PGTPPPMPaavnlayilYTSGTTG 1644
Cdd:TIGR03443 359 vrdyidkeleLRTEipalalqddgsLVGGSLEG-GETDVLAPYqalkdtptgvvvgPDSNPTLS---------FTSGSEG 428
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1645 EPKGVGITHRNVTRLFASLPAR--LSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVS 1722
Cdd:TIGR03443 429 IPKGVLGRHFSLAYYFPWMAKRfgLSENDKFTMLSGIAHDPIQRDMFTPLFLGAQLLVPTADDIGTPGRLAEWMAKYGAT 508
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1723 VLTQTPAAVAMLPTQglesvalvvAGEACPA---------ALVDR-------WAPGRVMLNAYGPTET-------TICAA 1779
Cdd:TIGR03443 509 VTHLTPAMGQLLSAQ---------ATTPIPSlhhaffvgdILTKRdclrlqtLAENVCIVNMYGTTETqravsyfEIPSR 579
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1780 ISAP--LRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVA--GELYIAGAGVGVGYWRRAGLTASRFVACPFG------- 1848
Cdd:TIGR03443 580 SSDStfLKNLKDVMPAGKGMKNVQLLVVNRNDRTQTCGVGevGEIYVRAGGLAEGYLGLPELNAEKFVNNWFVdpshwid 659
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1849 --------------GSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPG 1914
Cdd:TIGR03443 660 ldkennkperefwlGPRDRLYRTGDLGRYLPDGNVECCGRADDQVKIRGFRIELGEIDTHLSQHPLVRENVTLVRRDKDE 739
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1915 DKRLVGY--------ATEIAPGAVDPA--------GL----------RAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDH 1968
Cdd:TIGR03443 740 EPTLVSYivpqdksdELEEFKSEVDDEessdpvvkGLikyrklikdiREYLKKKLPSYAIPTVIVPLKKLPLNPNGKVDK 819
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1969 RALPAP---------EYGDTNGYRAPAGPVEKTVAGIFARVL--GLERVGVDDSFFELGGDSLAAMRVIAAINTTLNADL 2037
Cdd:TIGR03443 820 PALPFPdtaqlaavaKNRSASAADEEFTETEREIRDLWLELLpnRPATISPDDSFFDLGGHSILATRMIFELRKKLNVEL 899
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2038 PVRALLHASSTRGLSQLLGR--DARPTSDprlvsvHGDNPTEVHASDLTLDRFIDADTL--------ATAVNLPGPSPel 2107
Cdd:TIGR03443 900 PLGLIFKSPTIKGFAKEVDRlkKGEELAD------EGDSEIEEEETVLELDYAKDAKTLvdslpksyPSRKELDASTP-- 971
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2108 RTVLLTGATGFLGRYLVLELL-RRLDVDGRLICLVRAESDEDARRRLEK---TFDSGDPELlrhfkelaADRLEVVAGDK 2183
Cdd:TIGR03443 972 ITVFLTGATGFLGSFILRDLLtRRSNSNFKVFAHVRAKSEEAGLERLRKtgtTYGIWDEEW--------ASRIEVVLGDL 1043
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2184 SEPDLGLDQPMWRRLAETVDLIVDSAAMVN-AFPYHELFGPNVAGTAELIRIALTTKLKPFTYVSTAdvgAAIEPSAFTE 2262
Cdd:TIGR03443 1044 SKEKFGLSDEKWSDLTNEVDVIIHNGALVHwVYPYSKLRDANVIGTINVLNLCAEGKAKQFSFVSST---SALDTEYYVN 1120
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2263 DADIRV------ISPTRTVDG---GWAGGYGTSKWAGEVLLREANDLcALPVAVFRCGMILADtSYAGQLNMSDWVTRMV 2333
Cdd:TIGR03443 1121 LSDELVqaggagIPESDDLMGsskGLGTGYGQSKWVAEYIIREAGKR-GLRGCIVRPGYVTGD-SKTGATNTDDFLLRML 1198
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2334 lslmaTGIAPRSFYePDSEGNrqrahFDGLPVTFVAEaiAVLGARVAGSSLAGFATYHVMNpHdDGIGLDEYVDWLIEAG 2413
Cdd:TIGR03443 1199 -----KGCIQLGLI-PNINNT-----VNMVPVDHVAR--VVVAAALNPPKESELAVAHVTG-H-PRIRFNDFLGTLKTYG 1263
|
1370 1380 1390
....*....|....*....|....*....|....*.
gi 489495878 2414 YPIrRIDDFAEWLQRFEASlgaLPDRQRRHSVLPML 2449
Cdd:TIGR03443 1264 YDV-EIVDYVHWRKSLERF---VIERSEDNALFPLL 1295
|
|
| SDR_e1 |
cd05235 |
extended (e) SDRs, subgroup 1; This family consists of an SDR module of multidomain proteins ... |
2109-2425 |
6.56e-98 |
|
extended (e) SDRs, subgroup 1; This family consists of an SDR module of multidomain proteins identified as putative polyketide sythases fatty acid synthases (FAS), and nonribosomal peptide synthases, among others. However, unlike the usual ketoreductase modules of FAS and polyketide synthase, these domains are related to the extended SDRs, and have canonical NAD(P)-binding motifs and an active site tetrad. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187546 [Multi-domain] Cd Length: 290 Bit Score: 317.67 E-value: 6.56e-98
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2109 TVLLTGATGFLGRYLVLELLRRLDVdGRLICLVRAESDEDARRRLEKTFDSGDpelLRHFKELAADRLEVVAGDKSEPDL 2188
Cdd:cd05235 1 TVLLTGATGFLGAYLLRELLKRKNV-SKIYCLVRAKDEEAALERLIDNLKEYG---LNLWDELELSRIKVVVGDLSKPNL 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2189 GLDQPMWRRLAETVDLIVDSAAMVNAF-PYHELFGPNVAGTAELIRIALTTKLKPFTYVSTADVGAAIEPSAFTEDADir 2267
Cdd:cd05235 77 GLSDDDYQELAEEVDVIIHNGANVNWVyPYEELKPANVLGTKELLKLAATGKLKPLHFVSTLSVFSAEEYNALDDEES-- 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2268 viSPTRTVDGGWAGGYGTSKWAGEVLLREANDLcALPVAVFRCGMILADtSYAGQLNMSDWVTRMVLSLMATGIAPRSfy 2347
Cdd:cd05235 155 --DDMLESQNGLPNGYIQSKWVAEKLLREAANR-GLPVAIIRPGNIFGD-SETGIGNTDDFFWRLLKGCLQLGIYPIS-- 228
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 2348 epdsegnrqRAHFDGLPVTFVAEAIAVLgarvAGSSLAGFATYHVMNPHddGIGLDEYVDWLIEAGYPIRRIDDFaEW 2425
Cdd:cd05235 229 ---------GAPLDLSPVDWVARAIVKL----ALNESNEFSIYHLLNPP--LISLNDLLDALEEKGYSIKEVSYE-EW 290
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
1506-1972 |
1.60e-96 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 321.35 E-value: 1.60e-96
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML 1585
Cdd:cd17656 2 PDAVAVVFENQKLTYRELNERSNQLARFLREKGVKKDSIVAIMMERSAEMIVGILGILKAGGAFVPIDPEYPEERRIYIM 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1586 GDAVPVAAVTTAGLRSRLA---GHDLPIIDVVdalaaYPGTPPPMPAAVN---LAYILYTSGTTGEPKGVGITHRNVTRL 1659
Cdd:cd17656 82 LDSGVRVVLTQRHLKSKLSfnkSTILLEDPSI-----SQEDTSNIDYINNsddLLYIIYTSGTTGKPKGVQLEHKNMVNL 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1660 FA---SLPARLSAAQVWsQCHSYGFDASAWEIWGALLGGGRLVIVPESVAaspndfhgLLVAEHVSVLTQTPAAVAMLPT 1736
Cdd:cd17656 157 LHferEKTNINFSDKVL-QFATCSFDVCYQEIFSTLLSGGTLYIIREETK--------RDVEQLFDLVKRHNIEVVFLPV 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1737 QGLESVA---------------LVVAGEACPAA--LVDRWAPGRVML-NAYGPTETTICAAIS-APLRPGSGMPPIGVPV 1797
Cdd:cd17656 228 AFLKFIFserefinrfptcvkhIITAGEQLVITneFKEMLHEHNVHLhNHYGPSETHVVTTYTiNPEAEIPELPPIGKPI 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1798 SGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGgSGARMYRTGDLVCWRADGQLEFLGRTDD 1877
Cdd:cd17656 308 SNTWIYILDQEQQLQPQGIVGELYISGASVARGYLNRQELTAEKFFPDPFD-PNERMYRTGDLARYLPDGNIEFLGRADH 386
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1878 QVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYAteIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDA 1957
Cdd:cd17656 387 QVKIRGYRIELGEIEAQLLNHPGVSEAVVLDKADDKGEKYLCAYF--VMEQELNISQLREYLAKQLPEYMIPSFFVPLDQ 464
|
490
....*....|....*
gi 489495878 1958 LPLTVNGKLDHRALP 1972
Cdd:cd17656 465 LPLTPNGKVDRKALP 479
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
1023-1475 |
1.53e-93 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 311.96 E-value: 1.53e-93
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1023 IPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFP-AVDGVPRQLVIEARRADLgc 1101
Cdd:pfam00668 5 YPLSPAQKRMWFLEKLEPHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIrQENGEPVQVILEERPFEL-- 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1102 DIVDATAWPADRLQRAIEEAAR----HSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRC 1177
Cdd:pfam00668 83 EIIDISDLSESEEEEAIEAFIQrdlqSPFDLEKGPLFRAGLFRIAENRHHLLLSMHHIIVDGVSLGILLRDLADLYQQLL 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1178 AGRAPDWAPLPvQYVDYTLWQREILGDLDdsdspIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASV 1257
Cdd:pfam00668 163 KGEPLPLPPKT-PYKDYAEWLQQYLQSED-----YQKDAAYWLEQLEGELPVLQLPKDYARPADRSFKGDRLSFTLDEDT 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1258 QQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQV 1337
Cdd:pfam00668 237 EELLRKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPSPDIERMVGMFVNTLPLRIDPKGGKTFSELIKRV 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1338 RARSLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLA-----WQDNPVGQLNLGDLQATPMPIDTRTARMDLVFSLAE 1412
Cdd:pfam00668 317 QEDLLSAEPHQGYPFGDLVNDLRLPRDLSRHPLFDPMFSfqnylGQDSQEEEFQLSELDLSVSSVIEEEAKYDLSLTASE 396
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 489495878 1413 RfsEGsepaGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARL 1475
Cdd:pfam00668 397 R--GG----GLTIKIDYNTSLFDEETIERFAEHFKELLEQAIAHPSQPLSELDLLSDAEKQKL 453
|
|
| Lys2b |
COG3320 |
Thioester reductase domain of alpha aminoadipate reductase Lys2 and NRPSs [Secondary ... |
2108-2396 |
6.66e-90 |
|
Thioester reductase domain of alpha aminoadipate reductase Lys2 and NRPSs [Secondary metabolites biosynthesis, transport and catabolism]; Thioester reductase domain of alpha aminoadipate reductase Lys2 and NRPSs is part of the Pathway/BioSystem: Lysine biosynthesis
Pssm-ID: 442549 [Multi-domain] Cd Length: 265 Bit Score: 293.65 E-value: 6.66e-90
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2108 RTVLLTGATGFLGRYLVLELLRRldVDGRLICLVRAESDEDARRRLEKTFDSGDPELlrhfkELAADRLEVVAGDKSEPD 2187
Cdd:COG3320 1 RTVLLTGATGFLGAHLLRELLRR--TDARVYCLVRASDEAAARERLEALLERYGLWL-----ELDASRVVVVAGDLTQPR 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2188 LGLDQPMWRRLAETVDLIVDSAAMVN-AFPYHELFGPNVAGTAELIRIALTTKLKPFTYVSTADVGAAIEPSAFTEDADI 2266
Cdd:COG3320 74 LGLSEAEFQELAEEVDAIVHLAALVNlVAPYSELRAVNVLGTREVLRLAATGRLKPFHYVSTIAVAGPADRSGVFEEDDL 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2267 RvisptrtVDGGWAGGYGTSKWAGEVLLREANDLcALPVAVFRCGMILADTSyAGQLNMSDWVTRMVLSLMATGIAPrsf 2346
Cdd:COG3320 154 D-------EGQGFANGYEQSKWVAEKLVREARER-GLPVTIYRPGIVVGDSR-TGETNKDDGFYRLLKGLLRLGAAP--- 221
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|
gi 489495878 2347 yepdsegNRQRAHFDGLPVTFVAEAIAVLGARVAgsslAGFATYHVMNPH 2396
Cdd:COG3320 222 -------GLGDARLNLVPVDYVARAIVHLSRQPE----AAGRTFHLTNPQ 260
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
1494-1973 |
3.90e-89 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 299.03 E-value: 3.90e-89
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1494 IPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPID 1573
Cdd:COG0318 1 LADLLRRAAARHPDRPALVFGGRRLTYAELDARARRLAAALRALGVGPGDRVALLLPNSPEFVVAFLAALRAGAVVVPLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1574 PANPPPRVAFMLGDAVPVAAVTtaglrsrlaghdlpiidvvdalaaypgtpppmpaavnlAYILYTSGTTGEPKGVGITH 1653
Cdd:COG0318 81 PRLTAEELAYILEDSGARALVT--------------------------------------ALILYTSGTTGRPKGVMLTH 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1654 RNVTRLFASLPA--RLSAAQVWSQC----HSYGFdasAWEIWGALLGGGRLVIVPesvAASPNDFHGLLVAEHVSVLTQT 1727
Cdd:COG0318 123 RNLLANAAAIAAalGLTPGDVVLVAlplfHVFGL---TVGLLAPLLAGATLVLLP---RFDPERVLELIERERVTVLFGV 196
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1728 PAAVAML------PTQGLESVALVV-AGEACPAALVDRW--APGRVMLNAYGPTETTICAAISAPLRPGSGMPPIGVPVS 1798
Cdd:COG0318 197 PTMLARLlrhpefARYDLSSLRLVVsGGAPLPPELLERFeeRFGVRIVEGYGLTETSPVVTVNPEDPGERRPGSVGRPLP 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1799 GAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacpfGGsgarMYRTGDLVCWRADGQLEFLGRTDDQ 1878
Cdd:COG0318 277 GVEVRIVDEDGRELPPGEVGEIVVRGPNVMKGYWNDPEATAEAFR----DG----WLRTGDLGRLDEDGYLYIVGRKKDM 348
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1879 VKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATeIAPGA-VDPAGLRAQLAQRLPGYLVPAAVVVIDA 1957
Cdd:COG0318 349 IISGGENVYPAEVEEVLAAHPGVAEAAVVGVPDEKWGERVVAFVV-LRPGAeLDAEELRAFLRERLARYKVPRRVEFVDE 427
|
490
....*....|....*.
gi 489495878 1958 LPLTVNGKLDHRALPA 1973
Cdd:COG0318 428 LPRTASGKIDRRALRE 443
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
1023-1457 |
1.96e-88 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 296.24 E-value: 1.96e-88
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1023 IPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEAR-RADLG- 1100
Cdd:cd19066 2 IPLSPMQRGMWFLKKLATDPSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRFCEEAGRYEQVVLDKTvRFRIEi 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1101 CDIVDATAWPAdRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGR 1180
Cdd:cd19066 82 IDLRNLADPEA-RLLELIDQIQQTIYDLERGPLVRVALFRLADERDVLVVAIHHIIVDGGSFQILFEDISSVYDAAERQK 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1181 aPDWAPLPVQYVDYTLWQREILGDLDdsdspIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQ 1260
Cdd:cd19066 161 -PTLPPPVGSYADYAAWLEKQLESEA-----AQADLAYWTSYLHGLPPPLPLPKAKRPSQVASYEVLTLEFFLRSEETKR 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1261 VRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRAR 1340
Cdd:cd19066 235 LREVARESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPDEAVEDTIGLFLNLLPLRIDTSPDATFPELLKRTKEQ 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1341 SLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPvGQLNLGDLQATPMPIDTRTARMdlVFSLAERFSEGSeP 1420
Cdd:cd19066 315 SREAIEHQRVPFIELVRHLGVVPEAPKHPLFEPVFTFKNNQ-QQLGKTGGFIFTTPVYTSSEGT--VFDLDLEASEDP-D 390
|
410 420 430
....*....|....*....|....*....|....*..
gi 489495878 1421 AGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAP 1457
Cdd:cd19066 391 GDLLLRLEYSRGVYDERTIDRFAERYMTALRQLIENP 427
|
|
| AMP-binding |
pfam00501 |
AMP-binding enzyme; |
1498-1882 |
1.03e-86 |
|
AMP-binding enzyme;
Pssm-ID: 459834 [Multi-domain] Cd Length: 417 Bit Score: 290.75 E-value: 1.03e-86
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1498 LAAQVARIPEAEAVCCGD-ASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPAN 1576
Cdd:pfam00501 1 LERQAARTPDKTALEVGEgRRLTYRELDERANRLAAGLRALGVGKGDRVAILLPNSPEWVVAFLACLKAGAVYVPLNPRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1577 PPPRVAFMLGDAVPVAAVTTA------GLRSRLAGHDLPIIDVVDALAAYPGT--------------PPPMPAAVNLAYI 1636
Cdd:pfam00501 81 PAEELAYILEDSGAKVLITDDalkleeLLEALGKLEVVKLVLVLDRDPVLKEEplpeeakpadvpppPPPPPDPDDLAYI 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1637 LYTSGTTGEPKGVGITHRNVTRLFASL------PARLSAAQVWSQCHSYGFDAS-AWEIWGALLGGGRLVIVPESVAASP 1709
Cdd:pfam00501 161 IYTSGTTGKPKGVMLTHRNLVANVLSIkrvrprGFGLGPDDRVLSTLPLFHDFGlSLGLLGPLLAGATVVLPPGFPALDP 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1710 NDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVA-------LVVAGEACPAALVDRWAP--GRVMLNAYGPTETTICAAI 1780
Cdd:pfam00501 241 AALLELIERYKVTVLYGVPTLLNMLLEAGAPKRAllsslrlVLSGGAPLPPELARRFRElfGGALVNGYGLTETTGVVTT 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1781 SAPL-RPGSGMPPIGVPVSGAALFVLD-SWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVAcpfggsgARMYRTG 1858
Cdd:pfam00501 321 PLPLdEDLRSLGSVGRPLPGTEVKIVDdETGEPVPPGEPGELCVRGPGVMKGYLNDPELTAEAFDE-------DGWYRTG 393
|
410 420
....*....|....*....|....
gi 489495878 1859 DLVCWRADGQLEFLGRTDDQVKIR 1882
Cdd:pfam00501 394 DLGRRDEDGYLEIVGRKKDQIKLG 417
|
|
| NAD_binding_4 |
pfam07993 |
Male sterility protein; This family represents the C-terminal region of the male sterility ... |
2112-2372 |
2.94e-77 |
|
Male sterility protein; This family represents the C-terminal region of the male sterility protein in a number of arabidopsis and drosophila. A sequence-related jojoba acyl CoA reductase is also included.
Pssm-ID: 462334 [Multi-domain] Cd Length: 257 Bit Score: 257.15 E-value: 2.94e-77
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2112 LTGATGFLGRYLVLELLRRLDVDGRLICLVRAESDEDARRRLEKTFDSGDPELLrhFKELAADRLEVVAGDKSEPDLGLD 2191
Cdd:pfam07993 1 LTGATGFLGKVLLEKLLRSTPDVKKIYLLVRAKDGESALERLRQELEKYPLFDA--LLKEALERIVPVAGDLSEPNLGLS 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2192 QPMWRRLAETVDLIVDSAAMVN-AFPYHELFGPNVAGTAELIRIALTTK-LKPFTYVSTAdVGAAIEPSAFTEDA----- 2264
Cdd:pfam07993 79 EEDFQELAEEVDVIIHSAATVNfVEPYDDARAVNVLGTREVLRLAKQGKqLKPFHHVSTA-YVNGERGGLVEEKPypege 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2265 -DIRVISPTRTVDGGWAGGYGTSKWAGEVLLREANDlCALPVAVFRCGMILADtSYAGQLNMSDWVTRMVLSLMATGIAP 2343
Cdd:pfam07993 158 dDMLLDEDEPALLGGLPNGYTQTKWLAEQLVREAAR-RGLPVVIYRPSIITGE-PKTGWINNFDFGPRGLLGGIGKGVLP 235
|
250 260
....*....|....*....|....*....
gi 489495878 2344 RSFYEPDsegnrqrAHFDGLPVTFVAEAI 2372
Cdd:pfam07993 236 SILGDPD-------AVLDLVPVDYVANAI 257
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1024-1393 |
9.32e-76 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 259.31 E-value: 9.32e-76
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1024 PLSFAQRRLWFLDQ-LQRPApVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPA--VDGVPRQLVIEARRADLg 1100
Cdd:cd19532 3 PMSFGQSRFWFLQQyLEDPT-TFNVTFSYRLTGPLDVARLERAVRAVGQRHEALRTCFFTdpEDGEPMQGVLASSPLRL- 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1101 cDIVDATawPADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRcagr 1180
Cdd:cd19532 81 -EHVQIS--DEAEVEEEFERLKNHVYDLESGETMRIVLLSLSPTEHYLIFGYHHIAMDGVSFQIFLRDLERAYNGQ---- 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1181 apDWAPLPVQYVDYTLWQREIL--GDLDDsdspiaaQLAYWENALAGMPER---LRLPTARPYPPVA--DQRGASLVVDw 1253
Cdd:cd19532 154 --PLLPPPLQYLDFAARQRQDYesGALDE-------DLAYWKSEFSTLPEPlplLPFAKVKSRPPLTryDTHTAERRLD- 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1254 pASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAEL 1333
Cdd:cd19532 224 -AALAARIKEASRKLRVTPFHFYLAALQVLLARLLDVDDICIGIADANRTDEDFMETIGFFLNLLPLRFRRDPSQTFADV 302
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1334 LGQVRARSLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQLNLGDLQAT 1393
Cdd:cd19532 303 LKETRDKAYAALAHSRVPFDVLLDELGVPRSATHSPLFQVFINYRQGVAESRPFGDCELE 362
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
1025-1271 |
6.72e-73 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 244.18 E-value: 6.72e-73
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1025 LSFAQRRLWFLDQlqrPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEArrADLGCDIV 1104
Cdd:COG4908 1 LSPAQKRFLFLEP---GSNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFVEEDGEPVQRIDPD--ADLPLEVV 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1105 DATAWPA----DRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGR 1180
Cdd:COG4908 76 DLSALPEpereAELEELVAEEASRPFDLARGPLLRAALIRLGEDEHVLLLTIHHIISDGWSLGILLRELAALYAALLEGE 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1181 APDWAPLPVQYVDYTLWQREILGDLDdsdspIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQ 1260
Cdd:COG4908 156 PPPLPELPIQYADYAAWQRAWLQSEA-----LEKQLEYWRQQLAGAPPVLELPTDRPRPAVQTFRGATLSFTLPAELTEA 230
|
250
....*....|.
gi 489495878 1261 VRRIARQHNAT 1271
Cdd:COG4908 231 LKALAKAHGAT 241
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1023-1378 |
6.50e-69 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 239.85 E-value: 6.50e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1023 IPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADLGCD 1102
Cdd:cd20483 2 RPMSTFQRRLWFLHNFLEDKTFLNLLLVCHIKGKPDVNLLQKALSELVRRHEVLRTAYFEGDDFGEQQVLDDPSFHLIVI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1103 IVDATAWPADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAP 1182
Cdd:cd20483 82 DLSEAADPEAALDQLVRNLRRQELDIEEGEVIRGWLVKLPDEEFALVLASHHIAWDRGSSKSIFEQFTALYDALRAGRDL 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1183 D-WAPLPVQYVDYTLWQREILgdlddSDSPIAAQLAYWENALAGMPERLR-LPTA-RPYPPVADQRGASLVVDWPASVQQ 1259
Cdd:cd20483 162 AtVPPPPVQYIDFTLWHNALL-----QSPLVQPLLDFWKEKLEGIPDASKlLPFAkAERPPVKDYERSTVEATLDKELLA 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1260 QVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRA 1339
Cdd:cd20483 237 RMKRICAQHAVTPFMFLLAAFRAFLYRYTEDEDLTIGMVDGDRPHPDFDDLVGFFVNMLPIRCRMDCDMSFDDLLESTKT 316
|
330 340 350
....*....|....*....|....*....|....*....
gi 489495878 1340 RSLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQ 1378
Cdd:cd20483 317 TCLEAYEHSAVPFDYIVDALDVPRSTSHFPIGQIAVNYQ 355
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
575-1281 |
1.04e-66 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 250.54 E-value: 1.04e-66
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLAA 654
Cdd:COG1020 620 AYVIYTSGSTGRPKGVMVEHRALVNLLAWMQRRYGLGPGDRVLQFASLSFDASVWEIFGALLSGATLVLAPPEARRDPAA 699
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 655 LVDDLVARETTIVDLPTAVWQLLCADGDAidaiGRSRLRQIVIGGEAIRCSAVDKWLEsaASQGISLLSSYGPTEATVVA 734
Cdd:COG1020 700 LAELLARHRVTVLNLTPSLLRALLDAAPE----ALPSLRLVLVGGEALPPELVRRWRA--RLPGARLVNLYGPTETTVDS 773
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 735 TFLPivCDQTTMDGALLRLGRPIlPNTVFL------------AFGEVVIVGDLVADGYLGIDG--------DGFGtvtaA 794
Cdd:COG1020 774 TYYE--VTPPDADGGSVPIGRPI-ANTRVYvldahlqpvpvgVPGELYIGGAGLARGYLNRPEltaerfvaDPFG----F 846
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 795 DGSrrRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLG----VWFKSQRTR 870
Cdd:COG1020 847 PGA--RLYRTGDLARWLPDGNLEFLGRADDQVKIRGFRIELGEIEAALLQHPGVREAVVVAREDAPGdkrlVAYVVPEAG 924
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 871 EGEQDAAAATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKIDSDNLPRLPQWSAAGLNTAETGQRAAGLSQIWSRQLGRAI 950
Cdd:COG1020 925 AAAAAALLRLALALLLPPYMVPAAVVL-LLPLPLTGNGKLDRLALPAPAAAAAAAAAAPPAEEEEEEAALALLLLLVVVV 1003
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 951 GPDSSLLGEGIGSLDLIRILPETRRYLGWRLSLLDLIGADTAANLADYAPTPDAPTGedrfRPLVAAQRPAAIPLSFAQR 1030
Cdd:COG1020 1004 GDDDFFFFGGGLGLLLLLALARAARLLLLLLLLLLLFLAAAAAAAAAAAAAAAAAAA----APLAAAAAPLPLPPLLLSL 1079
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1031 RLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADLGCDIVDATAWP 1110
Cdd:COG1020 1080 LALLLALLLLLALLALLALLLLLLLLLLLLALLLLLALLLALLAALRARRAVRQEGPRLRLLVALAAALALAALLALLLA 1159
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1111 ADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAPDWAPLPVQ 1190
Cdd:COG1020 1160 AAAAAAELLAAAALLLLLALLLLALLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLAAAAAALLALALLLA 1239
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1191 YVDYTLWQREiLGDLDDSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQVRRIARQHNA 1270
Cdd:COG1020 1240 LLALAALLAL-AALAALAAALLALALALLALALLLLALALLLPALARARAARTARALALLLLLALLLLLALALALLLLLL 1318
|
730
....*....|.
gi 489495878 1271 TSFMVVAAGLA 1281
Cdd:COG1020 1319 LLLALLLLALL 1329
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
359-1339 |
1.50e-66 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 252.57 E-value: 1.50e-66
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 359 ATDIGPVEGMTVASVLDEEQRTLNLAIWNRADLPACKTHPKVAERIAAALESMAAMWDRPIAMIVND------------- 425
Cdd:PRK12316 2957 AAQLPGLHIESFAWDGAATQFDLALDTWESAEGLGASLTYATDLFDARTVERLARHWQNLLRGMVENpqrsvdelamlda 3036
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 426 --WFGIGPDGTRCQGDWP-------------ARQPSTPAWFLDSARGVHQFLGRRrfVYPWVAWLVQRGAAPgDVLVFTD 490
Cdd:PRK12316 3037 eeRGQLLEAWNATAAEYPlergvhrlfeeqvERTPDAVALAFGEQRLSYAELNRR--ANRLAHRLIERGVGP-DVLVGVA 3113
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 491 DDTDKTIDL-LIACHLAGCGYSVCDTADEISVRTNAITEHGDGILVTVVDVAATQLAVVGHDELRKVVDERVTQVTHDAL 569
Cdd:PRK12316 3114 VERSLEMVVgLLAILKAGGAYVPLDPEYPEERLAYMLEDSGAQLLLSQSHLRLPLAQGVQVLDLDRGDENYAEANPAIRT 3193
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 570 LATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKT 649
Cdd:PRK12316 3194 MPENLAYVIYTSGSTGKPKGVGIRHSALSNHLCWMQQAYGLGVGDRVLQFTTFSFDVFVEELFWPLMSGARVVLAGPEDW 3273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 650 GDLAALVDDLvarETTIVDLPTAVWQLLCADGDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLesaasQGISLLSSYGPTE 729
Cdd:PRK12316 3274 RDPALLVELI---NSEGVDVLHAYPSMLQAFLEEEDAHRCTSLKRIVCGGEALPADLQQQVF-----AGLPLYNLYGPTE 3345
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 730 ATVVATFLPIVCDQTtmdgALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYL---GIDGDGFGTVTAAD 795
Cdd:PRK12316 3346 ATITVTHWQCVEEGK----DAVPIGRPIANRACYIldgslepvpvgALGELYLGGEGLARGYHnrpGLTAERFVPDPFVP 3421
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 796 GSrrRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGVWFKSQRTREGEQD 875
Cdd:PRK12316 3422 GE--RLYRTGDLARYRADGVIEYIGRVDHQVKIRGFRIELGEIEARLLEHPWVREAVVLAVDGRQLVAYVVPEDEAGDLR 3499
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 876 AAAATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKIDSDNLPRLpqwSAAGLNT---AETGQRAAGLSQIWSRQLGRA-IG 951
Cdd:PRK12316 3500 EALKAHLKASLPEYMVPAHLLF-LERMPLTPNGKLDRKALPRP---DAALLQQdyvAPVNELERRLAAIWADVLKLEqVG 3575
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 952 PDSSLLGEGIGSLDLIRILPETRRyLGWRLSLLDLIGADTAANLADYAPTPDAP-------TGEdrfRPLVAAQRpAAIP 1024
Cdd:PRK12316 3576 LTDNFFELGGDSIISLQVVSRARQ-AGIRFTPKDLFQHQTIQGLARVARVGGGVavdqgpvSGE---TLLLPIQQ-QFFE 3650
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1025 LSFAQRRLWFLDQLqrpapvynmavaLRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDG--VPRQLVIEARRADLgcd 1102
Cdd:PRK12316 3651 EPVPERHHWNQSLL------------LKPREALDAAALEAALQALVEHHDALRLRFVEDAGgwTAEHLPVELGGALL--- 3715
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1103 iVDATAWPADRLQRAIEEAARhSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAP 1182
Cdd:PRK12316 3716 -WRAELDDAEELERLGEEAQR-SLDLADGPLLRALLATLADGSQRLLLVIHHLVVDGVSWRILLEDLQQAYQQLLQGEAP 3793
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1183 DWAPLPVQYVDYTLWQREILGdlddsDSPIAAQLAYWENALAGMPERLRL--PTARPYPPVADQRGASLVVDWPASVQQQ 1260
Cdd:PRK12316 3794 RLPAKTSSFKAWAERLQEHAR-----GEALKAELAYWQEQLQGVSSELPCdhPQGALQNRHAASVQTRLDRELTRRLLQQ 3868
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1261 VRRIAR-QHNAtsfmVVAAGLAVLLSKLSGSPDVAVGFPIAGR----SDPALDNLVGFFVNTLVLRVNLAGD--PSFAEL 1333
Cdd:PRK12316 3869 APAAYRtQVND----LLLTALARVVCRWTGEASALVQLEGHGRedlfADIDLSRTVGWFTSLFPVRLSPVEDlgASIKAI 3944
|
....*.
gi 489495878 1334 LGQVRA 1339
Cdd:PRK12316 3945 KEQLRA 3950
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
1024-1457 |
7.96e-64 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 224.77 E-value: 7.96e-64
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1024 PLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVF-PAVDGVPRQLVIEARRADLgcD 1102
Cdd:cd19543 3 PLSPMQEGMLFHSLLDPGSGAYVEQMVITLEGPLDPDRFRAAWQAVVDRHPILRTSFvWEGLGEPLQVVLKDRKLPW--R 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1103 IVDATAWPADRLQRAIEEAA----RHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCA 1178
Cdd:cd19543 81 ELDLSHLSEAEQEAELEALAeedrERGFDLARAPLMRLTLIRLGDDRYRLVWSFHHILLDGWSLPILLKELFAIYAALGE 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1179 GRAPDwAPLPVQYVDYTLWqreilgdLDDSDSpiAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQ 1258
Cdd:cd19543 161 GQPPS-LPPVRPYRDYIAW-------LQRQDK--EAAEAYWREYLAGFEEPTPLPKELPADADGSYEPGEVSFELSAELT 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1259 QQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGR-SD-PALDNLVGFFVNTLVLRVNLAGDPSFAELLGQ 1336
Cdd:cd19543 231 ARLQELARQHGVTLNTVVQGAWALLLSRYSGRDDVVFGTTVSGRpAElPGIETMVGLFINTLPVRVRLDPDQTVLELLKD 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1337 VRARSLAAYENQDVPfevLVDRLKptRALTHHPLIQVMLAWQDNPVGQLNLGDLQATPMPIDTRTARMDLVFSLAERFSE 1416
Cdd:cd19543 311 LQAQQLELREHEYVP---LYEIQA--WSEGKQALFDHLLVFENYPVDESLEEEQDEDGLRITDVSAEEQTNYPLTVVAIP 385
|
410 420 430 440
....*....|....*....|....*....|....*....|.
gi 489495878 1417 GSEpagIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAP 1457
Cdd:cd19543 386 GEE---LTIKLSYDAEVFDEATIERLLGHLRRVLEQVAANP 423
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
1506-1971 |
7.09e-63 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 224.77 E-value: 7.09e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML 1585
Cdd:PRK04813 16 PDFPAYDYLGEKLTYGQLKEDSDALAAFIDSLKLPDKSPIIVFGHMSPEMLATFLGAVKAGHAYIPVDVSSPAERIEMII 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1586 GDAVPVAAVTTAGLRsrLAGHDLPIIDVVDALAA-YPGTPPPMPAAV---NLAYILYTSGTTGEPKGVGITHRNV----- 1656
Cdd:PRK04813 96 EVAKPSLIIATEELP--LEILGIPVITLDELKDIfATGNPYDFDHAVkgdDNYYIIFTSGTTGKPKGVQISHDNLvsftn 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1657 --TRLFAslparLSAAQVW-SQChSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAM 1733
Cdd:PRK04813 174 wmLEDFA-----LPEGPQFlNQA-PYSFDLSVMDLYPTLASGGTLVALPKDMTANFKQLFETLPQLPINVWVSTPSFADM 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1734 ---LPTQGLESV-ALVV---AGEACPA----ALVDRWAPGRVMlNAYGPTETTIcaAISA------------PLrpgsgm 1790
Cdd:PRK04813 248 cllDPSFNEEHLpNLTHflfCGEELPHktakKLLERFPSATIY-NTYGPTEATV--AVTSieitdemldqykRL------ 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1791 pPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFvacpFGGSGARMYRTGDLVcWRADGQLE 1870
Cdd:PRK04813 319 -PIGYAKPDSPLLIIDEEGTKLPDGEQGEIVISGPSVSKGYLNNPEKTAEAF----FTFDGQPAYHTGDAG-YLEDGLLF 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1871 FLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIaredrPGDK-----RLVGYateIAPGAVD-------PAGLRAQ 1938
Cdd:PRK04813 393 YQGRIDFQIKLNGYRIELEEIEQNLRQSSYVESAVVV-----PYNKdhkvqYLIAY---VVPKEEDferefelTKAIKKE 464
|
490 500 510
....*....|....*....|....*....|...
gi 489495878 1939 LAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK04813 465 LKERLMEYMIPRKFIYRDSLPLTPNGKIDRKAL 497
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
1633-1967 |
7.86e-63 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 218.69 E-value: 7.86e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1633 LAYILYTSGTTGEPKGVGITHRNVTRLFASL--PARLSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPN 1710
Cdd:cd04433 2 PALILYTSGTTGKPKGVVLSHRNLLAAAAALaaSGGLTEGDVFLSTLPLFHIGGLFGLLGALLAGGTVVLLPKFDPEAAL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1711 DfhgLLVAEHVSVLTQTPAAVAMLPTQGLES-------VALVVAGEACPAALVDRW--APGRVMLNAYGPTETTICAAIS 1781
Cdd:cd04433 82 E---LIEREKVTILLGVPTLLARLLKAPESAgydlsslRALVSGGAPLPPELLERFeeAPGIKLVNGYGLTETGGTVATG 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1782 APLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFvacpfggsGARMYRTGDLV 1861
Cdd:cd04433 159 PPDDDARKPGSVGRPVPGVEVRIVDPDGGELPPGEIGELVVRGPSVMKGYWNNPEATAAVD--------EDGWYRTGDLG 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1862 CWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQ 1941
Cdd:cd04433 231 RLDEDGYLYIVGRLKDMIKSGGENVYPAEVEAVLLGHPGVAEAAVVGVPDPEWGERVVAVVVLRPGADLDAEELRAHVRE 310
|
330 340
....*....|....*....|....*.
gi 489495878 1942 RLPGYLVPAAVVVIDALPLTVNGKLD 1967
Cdd:cd04433 311 RLAPYKVPRRVVFVDALPRTASGKID 336
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
575-1327 |
5.51e-58 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 224.07 E-value: 5.51e-58
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLAA 654
Cdd:PRK12316 658 AYVIYTSGSTGKPKGAGNRHRALSNRLCWMQQAYGLGVGDTVLQKTPFSFDVSVWEFFWPLMSGARLVVAAPGDHRDPAK 737
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 655 LVdDLVARE--TTIVDLPTAVWQLLCADGDAidaiGRSRLRQIVIGGEAIRCSAVDKwLESAASQGiSLLSSYGPTEATV 732
Cdd:PRK12316 738 LV-ELINREgvDTLHFVPSMLQAFLQDEDVA----SCTSLRRIVCSGEALPADAQEQ-VFAKLPQA-GLYNLYGPTEAAI 810
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 733 VATFLPIVCDqttmDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYLG---IDGDGFGTVTAADGSR 798
Cdd:PRK12316 811 DVTHWTCVEE----GGDSVPIGRPIANLACYIldanlepvpvgVLGELYLAGRGLARGYHGrpgLTAERFVPSPFVAGER 886
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 799 RraFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGVWFKSQRTREGEQDAAA 878
Cdd:PRK12316 887 M--YRTGDLARYRADGVIEYAGRIDHQVKLRGLRIELGEIEARLLEHPWVREAAVLAVDGKQLVGYVVLESEGGDWREAL 964
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 879 ATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKIDSDNLPRLPQWSAAGLNTAETGQRAAGLSQIWSRQLG-RAIGPDSSLL 957
Cdd:PRK12316 965 KAHLAASLPEYMVPAQWLA-LERLPLTPNGKLDRKALPAPEASVAQQGYVAPRNALERTLAAIWQDVLGvERVGLDDNFF 1043
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 958 GEGIGSLDLIRILPETRRyLGWRLSLLDLIGADTAANLADYAptpdaptgedRFRPLVAA-QRPAA--IPLSFAQRRLWF 1034
Cdd:PRK12316 1044 ELGGDSIVSIQVVSRARQ-AGIQLSPRDLFQHQTIRSLALVA----------KAGQATAAdQGPASgeVALAPVQRWFFE 1112
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1035 LDQLQRPApvYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADLgcdIVDATAWPADRL 1114
Cdd:PRK12316 1113 QAIPQRQH--WNQSLLLQARQPLDPDRLGRALERLVAHHDALRLRFREEDGGWQQAYAAPQAGEV---LWQRQAASEEEL 1187
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1115 QRAIEEAARhSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGrapdwapLPVQYVDY 1194
Cdd:PRK12316 1188 LALCEEAQR-SLDLEQGPLLRALLVDMADGSQRLLLVIHHLVVDGVSWRILLEDLQRAYADLDAD-------LPARTSSY 1259
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1195 TLWQREilgdLDDSDSPIAAQLAYWENALAGMPErlRLPTARPYPPVADQRGASLVVDWPASVQQQVRRIARQHNATSFM 1274
Cdd:PRK12316 1260 QAWARR----LHEHAGARAEELDYWQAQLEDAPH--ELPCENPDGALENRHERKLELRLDAERTRQLLQEAPAAYRTQVN 1333
|
730 740 750 760 770
....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1275 -VVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPA----LDNLVGFFVNTLVLRVNLAGD 1327
Cdd:PRK12316 1334 dLLLTALARVTCRWSGQASVLVQLEGHGREDLFedidLSRTVGWFTSLFPVRLTPAAD 1391
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
1024-1457 |
8.45e-57 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 204.14 E-value: 8.45e-57
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1024 PLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADLgcDI 1103
Cdd:cd19533 3 PLTSAQRGVWFAEQLDPEGSIYNLAEYLEITGPVDLAVLERALRQVIAEAETLRLRFTEEEGEPYQWIDPYTPVPI--RH 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1104 VDATAWPADR--LQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRA 1181
Cdd:cd19533 81 IDLSGDPDPEgaAQQWMQEDLRKPLPLDNDPLFRHALFTLGDNRHFWYQRVHHIVMDGFSFALFGQRVAEIYTALLKGRP 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1182 PDWAPLPvQYVDYtlwqreILGDLDDSDSP-IAAQLAYWENALAGMPERLRLPTARPYPPVADQRGAslvVDWPASVQQQ 1260
Cdd:cd19533 161 APPAPFG-SFLDL------VEEEQAYRQSErFERDRAFWTEQFEDLPEPVSLARRAPGRSLAFLRRT---AELPPELTRT 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1261 VRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRAR 1340
Cdd:cd19533 231 LLEAAEAHGASWPSFFIALVAAYLHRLTGANDVVLGVPVMGRLGAAARQTPGMVANTLPLRLTVDPQQTFAELVAQVSRE 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1341 SLAAYENQDVPFEVLVDRLKPTRALTH--HPLIQVMlAWQdnpvGQLNLGDLQATPMPIDTRTARmDLVFSLAERFSEGs 1418
Cdd:cd19533 311 LRSLLRHQRYRYEDLRRDLGLTGELHPlfGPTVNYM-PFD----YGLDFGGVVGLTHNLSSGPTN-DLSIFVYDRDDES- 383
|
410 420 430
....*....|....*....|....*....|....*....
gi 489495878 1419 epaGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAP 1457
Cdd:cd19533 384 ---GLRIDFDANPALYSGEDLARHQERLLRLLEEAAADP 419
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
1517-1971 |
9.28e-52 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 193.40 E-value: 9.28e-52
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTT 1596
Cdd:COG0365 39 TLTYAELRREVNRFANALRALGVKKGDRVAIYLPNIPEAVIAMLACARIGAVHSPVFPGFGAEALADRIEDAEAKVLITA 118
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1597 AGLRSRlaGHDLPIIDVVDALAA------------YPGTPPPMPAAVNL---------------------AYILYTSGTT 1643
Cdd:COG0365 119 DGGLRG--GKVIDLKEKVDEALEelpslehvivvgRTGADVPMEGDLDWdellaaasaefepeptdaddpLFILYTSGTT 196
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1644 GEPKGVGITHRNVTrLFASLPARL-----------SAAQV-WSQCHSYGfdasaweIWGALLGGGRLVIVPES-VAASPN 1710
Cdd:COG0365 197 GKPKGVVHTHGGYL-VHAATTAKYvldlkpgdvfwCTADIgWATGHSYI-------VYGPLLNGATVVLYEGRpDFPDPG 268
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1711 DFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVA---------LVVAGEACPAALVDRW--APGRVMLNAYGPTETT---I 1776
Cdd:COG0365 269 RLWELIEKYGVTVFFTAPTAIRALMKAGDEPLKkydlsslrlLGSAGEPLNPEVWEWWyeAVGVPIVDGWGQTETGgifI 348
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1777 CAAISAPLRPGSgmppIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVG--VGYWRRAGLTASRFVACPFGgsgarM 1854
Cdd:COG0365 349 SNLPGLPVKPGS----MGKPVPGYDVAVVDEDGNPVPPGEEGELVIKGPWPGmfRGYWNDPERYRETYFGRFPG-----W 419
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1855 YRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATeIAPGAVDPAG 1934
Cdd:COG0365 420 YRTGDGARRDEDGYFWILGRSDDVINVSGHRIGTAEIESALVSHPAVAEAAVVGVPDEIRGQVVKAFVV-LKPGVEPSDE 498
|
490 500 510 520
....*....|....*....|....*....|....*....|.
gi 489495878 1935 LRAQL----AQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:COG0365 499 LAKELqahvREELGPYAYPREIEFVDELPKTRSGKIMRRLL 539
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
558-911 |
2.50e-51 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 188.89 E-value: 2.50e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 558 DERVTQVTHDA----LL--ATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEI 631
Cdd:cd05930 73 AERLAYILEDSgaklVLtdPDDLAYVIYTSGSTGKPKGVMVEHRGLVNLLLWMQEAYPLTPGDRVLQFTSFSFDVSVWEI 152
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 632 FGGAACGARLVRSAAMKTGDLAALVDDLVARETTIVDLPTAVWQLLCADGDAIDAigrSRLRQIVIGGEAIRCSAVDKWL 711
Cdd:cd05930 153 FGALLAGATLVVLPEEVRKDPEALADLLAEEGITVLHLTPSLLRLLLQELELAAL---PSLRLVLVGGEALPPDLVRRWR 229
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 712 EsaASQGISLLSSYGPTEATVVATFlpIVCDQTTMDGALLRLGRPIlPNTVFL------------AFGEVVIVGDLVADG 779
Cdd:cd05930 230 E--LLPGARLVNLYGPTEATVDATY--YRVPPDDEEDGRVPIGRPI-PNTRVYvldenlrpvppgVPGELYIGGAGLARG 304
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 780 YLGIDGDgfgtvTAA------DGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd05930 305 YLNRPEL-----TAErfvpnpFGPGERMYRTGDLVRWLPDGNLEFLGRIDDQVKIRGYRIELGEIEAALLAHPGVREAAV 379
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 854 ELHSGSLGvwfkSQR-----TREGEQDAAAAT---RIRLVLVSLGVSSFFVVgVPNIPRKPNGKID 911
Cdd:cd05930 380 VAREDGDG----EKRlvayvVPDEGGELDEEElraHLAERLPDYMVPSAFVV-LDALPLTPNGKVD 440
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
575-916 |
7.29e-50 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 184.88 E-value: 7.29e-50
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLAA 654
Cdd:cd17649 97 AYVIYTSGSTGTPKGVAVSHGPLAAHCQATAERYGLTPGDRELQFASFNFDGAHEQLLPPLICGACVVLRPDELWASADE 176
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 655 LVDDLVARETTIVDLPTAVWQLLCADGDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLesaaSQGISLLSSYGPTEATVVA 734
Cdd:cd17649 177 LAEMVRELGVTVLDLPPAYLQQLAEEADRTGDGRPPSLRLYIFGGEALSPELLRRWL----KAPVRLFNAYGPTEATVTP 252
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 735 TFLPIVCDqTTMDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYLGIDG--------DGFGtvtaAD 795
Cdd:cd17649 253 LVWKCEAG-AARAGASMPIGRPLGGRSAYIldadlnpvpvgVTGELYIGGEGLARGYLGRPEltaerfvpDPFG----AP 327
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 796 GSrrRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLG-------VWfkSQR 868
Cdd:cd17649 328 GS--RLYRTGDLARWRDDGVIEYLGRVDHQVKIRGFRIELGEIEAALLEHPGVREAAVVALDGAGGkqlvayvVL--RAA 403
|
330 340 350 360
....*....|....*....|....*....|....*....|....*...
gi 489495878 869 TREGEQDAAAATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKIDSDNLP 916
Cdd:cd17649 404 AAQPELRAQLRTALRASLPDYMVPAHLVF-LARLPLTPNGKLDRKALP 450
|
|
| AA-adenyl-dom |
TIGR01733 |
amino acid adenylation domain; This model represents a domain responsible for the specific ... |
500-853 |
7.34e-50 |
|
amino acid adenylation domain; This model represents a domain responsible for the specific recognition of amino acids and activation as adenylyl amino acids. The reaction catalyzed is aa + ATP -> aa-AMP + PPi. These domains are usually found as components of multi-domain non-ribosomal peptide synthetases and are usually called "A-domains" in that context. A-domains are almost invariably followed by "T-domains" (thiolation domains, pfam00550) to which the amino acid adenylate is transferred as a thiol-ester to a bound pantetheine cofactor with the release of AMP (these are also called peptide carrier proteins, or PCPs. When the A-domain does not represent the first module (corresponding to the first amino acid in the product molecule) it is usually preceded by a "C-domain" (condensation domain, pfam00668) which catalyzes the ligation of two amino acid thiol-esters from neighboring modules. This domain is a subset of the AMP-binding domain found in Pfam (pfam00501) which also hits substrate--CoA ligases and luciferases. Sequences scoring in between trusted and noise for this model may be ambiguous as to whether they activate amino acids or other molecules lacking an alpha amino group.
Pssm-ID: 273779 [Multi-domain] Cd Length: 409 Bit Score: 183.62 E-value: 7.34e-50
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 500 LIACHLAGCGYSVCDTADEISvRTNAITEHGD-GILVTVVDVAATQLAVVGH------DELRKVVDERVTQVTHDALLAT 572
Cdd:TIGR01733 42 ILAVLKAGAAYVPLDPAYPAE-RLAFILEDAGaRLLLTDSALASRLAGLVLPvilldpLELAALDDAPAPPPPDAPSGPD 120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 573 KTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARL-VRSAAMkTGD 651
Cdd:TIGR01733 121 DLAYVIYTSGSTGRPKGVVVTHRSLVNLLAWLARRYGLDPDDRVLQFASLSFDASVEEIFGALLAGATLvVPPEDE-ERD 199
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 652 LAALVDDLVA-RETTIVDLPTAVWQLLcadgDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLESAasQGISLLSSYGPTEA 730
Cdd:TIGR01733 200 DAALLAALIAeHPVTVLNLTPSLLALL----AAALPPALASLRLVILGGEALTPALVDRWRARG--PGARLINLYGPTET 273
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 731 TVVATFLPiVCDQTTMDGALLRLGRPIlPNTVFL------------AFGEVVIVGDLVADGYLGIDG---DGFGTVTAAD 795
Cdd:TIGR01733 274 TVWSTATL-VDPDDAPRESPVPIGRPL-ANTRLYvldddlrpvpvgVVGELYIGGPGVARGYLNRPEltaERFVPDPFAG 351
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 796 GSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:TIGR01733 352 GDGARLYRTGDLVRYLPDGNLEFLGRIDDQVKIRGYRIELGEIEAALLRHPGVREAVV 409
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
1494-1971 |
9.78e-50 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 185.07 E-value: 9.78e-50
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1494 IPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPID 1573
Cdd:cd05936 1 LADLLEEAARRFPDKTALIFMGRKLTYRELDALAEAFAAGLQNLGVQPGDRVALMLPNCPQFPIAYFGALKAGAVVVPLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1574 PANPPPRVAFMLGDAVPVAAVTTAGLRSRLAghdlpiidvvdalAAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITH 1653
Cdd:cd05936 81 PLYTPRELEHILNDSGAKALIVAVSFTDLLA-------------AGAPLGERVALTPEDVAVLQYTSGTTGVPKGAMLTH 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1654 RNVTrlfaslpARLSAAQVWSQC---------------HSYGFDASaweIWGALLGGGRLVIVPEsvaASPNDFHGLLVA 1718
Cdd:cd05936 148 RNLV-------ANALQIKAWLEDllegddvvlaalplfHVFGLTVA---LLLPLALGATIVLIPR---FRPIGVLKEIRK 214
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1719 EHVSVLTQTPAAVAMLPTQ------GLESVALVVAGEA-CPAALVDRW--APGRVMLNAYGPTET---TICAAISAPLRP 1786
Cdd:cd05936 215 HRVTIFPGVPTMYIALLNApefkkrDFSSLRLCISGGApLPVEVAERFeeLTGVPIVEGYGLTETspvVAVNPLDGPRKP 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1787 GSgmppIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacpfggSGArmYRTGDLVCWRAD 1866
Cdd:cd05936 295 GS----IGIPLPGTEVKIVDDDGEELPPGEVGELWVRGPQVMKGYWNRPEETAEAFV------DGW--LRTGDIGYMDED 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1867 GQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGY 1946
Cdd:cd05936 363 GYFFIVDRKKDMIIVGGFNVYPREVEEVLYEHPAVAEAAVVGVPDPYSGEAVKAFVVLKEGASLTEEEIIAFCREQLAGY 442
|
490 500
....*....|....*....|....*
gi 489495878 1947 LVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05936 443 KVPRQVEFRDELPKSAVGKILRREL 467
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
575-1199 |
1.54e-49 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 196.15 E-value: 1.54e-49
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVrSAAMKTGDLAA 654
Cdd:PRK12467 3240 AYVIYTSGSTGKPKGVGVRHGALANHLCWIAEAYELDANDRVLLFMSFSFDGAQERFLWTLICGGCLV-VRDNDLWDPEE 3318
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 655 LVDDLVARETTIVDLPTAVWQLLCADGDAIDAigrSRLRQIVIGGEAIRCSAVDKwLESAASQgISLLSSYGPTEATVVA 734
Cdd:PRK12467 3319 LWQAIHAHRISIACFPPAYLQQFAEDAGGADC---ASLDIYVFGGEAVPPAAFEQ-VKRKLKP-RGLTNGYGPTEAVVTV 3393
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 735 TFLPIVCDQTTMDGAlLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYL---GIDGDGFGTvTAADGSRRR 800
Cdd:PRK12467 3394 TLWKCGGDAVCEAPY-APIGRPVAGRSIYVldgqlnpvpvgVAGELYIGGVGLARGYHqrpSLTAERFVA-DPFSGSGGR 3471
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 801 AFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGVWFKSQRTREGEQDAAAAT 880
Cdd:PRK12467 3472 LYRTGDLARYRADGVIEYLGRIDHQVKIRGFRIELGEIEARLLQHPSVREAVVLARDGAGGKQLVAYVVPADPQGDWRET 3551
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 881 RIRLVLVSLG---VSSFFVVgVPNIPRKPNGKIDSDNLPRlPQWSAAGLNTAETGQRAAGLSQIWSRQLGRA-IGPDSSL 956
Cdd:PRK12467 3552 LRDHLAASLPdymVPAQLLV-LAAMPLGPNGKVDRKALPD-PDAKGSREYVAPRSEVEQQLAAIWADVLGVEqVGVTDNF 3629
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 957 LGEGIGSLDLIRILPETRRYLGWRLSLLDLIGADTAANLADYAPTPDAPtgedrfrplvaaQRPAaiplsfaqrrlwfld 1036
Cdd:PRK12467 3630 FELGGDSLLALQVLSRIRQSLGLKLSLRDLMSAPTIAELAGYSPLGDVP------------VNLL--------------- 3682
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1037 qlqrpapvynmavalrlrgyLDTEALGAAVADVVGRHESLRTVFpavDGVPRQLVIEarradlgcdivdatawpadrlqr 1116
Cdd:PRK12467 3683 --------------------LDLNRLETGFPALFCRHEGLGTVF---DYEPLAVILE----------------------- 3716
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1117 aieeaarhsfdlateiplrtwlfriaDDEHVLVAVAHHIAADGWSVapltadlsaayasrcagraPDWAPLPVQYVDYTL 1196
Cdd:PRK12467 3717 --------------------------GDRHVLGLTCRHLLDDGWQD-------------------TSLQAMAVQYADYIL 3751
|
...
gi 489495878 1197 WQR 1199
Cdd:PRK12467 3752 WQQ 3754
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
1502-1967 |
1.69e-49 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 183.58 E-value: 1.69e-49
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1502 VARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRV 1581
Cdd:cd17631 5 ARRHPDRTALVFGGRSLTYAELDERVNRLAHALRALGVAKGDRVAVLSKNSPEFLELLFAAARLGAVFVPLNFRLTPPEV 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1582 AFMLGDAvpvaavttaglRSRLAGHDLpiidvvdalaaypgtpppmpaavnlAYILYTSGTTGEPKGVGITHRNVT---- 1657
Cdd:cd17631 85 AYILADS-----------GAKVLFDDL-------------------------ALLMYTSGTTGRPKGAMLTHRNLLwnav 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1658 RLFASLPAR-----LSAAQVwsqCHSYGFDASaweIWGALLGGGRLVIVPESVAASpndFHGLLVAEHVSVLTQTPAAVA 1732
Cdd:cd17631 129 NALAALDLGpddvlLVVAPL---FHIGGLGVF---TLPTLLRGGTVVILRKFDPET---VLDLIERHRVTSFFLVPTMIQ 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1733 ML------PTQGLESV-ALVVAGEACPAALVDRW-APGRVMLNAYGPTETTICAAISAP----LRPGSgmppIGVPVSGA 1800
Cdd:cd17631 200 ALlqhprfATTDLSSLrAVIYGGAPMPERLLRALqARGVKFVQGYGMTETSPGVTFLSPedhrRKLGS----AGRPVFFV 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1801 ALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFvacpFGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVK 1880
Cdd:cd17631 276 EVRIVDPDGREVPPGEVGEIVVRGPHVMAGYWNRPEATAAAF----RDG----WFHTGDLGRLDEDGYLYIVDRKKDMII 347
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1881 IRGYRIELGEVATALAELAGVGQAVVIARED-RPGDkrlVGYA-TEIAPGA-VDPAGLRAQLAQRLPGYLVPAAVVVIDA 1957
Cdd:cd17631 348 SGGENVYPAEVEDVLYEHPAVAEVAVIGVPDeKWGE---AVVAvVVPRPGAeLDEDELIAHCRERLARYKIPKSVEFVDA 424
|
490
....*....|
gi 489495878 1958 LPLTVNGKLD 1967
Cdd:cd17631 425 LPRNATGKIL 434
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
1515-1971 |
3.37e-49 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 183.06 E-value: 3.37e-49
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1515 DASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAvpvaav 1594
Cdd:cd17654 14 DTTVSYADLAEKISNLSNFLRKKFQTEERAIGLRCDRGTESPVAILAILFLGAAYAPIDPASPEQRSLTVMKKC------ 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1595 ttagLRSRLAGHDLpiiDVVDALAAYPGTPP-PMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPA--RLSAAQ 1671
Cdd:cd17654 88 ----HVSYLLQNKE---LDNAPLSFTPEHRHfNIRTDECLAYVIHTSGTTGTPKIVAVPHKCILPNIQHFRSlfNITSED 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1672 VWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEH-VSVLTQTPAAVAMLPTQ--------GLESV 1742
Cdd:cd17654 161 ILFLTSPLTFDPSVVEIFLSLSSGATLLIVPTSVKVLPSKLADILFKRHrITVLQATPTLFRRFGSQsikstvlsATSSL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1743 A-LVVAGEACPAALVDR-WAP---GRVMLNAYGPTETTiCAAISAPLRPGSGMPPIGVPVSGAALFVLDSwlrpVPAGVA 1817
Cdd:cd17654 241 RvLALGGEPFPSLVILSsWRGkgnRTRIFNIYGITEVS-CWALAYKVPEEDSPVQLGSPLLGTVIEVRDQ----NGSEGT 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1818 GELYIAG-AGVGvgywrragltasrFVACPFGGSGARMYRTGDLVCwRADGQLEFLGRTDDQVKIRGYRIELGEVATALA 1896
Cdd:cd17654 316 GQVFLGGlNRVC-------------ILDDEVTVPKGTMRATGDFVT-VKDGELFFLGRKDSQIKRRGKRINLDLIQQVIE 381
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 489495878 1897 ELAGVgQAVVIAREDrpgDKRLVGYATeiAPGAVDPAGLRAQLAQrLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd17654 382 SCLGV-ESCAVTLSD---QQRLIAFIV--GESSSSRIHKELQLTL-LSSHAIPDTFVQIDKLPLTSHGKVDKSEL 449
|
|
| ligase_PEP_1 |
TIGR03098 |
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an ... |
1497-1973 |
4.00e-46 |
|
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an AMP-binding domain (pfam00501) associated with acyl CoA-ligases. These proteins are generally found in genomes containing the exosortase/PEP-CTERM protein expoert system, specifically the type 1 variant of this system described by the Genome Property GenProp0652. When found in this context they are invariably present next to a decarboxylase enzyme. A number of sequences from Burkholderia species also hit this model, but the genomic context is obviously different. The hypothesis of a constant substrate for this family is only strong where the exosortase context is present.
Pssm-ID: 211788 [Multi-domain] Cd Length: 517 Bit Score: 175.74 E-value: 4.00e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1497 MLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPAN 1576
Cdd:TIGR03098 5 LLEDAAARLPDATALVHHDRTLTYAALSERVLALASGLRGLGLARGERVAIYLDKRLETVTAMFGAALAGGVFVPINPLL 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1577 PPPRVAFMLGDAVPVAAVTTAGLRSRL-----AGHDLPIIDVVDALA-AYPGTPPPMPAAV------------------N 1632
Cdd:TIGR03098 85 KAEQVAHILADCNVRLLVTSSERLDLLhpalpGCHDLRTLIIVGDPAhASEGHPGEEPASWpkllalgdadpphpvidsD 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1633 LAYILYTSGTTGEPKGVGITHRNVT----------------RLFASLParlsaaqvwsqchsYGFDASAWEIWGALLGGG 1696
Cdd:TIGR03098 165 MAAILYTSGSTGRPKGVVLSHRNLVagaqsvatylenrpddRLLAVLP--------------LSFDYGFNQLTTAFYVGA 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1697 RLVIVPESVaasPNDFHGLLVAEHVSVLTQTPAAVAML-----PTQGLESVA-LVVAGEACPAALVDR---WAPGRVMLN 1767
Cdd:TIGR03098 231 TVVLHDYLL---PRDVLKALEKHGITGLAAVPPLWAQLaqldwPESAAPSLRyLTNSGGAMPRATLSRlrsFLPNARLFL 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1768 AYGPTE---TTICAAISAPLRPGSgmppIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVA 1844
Cdd:TIGR03098 308 MYGLTEafrSTYLPPEEVDRRPDS----IGKAIPNAEVLVLREDGSECAPGEEGELVHRGALVAMGYWNDPEKTAERFRP 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1845 CPFGGSGARMYRT----GDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVG 1920
Cdd:TIGR03098 384 LPPFPGELHLPELavwsGDTVRRDEEGFLYFVGRRDEMIKTSGYRVSPTEVEEVAYATGLVAEAVAFGVPDPTLGQAIVL 463
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|...
gi 489495878 1921 YATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPA 1973
Cdd:TIGR03098 464 VVTPPGGEELDRAALLAECRARLPNYMVPALIHVRQALPRNANGKIDRKALAK 516
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
1510-1971 |
6.23e-45 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 169.95 E-value: 6.23e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1510 AVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAV 1589
Cdd:cd05919 3 AFYAADRSVTYGQLHDGANRLGSALRNLGVSSGDRVLLLMLDSPELVQLFLGCLARGAIAVVINPLLHPDDYAYIARDCE 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1590 PVAAVTTAglrsrlaghdlpiidvvDALAaypgtpppmpaavnlaYILYTSGTTGEPKGVGITHRNvTRLFASLPAR--- 1666
Cdd:cd05919 83 ARLVVTSA-----------------DDIA----------------YLLYSSGTTGPPKGVMHAHRD-PLLFADAMAReal 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1667 --------LSAAQVWsqcHSYGFDASaweIWGALLGGGRLVIVPESVaaSPNDFHGLLVAEHVSVLTQTPAAVA-MLPTQ 1737
Cdd:cd05919 129 gltpgdrvFSSAKMF---FGYGLGNS---LWFPLAVGASAVLNPGWP--TAERVLATLARFRPTVLYGVPTFYAnLLDSC 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1738 GLESVAL------VVAGEACPAALVDRWAP--GRVMLNAYGPTET--TICAAISAPLRPGSgmppIGVPVSGAALFVLDS 1807
Cdd:cd05919 201 AGSPDALrslrlcVSAGEALPRGLGERWMEhfGGPILDGIGATEVghIFLSNRPGAWRLGS----TGRPVPGYEIRLVDE 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1808 WLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacpfGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIE 1887
Cdd:cd05919 277 EGHTIPPGEEGDLLVRGPSAAVGYWNNPEKSRATFN----GG----WYRTGDKFCRDADGWYTHAGRADDMLKVGGQWVS 348
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1888 LGEVATALAELAGVGQAVVIAREDRPGDKRLVGY---ATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNG 1964
Cdd:cd05919 349 PVEVESLIIQHPAVAEAAVVAVPESTGLSRLTAFvvlKSPAAPQESLARDIHRHLLERLSAHKVPRRIAFVDELPRTATG 428
|
....*..
gi 489495878 1965 KLDHRAL 1971
Cdd:cd05919 429 KLQRFKL 435
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
1491-1971 |
5.74e-44 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 169.21 E-value: 5.74e-44
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1491 PVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYL 1570
Cdd:PRK06187 5 PLTIGRILRHGARKHPDKEAVYFDGRRTTYAELDERVNRLANALRALGVKKGDRVAVFDWNSHEYLEAYFAVPKIGAVLH 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1571 PIDPANPPPRVAFMLGDA-----------VPVAavttAGLRSRL--------------AGHDLPIIDVVDALAAYPGTPP 1625
Cdd:PRK06187 85 PINIRLKPEEIAYILNDAedrvvlvdsefVPLL----AAILPQLptvrtvivegdgpaAPLAPEVGEYEELLAAASDTFD 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1626 -PMPAAVNLAYILYTSGTTGEPKGVGITHRNVT--RLFASLPARLSAAQVW----SQCHSYGfdasaweiWG----ALLG 1694
Cdd:PRK06187 161 fPDIDENDAAAMLYTSGTTGHPKGVVLSHRNLFlhSLAVCAWLKLSRDDVYlvivPMFHVHA--------WGlpylALMA 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1695 GGRLVIV----PESVAAspndfhgLLVAEHVSVLTQTPAAVAML------PTQGLESVALVVAG-EACPAALVDRWA--P 1761
Cdd:PRK06187 233 GAKQVIPrrfdPENLLD-------LIETERVTFFFAVPTIWQMLlkapraYFVDFSSLRLVIYGgAALPPALLREFKekF 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1762 GRVMLNAYGPTETTICAAIsapLRPGSGMPPI-------GVPVSGAALFVLDSWLRPVPA--GVAGELYIAGAGVGVGYW 1832
Cdd:PRK06187 306 GIDLVQGYGMTETSPVVSV---LPPEDQLPGQwtkrrsaGRPLPGVEARIVDDDGDELPPdgGEVGEIIVRGPWLMQGYW 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1833 RRAGLTASRFVacpfGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDR 1912
Cdd:PRK06187 383 NRPEATAETID----GG----WLHTGDVGYIDEDGYLYITDRIKDVIISGGENIYPRELEDALYGHPAVAEVAVIGVPDE 454
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1913 PGDKRLVGYaTEIAPGA-VDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK06187 455 KWGERPVAV-VVLKPGAtLDAKELRAFLRGRLAKFKLPKRIAFVDELPRTSVGKILKRVL 513
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
475-916 |
1.28e-42 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 164.82 E-value: 1.28e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 475 LVQRGAAPGDVLVFTDDDTDKTIDLLIACHLAGCGYSVCDTA--DEisvRTNAITEHGDGILVTVVDVAATQLAVVGHDE 552
Cdd:cd17651 37 LRARGVGPGDLVALCARRSAELVVALLAILKAGAAYVPLDPAypAE---RLAFMLADAGPVLVLTHPALAGELAVELVAV 113
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 553 LRKVVDERVTQVTHD---ALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVE 629
Cdd:cd17651 114 TLLDQPGAAAGADAEpdpALDADDLAYVIYTSGSTGRPKGVVMPHRSLANLVAWQARASSLGPGARTLQFAGLGFDVSVQ 193
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 630 EIFGGAACGARLVRSAAMKTGDLAALVDDLVARETTIVDLPTAVWQLLCADGDAIDAIGrSRLRQIVIGGEAIRC-SAVD 708
Cdd:cd17651 194 EIFSTLCAGATLVLPPEEVRTDPPALAAWLDEQRISRVFLPTVALRALAEHGRPLGVRL-AALRYLLTGGEQLVLtEDLR 272
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 709 KWLesAASQGISLLSSYGPTEATVV-ATFLPIVCDQTtmdGALLRLGRPIlPNT---VFLAF---------GEVVIVGDL 775
Cdd:cd17651 273 EFC--AGLPGLRLHNHYGPTETHVVtALSLPGDPAAW---PAPPPIGRPI-DNTrvyVLDAAlrpvppgvpGELYIGGAG 346
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 776 VADGYLGIDG--------DGFGTvtaadgsRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPA 847
Cdd:cd17651 347 LARGYLNRPEltaerfvpDPFVP-------GARMYRTGDLARWLPDGELEFLGRADDQVKIRGFRIELGEIEAALARHPG 419
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 489495878 848 VSDVAVELHSGSLG----VWFKSQRTREGEQDAAAATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKIDSDNLP 916
Cdd:cd17651 420 VREAVVLAREDRPGekrlVAYVVGDPEAPVDAAELRAALATHLPEYMVPSAFVL-LDALPLTPNGKLDRRALP 491
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1525-1971 |
1.66e-42 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 163.38 E-value: 1.66e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1525 EASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAA----YLPIDPANPPPRVAFMLGDAVPVAAVTTAGLR 1600
Cdd:cd05922 1 LGVSAAASALLEAGGVRGERVVLILPNRFTYIELSFAVAYAGGRlglvFVPLNPTLKESVLRYLVADAGGRIVLADAGAA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1601 SRL------AGHDLPIIDVVDALAAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPARL--SAAQV 1672
Cdd:cd05922 81 DRLrdalpaSPDPGTVLDADGIRAARASAPAHEVSHEDLALLLYTSGSTGSPKLVRLSHQNLLANARSIAEYLgiTADDR 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1673 WSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAasPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVAL------VV 1746
Cdd:cd05922 161 ALTVLPLSYDYGLSVLNTHLLRGATLVLTNDGVL--DDAFWEDLREHGATGLAGVPSTYAMLTRLGFDPAKLpslrylTQ 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1747 AGEACPAALVDRWA---PGRVMLNAYGPTETTICAAISAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIA 1823
Cdd:cd05922 239 AGGRLPQETIARLRellPGAQVYVMYGQTEATRRMTYLPPERILEKPGSIGLAIPGGEFEILDDDGTPTPPGEPGEIVHR 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1824 GAGVGVGYWRR-AGLTAsrfvacpfGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVG 1902
Cdd:cd05922 319 GPNVMKGYWNDpPYRRK--------EGRGGGVLHTGDLARRDEDGFLFIVGRRDRMIKLFGNRISPTEIEAAARSIGLII 390
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1903 QAVVIAREDRPGDkRLVGYATeiAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05922 391 EAAAVGLPDPLGE-KLALFVT--APDKIDPKDVLRSLAERLPPYKVPATVRVVDELPLTASGKVDYAAL 456
|
|
| C_PKS-NRPS_PksJ-like |
cd20484 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1022-1457 |
8.62e-42 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380472 [Multi-domain] Cd Length: 430 Bit Score: 160.56 E-value: 8.62e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1022 AIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARraDLGC 1101
Cdd:cd20484 1 RSPLSEGQKGLWMLQKMSPEMSAYNVPLCFRFSSKLDVEKFKQACQFVLEQHPILKSVIEEEDGVPFQKIEPSK--PLSF 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1102 DIVDATAWPADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRA 1181
Cdd:cd20484 79 QEEDISSLKESEIIAYLREKAKEPFVLENGPLMRVHLFSRSEQEHFVLITIHHIIFDGSSSLTLIHSLLDAYQALLQGKQ 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1182 PDWAPLPVQYVDYTLWQREILGDLDDsdspiAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQV 1261
Cdd:cd20484 159 PTLASSPASYYDFVAWEQDMLAGAEG-----EEHRAYWKQQLSGTLPILELPADRPRSSAPSFEGQTYTRRLPSELSNQI 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1262 RRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRARS 1341
Cdd:cd20484 234 KSFARSQSINLSTVFLGIFKLLLHRYTGQEDIIVGMPTMGRPEERFDSLIGYFINMLPIRSRILGEETFSDFIRKLQLTV 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1342 LAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQdNPVGQLNLGDLQA---TPMPID-----TRTARMDLVFSLAEr 1413
Cdd:cd20484 314 LDGLDHAAYPFPAMVRDLNIPRSQANSPVFQVAFFYQ-NFLQSTSLQQFLAeyqDVLSIEfvegiHQEGEYELVLEVYE- 391
|
410 420 430 440
....*....|....*....|....*....|....*....|....
gi 489495878 1414 fsegsEPAGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAP 1457
Cdd:cd20484 392 -----QEDRFTLNIKYNPDLFDASTIERMMEHYVKLAEELIANP 430
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
1517-1971 |
1.10e-41 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 162.15 E-value: 1.10e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTT 1596
Cdd:cd05959 29 SLTYAELEAEARRVAGALRALGVKREERVLLIMLDTVDFPTAFLGAIRAGIVPVPVNTLLTPDDYAYYLEDSRARVVVVS 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1597 AGLRSRLA------GHDLPIIDVVDALAAYPGTP----------PPMPAAV----NLAYILYTSGTTGEPKGVGITHRNV 1656
Cdd:cd05959 109 GELAPVLAaaltksEHTLVVLIVSGGAGPEAGALllaelvaaeaEQLKPAAthadDPAFWLYSSGSTGRPKGVVHLHADI 188
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1657 tRLFASLPAR-----------LSAAQVWsqcHSYGFDASaweIWGALLGGGRLVIVPESVAasPNDFHGLLVAEHVSVLT 1725
Cdd:cd05959 189 -YWTAELYARnvlgireddvcFSAAKLF---FAYGLGNS---LTFPLSVGATTVLMPERPT--PAAVFKRIRRYRPTVFF 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1726 QTPAAVA-ML-----PTQGLESVALVV-AGEACPAALVDRWAP--GRVMLNAYGPTET--TICAAISAPLRPGSGmppiG 1794
Cdd:cd05959 260 GVPTLYAaMLaapnlPSRDLSSLRLCVsAGEALPAEVGERWKArfGLDILDGIGSTEMlhIFLSNRPGRVRYGTT----G 335
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1795 VPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacpfGGsgarMYRTGDLVCWRADGQLEFLGR 1874
Cdd:cd05959 336 KPVPGYEVELRDEDGGDVADGEPGELYVRGPSSATMYWNNRDKTRDTFQ----GE----WTRTGDKYVRDDDGFYTYAGR 407
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1875 TDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGY---ATEIAPGAVDPAGLRAQLAQRLPGYLVPAA 1951
Cdd:cd05959 408 ADDMLKVSGIWVSPFEVESALVQHPAVLEAAVVGVEDEDGLTKPKAFvvlRPGYEDSEALEEELKEFVKDRLAPYKYPRW 487
|
490 500
....*....|....*....|
gi 489495878 1952 VVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05959 488 IVFVDELPKTATGKIQRFKL 507
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
574-915 |
1.91e-40 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 157.08 E-value: 1.91e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLV---RSAAMKTG 650
Cdd:cd17643 95 LAYVIYTSGSTGRPKGVVVSHANVLALFAATQRWFGFNEDDVWTLFHSYAFDFSVWEIWGALLHGGRLVvvpYEVARSPE 174
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 651 DLAALVDDlvARETTIVDLPTAVWQLLCAdgDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLESAASQGISLLSSYGPTEA 730
Cdd:cd17643 175 DFARLLRD--EGVTVLNQTPSAFYQLVEA--ADRDGRDPLALRYVIFGGEALEAAMLRPWAGRFGLDRPQLVNMYGITET 250
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 731 TVVATFLPIVCDQTTmDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYLGIDG---DGFGTVTAADG 796
Cdd:cd17643 251 TVHVTFRPLDAADLP-AAAASPIGRPLPGLRVYVldadgrpvppgVVGELYVSGAGVARGYLGRPEltaERFVANPFGGP 329
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 797 SRRRaFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGvwfkSQR------TR 870
Cdd:cd17643 330 GSRM-YRTGDLARRLPDGELEYLGRADEQVKIRGFRIELGEIEAALATHPSVRDAAVIVREDEPG----DTRlvayvvAD 404
|
330 340 350 360
....*....|....*....|....*....|....*....|....*..
gi 489495878 871 EGEQDAAAATR--IRLVLVSLGVSSFFvVGVPNIPRKPNGKIDSDNL 915
Cdd:cd17643 405 DGAAADIAELRalLKELLPDYMVPARY-VPLDALPLTVNGKLDRAAL 450
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
559-911 |
4.41e-40 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 156.25 E-value: 4.41e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 559 ERVTQVTH----DALLATKT--AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIF 632
Cdd:cd05945 78 ERIREILDaakpALLIADGDdnAYIIFTSGSTGRPKGVQISHDNLVSFTNWMLSDFPLGPGDVFLNQAPFSFDLSVMDLY 157
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 633 GGAACGARLVRSAAMKTGDLAALVDDLVARETTI-VDLPTAVWQLLCADGDAIDAIGRsrLRQIVIGGEAIRCSAVDKWL 711
Cdd:cd05945 158 PALASGATLVPVPRDATADPKQLFRFLAEHGITVwVSTPSFAAMCLLSPTFTPESLPS--LRHFLFCGEVLPHKTARALQ 235
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 712 EsaASQGISLLSSYGPTEATVVATF-------------LPI-----VCDQTTMDGAllrlGRPILPNTVflafGEVVIVG 773
Cdd:cd05945 236 Q--RFPDARIYNTYGPTEATVAVTYievtpevldgydrLPIgyakpGAKLVILDED----GRPVPPGEK----GELVISG 305
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 774 DLVADGYLGIDGDGFGTVTAADGsrRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSD-VA 852
Cdd:cd05945 306 PSVSKGYLNNPEKTAAAFFPDEG--QRAYRTGDLVRLEADGLLFYRGRLDFQVKLNGYRIELEEIEAALRQVPGVKEaVV 383
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 489495878 853 VELHSGSLGVWFKSQRTREGEQDAAAATRIRLVLVSL----GVSSFFVVgVPNIPRKPNGKID 911
Cdd:cd05945 384 VPKYKGEKVTELIAFVVPKPGAEAGLTKAIKAELAERlppyMIPRRFVY-LDELPLNANGKID 445
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
575-1323 |
9.44e-40 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 163.80 E-value: 9.44e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTG--DL 652
Cdd:PRK05691 2336 AYLIYTSGSTGKPKGVVVSHGEIAMHCQAVIERFGMRADDCELHFYSINFDAASERLLVPLLCGARVVLRAQGQWGaeEI 2415
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 653 AALVddlvaRETTIVDL---PTAVWQL---LCADGDaidaigRSRLRQIVIGGEAIRCSAVDKWleSAASQGISLLSSYG 726
Cdd:PRK05691 2416 CQLI-----REQQVSILgftPSYGSQLaqwLAGQGE------QLPVRMCITGGEALTGEHLQRI--RQAFAPQLFFNAYG 2482
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 727 PTEaTVVATFLPIVCDQTTMDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGY---LGIDGDGF-GTV 791
Cdd:PRK05691 2483 PTE-TVVMPLACLAPEQLEEGAASVPIGRVVGARVAYIldadlalvpqgATGELYVGGAGLAQGYhdrPGLTAERFvADP 2561
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 792 TAADGSRrrAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSD---VAVELHSGSLGVWFKSQR 868
Cdd:PRK05691 2562 FAADGGR--LYRTGDLVRLRADGLVEYVGRIDHQVKIRGFRIELGEIESRLLEHPAVREavvLALDTPSGKQLAGYLVSA 2639
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 869 TREGEQDAAAATR------IRLVLVSLGVSSFFVVgVPNIPRKPNGKIDSDNLPrLPQWSAAGLN-TAETGQRAAGLSQI 941
Cdd:PRK05691 2640 VAGQDDEAQAALRealkahLKQQLPDYMVPAHLIL-LDSLPLTANGKLDRRALP-APDPELNRQAyQAPRSELEQQLAQI 2717
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 942 WSRQLG-RAIGPDSSLLGEGIGSLDLIRILPETRRyLGWRLSLLDLIGADTAANLADYAPTPDAPTGEDrfrplvaAQRP 1020
Cdd:PRK05691 2718 WREVLNvERVGLGDNFFELGGDSILSIQVVSRARQ-LGIHFSPRDLFQHQTVQTLAAVATHSEAAQAEQ-------GPLQ 2789
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1021 AAIPLSFAQRrlWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPR---------QLV 1091
Cdd:PRK05691 2790 GASGLTPIQH--WFFDSPVPQPQHWNQALLLEPRQALDPALLEQALQALVEHHDALRLRFSQADGRWQaeyravtaqELL 2867
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1092 IEARRADLGcdivDATAWPADrLQRaieeaarhSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSA 1171
Cdd:PRK05691 2868 WQVTVADFA----ECAALFAD-AQR--------SLDLQQGPLLRALLVDGPQGQQRLLLAIHHLVVDGVSWRVLLEDLQA 2934
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1172 AYASRCAGRAPdwaPLPVQYVDYTLWQrEILGDLDDSDSpIAAQLAYWENALAGmpERLRLPTARPYPPVADQRGASLVV 1251
Cdd:PRK05691 2935 LYRQLSAGAEP---ALPAKTSAFRDWA-ARLQAYAGSES-LREELGWWQAQLGG--PRAELPCDRPQGGNLNRHAQTVSV 3007
|
730 740 750 760 770 780 790
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1252 DWPASVQQQV--RRIARQHNATSFMVVAAgLAVLLSKLSGSPDVAVGFPIAGRS----DPALDNLVGFFVNTLVLRVN 1323
Cdd:PRK05691 3008 RLDAERTRQLlqQAPAAYRTQVNDLLLTA-LARVLCRWSGQPSVLVQLEGHGREalfdDIDLTRSVGWFTSAYPLRLT 3084
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
1517-1971 |
1.35e-39 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 154.37 E-value: 1.35e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRL-AGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPvaavt 1595
Cdd:cd05941 11 SITYADLVARAARLANRLlALGKDLRGDRVAFLAPPSAEYVVAQLAIWRAGGVAVPLNPSYPLAELEYVITDSEP----- 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1596 taglrsrlaghdlpiidvvdalaaypgtpppmPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLparlsaAQVWS- 1674
Cdd:cd05941 86 --------------------------------SLVLDPALILYTSGTTGRPKGVVLTHANLAANVRAL------VDAWRw 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1675 -------QC----HSYG-FDASAweiwGALLGGGRLVIVPESVAASPNdfhGLLVAEHVSVLTQTP-------AAVAMLP 1735
Cdd:cd05941 128 teddvllHVlplhHVHGlVNALL----CPLFAGASVEFLPKFDPKEVA---ISRLMPSITVFMGVPtiytrllQYYEAHF 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1736 TQ-------GLESVALVVAGEAC-PAALVDRWAP--GRVMLNAYGPTETTIcaAISAPL----RPGS-GMPPIGVPVsga 1800
Cdd:cd05941 201 TDpqfaraaAAERLRLMVSGSAAlPVPTLEEWEAitGHTLLERYGMTEIGM--ALSNPLdgerRPGTvGMPLPGVQA--- 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1801 aLFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCWRADGQLEFLGRT-DDQV 1879
Cdd:cd05941 276 -RIVDEETGEPLPRGEVGEIQVRGPSVFKEYWNKPEATKEEFTDDGW-------FKTGDLGVVDEDGYYWILGRSsVDII 347
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1880 KIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGY-ATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDAL 1958
Cdd:cd05941 348 KSGGYKVSALEIERVLLAHPGVSECAVIGVPDPDWGERVVAVvVLRAGAAALSLEELKEWAKQRLAPYKRPRRLILVDEL 427
|
490
....*....|...
gi 489495878 1959 PLTVNGKLDHRAL 1971
Cdd:cd05941 428 PRNAMGKVNKKEL 440
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
575-916 |
4.23e-39 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 154.02 E-value: 4.23e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLAA 654
Cdd:cd17655 140 AYVIYTSGSTGKPKGVMIEHRGVVNLVEWANKVIYQGEHLRVALFASISFDASVTEIFASLLSGNTLYIVRKETVLDGQA 219
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 655 LVDDLVARETTIVDLPTAVWQLLcadgDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLESAASQgISLLSSYGPTEATVVA 734
Cdd:cd17655 220 LTQYIRQNRITIIDLTPAHLKLL----DAADDSEGLSLKHLIVGGEALSTELAKKIIELFGTN-PTITNAYGPTETTVDA 294
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 735 TFLPivCDQTTMDGALLRLGRPILPNTVFLA-----------FGEVVIVGDLVADGYLGIDgdgfgTVTAAD------GS 797
Cdd:cd17655 295 SIYQ--YEPETDQQVSVPIGKPLGNTRIYILdqygrpqpvgvAGELYIGGEGVARGYLNRP-----ELTAEKfvddpfVP 367
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 798 RRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV-----ELHSGSLGVWFKSQR--TR 870
Cdd:cd17655 368 GERMYRTGDLARWLPDGNIEFLGRIDHQVKIRGYRIELGEIEARLLQHPDIKEAVViarkdEQGQNYLCAYIVSEKelPV 447
|
330 340 350 360
....*....|....*....|....*....|....*....|....*.
gi 489495878 871 EGEQDAAAATrirlvLVSLGVSSFFvVGVPNIPRKPNGKIDSDNLP 916
Cdd:cd17655 448 AQLREFLARE-----LPDYMIPSYF-IKLDEIPLTPNGKVDRKALP 487
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
559-916 |
1.40e-38 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 152.20 E-value: 1.40e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 559 ERVTQVTHDA---LLATKT---AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIF 632
Cdd:cd17644 87 ERLTYILEDAqisVLLTQPenlAYVIYTSGSTGKPKGVMIEHQSLVNLSHGLIKEYGITSSDRVLQFASIAFDVAAEEIY 166
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 633 GGAACGARLV-RSAAMKTgDLAALVDDLVARETTIVDLPTAVWQLLCADGDAIDAIGRSRLRQIVIGGEAIRCSAVDKWL 711
Cdd:cd17644 167 VTLLSGATLVlRPEEMRS-SLEDFVQYIQQWQLTVLSLPPAYWHLLVLELLLSTIDLPSSLRLVIVGGEAVQPELVRQWQ 245
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 712 EsAASQGISLLSSYGPTEATVVATFLPIVCDQTTMDGALLrLGRPIlPNT---VFLAF---------GEVVIVGDLVADG 779
Cdd:cd17644 246 K-NVGNFIQLINVYGPTEATIAATVCRLTQLTERNITSVP-IGRPI-ANTqvyILDENlqpvpvgvpGELHIGGVGLARG 322
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 780 YLG---IDGDGFGTVTAADGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELH 856
Cdd:cd17644 323 YLNrpeLTAEKFISHPFNSSESERLYKTGDLARYLPDGNIEYLGRIDNQVKIRGFRIELGEIEAVLSQHNDVKTAVVIVR 402
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 857 SGSLG-----VWFKSQRTREGeqdaaAATRIRLVLVS----LGVSSFFVVgVPNIPRKPNGKIDSDNLP 916
Cdd:cd17644 403 EDQPGnkrlvAYIVPHYEESP-----STVELRQFLKAklpdYMIPSAFVV-LEELPLTPNGKIDRRALP 465
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1519-1972 |
3.44e-38 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 149.75 E-value: 3.44e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPanppprvafmlgdavpvaavttag 1598
Cdd:cd05934 5 TYAELLRESARIAAALAALGIRPGDRVALMLDNCPEFLFAWFALAKLGAVLVPINT------------------------ 60
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1599 lrsRLAGHDLP-IIDVVDALAAYpgtpppmpaaVNLAYILYTSGTTGEPKGVGITHRNVT----------------RLFA 1661
Cdd:cd05934 61 ---ALRGDELAyIIDHSGAQLVV----------VDPASILYTSGTTGPPKGVVITHANLTfagyysarrfglgeddVYLT 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1662 SLPARLSAAQVWSqchsygfdasaweIWGALLGGGRLVIVPesvAASPNDFHGLLVAEHVSVLTQTPAAVAML------P 1735
Cdd:cd05934 128 VLPLFHINAQAVS-------------VLAALSVGATLVLLP---RFSASRFWSDVRRYGATVTNYLGAMLSYLlaqppsP 191
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1736 TQGLESVALVVAGEACP---AALVDRWapGRVMLNAYGPTETTIC--AAISAPLRPGSgmppIGVPVSGAALFVLDSWLR 1810
Cdd:cd05934 192 DDRAHRLRAAYGAPNPPelhEEFEERF--GVRLLEGYGMTETIVGviGPRDEPRRPGS----IGRPAPGYEVRIVDDDGQ 265
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1811 PVPAGVAGELYIAGA---GVGVGYWRRAGLTASRFVacpfGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIE 1887
Cdd:cd05934 266 ELPAGEPGELVIRGLrgwGFFKGYYNMPEATAEAMR----NG----WFHTGDLGYRDADGFFYFVDRKKDMIRRRGENIS 337
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1888 LGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLD 1967
Cdd:cd05934 338 SAEVERAILRHPAVREAAVVAVPDEVGEDEVKAVVVLRPGETLDPEELFAFCEGQLAYFKVPRYIRFVDDLPKTPTEKVA 417
|
....*
gi 489495878 1968 HRALP 1972
Cdd:cd05934 418 KAQLR 422
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
475-911 |
3.44e-38 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 151.20 E-value: 3.44e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 475 LVQRGAAPGDVLVFTDDDTDKTIDLLIACHLAGCGYSVCDTADEISVRTNAITEHGDGILVT----VVDVAATQLAVVGH 550
Cdd:cd12117 39 LRAAGVGPGDVVGVLAERSPELVVALLAVLKAGAAYVPLDPELPAERLAFMLADAGAKVLLTdrslAGRAGGLEVAVVID 118
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 551 DELrkvvDERVTQVTHDALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCdAISRAYGWGAHDTVLQCAPLTSDISVEE 630
Cdd:cd12117 119 EAL----DAGPAGNPAVPVSPDDLAYVMYTSGSTGRPKGVAVTHRGVVRLV-KNTNYVTLGPDDRVLQTSPLAFDASTFE 193
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 631 IFGGAACGARLVRSAAMKTGDLAALVDDLVARETTIVDLPTAVWQLLcADgDAIDAIgrSRLRQIVIGGEAIRCSAVDKW 710
Cdd:cd12117 194 IWGALLNGARLVLAPKGTLLDPDALGALIAEEGVTVLWLTAALFNQL-AD-EDPECF--AGLRELLTGGEVVSPPHVRRV 269
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 711 LESAAsqGISLLSSYGPTEATVVATFLPIvcDQTTMDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADG 779
Cdd:cd12117 270 LAACP--GLRLVNGYGPTENTTFTTSHVV--TELDEVAGSIPIGRPIANTRVYVldedgrpvppgVPGELYVGGDGLALG 345
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 780 YLGIDG---DGFgtVTAADGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELH 856
Cdd:cd12117 346 YLNRPAltaERF--VADPFGPGERLYRTGDLARWLPDGRLEFLGRIDDQVKIRGFRIELGEIEAALRAHPGVREAVVVVR 423
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 489495878 857 SGSLGvwfkSQR-----TREGEQDAAAA-TRIRLVLVSLGVSSFFVVgVPNIPRKPNGKID 911
Cdd:cd12117 424 EDAGG----DKRlvayvVAEGALDAAELrAFLRERLPAYMVPAAFVV-LDELPLTANGKVD 479
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
575-1009 |
7.45e-38 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 157.81 E-value: 7.45e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAmKTGDLAA 654
Cdd:PRK12316 4697 AYVIYTSGSTGRPKGVAVSHGSLVNHLHATGERYELTPDDRVLQFMSFSFDGSHEGLYHPLINGASVVIRDD-SLWDPER 4775
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 655 LVDDLVARETTIVDLPTAVWQLLcADGDAIDAiGRSRLRQIVIGGEAIRCSAVDKWLESAASqgISLLSSYGPTEATVVA 734
Cdd:PRK12316 4776 LYAEIHEHRVTVLVFPPVYLQQL-AEHAERDG-EPPSLRVYCFGGEAVAQASYDLAWRALKP--VYLFNGYGPTETTVTV 4851
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 735 TFLPivCDQTTMDGA-LLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYLGIDG--------DGFGtvtaA 794
Cdd:PRK12316 4852 LLWK--ARDGDACGAaYMPIGTPLGNRSGYVldgqlnplpvgVAGELYLGGEGVARGYLERPAltaerfvpDPFG----A 4925
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 795 DGSrrRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGV----WFKSQRTR 870
Cdd:PRK12316 4926 PGG--RLYRTGDLARYRADGVIDYLGRVDHQVKIRGFRIELGEIEARLREHPAVREAVVIAQEGAVGKqlvgYVVPQDPA 5003
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 871 EGEQDAAAA-------TRIRLVLVSLGVSSFFVVgVPNIPRKPNGKIDSDNlprLPQWSAAGLNTA------ETGQRAAG 937
Cdd:PRK12316 5004 LADADEAQAelrdelkAALRERLPEYMVPAHLVF-LARMPLTPNGKLDRKA---LPQPDASLLQQAyvaprsELEQQVAA 5079
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 489495878 938 lsqIWSRQLG-RAIGPDSSLLGEGIGSLDLIRILPETRRYLGWRLSLLDLIGADTAANLADYAPTPDAPTGED 1009
Cdd:PRK12316 5080 ---IWAEVLQlERVGLDDNFFELGGHSLLAIQVTSRIQLELGLELPLRELFQTPTLAAFVELAAAAGSGDDEK 5149
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
531-911 |
1.84e-37 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 149.35 E-value: 1.84e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 531 DGILVTVVDVAATQLAVVGHDELRKVVDERVTQVTHDALLAT----KTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISR 606
Cdd:cd17646 93 DAGPAVVLTTADLAARLPAGGDVALLGDEALAAPPATPPLVPprpdNLAYVIYTSGSTGRPKGVMVTHAGIVNRLLWMQD 172
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 607 AYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLAALVDDLVARETTIVDLPTAVWQLLCADGDAIDA 686
Cdd:cd17646 173 EYPLGPGDRVLQKTPLSFDVSVWELFWPLVAGARLVVARPGGHRDPAYLAALIREHGVTTCHFVPSMLRVFLAEPAAGSC 252
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 687 IGrsrLRQIVIGGEAIRCSAVDKWLESAasqGISLLSSYGPTEATVVATFLPivCDQTTMDGALLrLGRPIlPNTVFL-- 764
Cdd:cd17646 253 AS---LRRVFCSGEALPPELAARFLALP---GAELHNLYGPTEAAIDVTHWP--VRGPAETPSVP-IGRPV-PNTRLYvl 322
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 765 ----------AFGEVVIVGDLVADGYLGIDGdgfgtVTAA------DGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKI 828
Cdd:cd17646 323 ddalrpvpvgVPGELYLGGVQLARGYLGRPA-----LTAErfvpdpFGPGSRMYRTGDLARWRPDGALEFLGRSDDQVKI 397
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 829 SGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGV-----WFKSQRTREGEQDAAAATRIRLVLVSLGVSSFFVVgVPNIP 903
Cdd:cd17646 398 RGFRVEPGEIEAALAAHPAVTHAVVVARAAPAGAarlvgYVVPAAGAAGPDTAALRAHLAERLPEYMVPAAFVV-LDALP 476
|
....*...
gi 489495878 904 RKPNGKID 911
Cdd:cd17646 477 LTANGKLD 484
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
1517-1974 |
4.24e-37 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 148.82 E-value: 4.24e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTT 1596
Cdd:cd17647 20 SFTYRDINEASNIVAHYLIKTGIKRGDVVMIYSYRGVDLMVAVMGVLKAGATFSVIDPAYPPARQNIYLGVAKPRGLIVI 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1597 aglrsRLAGhdlpiidVVDAlaayPGTPPPMPaavnlayilYTSGTTGEPKGVGITHRNVTRLFASLPAR--LSAAQVWS 1674
Cdd:cd17647 100 -----RAAG-------VVVG----PDSNPTLS---------FTSGSEGIPKGVLGRHFSLAYYFPWMAKRfnLSENDKFT 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1675 QCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLES---------VALV 1745
Cdd:cd17647 155 MLSGIAHDPIQRDMFTPLFLGAQLLVPTQDDIGTPGRLAEWMAKYGATVTHLTPAMGQLLTAQATTPfpklhhaffVGDI 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1746 VAGEACpaALVDRWAPGRVMLNAYGPTET---------TICAAISAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGV 1816
Cdd:cd17647 235 LTKRDC--LRLQTLAENVRIVNMYGTTETqravsyfevPSRSSDPTFLKNLKDVMPAGRGMLNVQLLVVNRNDRTQICGI 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1817 A--GELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGA---------------------RMYRTGDLVCWRADGQLEFLG 1873
Cdd:cd17647 313 GevGEIYVRAGGLAEGYRGLPELNKEKFVNNWFVEPDHwnyldkdnnepwrqfwlgprdRLYRTGDLGRYLPNGDCECCG 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1874 RTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGY-------------ATEIAPGAVDPAG------ 1934
Cdd:cd17647 393 RADDQVKIRGFRIELGEIDTHISQHPLVRENITLVRRDKDEEPTLVSYivprfdkpddesfAQEDVPKEVSTDPivkgli 472
|
490 500 510 520
....*....|....*....|....*....|....*....|....*...
gi 489495878 1935 --------LRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAP 1974
Cdd:cd17647 473 gyrklikdIREFLKKRLASYAIPSLIVVLDKLPLNPNGKVDKPKLQFP 520
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
1489-1971 |
5.76e-37 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 148.13 E-value: 5.76e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1489 PTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAA 1568
Cdd:PRK07656 2 NEWMTLPELLARAARRFGDKEAYVFGDQRLTYAELNARVRRAAAALAALGIGKGDRVAIWAPNSPHWVIAALGALKAGAV 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1569 YLPIDPANPPPRVAFMLGDAVPVAAVTTAGL--RSRLAGHDLPIIDVV-------------------DALAayPGTPPPM 1627
Cdd:PRK07656 82 VVPLNTRYTADEAAYILARGDAKALFVLGLFlgVDYSATTRLPALEHVviceteeddphtekmktftDFLA--AGDPAER 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1628 PAAVN---LAYILYTSGTTGEPKGVGITHRNVtrlfaslparLSAAQVWSQC----------------HSYGFDASaweI 1688
Cdd:PRK07656 160 APEVDpddVADILFTSGTTGRPKGAMLTHRQL----------LSNAADWAEYlgltegdrylaanpffHVFGYKAG---V 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1689 WGALLGGGRLVIVPesvAASPNDFHGLLVAEHVSVLTQTPA------AVAMLPTQGLESVALVVAGEAC-PAALVDRWA- 1760
Cdd:PRK07656 227 NAPLMRGATILPLP---VFDPDEVFRLIETERITVLPGPPTmynsllQHPDRSAEDLSSLRLAVTGAASmPVALLERFEs 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1761 --PGRVMLNAYGPTE----TTIC-AAISAPLRPGSgmppIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWR 1833
Cdd:PRK07656 304 elGVDIVLTGYGLSEasgvTTFNrLDDDRKTVAGT----IGTAIAGVENKIVNELGEEVPVGEVGELLVRGPNVMKGYYD 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1834 RAGLTASrfvACPFGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIARED-R 1912
Cdd:PRK07656 380 DPEATAA---AIDADG----WLHTGDLGRLDEEGYLYIVDRKKDMFIVGGFNVYPAEVEEVLYEHPAVAEAAVIGVPDeR 452
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 489495878 1913 PGDkrlVGYATEIA-PGA-VDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK07656 453 LGE---VGKAYVVLkPGAeLTEEELIAYCREHLAKYKVPRSIEFLDELPKNATGKVLKRAL 510
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
574-911 |
7.00e-37 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 146.88 E-value: 7.00e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDIS-VEEIFGGAACGARLVrsaAMKTGDL 652
Cdd:COG0318 102 TALILYTSGTTGRPKGVMLTHRNLLANAAAIAAALGLTPGDVVLVALPLFHVFGlTVGLLAPLLAGATLV---LLPRFDP 178
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 653 AALVDDLVARETTIVDLPTAVWQLLCADGDAiDAIGRSRLRQIVIGGEAIRCSAVDKWLESAasqGISLLSSYGPTEATV 732
Cdd:COG0318 179 ERVLELIERERVTVLFGVPTMLARLLRHPEF-ARYDLSSLRLVVSGGAPLPPELLERFEERF---GVRIVEGYGLTETSP 254
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 733 VATFLPIVCDQTT-------MDGALLRL----GRPILPNTVflafGEVVIVGDLVADGYLGiDGDGfgtvTA---ADGsr 798
Cdd:COG0318 255 VVTVNPEDPGERRpgsvgrpLPGVEVRIvdedGRELPPGEV----GEIVVRGPNVMKGYWN-DPEA----TAeafRDG-- 323
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 799 rrAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV-----ELHSGSLGVWFksqRTREGE 873
Cdd:COG0318 324 --WLRTGDLGRLDEDGYLYIVGRKKDMIISGGENVYPAEVEEVLAAHPGVAEAAVvgvpdEKWGERVVAFV---VLRPGA 398
|
330 340 350 360
....*....|....*....|....*....|....*....|
gi 489495878 874 QDAAAATR--IRLVLVSLGVSSFFVVgVPNIPRKPNGKID 911
Cdd:COG0318 399 ELDAEELRafLRERLARYKVPRRVEF-VDELPRTASGKID 437
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
574-911 |
1.48e-36 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 146.53 E-value: 1.48e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARL-VRSAAMKTGDL 652
Cdd:cd05918 108 AAYVIFTSGSTGKPKGVVIEHRALSTSALAHGRALGLTSESRVLQFASYTFDVSILEIFTTLAAGGCLcIPSEEDRLNDL 187
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 653 AALVDDL----------VARETTIVDLPTavwqllcadgdaidaigrsrLRQIVIGGEAIRCSAVDKWlesaaSQGISLL 722
Cdd:cd05918 188 AGFINRLrvtwafltpsVARLLDPEDVPS--------------------LRTLVLGGEALTQSDVDTW-----ADRVRLI 242
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 723 SSYGPTEATVVATFLPIVCDQTTmdgalLRLGRPIlPNTVFL-------------AFGEVVIVGDLVADGYLG------- 782
Cdd:cd05918 243 NAYGPAECTIAATVSPVVPSTDP-----RNIGRPL-GATCWVvdpdnhdrlvpigAVGELLIEGPILARGYLNdpektaa 316
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 783 --IDGDGFGTvTAADGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAE-DPAVSDVAVEL--HS 857
Cdd:cd05918 317 afIEDPAWLK-QEGSGRGRRLYRTGDLVRYNPDGSLEYVGRKDTQVKIRGQRVELGEIEHHLRQsLPGAKEVVVEVvkPK 395
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 489495878 858 GSLG----VWFKSQRTREGEQD-----------------AAAATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKID 911
Cdd:cd05918 396 DGSSspqlVAFVVLDGSSSGSGdgdslflepsdefralvAELRSKLRQRLPSYMVPSVFLP-LSHLPLTASGKID 469
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
574-911 |
3.97e-35 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 138.57 E-value: 3.97e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVrsaaMKTGDLA 653
Cdd:cd04433 2 PALILYTSGTTGKPKGVVLSHRNLLAAAAALAASGGLTEGDVFLSTLPLFHIGGLFGLLGALLAGGTVV----LLPKFDP 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 654 ALVDDLVARE--TTIVDLPTAVWqlLCADGDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLEsaaSQGISLLSSYGPTEAT 731
Cdd:cd04433 78 EAALELIEREkvTILLGVPTLLA--RLLKAPESAGYDLSSLRALVSGGAPLPPELLERFEE---APGIKLVNGYGLTETG 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 732 VVATFLPIVCDQTTMDGAllrlGRPIL--------PNTVFLAF---GEVVIVGDLVADGYLGIDgdgfgtVTAADGSRRR 800
Cdd:cd04433 153 GTVATGPPDDDARKPGSV----GRPVPgvevrivdPDGGELPPgeiGELVVRGPSVMKGYWNNP------EATAAVDEDG 222
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 801 AFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV-----ELHSGSLGVWFksQRTREGEQD 875
Cdd:cd04433 223 WYRTGDLGRLDEDGYLYIVGRLKDMIKSGGENVYPAEVEAVLLGHPGVAEAAVvgvpdPEWGERVVAVV--VLRPGADLD 300
|
330 340 350
....*....|....*....|....*....|....*..
gi 489495878 876 AAA-ATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKID 911
Cdd:cd04433 301 AEElRAHVRERLAPYKVPRRVVF-VDALPRTASGKID 336
|
|
| PRK07798 |
PRK07798 |
acyl-CoA synthetase; Validated |
1493-1969 |
4.34e-35 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236100 [Multi-domain] Cd Length: 533 Bit Score: 143.10 E-value: 4.34e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1493 SIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPI 1572
Cdd:PRK07798 4 NIADLFEAVADAVPDRVALVCGDRRLTYAELEERANRLAHYLIAQGLGPGDHVGIYARNRIEYVEAMLGAFKARAVPVNV 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1573 DPANPPPRVAFMLGDAVPVAAVTTAGLRSRLAG--HDLPIIDVV-------------------DALAAYPGTPPPMPAAV 1631
Cdd:PRK07798 84 NYRYVEDELRYLLDDSDAVALVYEREFAPRVAEvlPRLPKLRTLvvvedgsgndllpgavdyeDALAAGSPERDFGERSP 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1632 NLAYILYTSGTTGEPKGVGITHRNV------TRLFASLPARLSAAQVWSQCHSYGF-----------DASAWEIWGALLG 1694
Cdd:PRK07798 164 DDLYLLYTGGTTGMPKGVMWRQEDIfrvllgGRDFATGEPIEDEEELAKRAAAGPGmrrfpapplmhGAGQWAAFAALFS 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1695 GGRLVIVPESVAaspnDFHGLL--VAEH-VSVLTQT------PAAVAMLPTQG--LESVALVVAG-----EACPAALVDr 1758
Cdd:PRK07798 244 GQTVVLLPDVRF----DADEVWrtIEREkVNVITIVgdamarPLLDALEARGPydLSSLFAIASGgalfsPSVKEALLE- 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1759 WAPGRVMLNAYGPTETTICA-AISAPLRPGSGMPPIGVpvsGAALFVLDSWLRPVPAGVAGELYIAGAG-VGVGYWRRAG 1836
Cdd:PRK07798 319 LLPNVVLTDSIGSSETGFGGsGTVAKGAVHTGGPRFTI---GPRTVVLDEDGNPVEPGSGEIGWIARRGhIPLGYYKDPE 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1837 LTASRFvacpFGGSGARMYRTGDLVCWRADGQLEFLGRtdDQVKIR--GYRIELGEVATALAELAGVGQAVVIAREDRPG 1914
Cdd:PRK07798 396 KTAETF----PTIDGVRYAIPGDRARVEADGTITLLGR--GSVCINtgGEKVFPEEVEEALKAHPDVADALVVGVPDERW 469
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 1915 DKRLVGyATEIAPGA-VDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHR 1969
Cdd:PRK07798 470 GQEVVA-VVQLREGArPDLAELRAHCRSSLAGYKVPRAIWFVDEVQRSPAGKADYR 524
|
|
| MACS_like |
cd05972 |
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of ... |
1519-1971 |
4.40e-35 |
|
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes.
Pssm-ID: 341276 [Multi-domain] Cd Length: 428 Bit Score: 140.94 E-value: 4.40e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTag 1598
Cdd:cd05972 2 SFRELKRESAKAANVLAKLGLRKGDRVAVLLPRVPELWAVILAVIKLGAVYVPLTTLLGPKDIEYRLEAAGAKAIVTD-- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1599 lrsrlaghdlpiidvvdalaaypgtpppmpaAVNLAYILYTSGTTGEPKGVGITHRnvtRLFASLParlsAAQVWSQCHS 1678
Cdd:cd05972 80 -------------------------------AEDPALIYFTSGTTGLPKGVLHTHS---YPLGHIP----TAAYWLGLRP 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1679 ----YGFDASAWE--IWGALLG---GGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVAL----- 1744
Cdd:cd05972 122 ddihWNIADPGWAkgAWSSFFGpwlLGATVFVYEGPRFDAERILELLERYGVTSFCGPPTAYRMLIKQDLSSYKFshlrl 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1745 -VVAGEACPAALVDRW--APGRVMLNAYGPTETTICAAIS--APLRPGSgmppIGVPVSGAALFVLDSWLRPVPAGVAGE 1819
Cdd:cd05972 202 vVSAGEPLNPEVIEWWraATGLPIRDGYGQTETGLTVGNFpdMPVKPGS----MGRPTPGYDVAIIDDDGRELPPGEEGD 277
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1820 LYIAGAGVG--VGYWRRAGLTASRFVacpfGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAE 1897
Cdd:cd05972 278 IAIKLPPPGlfLGYVGDPEKTEASIR----GD----YYLTGDRAYRDEDGYFWFVGRADDIIKSSGYRIGPFEVESALLE 349
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1898 LAGVGQAVVIAREDrPGDKRLVGYATEIAPGAVDPAGLRAQLA----QRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05972 350 HPAVAEAAVVGSPD-PVRGEVVKAFVVLTSGYEPSEELAEELQghvkKVLAPYKYPREIEFVEELPKTISGKIRRVEL 426
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
1022-1409 |
8.19e-35 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 139.89 E-value: 8.19e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1022 AIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVD-GVPRQLVIEARRADLG 1100
Cdd:cd19536 1 MYPLSSLQEGMLFHSLLNPGGSVYLHNYTYTVGRRLNLDLLLEALQVLIDRHDILRTSFIEDGlGQPVQVVHRQAQVPVT 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1101 CDIVDATAWPADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVA-HHIAADGWSVAPLTADLSAAYASRCAG 1179
Cdd:cd19536 81 ELDLTPLEEQLDPLRAYKEETKIRRFDLGRAPLVRAALVRKDERERFLLVISdHHSILDGWSLYLLVKEILAVYNQLLEY 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1180 RApdWAPLPVQ-YVDYTLWQREILGDlddsdspiAAQLAYWENALAGMperlRLPTArPYPPVADQRGASLVVDWPASVQ 1258
Cdd:cd19536 161 KP--LSLPPAQpYRDFVAHERASIQQ--------AASERYWREYLAGA----TLATL-PALSEAVGGGPEQDSELLVSVP 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1259 QQVR---RIARQHNATSFMVVAAgLAVLLSKLSGSPDVAVGFPIAGRSDPALD--NLVGFFVNTLVLRVNLAgDPSFAEL 1333
Cdd:cd19536 226 LPVRsrsLAKRSGIPLSTLLLAA-WALVLSRHSGSDDVVFGTVVHGRSEETTGaeRLLGLFLNTLPLRVTLS-EETVEDL 303
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 1334 LGQVRARSLAAYENQDVPfevLVDRLKPTRALthhPLIQVMLAWQDNPVGqlnlgdlQATPMPIDTRTARMDLVFS 1409
Cdd:cd19536 304 LKRAQEQELESLSHEQVP---LADIQRCSEGE---PLFDSIVNFRHFDLD-------FGLPEWGSDEGMRRGLLFS 366
|
|
| MACS_like_4 |
cd05969 |
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most ... |
1519-1975 |
1.13e-34 |
|
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most similar to acetyl-CoA synthetase. Acetyl-CoA synthetase (ACS) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is only present in bacteria.
Pssm-ID: 341273 [Multi-domain] Cd Length: 442 Bit Score: 139.94 E-value: 1.13e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAG 1598
Cdd:cd05969 2 TFAQLKVLSARFANVLKSLGVGKGDRVFVLSPRSPELYFSMLGIGKIGAVICPLFSAFGPEAIRDRLENSEAKVLITTEE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1599 LRSRLAghdlpiidvvdalaayPGTPppmpaavnlAYILYTSGTTGEPKGVGITHRNVTRLFaslparLSAAQV------ 1672
Cdd:cd05969 82 LYERTD----------------PEDP---------TLLHYTSGTTGTPKGVLHVHDAMIFYY------FTGKYVldlhpd 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1673 ----------WSQCHSYGfdasaweIWGALLGGGRLVIVPESVaaSPNDFHGLLVAEHVSVLTQTPAAVAMLPTQG---- 1738
Cdd:cd05969 131 diywctadpgWVTGTVYG-------IWAPWLNGVTNVVYEGRF--DAESWYGIIERVKVTVWYTAPTAIRMLMKEGdela 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1739 ----LESVALVVA-GEAC-PAALvdRW---APGRVMLNAYGPTET---TICAAISAPLRPGSgmppIGVPVSGAALFVLD 1806
Cdd:cd05969 202 rkydLSSLRFIHSvGEPLnPEAI--RWgmeVFGVPIHDTWWQTETgsiMIANYPCMPIKPGS----MGKPLPGVKAAVVD 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1807 SWLRPVPAGVAGELYIAGA--GVGVGYWRRAGLTASRFVacpfGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGY 1884
Cdd:cd05969 276 ENGNELPPGTKGILALKPGwpSMFRGIWNDEERYKNSFI----DG----WYLTGDLAYRDEDGYFWFVGRADDIIKTSGH 347
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1885 RIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATeIAPGAVDPAGLRAQL----AQRLPGYLVPAAVVVIDALPL 1960
Cdd:cd05969 348 RVGPFEVESALMEHPAVAEAGVIGKPDPLRGEIIKAFIS-LKEGFEPSDELKEEIinfvRQKLGAHVAPREIEFVDNLPK 426
|
490
....*....|....*
gi 489495878 1961 TVNGKLDHRALPAPE 1975
Cdd:cd05969 427 TRSGKIMRRVLKAKE 441
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
574-911 |
4.56e-34 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 138.58 E-value: 4.56e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLA 653
Cdd:cd12116 128 LAYVIYTSGSTGRPKGVVVSHRNLVNFLHSMRERLGLGPGDRLLAVTTYAFDISLLELLLPLLAGARVVIAPRETQRDPE 207
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 654 ALVDDLVARETTIVDLPTAVWQLLCADGDAidaiGRSRLRqIVIGGEAIRCSAVDKWLesaaSQGISLLSSYGPTEATVV 733
Cdd:cd12116 208 ALARLIEAHSITVMQATPATWRMLLDAGWQ----GRAGLT-ALCGGEALPPDLAARLL----SRVGSLWNLYGPTETTIW 278
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 734 ATFLPIvcdqtTMDGALLRLGRPIlPNTVFL------------AFGEVVIVGDLVADGYLGIDGDGFGTVTA--ADGSRR 799
Cdd:cd12116 279 STAARV-----TAAAGPIPIGRPL-ANTQVYvldaalrpvppgVPGELYIGGDGVAQGYLGRPALTAERFVPdpFAGPGS 352
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 800 RAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLG------VWFKsqrtrEGE 873
Cdd:cd12116 353 RLYRTGDLVRRRADGRLEYLGRADGQVKIRGHRIELGEIEAALAAHPGVAQAAVVVREDGGDrrlvayVVLK-----AGA 427
|
330 340 350 360
....*....|....*....|....*....|....*....|
gi 489495878 874 QDAAAATRIRL--VLVSLGVSSFFVVgVPNIPRKPNGKID 911
Cdd:cd12116 428 APDAAALRAHLraTLPAYMVPSAFVR-LDALPLTANGKLD 466
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
574-915 |
6.84e-34 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 137.44 E-value: 6.84e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKT-GDL 652
Cdd:cd17653 107 LAYIIFTSGSTGIPKGVMVPHRGVLNYVSQPPARLDVGPGSRVAQVLSIAFDACIGEIFSTLCNGGTLVLADPSDPfAHV 186
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 653 AALVDDLVARETTIVDLPTAVWQllcadgdaidaigrsRLRQIVIGGEAIRCSAVDKWLEsaasqGISLLSSYGPTEATV 732
Cdd:cd17653 187 ARTVDALMSTPSILSTLSPQDFP---------------NLKTIFLGGEAVPPSLLDRWSP-----GRRLYNAYGPTECTI 246
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 733 VATFlpivcdQTTMDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYLGID---GDGFGTVTAADGSr 798
Cdd:cd17653 247 SSTM------TELLPGQPVTIGKPIPNSTCYIldadlqpvpegVVGEICISGVQVARGYLGNPaltASKFVPDPFWPGS- 319
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 799 rRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRI-AEDPAVSDVAVELHSGSLgVWFKsqrTREGEQDAA 877
Cdd:cd17653 320 -RMYRTGDYGRWTEDGGLEFLGREDNQVKVRGFRINLEEIEEVVlQSQPEVTQAAAIVVNGRL-VAFV---TPETVDVDG 394
|
330 340 350
....*....|....*....|....*....|....*...
gi 489495878 878 AATRIRLVLVSLGVSSFFvVGVPNIPRKPNGKIDSDNL 915
Cdd:cd17653 395 LRSELAKHLPSYAVPDRI-IALDSFPLTANGKVDRKAL 431
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
1034-1457 |
7.17e-34 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 136.67 E-value: 7.17e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1034 FLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVF--PAVDGVPRQLVIeaRRADLGCDIVDatawpa 1111
Cdd:cd19542 11 MLLSQLRSPGLYFNHFVFDLDSSVDVERLRNAWRQLVQRHDILRTVFveSSAEGTFLQVVL--KSLDPPIEEVE------ 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1112 dRLQRAIEEAARHSFD---LATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAPDWAplp 1188
Cdd:cd19542 83 -TDEDSLDALTRDLLDdptLFGQPPHRLTLLETSSGEVYLVLRISHALYDGVSLPIILRDLAAAYNGQLLPPAPPFS--- 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1189 vQYVDYTlwqreilgdlddSDSPIAAQLAYWENALAGMperlrlpTARPYPPVADQRGASLVVDWPASVQQQVRRIARQH 1268
Cdd:cd19542 159 -DYISYL------------QSQSQEESLQYWRKYLQGA-------SPCAFPSLSPKRPAERSLSSTRRSLAKLEAFCASL 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1269 NATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGR--SDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRARSLAAYE 1346
Cdd:cd19542 219 GVTLASLFQAAWALVLARYTGSRDVVFGYVVSGRdlPVPGIDDIVGPCINTLPVRVKLDPDWTVLDLLRQLQQQYLRSLP 298
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1347 NQDVPFEVLVDRLKPTRA-------LTHHPL--IQVMLAWQDNPVGQLNLGDLQATPMPIDTRTARMDLVFSLAerfseg 1417
Cdd:cd19542 299 HQHLSLREIQRALGLWPSgtlfntlVSYQNFeaSPESELSGSSVFELSAAEDPTEYPVAVEVEPSGDSLKVSLA------ 372
|
410 420 430 440
....*....|....*....|....*....|....*....|
gi 489495878 1418 sepagiggaveYRTDVFEAQAIDVLIERLRKVLVAVAAAP 1457
Cdd:cd19542 373 -----------YSTSVLSEEQAEELLEQFDDILEALLANP 401
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
575-916 |
1.29e-33 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 136.61 E-value: 1.29e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLAA 654
Cdd:cd17652 96 AYVIYTSGSTGRPKGVVVTHRGLANLAAAQIAAFDVGPGSRVLQFASPSFDASVWELLMALLAGATLVLAPAEELLPGEP 175
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 655 LVDDLVARETTIVDLPTAVWQLLCADGDAidaigrsRLRQIVIGGEAIRCSAVDKWlesaaSQGISLLSSYGPTEATVVA 734
Cdd:cd17652 176 LADLLREHRITHVTLPPAALAALPPDDLP-------DLRTLVVAGEACPAELVDRW-----APGRRMINAYGPTETTVCA 243
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 735 TFLpivcdQTTMDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYLGIDG--------DGFGtvtaAD 795
Cdd:cd17652 244 TMA-----GPLPGGGVPPIGRPVPGTRVYVldarlrpvppgVPGELYIAGAGLARGYLNRPGltaerfvaDPFG----AP 314
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 796 GSrrRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGVwfksQR------T 869
Cdd:cd17652 315 GS--RMYRTGDLARWRADGQLEFLGRADDQVKIRGFRIELGEVEAALTEHPGVAEAVVVVRDDRPGD----KRlvayvvP 388
|
330 340 350 360
....*....|....*....|....*....|....*....|....*....
gi 489495878 870 REGEQDAAAATRIRLV--LVSLGVSSFFVVgVPNIPRKPNGKIDSDNLP 916
Cdd:cd17652 389 APGAAPTAAELRAHLAerLPGYMVPAAFVV-LDALPLTPNGKLDRRALP 436
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
1482-1974 |
2.37e-33 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 137.81 E-value: 2.37e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1482 AVLTAPAPTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVA 1561
Cdd:PRK06188 2 ATMADLLHSGATYGHLLVSALKRYPDRPALVLGDTRLTYGQLADRISRYIQAFEALGLGTGDAVALLSLNRPEVLMAIGA 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1562 VLKTGAAYLPIDPANPPPRVAFMLGDAV-------PVAAVTTA-GLRSRLAG--HDLPIIDVVD-----ALAAYPGTPPP 1626
Cdd:PRK06188 82 AQLAGLRRTALHPLGSLDDHAYVLEDAGistlivdPAPFVERAlALLARVPSlkHVLTLGPVPDgvdllAAAAKFGPAPL 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1627 MPAAV--NLAYILYTSGTTGEPKGVGITHRNVTRLFASL------PARLSAAQVWSQCHsygfdASAWEIWGALLGGGRL 1698
Cdd:PRK06188 162 VAAALppDIAGLAYTGGTTGKPKGVMGTHRSIATMAQIQlaewewPADPRFLMCTPLSH-----AGGAFFLPTLLRGGTV 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1699 VIVPesvAASPNDF------HG----LLVAEHVSVLTQTPAavamLPTQGLESVALVVAGEA--CPAALV---DRWAPgr 1763
Cdd:PRK06188 237 IVLA---KFDPAEVlraieeQRitatFLVPTMIYALLDHPD----LRTRDLSSLETVYYGASpmSPVRLAeaiERFGP-- 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1764 VMLNAYGPTETTICAAIsapLRPGSGMPPI-------GVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAG 1836
Cdd:PRK06188 308 IFAQYYGQTEAPMVITY---LRKRDHDPDDpkrltscGRPTPGLRVALLDEDGREVAQGEVGEICVRGPLVMDGYWNRPE 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1837 LTASRFVacpfGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAredRPGDK 1916
Cdd:PRK06188 385 ETAEAFR----DG----WLHTGDVAREDEDGFYYIVDRKKDMIVTGGFNVFPREVEDVLAEHPAVAQVAVIG---VPDEK 453
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 489495878 1917 --RLVGYATEIAPGA-VDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAP 1974
Cdd:PRK06188 454 wgEAVTAVVVLRPGAaVDAAELQAHVKERKGSVHAPKQVDFVDSLPLTALGKPDKKALRAR 514
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
1519-1966 |
4.46e-33 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 136.09 E-value: 4.46e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAG 1598
Cdd:PRK09088 24 TYAELDALVGRLAAVLRRRGCVDGERLAVLARNSVWLVALHFACARVGAIYVPLNWRLSASELDALLQDAEPRLLLGDDA 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1599 LRS-RLAGHDLP-IIDVVDALAAYPgTPPPMPAAVNLayILYTSGTTGEPKGVGITHRNV--TRLFASLPARLSAAQvws 1674
Cdd:PRK09088 104 VAAgRTDVEDLAaFIASADALEPAD-TPSIPPERVSL--ILFTSGTSGQPKGVMLSERNLqqTAHNFGVLGRVDAHS--- 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1675 qchSYGFDASAWEIWG-------ALLGGGRLVIVPESVAASPNDFHG---LLVAEHVSVltqtPAAVAMLPTQ-GLES-- 1741
Cdd:PRK09088 178 ---SFLCDAPMFHIIGlitsvrpVLAVGGSILVSNGFEPKRTLGRLGdpaLGITHYFCV----PQMAQAFRAQpGFDAaa 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1742 ----VALVVAGEACPAALVDRW-APGRVMLNAYGPTET-TI------CAAISAplRPGSGmppiGVPVSGAALFVLDSWL 1809
Cdd:PRK09088 251 lrhlTALFTGGAPHAAEDILGWlDDGIPMVDGFGMSEAgTVfgmsvdCDVIRA--KAGAA----GIPTPTVQTRVVDDQG 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1810 RPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFvacpfggSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELG 1889
Cdd:PRK09088 325 NDCPAGVPGELLLRGPNLSPGYWRRPQATARAF-------TGDGWFRTGDIARRDADGFFWVVDRKKDMFISGGENVYPA 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1890 EVATALAELAGVGQAVVIARED-RPGDkrlVGY-ATEIAPG-AVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:PRK09088 398 EIEAVLADHPGIRECAVVGMADaQWGE---VGYlAIVPADGaPLDLERIRSHLSTRLAKYKVPKHLRLVDALPRTASGKL 474
|
|
| PRK07787 |
PRK07787 |
acyl-CoA synthetase; Validated |
1507-1975 |
8.67e-33 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236096 [Multi-domain] Cd Length: 471 Bit Score: 134.73 E-value: 8.67e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1507 EAEAVCCGDASMTYRELDEASNRLAHRLAGCGAgpgecVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLG 1586
Cdd:PRK07787 15 IADAVRIGGRVLSRSDLAGAATAVAERVAGARR-----VAVLATPTLATVLAVVGALIAGVPVVPVPPDSGVAERRHILA 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1587 DAVPVAAVttAGLRSRLAGhdLPIIDVvdALAAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTrlfASLPAr 1666
Cdd:PRK07787 90 DSGAQAWL--GPAPDDPAG--LPHVPV--RLHARSWHRYPEPDPDAPALIVYTSGTTGPPKGVVLSRRAIA---ADLDA- 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1667 LSAAQVWSQ----------CHSYGFdasAWEIWGALLGGGRLVIV----PESVAASPNDFHGLL--VAEHVSVLTQTPAA 1730
Cdd:PRK07787 160 LAEAWQWTAddvlvhglplFHVHGL---VLGVLGPLRIGNRFVHTgrptPEAYAQALSEGGTLYfgVPTVWSRIAADPEA 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1731 vamlpTQGLESVALVVAGEAC-PAALVDRWA--PGRVMLNAYGPTET--TICAAISAPLRPGSgmppIGVPVSGAALFVL 1805
Cdd:PRK07787 237 -----ARALRGARLLVSGSAAlPVPVFDRLAalTGHRPVERYGMTETliTLSTRADGERRPGW----VGLPLAGVETRLV 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1806 DSWLRPVPAGVA--GELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCWRADGQLEFLGR-TDDQVKIR 1882
Cdd:PRK07787 308 DEDGGPVPHDGEtvGELQVRGPTLFDGYLNRPDATAAAFTADGW-------FRTGDVAVVDPDGMHRIVGReSTDLIKSG 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1883 GYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYAteIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTV 1962
Cdd:PRK07787 381 GYRIGAGEIETALLGHPGVREAAVVGVPDDDLGQRIVAYV--VGADDVAADELIDFVAQQLSVHKRPREVRFVDALPRNA 458
|
490
....*....|...
gi 489495878 1963 NGKLDHRALPAPE 1975
Cdd:PRK07787 459 MGKVLKKQLLSEG 471
|
|
| PRK07514 |
PRK07514 |
malonyl-CoA synthase; Validated |
1518-1965 |
2.13e-32 |
|
malonyl-CoA synthase; Validated
Pssm-ID: 181011 [Multi-domain] Cd Length: 504 Bit Score: 134.23 E-value: 2.13e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1518 MTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTT- 1596
Cdd:PRK07514 29 YTYGDLDAASARLANLLVALGVKPGDRVAVQVEKSPEALALYLATLRAGAVFLPLNTAYTLAELDYFIGDAEPALVVCDp 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1597 ---AGLRSRLAGHDLPIIDVVDA------LAAYPGTPPPMPAAV----NLAYILYTSGTTGEPKGVGITHRNVtrlfasl 1663
Cdd:PRK07514 109 anfAWLSKIAAAAGAPHVETLDAdgtgslLEAAAAAPDDFETVPrgadDLAAILYTSGTTGRSKGAMLSHGNL------- 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1664 parLSAAQVWSQC----------------HSYG-FDASAweiwGALLGGGRLVIVPESVAAspndfhgllvaehvSVLTQ 1726
Cdd:PRK07514 182 ---LSNALTLVDYwrftpddvlihalpifHTHGlFVATN----VALLAGASMIFLPKFDPD--------------AVLAL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1727 TPAAVAML--PT--------QGL--ESVA---LVVAGEAcP--AALVDRWAP--GRVMLNAYGPTETtiCAAISAPL--- 1784
Cdd:PRK07514 241 MPRATVMMgvPTfytrllqePRLtrEAAAhmrLFISGSA-PllAETHREFQErtGHAILERYGMTET--NMNTSNPYdge 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1785 -RPGSgmppIGVPVSGAALFVLDSWL-RPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVC 1862
Cdd:PRK07514 318 rRAGT----VGFPLPGVSLRVTDPETgAELPPGEIGMIEVKGPNVFKGYWRMPEKTAEEFRADGF-------FITGDLGK 386
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1863 WRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGV----------------GQAVVIAredRPGdkrlvgyateia 1926
Cdd:PRK07514 387 IDERGYVHIVGRGKDLIISGGYNVYPKEVEGEIDELPGVvesavigvphpdfgegVTAVVVP---KPG------------ 451
|
490 500 510
....*....|....*....|....*....|....*....
gi 489495878 1927 pGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGK 1965
Cdd:PRK07514 452 -AALDEAAILAALKGRLARFKQPKRVFFVDELPRNTMGK 489
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
1517-1966 |
5.86e-32 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 131.73 E-value: 5.86e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTT 1596
Cdd:cd05903 1 RLTYSELDTRADRLAAGLAALGVGPGDVVAFQLPNWWEFAVLYLACLRIGAVTNPILPFFREHELAFILRRAKAKVFVVP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1597 aglrSRLAGHDlpiidvvdalaaypgtPPPMPAAVnlAYILYTSGTTGEPKGVGITHRNvtrLFASLPArlsaaqvwsQC 1676
Cdd:cd05903 81 ----ERFRQFD----------------PAAMPDAV--ALLLFTSGTTGEPKGVMHSHNT---LSASIRQ---------YA 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1677 HSYGFDASAwEIWGA-----LLGGGRLVIVPESVAAS--------PNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVA 1743
Cdd:cd05903 127 ERLGLGPGD-VFLVAspmahQTGFVYGFTLPLLLGAPvvlqdiwdPDKALALMREHGVTFMMGATPFLTDLLNAVEEAGE 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1744 -------LVVAGEACPAALVDRWAP--GRVMLNAYGPTETTICAAISAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPA 1814
Cdd:cd05903 206 plsrlrtFVCGGATVPRSLARRAAEllGAKVCSAYGSTECPGAVTSITPAPEDRRLYTDGRPLPGVEIKVVDDTGATLAP 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1815 GVAGELYIAGAGVGVGYWRRAGLTasrFVACPFGgsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATA 1894
Cdd:cd05903 286 GVEGELLSRGPSVFLGYLDRPDLT---ADAAPEG-----WFRTGDLARLDEDGYLRITGRSKDIIIRGGENIPVLEVEDL 357
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 489495878 1895 LAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQL-AQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:cd05903 358 LLGHPGVIEAAVVALPDERLGERACAVVVTKSGALLTFDELVAYLdRQGVAKQYWPERLVHVDDLPRTPSGKV 430
|
|
| Firefly_Luc_like |
cd05911 |
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family ... |
1517-1966 |
6.23e-32 |
|
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341237 [Multi-domain] Cd Length: 486 Bit Score: 132.72 E-value: 6.23e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVP------ 1590
Cdd:cd05911 10 ELTYAQLRTLSRRLAAGLRKLGLKKGDVVGIISPNSTYYPPVFLGCLFAGGIFSAANPIYTADELAHQLKISKPkviftd 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1591 ---VAAVTTAG-----------LRSRLAGHdLPIIDVVDALAAYPGTPPPMP---AAVNLAYILYTSGTTGEPKGVGITH 1653
Cdd:cd05911 90 pdgLEKVKEAAkelgpkdkiivLDDKPDGV-LSIEDLLSPTLGEEDEDLPPPlkdGKDDTAAILYSSGTTGLPKGVCLSH 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1654 RNVT------------------RLFASLPARlsaaqvwsqcHSYGFDAsaweIWGALLGGGRLVIVPEsvaASPNDFHGL 1715
Cdd:cd05911 169 RNLIanlsqvqtflygndgsndVILGFLPLY----------HIYGLFT----TLASLLNGATVIIMPK---FDSELFLDL 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1716 LVAEHVSVLTQTPAAVAML------PTQGLESV-ALVVAGEACPAALVDRWA---PGRVMLNAYGPTETT--ICAAISAP 1783
Cdd:cd05911 232 IEKYKITFLYLVPPIAAALakspllDKYDLSSLrVILSGGAPLSKELQELLAkrfPNATIKQGYGMTETGgiLTVNPDGD 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1784 LRPGSgmppIGVPVSGAALFVLD----SWLRPvpaGVAGELYIAGAGVGVGYWRRAGLTASRFvacPFGGsgarMYRTGD 1859
Cdd:cd05911 312 DKPGS----VGRLLPNVEAKIVDddgkDSLGP---NEPGEICVRGPQVMKGYYNNPEATKETF---DEDG----WLHTGD 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1860 LVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQL 1939
Cdd:cd05911 378 IGYFDEDGYLYIVDRKKELIKYKGFQVAPAELEAVLLEHPGVADAAVIGIPDEVSGELPRAYVVRKPGEKLTEKEVKDYV 457
|
490 500
....*....|....*....|....*....
gi 489495878 1940 AQRLPGY--LVpAAVVVIDALPLTVNGKL 1966
Cdd:cd05911 458 AKKVASYkqLR-GGVVFVDEIPKSASGKI 485
|
|
| 23DHB-AMP_lg |
cd05920 |
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2, ... |
1498-1971 |
1.28e-31 |
|
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2,3-dihydroxybenzoate (DHB) by ligation of AMP from ATP with the release of pyrophosphate. However, it can also catalyze the ATP-PPi exchange for 2,3-DHB analogs, such as salicyclic acid (o-hydrobenzoate), as well as 2,4-DHB and 2,5-DHB, but with less efficiency. Proteins in this family are the stand-alone adenylation components of non-ribosomal peptide synthases (NRPSs) involved in the biosynthesis of siderophores, which are low molecular weight iron-chelating compounds synthesized by many bacteria to aid in the acquisition of this vital trace elements. In Escherichia coli, the 2,3-dihydroxybenzoate-AMP ligase is called EntE, the adenylation component of the enterobactin NRPS system.
Pssm-ID: 341244 [Multi-domain] Cd Length: 482 Bit Score: 131.68 E-value: 1.28e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1498 LAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAayLPIDpANP 1577
Cdd:cd05920 21 LARSAARHPDRIAVVDGDRRLTYRELDRRADRLAAGLRGLGIRPGDRVVVQLPNVAEFVVLFFALLRLGA--VPVL-ALP 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1578 PPRVAFMLGDAVPVAAVTTAGLRsRLAGHDlPIIDVVDALAAYPGTpppmpaavnlAYILYTSGTTGEPKGVGITHRNV- 1656
Cdd:cd05920 98 SHRRSELSAFCAHAEAVAYIVPD-RHAGFD-HRALARELAESIPEV----------ALFLLSGGTTGTPKLIPRTHNDYa 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1657 ---------------TRLFASLPArlsaaqvwsqchSYGFDASAWEIWGALLGGGRLVIVPEsvaASPNDFHGLLVAEHV 1721
Cdd:cd05920 166 ynvrasaevcgldqdTVYLAVLPA------------AHNFPLACPGVLGTLLAGGRVVLAPD---PSPDAAFPLIEREGV 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1722 SVLTQTPAAVAML------PTQGLESVALVVAGEA---------CPAAL---VDRW---APGRVMLNAYGPTETTICAAI 1780
Cdd:cd05920 231 TVTALVPALVSLWldaaasRRADLSSLRLLQVGGArlspalarrVPPVLgctLQQVfgmAEGLLNYTRLDDPDEVIIHTQ 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1781 SAPLRPGSgmppigvpvsgaALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDL 1860
Cdd:cd05920 311 GRPMSPDD------------EIRVVDEEGNPVPPGEEGELLTRGPYTIRGYYRAPEHNARAFTPDGF-------YRTGDL 371
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1861 VCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATeIAPGAVDPAGLRAQLA 1940
Cdd:cd05920 372 VRRTPDGYLVVEGRIKDQINRGGEKIAAEEVENLLLRHPAVHDAAVVAMPDELLGERSCAFVV-LRDPPPSAAQLRRFLR 450
|
490 500 510
....*....|....*....|....*....|..
gi 489495878 1941 QR-LPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05920 451 ERgLAAYKLPDRIEFVDSLPLTAVGKIDKKAL 482
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
1517-1971 |
1.36e-31 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 130.68 E-value: 1.36e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTT 1596
Cdd:cd05935 1 SLTYLELLEVVKKLASFLSNKGVRKGDRVGICLQNSPQYVIAYFAIWRANAVVVPINPMLKERELEYILNDSGAKVAVVG 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1597 AGLRsrlaghdlpiidvvdalaaypgtpppmpaavNLAYILYTSGTTGEPKGVGITHRNVTrLFASLPAR---LSAAQVW 1673
Cdd:cd05935 81 SELD-------------------------------DLALIPYTSGTTGLPKGCMHTHFSAA-ANALQSAVwtgLTPSDVI 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1674 SQC----HSYGFDASaweIWGALLGGGRLVIvpesVAASPNDFHGLLVAEH-VSVLTQTPAAVA-MLPTQGLE----SVA 1743
Cdd:cd05935 129 LAClplfHVTGFVGS---LNTAVYVGGTYVL----MARWDRETALELIEKYkVTFWTNIPTMLVdLLATPEFKtrdlSSL 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1744 LVVA--GEACPAALVDRW--APGRVMLNAYGPTETTICAAISAPLRPGSGMppIGVPVSGAALFVLD-SWLRPVPAGVAG 1818
Cdd:cd05935 202 KVLTggGAPMPPAVAEKLlkLTGLRFVEGYGLTETMSQTHTNPPLRPKLQC--LGIP*FGVDARVIDiETGRELPPNEVG 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1819 ELYIAGAGVGVGYWRRAGLTASRFVACpfggSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAEL 1898
Cdd:cd05935 280 EIVVRGPQIFKGYWNRPEETEESFIEI----KGRRFFRTGDLGYMDEEGYFFFVDRVKRMINVSGFKVWPAEVEAKLYKH 355
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 1899 AGVGQAVVIARED-RPGD--KRLVGYATEIApGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05935 356 PAI*EVCVISVPDeRVGEevKAFIVLRPEYR-GKVTEEDIIEWAREQMAAYKYPREVEFVDELPRSASGKILWRLL 430
|
|
| PRK05605 |
PRK05605 |
long-chain-fatty-acid--CoA ligase; Validated |
1493-1969 |
1.37e-31 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235531 [Multi-domain] Cd Length: 573 Bit Score: 133.20 E-value: 1.37e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1493 SIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPI 1572
Cdd:PRK05605 33 TLVDLYDNAVARFGDRPALDFFGATTTYAELGKQVRRAAAGLRALGVRPGDRVAIVLPNCPQHIVAFYAVLRLGAVVVEH 112
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1573 DPANPPPRVAFMLGD---AVPVA----AVTTAGLRSRLAGHDLPIIDVVDAL-----------------------AAYPG 1622
Cdd:PRK05605 113 NPLYTAHELEHPFEDhgaRVAIVwdkvAPTVERLRRTTPLETIVSVNMIAAMpllqrlalrlpipalrkaraaltGPAPG 192
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1623 T------------------PPPMPAAVNLAYILYTSGTTGEPKGVGITHRNvtrLFASL-------------PARLSAAq 1671
Cdd:PRK05605 193 TvpwetlvdaaiggdgsdvSHPRPTPDDVALILYTSGTTGKPKGAQLTHRN---LFANAaqgkawvpglgdgPERVLAA- 268
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1672 vWSQCHSYGFDASAWEiwgALLGGGRLVIVP--------ESVAASPNDFhglLVAehVSVLTQTPAAVAMLPTQGLESVA 1743
Cdd:PRK05605 269 -LPMFHAYGLTLCLTL---AVSIGGELVLLPapdidlilDAMKKHPPTW---LPG--VPPLYEKIAEAAEERGVDLSGVR 339
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1744 LVVAGE-ACPAALVDRW--APGRVMLNAYGPTETT---ICAAISAPLRPGSgmppIGVPVSGAALFVLD--SWLRPVPAG 1815
Cdd:PRK05605 340 NAFSGAmALPVSTVELWekLTGGLLVEGYGLTETSpiiVGNPMSDDRRPGY----VGVPFPDTEVRIVDpeDPDETMPDG 415
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1816 VAGELYIAGAGVGVGYWRRAGLTASRFVAcpfggsgaRMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATAL 1895
Cdd:PRK05605 416 EEGELLVRGPQVFKGYWNRPEETAKSFLD--------GWFRTGDVVVMEEDGFIRIVDRIKELIITGGFNVYPAEVEEVL 487
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 1896 AELAGVGQAVV--IAREDrpGDKRLVGyATEIAPGAV-DPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHR 1969
Cdd:PRK05605 488 REHPGVEDAAVvgLPRED--GSEEVVA-AVVLEPGAAlDPEGLRAYCREHLTRYKVPRRFYHVDELPRDQLGKVRRR 561
|
|
| AMP-binding |
pfam00501 |
AMP-binding enzyme; |
473-829 |
2.46e-31 |
|
AMP-binding enzyme;
Pssm-ID: 459834 [Multi-domain] Cd Length: 417 Bit Score: 129.35 E-value: 2.46e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 473 AWLVQRGAAPGDVLVFTDDDTDKTIDLLIACHLAGCGYSVCD---TADEISVRTNA------ITEH-----------GDG 532
Cdd:pfam00501 36 AGLRALGVGKGDRVAILLPNSPEWVVAFLACLKAGAVYVPLNprlPAEELAYILEDsgakvlITDDalkleellealGKL 115
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 533 ILVTVVDVAATQLAVVGHDELRKVVDERVTQVTHDALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGW-- 610
Cdd:pfam00501 116 EVVKLVLVLDRDPVLKEEPLPEEAKPADVPPPPPPPPDPDDLAYIIYTSGTTGKPKGVMLTHRNLVANVLSIKRVRPRgf 195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 611 --GAHDTVLQCAPLTSDISVE-EIFGGAACGARLVRSAAMKTGDLAALVDDLVARETTIVDLPTAVWQLLcADGDAIDAI 687
Cdd:pfam00501 196 glGPDDRVLSTLPLFHDFGLSlGLLGPLLAGATVVLPPGFPALDPAALLELIERYKVTVLYGVPTLLNML-LEAGAPKRA 274
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 688 GRSRLRQIVIGGEAIRCSAVDKWLESAasqGISLLSSYGPTEATVVATFLPIVCDQTTMDGallRLGRPILPNTVFL--- 764
Cdd:pfam00501 275 LLSSLRLVLSGGAPLPPELARRFRELF---GGALVNGYGLTETTGVVTTPLPLDEDLRSLG---SVGRPLPGTEVKIvdd 348
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 489495878 765 ---------AFGEVVIVGDLVADGYLGIDGDgfgtvTAADGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKIS 829
Cdd:pfam00501 349 etgepvppgEPGELCVRGPGVMKGYLNDPEL-----TAEAFDEDGWYRTGDLGRRDEDGYLEIVGRKKDQIKLG 417
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
559-911 |
3.33e-31 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 129.74 E-value: 3.33e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 559 ERVTQVTHDALLA------TKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIF 632
Cdd:cd12115 86 ERLRFILEDAQARlvltdpDDLAYVIYTSGSTGRPKGVAIEHRNAAAFLQWAAAAFSAEELAGVLASTSICFDLSVFELF 165
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 633 GGAACGARLVRSAamktgDLAALVDDLVARETTIVD-LPTAVWQLLcadgdAIDAIGRSrLRQIVIGGEAIRCSAVDKWl 711
Cdd:cd12115 166 GPLATGGKVVLAD-----NVLALPDLPAAAEVTLINtVPSAAAELL-----RHDALPAS-VRVVNLAGEPLPRDLVQRL- 233
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 712 eSAASQGISLLSSYGPTEATVVATFLPIvcdqTTMDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGY 780
Cdd:cd12115 234 -YARLQVERVVNLYGPSEDTTYSTVAPV----PPGASGEVSIGRPLANTQAYVldralqpvplgVPGELYIGGAGVARGY 308
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 781 LGIDG---DGFgtVTAADGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHS 857
Cdd:cd12115 309 LGRPGltaERF--LPDPFGPGARLYRTGDLVRWRPDGLLEFLGRADNQVKVRGFRIELGEIEAALRSIPGVREAVVVAIG 386
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 858 GSLG----VWFKSQRTREGEQDAAAATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKID 911
Cdd:cd12115 387 DAAGerrlVAYIVAEPGAAGLVEDLRRHLGTRLPAYMVPSRFVR-LDALPLTPNGKID 443
|
|
| PRK06178 |
PRK06178 |
acyl-CoA synthetase; Validated |
1492-1967 |
3.69e-31 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235724 [Multi-domain] Cd Length: 567 Bit Score: 131.70 E-value: 3.69e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1492 VSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLP 1571
Cdd:PRK06178 33 RPLTEYLRAWARERPQRPAIIFYGHVITYAELDELSDRFAALLRQRGVGAGDRVAVFLPNCPQFHIVFFGILKLGAVHVP 112
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1572 IDPANPPPRVAFMLGDAVPVAAVTTAGL-------RSRLA-----------------------GHDLP------IIDVVD 1615
Cdd:PRK06178 113 VSPLFREHELSYELNDAGAEVLLALDQLapvveqvRAETSlrhvivtsladvlpaeptlplpdSLRAPrlaaagAIDLLP 192
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1616 ALAAYPGTPPPMPAAVN-LAYILYTSGTTGEPKGVGITHRNVTRLFAslpARLSAAQVWSQCH-SYGFDASAWeIWGALL 1693
Cdd:PRK06178 193 ALRACTAPVPLPPPALDaLAALNYTGGTTGMPKGCEHTQRDMVYTAA---AAYAVAVVGGEDSvFLSFLPEFW-IAGENF 268
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1694 G-------GGRLVIV----PESVAASPNDF---HGLLVAEHVSVLTQTPAaVAMLPTQGLESVALVVAGEACPAALVDRW 1759
Cdd:PRK06178 269 GllfplfsGATLVLLarwdAVAFMAAVERYrvtRTVMLVDNAVELMDHPR-FAEYDLSSLRQVRVVSFVKKLNPDYRQRW 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1760 --APGRVMLNA-YGPTETTICAAISAPLRPG----SGMPP-IGVPVSGAALFVLD-SWLRPVPAGVAGELYIAGAGVGVG 1830
Cdd:PRK06178 348 raLTGSVLAEAaWGMTETHTCDTFTAGFQDDdfdlLSQPVfVGLPVPGTEFKICDfETGELLPLGAEGEIVVRTPSLLKG 427
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1831 YWRRAGLTASRFVacpfGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIARE 1910
Cdd:PRK06178 428 YWNKPEATAEALR----DG----WLHTGDIGKIDEQGFLHYLGRRKEMLKVNGMSVFPSEVEALLGQHPAVLGSAVVGRP 499
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1911 DRpgDKRLVGYA-TEIAPGA-VDPAGLRAQLAQRLPGYLVPaAVVVIDALPLTVNGKLD 1967
Cdd:PRK06178 500 DP--DKGQVPVAfVQLKPGAdLTAAALQAWCRENMAVYKVP-EIRIVDALPMTATGKVR 555
|
|
| FAR-N_SDR_e |
cd05236 |
fatty acyl CoA reductases (FARs), extended (e) SDRs; SDRs are Rossmann-fold NAD(P)H-binding ... |
2108-2392 |
9.40e-31 |
|
fatty acyl CoA reductases (FARs), extended (e) SDRs; SDRs are Rossmann-fold NAD(P)H-binding proteins, many of which may function as fatty acyl CoA reductases (FAR), acting on medium and long chain fatty acids, and have been reported to be involved in diverse processes such as biosynthesis of insect pheromones, plant cuticular wax production, and mammalian wax biosynthesis. In Arabidopsis thaliana, proteins with this particular architecture have also been identified as the MALE STERILITY 2 (MS2) gene product, which is implicated in male gametogenesis. Mutations in MS2 inhibit the synthesis of exine (sporopollenin), rendering plants unable to reduce pollen wall fatty acids to corresponding alcohols. This N-terminal domain shares the catalytic triad (but not the upstream Asn) and characteristic NADP-binding motif of the extended SDR family. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187547 [Multi-domain] Cd Length: 320 Bit Score: 125.10 E-value: 9.40e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2108 RTVLLTGATGFLGRYLVLELLRRLDVDGRLICLVRAESDEDARRRLEKTFDSGDPELLRHFKELAADRLEVVAGDKSEPD 2187
Cdd:cd05236 1 KSVLITGATGFLGKVLLEKLLRSCPDIGKIYLLIRGKSGQSAEERLRELLKDKLFDRGRNLNPLFESKIVPIEGDLSEPN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2188 LGLDQPMWRRLAETVDLIVDSAAMVNaF--PYHELFGPNVAGTAELIRIALT-TKLKPFTYVSTA-------DVGAAIEP 2257
Cdd:cd05236 81 LGLSDEDLQTLIEEVNIIIHCAATVT-FdeRLDEALSINVLGTLRLLELAKRcKKLKAFVHVSTAyvngdrqLIEEKVYP 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2258 SAFTEDA---------DIRVISPTRTVDGGWAGGYGTSKWAGEVLLREANDlcALPVAVFRCGMILADT-----SYAGQL 2323
Cdd:cd05236 160 PPADPEKlidilelmdDLELERATPKLLGGHPNTYTFTKALAERLVLKERG--NLPLVIVRPSIVGATLkepfpGWIDNF 237
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 2324 NMSDwvtrMVLSLMATGIApRSFYepdsegNRQRAHFDGLPVTFVAEAIAVLGARVAGSSLAGFATYHV 2392
Cdd:cd05236 238 NGPD----GLFLAYGKGIL-RTMN------ADPNAVADIIPVDVVANALLAAAAYSGVRKPRELEVYHC 295
|
|
| PRK06155 |
PRK06155 |
crotonobetaine/carnitine-CoA ligase; Provisional |
1473-1966 |
1.72e-30 |
|
crotonobetaine/carnitine-CoA ligase; Provisional
Pssm-ID: 235719 [Multi-domain] Cd Length: 542 Bit Score: 129.11 E-value: 1.72e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1473 ARLDEWGNRAVLTAPAP-TPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFER 1551
Cdd:PRK06155 1 GEPLGAGLAARAVDPLPpSERTLPAMLARQAERYPDRPLLVFGGTRWTYAEAARAAAAAAHALAAAGVKRGDRVALMCGN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1552 CAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLRSRLAGHDLP--------IIDVVDALAAYPG- 1622
Cdd:PRK06155 81 RIEFLDVFLGCAWLGAIAVPINTALRGPQLEHILRNSGARLLVVEAALLAALEAADPGdlplpavwLLDAPASVSVPAGw 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1623 ---TPPPMPAAV--------NLAYILYTSGTTGEPKGVGITH-------RNVTRLFAslparLSAAQVWSQC----HSYG 1680
Cdd:PRK06155 161 staPLPPLDAPApaaavqpgDTAAILYTSGTTGPSKGVCCPHaqfywwgRNSAEDLE-----IGADDVLYTTlplfHTNA 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1681 FDAsaweIWGALLGGGRLVIVPESVAASpndFHGLLVAEHVSVLTQTPAAVAML---PTQGLES-----VALvvaGEACP 1752
Cdd:PRK06155 236 LNA----FFQALLAGATYVLEPRFSASG---FWPAVRRHGATVTYLLGAMVSILlsqPARESDRahrvrVAL---GPGVP 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1753 AALVD--RWAPGRVMLNAYGPTETT-ICAAISAPLRPGSgmppIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGA---G 1826
Cdd:PRK06155 306 AALHAafRERFGVDLLDGYGSTETNfVIAVTHGSQRPGS----MGRLAPGFEARVVDEHDQELPDGEPGELLLRADepfA 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1827 VGVGYWRRAGLTASRFVACPFggsgarmyRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVV 1906
Cdd:PRK06155 382 FATGYFGMPEKTVEAWRNLWF--------HTGDRVVRDADGWFRFVDRIKDAIRRRGENISSFEVEQVLLSHPAVAAAAV 453
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 489495878 1907 IAREDRPGDKRlVGYATEIAPG-AVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:PRK06155 454 FPVPSELGEDE-VMAAVVLRDGtALEPVALVRHCEPRLAYFAVPRYVEFVAALPKTENGKV 513
|
|
| PRK08316 |
PRK08316 |
acyl-CoA synthetase; Validated |
1493-1971 |
1.80e-30 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181381 [Multi-domain] Cd Length: 523 Bit Score: 128.90 E-value: 1.80e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1493 SIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPI 1572
Cdd:PRK08316 12 TIGDILRRSARRYPDKTALVFGDRSWTYAELDAAVNRVAAALLDLGLKKGDRVAALGHNSDAYALLWLACARAGAVHVPV 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1573 DPANPPPRVAFMLGDAVPVAAVTTAGLRSRL--------------------AGHDLPIIDVVDALAAYPGTPP-PMPAAV 1631
Cdd:PRK08316 92 NFMLTGEELAYILDHSGARAFLVDPALAPTAeaalallpvdtlilslvlggREAPGGWLDFADWAEAGSVAEPdVELADD 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1632 NLAYILYTSGTTGEPKGVGITHRNVTRLFAS--LPARLSAAQVWSQC----HSYGFDASAWEIwgaLLGGGRLVIVPesv 1705
Cdd:PRK08316 172 DLAQILYTSGTESLPKGAMLTHRALIAEYVSciVAGDMSADDIPLHAlplyHCAQLDVFLGPY---LYVGATNVILD--- 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1706 AASPNDFHGLLVAEHVSVLTQTPAA-VAMLPTQGLESVALVVAGEACPAA----------LVDRWaPGRVMLNAYGPTET 1774
Cdd:PRK08316 246 APDPELILRTIEAERITSFFAPPTVwISLLRHPDFDTRDLSSLRKGYYGAsimpvevlkeLRERL-PGLRFYNCYGQTEI 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1775 TICAAISAP----LRPGS-GMPPIGVPVSgaalfVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacpfGG 1849
Cdd:PRK08316 325 APLATVLGPeehlRRPGSaGRPVLNVETR-----VVDDDGNDVAPGEVGEIVHRSPQLMLGYWDDPEKTAEAFR----GG 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1850 sgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREdrpgDKRLVGYATEI---- 1925
Cdd:PRK08316 396 ----WFHSGDLGVMDEEGYITVVDRKKDMIKTGGENVASREVEEALYTHPAVAEVAVIGLP----DPKWIEAVTAVvvpk 467
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 489495878 1926 APGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK08316 468 AGATVTEDELIAHCRARLAGFKVPKRVIFVDELPRNPSGKILKREL 513
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
1519-1971 |
2.20e-30 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 127.16 E-value: 2.20e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTtag 1598
Cdd:cd05971 8 TFKELKTASNRFANVLKEIGLEKGDRVGVFLSQGPECAIAHIAILRSGAIAVPLFALFGPEALEYRLSNSGASALVT--- 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1599 lrsrlaghdlpiiDVVDalaaypgtpppmpaavNLAYILYTSGTTGEPKGVGITHRnvtRLFASLPARLSAAQVWSQCHS 1678
Cdd:cd05971 85 -------------DGSD----------------DPALIIYTSGTTGPPKGALHAHR---VLLGHLPGVQFPFNLFPRDGD 132
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1679 YGFDASAWEIWGALLGggrlVIVPES------VAASPNDFHG----LLVAEH-VSVLTQTPAAVAMLPTQG-------LE 1740
Cdd:cd05971 133 LYWTPADWAWIGGLLD----VLLPSLyfgvpvLAHRMTKFDPkaalDLMSRYgVTTAFLPPTALKMMRQQGeqlkhaqVK 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1741 SVALVVAGEACPAALVdRWAP---GRVMLNAYGPTETTI----CAAIsAPLRPGSgmppIGVPVSGAALFVLDSWLRPVP 1813
Cdd:cd05971 209 LRAIATGGESLGEELL-GWAReqfGVEVNEFYGQTECNLvignCSAL-FPIKPGS----MGKPIPGHRVAIVDDNGTPLP 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1814 AGVAGELYI--AGAGVGVGYWRRAGLTASRFVAcpfggsgaRMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEV 1891
Cdd:cd05971 283 PGEVGEIAVelPDPVAFLGYWNNPSATEKKMAG--------DWLLTGDLGRKDSDGYFWYVGRDDDVITSSGYRIGPAEI 354
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1892 ATALAELAGVGQAVVIAREDrPGDKRLVGYATEIAPGAVDPAGLRAQL----AQRLPGYLVPAAVVVIDALPLTVNGKLD 1967
Cdd:cd05971 355 EECLLKHPAVLMAAVVGIPD-PIRGEIVKAFVVLNPGETPSDALAREIqelvKTRLAAHEYPREIEFVNELPRTATGKIR 433
|
....
gi 489495878 1968 HRAL 1971
Cdd:cd05971 434 RREL 437
|
|
| ABCL |
cd05958 |
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate ... |
1510-1971 |
2.78e-30 |
|
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate aerobic degradation pathway by activating 2-aminobenzoate to 2-aminobenzoyl-CoA. The reaction is carried out via a two-step process; the first step is ATP-dependent and forms a 2-aminobenzoyl-AMP intermediate, and the second step forms the 2-aminobenzoyl-CoA ester and releases the AMP. 2-Aminobenzoyl-CoA is further converted to 2-amino-5-oxo-cyclohex-1-ene-1-carbonyl-CoA catalyzed by 2-aminobenzoyl-CoA monooxygenase/reductase. ABCL has been purified from cells aerobically grown with 2-aminobenzoate as sole carbon, energy, and nitrogen source, and has been characterized as a monomer.
Pssm-ID: 341268 [Multi-domain] Cd Length: 439 Bit Score: 126.82 E-value: 2.78e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1510 AVCCGDASMTYRELDEASNRLAHRLAGCGAG-PGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDA 1588
Cdd:cd05958 3 CLRSPEREWTYRDLLALANRIANVLVGELGIvPGNRVLLRGSNSPELVACWFGIQKAGAIAVATMPLLRPKELAYILDKA 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1589 VPVAAVttaglrsrlaghdlpiidVVDALAaypgtpppmpAAVNLAYILYTSGTTGEPKGVGITHRNVTrlfasLPARLS 1668
Cdd:cd05958 83 RITVAL------------------CAHALT----------ASDDICILAFTSGTTGAPKATMHFHRDPL-----ASADRY 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1669 AAQVWSQCHSYGFDASAWEIWGALLGGgrLVIVPESVAAS--------PNDFHGLLVAEHVSVLTQTP----AAVAMLPT 1736
Cdd:cd05958 130 AVNVLRLREDDRFVGSPPLAFTFGLGG--VLLFPFGVGASgvlleeatPDLLLSAIARYKPTVLFTAPtayrAMLAHPDA 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1737 QG--LESVALVV-AGEACPAALVDRW--APGRVMLNAYGPTET--TICAAISAPLRPGSgmppIGVPVSGAALFVLDSWL 1809
Cdd:cd05958 208 AGpdLSSLRKCVsAGEALPAALHRAWkeATGIPIIDGIGSTEMfhIFISARPGDARPGA----TGKPVPGYEAKVVDDEG 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1810 RPVPAGVAGELYIAGAgvgVGYWRRAGLTASRFVAcpfGGSGArmyrTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELG 1889
Cdd:cd05958 284 NPVPDGTIGRLAVRGP---TGCRYLADKRQRTYVQ---GGWNI----TGDTYSRDPDGYFRHQGRSDDMIVSGGYNIAPP 353
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1890 EVATALAELAGVGQAVVIAREDRPGD---KRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:cd05958 354 EVEDVLLQHPAVAECAVVGHPDESRGvvvKAFVVLRPGVIPGPVLARELQDHAKAHIAPYKYPRAIEFVTELPRTATGKL 433
|
....*
gi 489495878 1967 DHRAL 1971
Cdd:cd05958 434 QRFAL 438
|
|
| C_NRPS-like |
cd19537 |
Condensation family domain with an atypical active site motif; Condensation (C) domains of ... |
1024-1450 |
6.17e-30 |
|
Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380460 [Multi-domain] Cd Length: 395 Bit Score: 124.61 E-value: 6.17e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1024 PLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVP-RQLVIEARRADLgCD 1102
Cdd:cd19537 3 ALSPIEREWWHKYQLSTGTSSFNVSFACRLSGDVDRDRLASAWNTVLARHRILRSRYVPRDGGLrRSYSSSPPRVQR-VD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1103 IVDatawpadrlqraIEEAARHSFDLATEIPLRTwlfRIADDEhvLVAVAHHIAADGWSVAPLTADLSAAYasrcAGRAP 1182
Cdd:cd19537 82 TLD------------VWKEINRPFDLEREDPIRV---FISPDT--LLVVMSHIICDLTTLQLLLREVSAAY----NGKLL 140
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1183 dwAPLPVQYVDYTLWQREILGDlddsdspiaaQLAYWENALAGMPERL--RLPTARPYppvadqRGASLVVDWPASVQQQ 1260
Cdd:cd19537 141 --PPVRREYLDSTAWSRPASPE----------DLDFWSEYLSGLPLLNlpRRTSSKSY------RGTSRVFQLPGSLYRS 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1261 VRRIARQHNATS--FMVVAAGLAvlLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRV--NLAGDPSFAELLGQ 1336
Cdd:cd19537 203 LLQFSTSSGITLhqLALAAVALA--LQDLSDRTDIVLGAPYLNRTSEEDMETVGLFLEPLPIRIrfPSSSDASAADFLRA 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1337 VRARSLAAYENQdVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQLNLgDLQ-ATPMPIDTRTARmdlvFSLAERFS 1415
Cdd:cd19537 281 VRRSSQAALAHA-IPWHQLLEHLGLPPDSPNHPLFDVMVTFHDDRGVSLAL-PIPgVEPLYTWAEGAK----FPLMFEFT 354
|
410 420 430
....*....|....*....|....*....|....*
gi 489495878 1416 EGSEpAGIGGAVEYRTDVFEAQAIDVLIERLRKVL 1450
Cdd:cd19537 355 ALSD-DSLLLRLEYDTDCFSEEEIDRIESLILAAL 388
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
1514-1971 |
2.83e-29 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 124.73 E-value: 2.83e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1514 GDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAA 1593
Cdd:cd05926 11 STPALTYADLAELVDDLARQLAALGIKKGDRVAIALPNGLEFVVAFLAAARAGAVVAPLNPAYKKAEFEFYLADLGSKLV 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1594 VTTAG-----LRSRL--------AGHDLPIIDVV---DALAAYPG-----TPPPMPAAVNLAYILYTSGTTGEPKGVGIT 1652
Cdd:cd05926 91 LTPKGelgpaSRAASklglaileLALDVGVLIRApsaESLSNLLAdkknaKSEGVPLPDDLALILHTSGTTGRPKGVPLT 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1653 HRNVTRLFASLPA--RLSAAQ----VWSQCHSYGFDASAWEIwgaLLGGGRLVIVPESvaaSPNDFHGLLVAEHVSVLTQ 1726
Cdd:cd05926 171 HRNLAASATNITNtyKLTPDDrtlvVMPLFHVHGLVASLLST---LAAGGSVVLPPRF---SASTFWPDVRDYNATWYTA 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1727 TPAAVAML-----PTQGLESVALVV---AGEACPAALVDRW-----APgrvMLNAYGPTETTiCAAISAPL-----RPGS 1788
Cdd:cd05926 245 VPTIHQILlnrpePNPESPPPKLRFirsCSASLPPAVLEALeatfgAP---VLEAYGMTEAA-HQMTSNPLppgprKPGS 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1789 gmppIGVPVsGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCWRADGQ 1868
Cdd:cd05926 321 ----VGKPV-GVEVRILDEDGEILPPGVVGEICLRGPNVTRGYLNNPEANAEAAFKDGW-------FRTGDLGYLDADGY 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1869 LEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAredRPGDKrlvgYATEIA-------PGAVDPAGLRAQLAQ 1941
Cdd:cd05926 389 LFLTGRIKELINRGGEKISPLEVDGVLLSHPAVLEAVAFG---VPDEK----YGEEVAaavvlreGASVTEEELRAFCRK 461
|
490 500 510
....*....|....*....|....*....|
gi 489495878 1942 RLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05926 462 HLAAFKVPKKVYFVDELPKTATGKIQRRKV 491
|
|
| MupV_like_SDR_e |
cd05263 |
Pseudomonas fluorescens MupV-like, extended (e) SDRs; This subgroup of extended SDR family ... |
2110-2395 |
2.63e-28 |
|
Pseudomonas fluorescens MupV-like, extended (e) SDRs; This subgroup of extended SDR family domains have the characteristic active site tetrad and a well-conserved NAD(P)-binding motif. This subgroup is not well characterized, its members are annotated as having a variety of putative functions. One characterized member is Pseudomonas fluorescens MupV a protein involved in the biosynthesis of Mupirocin, a polyketide-derived antibiotic. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187573 [Multi-domain] Cd Length: 293 Bit Score: 117.47 E-value: 2.63e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2110 VLLTGATGFLGRYLVLELLRRldvDGRLICLVRAESDEDARRRLEKTfdsgdpellrhfkELAADRLEVVAGDKSEPDLG 2189
Cdd:cd05263 1 VFVTGGTGFLGRHLVKRLLEN---GFKVLVLVRSESLGEAHERIEEA-------------GLEADRVRVLEGDLTQPNLG 64
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2190 LDQPMWRRLAETVDLIVDSAAMVN-AFPYHELFGPNVAGTAELIRIALTTKLKPFTYVSTAdvGAAIEPS-AFTEDADir 2267
Cdd:cd05263 65 LSAAASRELAGKVDHVIHCAASYDfQAPNEDAWRTNIDGTEHVLELAARLDIQRFHYVSTA--YVAGNREgNIRETEL-- 140
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2268 visptrTVDGGWAGGYGTSKWAGEVLLREANDlcALPVAVFRCGMILADtSYAGQLNMSDWVTRMVLSLMATGIAPRSfy 2347
Cdd:cd05263 141 ------NPGQNFKNPYEQSKAEAEQLVRAAAT--QIPLTVYRPSIVVGD-SKTGRIEKIDGLYELLNLLAKLGRWLPM-- 209
|
250 260 270 280
....*....|....*....|....*....|....*....|....*...
gi 489495878 2348 ePDSEGNRqrahFDGLPVTFVAEAIavlgARVAGSSLAGFATYHVMNP 2395
Cdd:cd05263 210 -PGNKGAR----LNLVPVDYVADAI----VYLSKKPEANGQIFHLTDP 248
|
|
| PRK08314 |
PRK08314 |
long-chain-fatty-acid--CoA ligase; Validated |
1484-1977 |
3.28e-28 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236235 [Multi-domain] Cd Length: 546 Bit Score: 122.38 E-value: 3.28e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1484 LTAPAptpVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAG-CGAGPGECVALLFERCAPAVVAMVAV 1562
Cdd:PRK08314 5 LTLPE---TSLFHNLEVSARRYPDKTAIVFYGRAISYRELLEEAERLAGYLQQeCGVRKGDRVLLYMQNSPQFVIAYYAI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1563 LKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLRSRL--AGHDLPIIDVV-----DALAAYPG------------- 1622
Cdd:PRK08314 82 LRANAVVVPVNPMNREEELAHYVTDSGARVAIVGSELAPKVapAVGNLRLRHVIvaqysDYLPAEPEiavpawlraeppl 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1623 -------------------TPPPMPAAVN-LAYILYTSGTTGEPKGVGITHRNVTrlfaslpARLSAAQVWSQC------ 1676
Cdd:PRK08314 162 qalapggvvawkealaaglAPPPHTAGPDdLAVLPYTSGTTGVPKGCMHTHRTVM-------ANAVGSVLWSNStpesvv 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1677 -------HSYGFDASaweIWGALLGGGRLVIVP--ESVAAspndfhGLLVAEH-VSVLTQTPA-AVAMLPTQGLE----- 1740
Cdd:PRK08314 235 lavlplfHVTGMVHS---MNAPIYAGATVVLMPrwDREAA------ARLIERYrVTHWTNIPTmVVDFLASPGLAerdls 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1741 SVALVVAGEAC-PAA----LVDRWapGRVMLNAYGPTETTICAAISAPLRPGS---GMPPIGVPvsgaALFVLDSWLRPV 1812
Cdd:PRK08314 306 SLRYIGGGGAAmPEAvaerLKELT--GLDYVEGYGLTETMAQTHSNPPDRPKLqclGIPTFGVD----ARVIDPETLEEL 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1813 PAGVAGELYIAGAGVGVGYWRRAGLTASRFVACpfggSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVA 1892
Cdd:PRK08314 380 PPGEVGEIVVHGPQVFKGYWNRPEATAEAFIEI----DGKRFFRTGDLGRMDEEGYFFITDRLKRMINASGFKVWPAEVE 455
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1893 TALAELAGVGQAVVIA-REDRPGD--KRLVGYATEiAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHR 1969
Cdd:PRK08314 456 NLLYKHPAIQEACVIAtPDPRRGEtvKAVVVLRPE-ARGKTTEEEIIAWAREHMAAYKYPRIVEFVDSLPKSGSGKILWR 534
|
....*...
gi 489495878 1970 ALPAPEYG 1977
Cdd:PRK08314 535 QLQEQEKA 542
|
|
| FAAL |
cd05931 |
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and ... |
1514-1970 |
1.05e-27 |
|
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and is homologous to fatty acyl-coenzyme A (CoA) ligases (FACLs). However, FAALs produce only the acyl adenylate and are unable to perform the thioester-forming reaction, while FACLs perform a two-step catalytic reaction; AMP ligation followed by CoA ligation using ATP and CoA as cofactors. FAALs have insertion motifs between the N-terminal and C-terminal subdomains that distinguish them from the FACLs. This insertion motif precludes the binding of CoA, thus preventing CoA ligation. It has been suggested that the acyl adenylates serve as substrates for multifunctional polyketide synthases to permit synthesis of complex lipids such as phthiocerol dimycocerosate, sulfolipids, mycolic acids, and mycobactin.
Pssm-ID: 341254 [Multi-domain] Cd Length: 547 Bit Score: 120.81 E-value: 1.05e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1514 GDASMTYRELDEASNRLAHRLAGCGAgPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPP---PRVAFMLGDAVP 1590
Cdd:cd05931 21 REETLTYAELDRRARAIAARLQAVGK-PGDRVLLLAPPGLDFVAAFLGCLYAGAIAVPLPPPTPGrhaERLAAILADAGP 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1591 VAAVTTAGLRSRLAGH-------DLPIIDVVDALAAYPGT--PPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVtrlfa 1661
Cdd:cd05931 100 RVVLTTAAALAAVRAFaasrpaaGTPRLLVVDLLPDTSAAdwPPPSPDPDDIAYLQYTSGSTGTPKGVVVTHRNL----- 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1662 slparlsAAQVWSQCHSYGFDASA----W-----------EIWGALLGGGRLVIVpesvaaSPNDFhgL--------LVA 1718
Cdd:cd05931 175 -------LANVRQIRRAYGLDPGDvvvsWlplyhdmgligGLLTPLYSGGPSVLM------SPAAF--LrrplrwlrLIS 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1719 EHVSVLTQTPA-----AVAMLPTQGLESVAL------VVAGEACPAALVDRWA--------PGRVMLNAYGPTETTI--- 1776
Cdd:cd05931 240 RYRATISAAPNfaydlCVRRVRDEDLEGLDLsswrvaLNGAEPVRPATLRRFAeafapfgfRPEAFRPSYGLAEATLfvs 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1777 --------------CAAISAPLRPGSGMPPIGVPVSGAALFVLDSWLR--------PVPAGVAGELYIAGAGVGVGYWRR 1834
Cdd:cd05931 320 ggppgtgpvvlrvdRDALAGRAVAVAADDPAARELVSCGRPLPDQEVRivdpetgrELPDGEVGEIWVRGPSVASGYWGR 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1835 AGLTASRFVACPfGGSGARMYRTGDLvCWRADGQLEFLGRTDDQVKIRGYRI---ELGEVATALAELAGVGQAVVIARED 1911
Cdd:cd05931 400 PEATAETFGALA-ATDEGGWLRTGDL-GFLHDGELYITGRLKDLIIVRGRNHypqDIEATAEEAHPALRPGCVAAFSVPD 477
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 489495878 1912 RPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLP---GyLVPAAVVVI--DALPLTVNGKLDHRA 1970
Cdd:cd05931 478 DGEERLVVVAEVERGADPADLAAIAAAIRAAVArehG-VAPADVVLVrpGSIPRTSSGKIQRRA 540
|
|
| benz_CoA_lig |
TIGR02262 |
benzoate-CoA ligase family; Characterized members of this protein family include benzoate-CoA ... |
1517-1966 |
3.42e-27 |
|
benzoate-CoA ligase family; Characterized members of this protein family include benzoate-CoA ligase, 4-hydroxybenzoate-CoA ligase, 2-aminobenzoate-CoA ligase, etc. Members are related to fatty acid and acetate CoA ligases.
Pssm-ID: 274059 [Multi-domain] Cd Length: 505 Bit Score: 118.40 E-value: 3.42e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTT 1596
Cdd:TIGR02262 30 SLSYGELEAQVRRLAAALRRLGVKREERVLLLMLDGVDFPIAFLGAIRAGIVPVALNTLLTADDYAYMLEDSRARVVFVS 109
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1597 AGLRS--RLAGHDLPIIDVV----------DALAAYPGTPPPM--PAAV---NLAYILYTSGTTGEPKGVGITHRNVtRL 1659
Cdd:TIGR02262 110 GALLPviKAALGKSPHLEHRvvvgrpeageVQLAELLATESEQfkPAATqadDPAFWLYSSGSTGMPKGVVHTHSNP-YW 188
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1660 FASLPAR-----------LSAAQVWsqcHSYGFdasaweiwgallggGRLVIVPESVAAS---------PNDFHGLLVAE 1719
Cdd:TIGR02262 189 TAELYARntlgireddvcFSAAKLF---FAYGL--------------GNALTFPMSVGATtvlmgerptPDAVFDRLRRH 251
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1720 HVSVLTQTPAAVA-ML-----PTQGLESVALVV-AGEACPAALVDRWAP--GRVMLNAYGPTETTICAAISAPLRPGSGM 1790
Cdd:TIGR02262 252 QPTIFYGVPTLYAaMLadpnlPSEDQVRLRLCTsAGEALPAEVGQRWQArfGVDIVDGIGSTEMLHIFLSNLPGDVRYGT 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1791 PpiGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVAcpfggsgaRMYRTGDLVCWRADGQLE 1870
Cdd:TIGR02262 332 S--GKPVPGYRLRLVGDGGQDVADGEPGELLISGPSSATMYWNNRAKSRDTFQG--------EWTRSGDKYVRNDDGSYT 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1871 FLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPA 1950
Cdd:TIGR02262 402 YAGRTDDMLKVSGIYVSPFEIESALIQHPAVLEAAVVGVADEDGLIKPKAFVVLRPGQTALETELKEHVKDRLAPYKYPR 481
|
490
....*....|....*.
gi 489495878 1951 AVVVIDALPLTVNGKL 1966
Cdd:TIGR02262 482 WIVFVDDLPKTATGKI 497
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
1496-1971 |
6.15e-27 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 117.61 E-value: 6.15e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1496 QMLAAQVARIPEAEAVC--CGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPID 1573
Cdd:cd05923 5 EMLRRAASRAPDACAIAdpARGLRLTYSELRARIEAVAARLHARGLRPGQRVAVVLPNSVEAVIALLALHRLGAVPALIN 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1574 P-----------ANPPPRVAFMLGDAVPVAAVTTAGLRSrLAGHDLPIIDVVDALAAYPGTPPPMPAAVnlAYILYTSGT 1642
Cdd:cd05923 85 PrlkaaelaeliERGEMTAAVIAVDAQVMDAIFQSGVRV-LALSDLVGLGEPESAGPLIEDPPREPEQP--AFVFYTSGT 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1643 TGEPKGVGITHRNVTR--LFASLPARLSAAQ------VWSQCHSYGFDASaweIWGALLGGGRLVIVPESvaaSPNDFHG 1714
Cdd:cd05923 162 TGLPKGAVIPQRAAESrvLFMSTQAGLRHGRhnvvlgLMPLYHVIGFFAV---LVAALALDGTYVVVEEF---DPADALK 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1715 LLVAEHVSVLTQTP-------AAVAMLPTQgLESV-ALVVAGEACPAALVDR---WAPGRVmLNAYGPTETTICAAISAP 1783
Cdd:cd05923 236 LIEQERVTSLFATPthldalaAAAEFAGLK-LSSLrHVTFAGATMPDAVLERvnqHLPGEK-VNIYGTTEAMNSLYMRDA 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1784 lRPGSGMPPiGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAG--VGVGYWRRAGLTASRFVAcpfggsgaRMYRTGDLV 1861
Cdd:cd05923 314 -RTGTEMRP-GFFSEVRIVRIGGSPDEALANGEEGELIVAAAAdaAFTGYLNQPEATAKKLQD--------GWYRTGDVG 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1862 CWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATeIAPGAVDPAGLRA-QLA 1940
Cdd:cd05923 384 YVDPSGDVRILGRVDDMIISGGENIHPSEIERVLSRHPGVTEVVVIGVADERWGQSVTACVV-PREGTLSADELDQfCRA 462
|
490 500 510
....*....|....*....|....*....|.
gi 489495878 1941 QRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05923 463 SELADFKRPRRYFFLDELPKNAMNKVLRRQL 493
|
|
| ACS-like |
cd17634 |
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the ... |
1519-1966 |
1.18e-26 |
|
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases. The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341289 [Multi-domain] Cd Length: 587 Bit Score: 118.06 E-value: 1.18e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAG 1598
Cdd:cd17634 86 SYRELHREVCRFAGTLLDLGVKKGDRVAIYMPMIPEAAVAMLACARIGAVHSVIFGGFAPEAVAGRIIDSSSRLLITADG 165
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1599 LRSRlaGHDLPIIDVVDALAAYPGTPPP---------------------------------MPAAVNLA---YILYTSGT 1642
Cdd:cd17634 166 GVRA--GRSVPLKKNVDDALNPNVTSVEhvivlkrtgsdidwqegrdlwwrdliakaspehQPEAMNAEdplFILYTSGT 243
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1643 TGEPKGVGITHRNVTrlfaslparLSAAQVWSQCHSYG-------------FDASAWEIWGALLGGGRLVI---VPesVA 1706
Cdd:cd17634 244 TGKPKGVLHTTGGYL---------VYAATTMKYVFDYGpgdiywctadvgwVTGHSYLLYGPLACGATTLLyegVP--NW 312
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1707 ASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVA---------LVVAGEAC-PAALvdRWA------PGRVMLNAYG 1770
Cdd:cd17634 313 PTPARMWQVVDKHGVNILYTAPTAIRALMAAGDDAIEgtdrsslriLGSVGEPInPEAY--EWYwkkigkEKCPVVDTWW 390
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1771 PTETT--ICA--AISAPLRPGSGMppigVPVSGAALFVLDSWLRPVPAGVAGELYIAGA--GVGVGYWRRAGLTASRFVA 1844
Cdd:cd17634 391 QTETGgfMITplPGAIELKAGSAT----RPVFGVQPAVVDNEGHPQPGGTEGNLVITDPwpGQTRTLFGDHERFEQTYFS 466
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1845 cPFGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATe 1924
Cdd:cd17634 467 -TFKG----MYFSGDGARRDEDGYYWITGRSDDVINVAGHRLGTAEIESVLVAHPKVAEAAVVGIPHAIKGQAPYAYVV- 540
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 489495878 1925 IAPGAVDPAGLRAQL----AQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:cd17634 541 LNHGVEPSPELYAELrnwvRKEIGPLATPDVVHWVDSLPKTRSGKI 586
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
473-911 |
1.23e-26 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 116.60 E-value: 1.23e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 473 AWLVQRGAAPGDVLVFTDDDTDKTIDLLIACHLAGCGYSVCDtADEISVRTNAITEHGdGILVTVVDVAATQLAVVGHDE 552
Cdd:cd12114 27 GALKAAGVRPGDLVAVTLPKGPEQVVAVLGILAAGAAYVPVD-IDQPAARREAILADA-GARLVLTDGPDAQLDVAVFDV 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 553 LrkvVDERVTQVTHDALLATKT-----AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDIS 627
Cdd:cd12114 105 L---ILDLDALAAPAPPPPVDVapddlAYVIFTSGSTGTPKGVMISHRAALNTILDINRRFAVGPDDRVLALSSLSFDLS 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 628 VEEIFGGAACGARLVRSAAMKTGDLAALVDDLVARETTIVDLPTAVWQLLCADGDAIDAIGRSrLRQIVIGGEAIRCSAV 707
Cdd:cd12114 182 VYDIFGALSAGATLVLPDEARRRDPAHWAELIERHGVTLWNSVPALLEMLLDVLEAAQALLPS-LRLVLLSGDWIPLDLP 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 708 DKWLESAAsqGISLLSSYGPTEATVVATFLPIvcDQTTMDGALLRLGRPiLPNTVF------------LAFGEVVIVGDL 775
Cdd:cd12114 261 ARLRALAP--DARLISLGGATEASIWSIYHPI--DEVPPDWRSIPYGRP-LANQRYrvldprgrdcpdWVPGELWIGGRG 335
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 776 VADGYLgidGDGFGT----VTAADGsrRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDV 851
Cdd:cd12114 336 VALGYL---GDPELTaarfVTHPDG--ERLYRTGDLGRYRPDGTLEFLGRRDGQVKVRGYRIELGEIEAALQAHPGVARA 410
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 852 AV----ELHSGSLGVWFKSQrtREGEQDAAAATRIRLV--LVSLGVSSFFVVgVPNIPRKPNGKID 911
Cdd:cd12114 411 VVvvlgDPGGKRLAAFVVPD--NDGTPIAPDALRAFLAqtLPAYMIPSRVIA-LEALPLTANGKVD 473
|
|
| AAS_C |
cd05909 |
C-terminal domain of the acyl-acyl carrier protein synthetase (also called ... |
1633-1971 |
1.51e-26 |
|
C-terminal domain of the acyl-acyl carrier protein synthetase (also called 2-acylglycerophosphoethanolamine acyltransferase, Aas); Acyl-acyl carrier protein synthase (Aas) is a membrane protein responsible for a minor pathway of incorporating exogenous fatty acids into membrane phospholipids. Its in vitro activity is characterized by the ligation of free fatty acids between 8 and 18 carbons in length to the acyl carrier protein sulfydryl group (ACP-SH) in the presence of ATP and Mg2+. However, its in vivo function is as a 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase. The reaction occurs in two steps: the acyl chain is first esterified to acyl carrier protein (ACP) via a thioester bond, followed by a second step where the acyl chain is transferred to a 2-acyllysophospholipid, thus completing the transacylation reaction. This model represents the C-terminal domain of the enzyme, which belongs to the class I adenylate-forming enzyme family, including acyl-CoA synthetases.
Pssm-ID: 341235 [Multi-domain] Cd Length: 490 Bit Score: 116.28 E-value: 1.51e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1633 LAYILYTSGTTGEPKGVGITHRNVTRLFASLPARLSAAQVWSQC------HSYGFDASaweIWGALLGGGrlvivpeSVA 1706
Cdd:cd05909 149 PAVILFTSGSEGLPKGVVLSHKNLLANVEQITAIFDPNPEDVVFgalpffHSFGLTGC---LWLPLLSGI-------KVV 218
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1707 ASPNDFHGLLVAE-----HVSVLTQTPA-----AVAMLPTQgLESVALVVAG-EACPAALVDRWAP--GRVMLNAYGPTE 1773
Cdd:cd05909 219 FHPNPLDYKKIPEliydkKATILLGTPTflrgyARAAHPED-FSSLRLVVAGaEKLKDTLRQEFQEkfGIRILEGYGTTE 297
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1774 TTICAAISAPL---RPGSgmppIGVPVSG-AALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFvacpfgg 1849
Cdd:cd05909 298 CSPVISVNTPQspnKEGT----VGRPLPGmEVKIVSVETHEEVPIGEGGLLLVRGPNVMLGYLNEPELTSFAF------- 366
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1850 sGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAG--VGQAVVIAREDRPGDKRLVGYATEIAp 1927
Cdd:cd05909 367 -GDGWYDTGDIGKIDGEGFLTITGRLSRFAKIAGEMVSLEAIEDILSEILPedNEVAVVSVPDGRKGEKIVLLTTTTDT- 444
|
330 340 350 360
....*....|....*....|....*....|....*....|....*
gi 489495878 1928 gavDPAGLRAQL-AQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05909 445 ---DPSSLNDILkNAGISNLAKPSYIHQVEEIPLLGTGKPDYVTL 486
|
|
| PRK12406 |
PRK12406 |
long-chain-fatty-acid--CoA ligase; Provisional |
1514-1974 |
1.60e-26 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 183506 [Multi-domain] Cd Length: 509 Bit Score: 116.72 E-value: 1.60e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1514 GDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAA 1593
Cdd:PRK12406 8 GDRRRSFDELAQRAARAAGGLAALGVRPGDCVALLMRNDFAFFEAAYAAMRLGAYAVPVNWHFKPEEIAYILEDSGARVL 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1594 VTTAGLRSRLAGHDLPIIDVVDA------LAAY------------------------PGTPPPMPAAVNLayiLYTSGTT 1643
Cdd:PRK12406 88 IAHADLLHGLASALPAGVTVLSVptppeiAAAYrispalltppagaidwegwlaqqePYDGPPVPQPQSM---IYTSGTT 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1644 GEPKGVgithrnvtRLFASLPaRLSAAQVWSQCHSYGFDA------------SAWEIWG--ALLGGGRLVIVPEsvaASP 1709
Cdd:PRK12406 165 GHPKGV--------RRAAPTP-EQAAAAEQMRALIYGLKPgiralltgplyhSAPNAYGlrAGRLGGVLVLQPR---FDP 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1710 NDFHGLLVAEHVSVLTQTPAA---VAMLPTQ-----GLESVALVVAGEA-CPA----ALVDRWAPgrVMLNAYGPTET-- 1774
Cdd:PRK12406 233 EELLQLIERHRITHMHMVPTMfirLLKLPEEvrakyDVSSLRHVIHAAApCPAdvkrAMIEWWGP--VIYEYYGSTESga 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1775 -TICAAISAPLRPGSgmppIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVG-VGYW---------RRAGLTASrfv 1843
Cdd:PRK12406 311 vTFATSEDALSHPGT----VGKAAPGAELRFVDEDGRPLPQGEIGEIYSRIAGNPdFTYHnkpekraeiDRGGFITS--- 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1844 acpfggsgarmyrtGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYaT 1923
Cdd:PRK12406 384 --------------GDVGYLDADGYLFLCDRKRDMVISGGVNIYPAEIEAVLHAVPGVHDCAVFGIPDAEFGEALMAV-V 448
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 489495878 1924 EIAPGA-VDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAP 1974
Cdd:PRK12406 449 EPQPGAtLDEADIRAQLKARLAGYKVPKHIEIMAELPREDSGKIFKRRLRDP 500
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
564-915 |
5.00e-26 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 114.11 E-value: 5.00e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 564 VTHDALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARL-- 641
Cdd:cd17654 110 RHFNIRTDECLAYVIHTSGTTGTPKIVAVPHKCILPNIQHFRSLFNITSEDILFLTSPLTFDPSVVEIFLSLSSGATLli 189
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 642 VRSAAMKTGDLAALVDDLVARETTIVDLPTAVWQLLCADGDAIDAIGRSRLRQIVIGGEAIRCSAVDK-WleSAASQGIS 720
Cdd:cd17654 190 VPTSVKVLPSKLADILFKRHRITVLQATPTLFRRFGSQSIKSTVLSATSSLRVLALGGEPFPSLVILSsW--RGKGNRTR 267
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 721 LLSSYGPTEATVVATFLPIVCDQTTmdgalLRLGRPILpntvflafGEVVIVGDLVADGYLGIDGDGF--------GTVT 792
Cdd:cd17654 268 IFNIYGITEVSCWALAYKVPEEDSP-----VQLGSPLL--------GTVIEVRDQNGSEGTGQVFLGGlnrvcildDEVT 334
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 793 AADGSRRrafATGDRVTVDaEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVelhsgslgVWFKSQR---- 868
Cdd:cd17654 335 VPKGTMR---ATGDFVTVK-DGELFFLGRKDSQIKRRGKRINLDLIQQVIESCLGVESCAV--------TLSDQQRliaf 402
|
330 340 350 360
....*....|....*....|....*....|....*....|....*..
gi 489495878 869 TREGEQDAAAATRIRLVLVSLGVSSFFVVGVPNIPRKPNGKIDSDNL 915
Cdd:cd17654 403 IVGESSSSRIHKELQLTLLSSHAIPDTFVQIDKLPLTSHGKVDKSEL 449
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
1494-1971 |
8.65e-26 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 114.47 E-value: 8.65e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1494 IPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPG-----------ECVALLFercapavvamvAV 1562
Cdd:COG1021 27 LGDLLRRRAERHPDRIAVVDGERRLSYAELDRRADRLAAGLLALGLRPGdrvvvqlpnvaEFVIVFF-----------AL 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1563 LKTGAAylpidPANPPPR---------------VAFMLGDAVP----------VAAvTTAGLRSRLAGHDL-PIIDVVDA 1616
Cdd:COG1021 96 FRAGAI-----PVFALPAhrraeishfaeqseaVAYIIPDRHRgfdyralareLQA-EVPSLRHVLVVGDAgEFTSLDAL 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1617 LAAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHR----NV------------TRLFASLPArlsaaqvwsqCHSYG 1680
Cdd:COG1021 170 LAAPADLSEPRPDPDDVAFFQLSGGTTGLPKLIPRTHDdylySVrasaeicgldadTVYLAALPA----------AHNFP 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1681 FdaSAWEIWGALLGGGRLVIVPEsvaASPNDFHGLLVAEHVSVLTQTPAAVAMLptqgLESVA-----------LVVAGE 1749
Cdd:COG1021 240 L--SSPGVLGVLYAGGTVVLAPD---PSPDTAFPLIERERVTVTALVPPLALLW----LDAAErsrydlsslrvLQVGGA 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1750 ACPAALVDRWAP--GRVMLNAYGPTETTICAAisaplRPGSgmPP------IGVPVSGA-ALFVLDSWLRPVPAGVAGEL 1820
Cdd:COG1021 311 KLSPELARRVRPalGCTLQQVFGMAEGLVNYT-----RLDD--PEevilttQGRPISPDdEVRIVDEDGNPVPPGEVGEL 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1821 YIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCWRADGQLEFLGRTDDQVkIR-GYRIELGEVATALAELA 1899
Cdd:COG1021 384 LTRGPYTIRGYYRAPEHNARAFTPDGF-------YRTGDLVRRTPDGYLVVEGRAKDQI-NRgGEKIAAEEVENLLLAHP 455
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 1900 GVGQAVVIAREDrpgdkRLVGYAT----EIAPGAVDPAGLRAQLAQR-LPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:COG1021 456 AVHDAAVVAMPD-----EYLGERScafvVPRGEPLTLAELRRFLRERgLAAFKLPDRLEFVDALPLTAVGKIDKKAL 527
|
|
| MACS_like_2 |
cd05973 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
1518-1966 |
4.39e-25 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341277 [Multi-domain] Cd Length: 437 Bit Score: 111.07 E-value: 4.39e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1518 MTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTA 1597
Cdd:cd05973 1 LTFGELRALSARFANALQELGVGPGDVVAGLLPRTPELVVTILGIWRLGAVYQPLFTAFGPKAIEHRLRTSGARLVVTDA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1598 GLRSRLAGhdlpiidvvdalaaypgtpppmpaavNLAYILYTSGTTGEPKGVgithrnvtrlfaslPARLSAAQVWSQCH 1677
Cdd:cd05973 81 ANRHKLDS--------------------------DPFVMMFTSGTTGLPKGV--------------PVPLRALAAFGAYL 120
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1678 SYGFD----ASAWEI----W---------GALLGGGRLVIV-----PESV------------AASPNDFHGLLVAehvsv 1723
Cdd:cd05973 121 RDAVDlrpeDSFWNAadpgWayglyyaitGPLALGHPTILLeggfsVESTwrvierlgvtnlAGSPTAYRLLMAA----- 195
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1724 ltqtPAAVAMLPTQGLESVAlvVAGEACPAAlVDRWAPGRVML---NAYGPTETTICAA----ISAPLRPGSgmppIGVP 1796
Cdd:cd05973 196 ----GAEVPARPKGRLRRVS--SAGEPLTPE-VIRWFDAALGVpihDHYGQTELGMVLAnhhaLEHPVHAGS----AGRA 264
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1797 VSGAALFVLDSWLRPVPAGVAGELYIAGAGVGV----GYWRRAGLTASrfvacpfggsgARMYRTGDLVCWRADGQLEFL 1872
Cdd:cd05973 265 MPGWRVAVLDDDGDELGPGEPGRLAIDIANSPLmwfrGYQLPDTPAID-----------GGYYLTGDTVEFDPDGSFSFI 333
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1873 GRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDrPGDKRLVGYATEIAPGAVDPAGLRAQLA----QRLPGYLV 1948
Cdd:cd05973 334 GRADDVITMSGYRIGPFDVESALIEHPAVAEAAVIGVPD-PERTEVVKAFVVLRGGHEGTPALADELQlhvkKRLSAHAY 412
|
490
....*....|....*...
gi 489495878 1949 PAAVVVIDALPLTVNGKL 1966
Cdd:cd05973 413 PRTIHFVDELPKTPSGKI 430
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
1519-1971 |
8.30e-25 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 111.57 E-value: 8.30e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDA---VPVAAVT 1595
Cdd:cd12119 27 TYAEVAERARRLANALRRLGVKPGDRVATLAWNTHRHLELYYAVPGMGAVLHTINPRLFPEQIAYIINHAedrVVFVDRD 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1596 TAGLRSRLAGHdLPIIDVVDALAayPGTPPPMPAAVNL------------------------AYILYTSGTTGEPKGVGI 1651
Cdd:cd12119 107 FLPLLEAIAPR-LPTVEHVVVMT--DDAAMPEPAGVGVlayeellaaespeydwpdfdentaAAICYTSGTTGNPKGVVY 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1652 THRNVtrLFASLPARLSAAQVWSQCHSY-----GFDASAWEI-WGALLGGGRLVIvPeSVAASPNDFHGLLVAEHVSVlt 1725
Cdd:cd12119 184 SHRSL--VLHAMAALLTDGLGLSESDVVlpvvpMFHVNAWGLpYAAAMVGAKLVL-P-GPYLDPASLAELIEREGVTF-- 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1726 qtpaaVAMLPT--QGLES------------VALVVAGEACPAALVDRWAPGRV-MLNAYGPTETTICAAISAPLRPGSGM 1790
Cdd:cd12119 258 -----AAGVPTvwQGLLDhleangrdlsslRRVVIGGSAVPRSLIEAFEERGVrVIHAWGMTETSPLGTVARPPSEHSNL 332
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1791 PP---------IGVPVSGAALFVLDSWLRPVPA-GVA-GELYIAGAGVGVGYWRRAGLTASRFVacpfGGsgarMYRTGD 1859
Cdd:cd12119 333 SEdeqlalrakQGRPVPGVELRIVDDDGRELPWdGKAvGELQVRGPWVTKSYYKNDEESEALTE----DG----WLRTGD 404
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1860 LVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATeIAPGA-VDPAGLRAQ 1938
Cdd:cd12119 405 VATIDEDGYLTITDRSKDVIKSGGEWISSVELENAIMAHPAVAEAAVIGVPHPKWGERPLAVVV-LKEGAtVTAEELLEF 483
|
490 500 510
....*....|....*....|....*....|...
gi 489495878 1939 LAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd12119 484 LADKVAKWWLPDDVVFVDEIPKTSTGKIDKKAL 516
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
558-916 |
1.24e-24 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 109.95 E-value: 1.24e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 558 DERVTQVTHD---ALLATKT---AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEI 631
Cdd:cd17645 84 GERIAYMLADssaKILLTNPddlAYVIYTSGSTGLPKGVMIEHHNLVNLCEWHRPYFGVTPADKSLVYASFSFDASAWEI 163
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 632 FGGAACGARL-VRSAAMKTgDLAALVDDLVARETTIVDLPTAVwqllcadGDAIDAIGRSRLRQIVIGGeaircsavDKw 710
Cdd:cd17645 164 FPHLTAGAALhVVPSERRL-DLDALNDYFNQEGITISFLPTGA-------AEQFMQLDNQSLRVLLTGG--------DK- 226
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 711 LESAASQGISLLSSYGPTEATVVATFLPIvcdqtTMDGALLRLGRPIlPNTVFLAFGEVVIVGDLVADGYLGIDGDGF-- 788
Cdd:cd17645 227 LKKIERKGYKLVNNYGPTENTVVATSFEI-----DKPYANIPIGKPI-DNTRVYILDEALQLQPIGVAGELCIAGEGLar 300
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 789 GTVTAADGSRR-----------RAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVEL-- 855
Cdd:cd17645 301 GYLNRPELTAEkfivhpfvpgeRMYRTGDLAKFLPDGNIEFLGRLDQQVKIRGYRIEPGEIEPFLMNHPLIELAAVLAke 380
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 489495878 856 ---HSGSLGVWFKSQrtREGEQDAAAATrIRLVLVSLGVSSFFVVgVPNIPRKPNGKIDSDNLP 916
Cdd:cd17645 381 dadGRKYLVAYVTAP--EEIPHEELREW-LKNDLPDYMIPTYFVH-LKALPLTANGKVDRKALP 440
|
|
| PRK06145 |
PRK06145 |
acyl-CoA synthetase; Validated |
1492-1971 |
2.08e-24 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 102207 [Multi-domain] Cd Length: 497 Bit Score: 109.98 E-value: 2.08e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1492 VSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLP 1571
Cdd:PRK06145 2 FNLSASIAFHARRTPDRAALVYRDQEISYAEFHQRILQAAGMLHARGIGQGDVVALLMKNSAAFLELAFAASYLGAVFLP 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1572 IDPANPPPRVAFMLGDA------------VPVAAVTTAGLRSRLAGHDLPIIdvvdALAAYPGTPPPMPAAVNLAYILYT 1639
Cdd:PRK06145 82 INYRLAADEVAYILGDAgaklllvdeefdAIVALETPKIVIDAAAQADSRRL----AQGGLEIPPQAAVAPTDLVRLMYT 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1640 SGTTGEPKGVGITHRNVTRLFASLPARLSAAQ------VWSQCHSYGFDASAWEIwgaLLGGGRLVIV----PESVAASP 1709
Cdd:PRK06145 158 SGTTDRPKGVMHSYGNLHWKSIDHVIALGLTAserllvVGPLYHVGAFDLPGIAV---LWVGGTLRIHrefdPEAVLAAI 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1710 NDfHGLLVAEHVSVLTqtpAAVAMLPTQ---GLESVALVVA-GEACPAALV---DRWAPGRVMLNAYGPTETTICAAISA 1782
Cdd:PRK06145 235 ER-HRLTCAWMAPVML---SRVLTVPDRdrfDLDSLAWCIGgGEKTPESRIrdfTRVFTRARYIDAYGLTETCSGDTLME 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1783 PLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFvacpFGGsgarMYRTGDLVC 1862
Cdd:PRK06145 311 AGREIEKIGSTGRALAHVEIRIADGAGRWLPPNMKGEICMRGPKVTKGYWKDPEKTAEAF----YGD----WFRSGDVGY 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1863 WRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVI-AREDRPGDKrlVGYATEIAPGA-VDPAGLRAQLA 1940
Cdd:PRK06145 383 LDEEGFLYLTDRKKDMIISGGENIASSEVERVIYELPEVAEAAVIgVHDDRWGER--ITAVVVLNPGAtLTLEALDRHCR 460
|
490 500 510
....*....|....*....|....*....|.
gi 489495878 1941 QRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK06145 461 QRLASFKVPRQLKVRDELPRNPSGKVLKRVL 491
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
1038-1353 |
3.41e-24 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 107.77 E-value: 3.41e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1038 LQRPApVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVF---PAVDGVprQLVIeaRRADLgcdivdatAWP-ADR 1113
Cdd:cd19545 16 ARQPG-AYVGQRVFELPPDIDLARLQAAWEQVVQANPILRTRIvqsDSGGLL--QVVV--KESPI--------SWTeSTS 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1114 LQRAIEEAARHSFDLATeiPL-RTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAPDWAPLpVQYV 1192
Cdd:cd19545 83 LDEYLEEDRAAPMGLGG--PLvRLALVEDPDTERYFVWTIHHALYDGWSLPLILRQVLAAYQGEPVPQPPPFSRF-VKYL 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1193 DYTlwqreilgDLDDSDSpiaaqlaYWENALAG--MPERLRLPTARpYPPVADQRgASLVVDWPASVQQQVrriarqhna 1270
Cdd:cd19545 160 RQL--------DDEAAAE-------FWRSYLAGldPAVFPPLPSSR-YQPRPDAT-LEHSISLPSSASSGV--------- 213
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1271 TSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPA--LDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRARSLAAyenq 1348
Cdd:cd19545 214 TLATVLRAAWALVLSRYTGSDDVVFGVTLSGRNAPVpgIEQIVGPTIATVPLRVRIDPEQSVEDFLQTVQKDLLDM---- 289
|
....*
gi 489495878 1349 dVPFE 1353
Cdd:cd19545 290 -IPFE 293
|
|
| PRK07786 |
PRK07786 |
long-chain-fatty-acid--CoA ligase; Validated |
1501-1966 |
8.82e-24 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 169098 [Multi-domain] Cd Length: 542 Bit Score: 108.33 E-value: 8.82e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1501 QVAR----IPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPAN 1576
Cdd:PRK07786 22 QLARhalmQPDAPALRFLGNTTTWRELDDRVAALAGALSRRGVGFGDRVLILMLNRTEFVESVLAANMLGAIAVPVNFRL 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1577 PPPRVAFMLGDAVPVAAVTTAGLRSRLAG--HDLPIIDVV--------------DALAAYPGTPPPmPAAV---NLAYIL 1637
Cdd:PRK07786 102 TPPEIAFLVSDCGAHVVVTEAALAPVATAvrDIVPLLSTVvvaggssddsvlgyEDLLAEAGPAHA-PVDIpndSPALIM 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1638 YTSGTTGEPKGVGITHRN-----VTRLFASlpaRLSAAqvwsqcHSYGFDASA-WEIWG------ALLGGGRLVIVPESv 1705
Cdd:PRK07786 181 YTSGTTGRPKGAVLTHANltgqaMTCLRTN---GADIN------SDVGFVGVPlFHIAGigsmlpGLLLGAPTVIYPLG- 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1706 AASPNDFHGLLVAEHVSVLTQTPA---AVAMLPTQGLESVAL-VVAGEACPA--ALVDRWA---PGRVMLNAYGPTE--- 1773
Cdd:PRK07786 251 AFDPGQLLDVLEAEKVTGIFLVPAqwqAVCAEQQARPRDLALrVLSWGAAPAsdTLLRQMAatfPEAQILAAFGQTEmsp 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1774 -TTICAAISAPLRPGSgmppIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacpfGGsga 1852
Cdd:PRK07786 331 vTCMLLGEDAIRKLGS----VGKVIPTVAARVVDENMNDVPVGEVGEIVYRAPTLMSGYWNNPEATAEAFA----GG--- 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1853 rMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGA-VD 1931
Cdd:PRK07786 400 -WFHSGDLVRQDEEGYVWVVDRKKDMIISGGENIYCAEVENVLASHPDIVEVAVIGRADEKWGEVPVAVAAVRNDDAaLT 478
|
490 500 510
....*....|....*....|....*....|....*
gi 489495878 1932 PAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:PRK07786 479 LEDLAEFLTDRLARYKHPKALEIVDALPRNPAGKV 513
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
267-1021 |
9.28e-24 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 110.52 E-value: 9.28e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 267 RFGDSDLNVATCLVNSVAQTVRFPPFASVSDVVRTLDRGYVKAVRRRWLREEHYRRMYLAINRTSHVEALTLN---FIRE 343
Cdd:PRK10252 281 RLGSAALTATGPVLNVLPLRVHIAAQETLPELATRLAAQLKKMRRHQRYDAEQIVRDSGRAAGDEPLFGPVLNikvFDYQ 360
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 344 PCAPGLRPFLSEvpIATdiGPVEGMTVASVLDEeQRTLNLAIWNRADLPACKTHPKVAERIAAALESMAAMWDRPIAMI- 422
Cdd:PRK10252 361 LDFPGVQAQTHT--LAT--GPVNDLELALFPDE-HGGLSIEILANPQRYDEATLIAHAERLKALIAQFAADPALLCGDVd 435
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 423 ------------VNDWFGIGPDGTRCQ--GDWPARQPSTPAWfldsARGVHQFLGR--RRFVYPWVAWLVQRGAAPGDVL 486
Cdd:PRK10252 436 illpgeyaqlaqVNATAVEIPETTLSAlvAQQAAKTPDAPAL----ADARYQFSYRemREQVVALANLLRERGVKPGDSV 511
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 487 VFTDDDTDKTIDLLIACHLAGCGYSVCDTAdeisvrtnaiteHGDGILVTVVDVAATQLAVVGHDELRKVVD-ERVTQVT 565
Cdd:PRK10252 512 AVALPRSVFLTLALHAIVEAGAAWLPLDTG------------YPDDRLKMMLEDARPSLLITTADQLPRFADvPDLTSLC 579
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 566 HDALLAT------------KTAYIMPTSGTTGQPKLVRISHgslavfcDAI-------SRAYGWGAHDTVLQCAPLTSDI 626
Cdd:PRK10252 580 YNAPLAPqgaaplqlsqphHTAYIIFTSGSTGRPKGVMVGQ-------TAIvnrllwmQNHYPLTADDVVLQKTPCSFDV 652
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 627 SVEEIFGGAACGARLVRSAAMKTGDLAALvDDLVARE--TTIVDLPTAVWQLLCADGDAIDAIGRSRLRQIVIGGEAIRC 704
Cdd:PRK10252 653 SVWEFFWPFIAGAKLVMAEPEAHRDPLAM-QQFFAEYgvTTTHFVPSMLAAFVASLTPEGARQSCASLRQVFCSGEALPA 731
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 705 SAVDKWLESAASQgisLLSSYGPTEATVVATFLPIVC-DQTTMDGALLRLGRPILpNT---VFLAFGEVV---IVGDL-- 775
Cdd:PRK10252 732 DLCREWQQLTGAP---LHNLYGPTEAAVDVSWYPAFGeELAAVRGSSVPIGYPVW-NTglrILDARMRPVppgVAGDLyl 807
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 776 ----VADGYLGIDGdgfgtVTA----AD--GSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAED 845
Cdd:PRK10252 808 tgiqLAQGYLGRPD-----LTAsrfiADpfAPGERMYRTGDVARWLDDGAVEYLGRSDDQLKIRGQRIELGEIDRAMQAL 882
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 846 PAVSDV---AVELHSGSLG-------VWFKSQRTREGEQDAAAATRIRLVLVSLGVSSFFvVGVPNIPRKPNGKIDSDNL 915
Cdd:PRK10252 883 PDVEQAvthACVINQAAATggdarqlVGYLVSQSGLPLDTSALQAQLRERLPPHMVPVVL-LQLDQLPLSANGKLDRKAL 961
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 916 PRLPQWSAAGLNTAETGQRAAgLSQIWSRQLGR-AIGPDSSLLGEGIGSLDLIRILPETRRYLGWRLSLLDLIGADTAAN 994
Cdd:PRK10252 962 PLPELKAQVPGRAPKTGTETI-IAAAFSSLLGCdVVDADADFFALGGHSLLAMKLAAQLSRQFARQVTPGQVMVASTVAK 1040
|
810 820 830
....*....|....*....|....*....|
gi 489495878 995 LA---DYAPTPDAPTGEDRFRPLVAAQRPA 1021
Cdd:PRK10252 1041 LAtllDAEEDESRRLGFGTILPLREGDGPT 1070
|
|
| 4CL |
cd05904 |
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the ... |
1516-1911 |
2.11e-23 |
|
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the phenylpropanoid metabolic pathway for monolignol and flavonoid biosynthesis. It catalyzes the synthesis of hydroxycinnamate-CoA thioesters in a two-step reaction, involving the formation of hydroxycinnamate-AMP anhydride and the nucleophilic substitution of AMP by CoA. The phenylpropanoid pathway is one of the most important secondary metabolism pathways in plants and hydroxycinnamate-CoA thioesters are the precursors of lignin and other important phenylpropanoids.
Pssm-ID: 341230 [Multi-domain] Cd Length: 505 Bit Score: 106.94 E-value: 2.11e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1516 ASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVT 1595
Cdd:cd05904 31 RALTYAELERRVRRLAAGLAKRGGRKGDVVLLLSPNSIEFPVAFLAVLSLGAVVTTANPLSTPAEIAKQVKDSGAKLAFT 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1596 TAGLRSRLAGHDLPII----DVVDALAAYPGT---PPPMPAAVN-----LAYILYTSGTTGEPKGVGITHRNvtrLFASL 1663
Cdd:cd05904 111 TAELAEKLASLALPVVlldsAEFDSLSFSDLLfeaDEAEPPVVVikqddVAALLYSSGTTGRSKGVMLTHRN---LIAMV 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1664 parlsAAQVWSQ----------------CHSYGFdasAWEIWGALLGGGRLVIVPESvaaspnDFHGLL--VAEH-VSVL 1724
Cdd:cd05904 188 -----AQFVAGEgsnsdsedvflcvlpmFHIYGL---SSFALGLLRLGATVVVMPRF------DLEELLaaIERYkVTHL 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1725 TQTPAAVAMLPTQG------LESVALVVAGEA-CPAALVDRWA---PGRVMLNAYGPTETTICAA-----ISAPLRPGSg 1789
Cdd:cd05904 254 PVVPPIVLALVKSPivdkydLSSLRQIMSGAApLGKELIEAFRakfPNVDLGQGYGMTESTGVVAmcfapEKDRAKYGS- 332
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1790 mppIGVPVSGA-ALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacpfggsGARMYRTGDLVCWRADGQ 1868
Cdd:cd05904 333 ---VGRLVPNVeAKIVDPETGESLPPNQTGELWIRGPSIMKGYLNNPEATAATID-------KEGWLHTGDLCYIDEDGY 402
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 489495878 1869 LEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIARED 1911
Cdd:cd05904 403 LFIVDRLKELIKYKGFQVAPAELEALLLSHPEILDAAVIPYPD 445
|
|
| VL_LC_FACS_like |
cd05907 |
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA ... |
1517-1942 |
2.55e-23 |
|
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA synthetases; This family includes long-chain fatty acid (C12-C20) CoA synthetases and Bubblegum-like very long-chain (>C20) fatty acid CoA synthetases. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Drosophila melanogaster mutant bubblegum (BGM) have elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene later named bubblegum. The human homolog (hsBG) of bubblegum has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341233 [Multi-domain] Cd Length: 452 Bit Score: 105.76 E-value: 2.55e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTt 1596
Cdd:cd05907 5 PITWAEFAEEVRALAKGLIALGVEPGDRVAILSRNRPEWTIADLAILAIGAVPVPIYPTSSAEQIAYILNDSEAKALFV- 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1597 aglrsrlaghdlpiidvvdalaaypgtpppmPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPARLSAAQVWSQ- 1675
Cdd:cd05907 84 -------------------------------EDPDDLATIIYTSGTTGRPKGVMLSHRNILSNALALAERLPATEGDRHl 132
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1676 -----CHSYGFDASaweIWGALLGGGRLV-------IVPESVAASPNDFHGLL-----VAEHVSVLTQTPAAVAMLPTQG 1738
Cdd:cd05907 133 sflplAHVFERRAG---LYVPLLAGARIYfassaetLLDDLSEVRPTVFLAVPrvwekVYAAIKVKAVPGLKRKLFDLAV 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1739 LESV-ALVVAGEACPAALVDRW-APGRVMLNAYGPTETTICAAISAP--LRPGSgmppIGVPVSGAALFVldswlrpvpa 1814
Cdd:cd05907 210 GGRLrFAASGGAPLPAELLHFFrALGIPVYEGYGLTETSAVVTLNPPgdNRIGT----VGKPLPGVEVRI---------- 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1815 GVAGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCWRADGQLEFLGRTDD-QVKIRGYRIELGEVAT 1893
Cdd:cd05907 276 ADDGEILVRGPNVMLGYYKNPEATAEALDADGW-------LHTGDLGEIDEDGFLHITGRKKDlIITSGGKNISPEPIEN 348
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 1894 ALAELAGVGQAVVIArEDRPG--------DKRLVGYATEIAPGAVDPAGLRAQLAQR 1942
Cdd:cd05907 349 ALKASPLISQAVVIG-DGRPFlvalivpdPEALEAWAEEHGIAYTDVAELAANPAVR 404
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
1633-1971 |
2.87e-23 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 103.18 E-value: 2.87e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1633 LAYILYTSGTTGEPKGVGITHRNVTRLFASLPARLS--AAQVWSQCHSYGFDASAWEIWGALLGGGRLViVPESVAASPN 1710
Cdd:cd17630 2 LATVILTSGSTGTPKAVVHTAANLLASAAGLHSRLGfgGGDSWLLSLPLYHVGGLAILVRSLLAGAELV-LLERNQALAE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1711 DFHGLLVaEHVSVltqTPAAVAMLPTQGLESVAL------VVAGEACPAALVDRWAPGRV-MLNAYGPTETTICAAISAP 1783
Cdd:cd17630 81 DLAPPGV-THVSL---VPTQLQRLLDSGQGPAALkslravLLGGAPIPPELLERAADRGIpLYTTYGMTETASQVATKRP 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1784 lrPGSGMPPIGVPVSGAALFVLDswlrpvpagvAGELYIAGAGVGVGYWRRAGLTasrfvacPFGGSGarMYRTGDLVCW 1863
Cdd:cd17630 157 --DGFGRGGVGVLLPGRELRIVE----------DGEIWVGGASLAMGYLRGQLVP-------EFNEDG--WFTTKDLGEL 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1864 RADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVgyATEIAPGAVDPAGLRAQLAQRL 1943
Cdd:cd17630 216 HADGRLTVLGRADNMIISGGENIQPEEIEAALAAHPAVRDAFVVGVPDEELGQRPV--AVIVGRGPADPAELRAWLKDKL 293
|
330 340
....*....|....*....|....*...
gi 489495878 1944 PGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd17630 294 ARFKLPKRIYPVPELPRTGGGKVDRRAL 321
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1491-2057 |
9.60e-23 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 107.56 E-value: 9.60e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1491 PVSIPQMLAAQVARIPEAEAVCC------GDASMTYRELDEASNRLAHRLAGcGAGPGECVALLFERCAPAVVAMVAVLK 1564
Cdd:PRK05691 8 PLTLVQALQRRAAQTPDRLALRFladdpgEGVVLSYRDLDLRARTIAAALQA-RASFGDRAVLLFPSGPDYVAAFFGCLY 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1565 TGAAYLPidpANPPP--------RVAFMLGDAVPVAAVTTAGLR------SRLAGHDLPIIDVVDALAAYPGTPPPMPA- 1629
Cdd:PRK05691 87 AGVIAVP---AYPPEsarrhhqeRLLSIIADAEPRLLLTVADLRdsllqmEELAAANAPELLCVDTLDPALAEAWQEPAl 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1630 -AVNLAYILYTSGTTGEPKGVGITHRNVTrlfaslparlsaAQVWSQCHSYGFDASAWEI---WGAL-----LGGGRLVI 1700
Cdd:PRK05691 164 qPDDIAFLQYTSGSTALPKGVQVSHGNLV------------ANEQLIRHGFGIDLNPDDVivsWLPLyhdmgLIGGLLQP 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1701 ----VPeSVAASPNDFHGLLV------AEHVSVLTQTP--------AAVAMLPTQGLESVALVVA-------GEACPAAL 1755
Cdd:PRK05691 232 ifsgVP-CVLMSPAYFLERPLrwleaiSEYGGTISGGPdfayrlcsERVSESALERLDLSRWRVAysgsepiRQDSLERF 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1756 VDRWAPGRV----MLNAYGPTETTICAAISAP------LR------------PGSGMPPI--GVPVSGAALFVLD-SWLR 1810
Cdd:PRK05691 311 AEKFAACGFdpdsFFASYGLAEATLFVSGGRRgqgipaLEldaealarnraePGTGSVLMscGRSQPGHAVLIVDpQSLE 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1811 PVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACpfggSGARMYRTGDLVCWRaDGQLEFLGRTDDQVKIRG---YRIE 1887
Cdd:PRK05691 391 VLGDNRVGEIWASGPSIAHGYWRNPEASAKTFVEH----DGRTWLRTGDLGFLR-DGELFVTGRLKDMLIVRGhnlYPQD 465
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1888 LGEVATALAELAGVGQAVVIAREDRPGDKrlVGYATEIAPG---AVDPAGLRAQLAQRLPGYL--VPAAVVVID--ALPL 1960
Cdd:PRK05691 466 IEKTVEREVEVVRKGRVAAFAVNHQGEEG--IGIAAEISRSvqkILPPQALIKSIRQAVAEACqeAPSVVLLLNpgALPK 543
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1961 TVNGKLDHRA---------------LPAPEYGDTNGYRAPAGPVEKTVAGIFARVLGLERVGVDDSFFELGGDSLAAMRV 2025
Cdd:PRK05691 544 TSSGKLQRSAcrlrladgsldsyalFPALQAVEAAQTAASGDELQARIAAIWCEQLKVEQVAADDHFFLLGGNSIAATQV 623
|
650 660 670
....*....|....*....|....*....|..
gi 489495878 2026 IAAINTTLNADLPVRALLHASSTRGLSQLLGR 2057
Cdd:PRK05691 624 VARLRDELGIDLNLRQLFEAPTLAAFSAAVAR 655
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
1498-1966 |
2.42e-22 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 103.98 E-value: 2.42e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1498 LAAQVARIPEAEAVCCGDA------SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLP 1571
Cdd:PRK13295 30 LDACVASCPDKTAVTAVRLgtgaprRFTYRELAALVDRVAVGLARLGVGRGDVVSCQLPNWWEFTVLYLACSRIGAVLNP 109
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1572 IDPANPPPRVAFMLGDA------VPVA------AVTTAGLRSRLAghDLPIIDVVDALAA--------------YPGTPP 1625
Cdd:PRK13295 110 LMPIFRERELSFMLKHAeskvlvVPKTfrgfdhAAMARRLRPELP--ALRHVVVVGGDGAdsfeallitpaweqEPDAPA 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1626 PM----PAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPAR--LSAAQVW----SQCHSYGFdasaweIWGALLgg 1695
Cdd:PRK13295 188 ILarlrPGPDDVTQLIYTSGTTGEPKGVMHTANTLMANIVPYAERlgLGADDVIlmasPMAHQTGF------MYGLMM-- 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1696 grlvivPESVAAS--------PNDFHGLLVAEHVS-VLTQTPAAVAMLPTQGLESVAL------VVAGEACPAALVDRW- 1759
Cdd:PRK13295 260 ------PVMLGATavlqdiwdPARAAELIRTEGVTfTMASTPFLTDLTRAVKESGRPVsslrtfLCAGAPIPGALVERAr 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1760 -APGRVMLNAYGPTE----TTICaaISAPLRPGSGMPpiGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRR 1834
Cdd:PRK13295 334 aALGAKIVSAWGMTEngavTLTK--LDDPDERASTTD--GCPLPGVEVRVVDADGAPLPAGQIGRLQVRGCSNFGGYLKR 409
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1835 AGLTASRFVAcpfggsgarMYRTGDLVCWRADGQLEFLGRTDDqVKIRG-YRIELGEVATALAELAGVGQAVVIAREDRP 1913
Cdd:PRK13295 410 PQLNGTDADG---------WFDTGDLARIDADGYIRISGRSKD-VIIRGgENIPVVEIEALLYRHPAIAQVAIVAYPDER 479
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 489495878 1914 GDKRLVGYATEIAPGAVDPAGLRAQL-AQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:PRK13295 480 LGERACAFVVPRPGQSLDFEEMVEFLkAQKVAKQYIPERLVVRDALPRTPSGKI 533
|
|
| PRK06087 |
PRK06087 |
medium-chain fatty-acid--CoA ligase; |
1499-1966 |
4.60e-22 |
|
medium-chain fatty-acid--CoA ligase;
Pssm-ID: 180393 [Multi-domain] Cd Length: 547 Bit Score: 103.29 E-value: 4.60e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1499 AAQVARIPEAEAVCcgD---ASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPA 1575
Cdd:PRK06087 30 QQTARAMPDKIAVV--DnhgASYTYSALDHAASRLANWLLAKGIEPGDRVAFQLPGWCEFTIIYLACLKVGAVSVPLLPS 107
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1576 NPPPRVAFMLGDAVPVAAVTTAGLRSR------LA-GHDLPIID---VVDALAA--------------YPGTPPPMPAAV 1631
Cdd:PRK06087 108 WREAELVWVLNKCQAKMFFAPTLFKQTrpvdliLPlQNQLPQLQqivGVDKLAPatsslslsqiiadyEPLTTAITTHGD 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1632 NLAYILYTSGTTGEPKGVGITHRNV---TRLFAS-----------LPARLSaaqvwsqcHSYGFDASaweIWGALLGGGR 1697
Cdd:PRK06087 188 ELAAVLFTSGTEGLPKGVMLTHNNIlasERAYCArlnltwqdvfmMPAPLG--------HATGFLHG---VTAPFLIGAR 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1698 LVIV----PESVAAspndfhgLLVAEHVS-VLTQTPAAVAML------PTQgLESVALVVAGEA-CPAALVDR-WAPGRV 1764
Cdd:PRK06087 257 SVLLdiftPDACLA-------LLEQQRCTcMLGATPFIYDLLnllekqPAD-LSALRFFLCGGTtIPKKVAREcQQRGIK 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1765 MLNAYGPTETtiCAAISAPL-RPGS-GMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASrf 1842
Cdd:PRK06087 329 LLSVYGSTES--SPHAVVNLdDPLSrFMHTDGYAAAGVEIKVVDEARKTLPPGCEGEEASRGPNVFMGYLDEPELTAR-- 404
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1843 vACPFGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYA 1922
Cdd:PRK06087 405 -ALDEEG----WYYSGDLCRMDEAGYIKITGRKKDIIVRGGENISSREVEDILLQHPKIHDACVVAMPDERLGERSCAYV 479
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 489495878 1923 TEIAP-GAVDPAGLRAQLA-QRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:PRK06087 480 VLKAPhHSLTLEEVVAFFSrKRVAKYKYPEHIVVIDKLPRTASGKI 525
|
|
| PRK08633 |
PRK08633 |
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated |
1633-1971 |
8.87e-22 |
|
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated
Pssm-ID: 236315 [Multi-domain] Cd Length: 1146 Bit Score: 103.85 E-value: 8.87e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1633 LAYILYTSGTTGEPKGVGITHRNVT----------------RLFASLPArlsaaqvwsqCHSYGFDASaweIWGALLGGG 1696
Cdd:PRK08633 784 TATIIFSSGSEGEPKGVMLSHHNILsnieqisdvfnlrnddVILSSLPF----------FHSFGLTVT---LWLPLLEGI 850
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1697 RLVIVPesvaaSPNDFHGL--LVAEH-VSVLTQTPA-------AVAMLPTQgLESVALVVAG-EACPAALVDRWAP--GR 1763
Cdd:PRK08633 851 KVVYHP-----DPTDALGIakLVAKHrATILLGTPTflrlylrNKKLHPLM-FASLRLVVAGaEKLKPEVADAFEEkfGI 924
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1764 VMLNAYGPTETTICAAISAP------------LRPGSgmppIGVPVSGAALFVLD-SWLRPVPAGVAGELYIAGAGVGVG 1830
Cdd:PRK08633 925 RILEGYGATETSPVASVNLPdvlaadfkrqtgSKEGS----VGMPLPGVAVRIVDpETFEELPPGEDGLILIGGPQVMKG 1000
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1831 YWRRAGLTASRFVACpfggSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGvGQAVVIARE 1910
Cdd:PRK08633 1001 YLGDPEKTAEVIKDI----DGIGWYVTGDKGHLDEDGFLTITDRYSRFAKIGGEMVPLGAVEEELAKALG-GEEVVFAVT 1075
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 1911 DRPGDKRLVGYATEIAPGAVDPAGLRAQLAQ-RLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK08633 1076 AVPDEKKGEKLVVLHTCGAEDVEELKRAIKEsGLPNLWKPSRYFKVEALPLLGSGKLDLKGL 1137
|
|
| MACS_AAE_MA_like |
cd05970 |
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation ... |
1506-1966 |
1.05e-21 |
|
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This family of MACS enzymes is found in archaea and bacteria. It is represented by the acyl-adenylating enzyme from Methanosarcina acetivorans (AAE_MA). AAE_MA is most active with propionate, butyrate, and the branched analogs: 2-methyl-propionate, butyrate, and pentanoate. The specific activity is weaker for smaller or larger acids.
Pssm-ID: 341274 [Multi-domain] Cd Length: 537 Bit Score: 101.80 E-value: 1.05e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEA-VCCGDAS----MTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLP--------- 1571
Cdd:cd05970 31 PDKLAlVWCDDAGeeriFTFAELADYSDKTANFFKAMGIGKGDTVMLTLKRRYEFWYSLLALHKLGAIAIPathqltakd 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1572 ----IDPANPPPRVAfMLGDAVP---VAAVTTAGLRSRLA--GHDLP--IIDVVDALA-AYPGTPPP----MPAAVNLAY 1635
Cdd:cd05970 111 ivyrIESADIKMIVA-IAEDNIPeeiEKAAPECPSKPKLVwvGDPVPegWIDFRKLIKnASPDFERPtansYPCGEDILL 189
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1636 ILYTSGTTGEPKGVgiTHRNVTRLfaslpARLSAAQVWSQCHS----YGFDASAW--EIWGALLG---GGRLVIVPESVA 1706
Cdd:cd05970 190 VYFSSGTTGMPKMV--EHDFTYPL-----GHIVTAKYWQNVREgglhLTVADTGWgkAVWGKIYGqwiAGAAVFVYDYDK 262
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1707 ASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVAL------VVAGEACPAALVDRW--APGRVMLNAYGPTETTICA 1778
Cdd:cd05970 263 FDPKALLEKLSKYGVTTFCAPPTIYRFLIREDLSRYDLsslrycTTAGEALNPEVFNTFkeKTGIKLMEGFGQTETTLTI 342
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1779 AISAPLRPGSGmpPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGA-----GVGVGYWRRAGLTASRFvacpFGGsgar 1853
Cdd:cd05970 343 ATFPWMEPKPG--SMGKPAPGYEIDLIDREGRSCEAGEEGEIVIRTSkgkpvGLFGGYYKDAEKTAEVW----HDG---- 412
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1854 MYRTGDlVCWR-ADGQLEFLGRTDDQVKIRGYRIELGEVATAL--------AELAGV-----GQAV----VIAREDRPGD 1915
Cdd:cd05970 413 YYHTGD-AAWMdEDGYLWFVGRTDDLIKSSGYRIGPFEVESALiqhpavleCAVTGVpdpirGQVVkatiVLAKGYEPSE 491
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*
gi 489495878 1916 ---KRLVGYATEI-APgavdpaglraqlaqrlpgYLVPAAVVVIDALPLTVNGKL 1966
Cdd:cd05970 492 elkKELQDHVKKVtAP------------------YKYPRIVEFVDELPKTISGKI 528
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
1496-1973 |
1.31e-21 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 101.93 E-value: 1.31e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1496 QMLAAQVARI-PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDP 1574
Cdd:PRK07788 52 AGLVAHAARRaPDRAALIDERGTLTYAELDEQSNALARGLLALGVRAGDGVAVLARNHRGFVLALYAAGKVGARIILLNT 131
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1575 ANPPPRVA----------------FM-LGDAVP--VAAVTTAGLRSRLAGHDLPIIDVVDALAAYPGTPPPMPAAVNLAY 1635
Cdd:PRK07788 132 GFSGPQLAevaaregvkalvyddeFTdLLSALPpdLGRLRAWGGNPDDDEPSGSTDETLDDLIAGSSTAPLPKPPKPGGI 211
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1636 ILYTSGTTGEPKGVgitHRNVTRLFASLPARLSA----AQVWSQCHSYGFDASAWEIWGALLGGGRLVIV-----PESVA 1706
Cdd:PRK07788 212 VILTSGTTGTPKGA---PRPEPSPLAPLAGLLSRvpfrAGETTLLPAPMFHATGWAHLTLAMALGSTVVLrrrfdPEATL 288
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1707 AspndfhglLVAEH-----VSV-------LTQTPAAVAMLPTQGLESValVVAGEACPAALVDRW--APGRVMLNAYGPT 1772
Cdd:PRK07788 289 E--------DIAKHkatalVVVpvmlsriLDLGPEVLAKYDTSSLKII--FVSGSALSPELATRAleAFGPVLYNLYGST 358
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1773 ETTIcAAISAP--LR--PGS-GMPPIGVPVSgaalfVLDSWLRPVPAGVAGELYIagagvgvgywrRAGLTASRFVAcpf 1847
Cdd:PRK07788 359 EVAF-ATIATPedLAeaPGTvGRPPKGVTVK-----ILDENGNEVPRGVVGRIFV-----------GNGFPFEGYTD--- 418
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1848 GGSGAR---MYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATE 1924
Cdd:PRK07788 419 GRDKQIidgLLSSGDVGYFDEDGLLFVDGRDDDMIVSGGENVFPAEVEDLLAGHPDVVEAAVIGVDDEEFGQRLRAFVVK 498
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 489495878 1925 IAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPA 1973
Cdd:PRK07788 499 APGAALDEDAIKDYVRDNLARYKVPRDVVFLDELPRNPTGKVLKRELRE 547
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
558-916 |
2.03e-21 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 100.17 E-value: 2.03e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 558 DERVTQVTHD----ALLATKT--AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDT--VLQCAPLTSDISVE 629
Cdd:cd17648 74 DERIQFILEDtgarVVITNSTdlAYAIYTSGTTGKPKGVLVEHGSVVNLRTSLSERYFGRDNGDeaVLFFSNYVFDFFVE 153
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 630 EIFGGAACGARLVRSAAMKTGDLAALVDDLVARETTIVDLPTAVWQLlcadgdaIDAIGRSRLRQIVIGGEAIRCSAVDK 709
Cdd:cd17648 154 QMTLALLNGQKLVVPPDEMRFDPDRFYAYINREKVTYLSGTPSVLQQ-------YDLARLPHLKRVDAAGEEFTAPVFEK 226
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 710 WLESAASQgisLLSSYGPTEATVVATFLPIVCDQTTmDGAllrLGRPiLPNTV------------FLAFGEVVIVGDLVA 777
Cdd:cd17648 227 LRSRFAGL---IINAYGPTETTVTNHKRFFPGDQRF-DKS---LGRP-VRNTKcyvlndamkrvpVGAVGELYLGGDGVA 298
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 778 DGYLGID---GDGFGT------VTAADGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAV 848
Cdd:cd17648 299 RGYLNRPeltAERFLPnpfqteQERARGRNARLYKTGDLVRWLPSGELEYLGRNDFQVKIRGQRIEPGEVEAALASYPGV 378
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 849 SDVAVELHSGSLGVWFKSQR-------TREG---EQDAAAATRIRLVLVSLGVssfFVVGVPNIPRKPNGKIDSDNLP 916
Cdd:cd17648 379 RECAVVAKEDASQAQSRIQKylvgyylPEPGhvpESDLLSFLRAKLPRYMVPA---RLVRLEGIPVTINGKLDVRALP 453
|
|
| PRK07470 |
PRK07470 |
acyl-CoA synthetase; Validated |
1496-1966 |
2.07e-21 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 180988 [Multi-domain] Cd Length: 528 Bit Score: 100.89 E-value: 2.07e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1496 QMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPA 1575
Cdd:PRK07470 11 HFLRQAARRFPDRIALVWGDRSWTWREIDARVDALAAALAARGVRKGDRILVHSRNCNQMFESMFAAFRLGAVWVPTNFR 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1576 NPPPRVAF---------MLGDA-----VPVAAVTTAGLRSRLAGHDLPI-IDVVDALAAYPGTPPPmPAAVNL---AYIL 1637
Cdd:PRK07470 91 QTPDEVAYlaeasgaraMICHAdfpehAAAVRAASPDLTHVVAIGGARAgLDYEALVARHLGARVA-NAAVDHddpCWFF 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1638 YTSGTTGEPKGVGITHRN----VTR----LFASLPARLSAAQVWSQCHSYGFDASAWEIWGA---LLGGGRLviVPESVA 1706
Cdd:PRK07470 170 FTSGTTGRPKAAVLTHGQmafvITNhladLMPGTTEQDASLVVAPLSHGAGIHQLCQVARGAatvLLPSERF--DPAEVW 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1707 AspndfhglLVAEH-VSVLTQTPAAVAMLPTQglESVA---------LVVAGeaCPAALVDRWAP----GRVMLNAYGPT 1772
Cdd:PRK07470 248 A--------LVERHrVTNLFTVPTILKMLVEH--PAVDrydhsslryVIYAG--APMYRADQKRAlaklGKVLVQYFGLG 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1773 ETTICAAISAPL------RPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacp 1846
Cdd:PRK07470 316 EVTGNITVLPPAlhdaedGPDARIGTCGFERTGMEVQIQDDEGRELPPGETGEICVIGPAVFAGYYNNPEANAKAFR--- 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1847 fGGsgarMYRTGDLVCWRADGQLEFLGRTDDqVKIRG----YRIELGE---VATALAELA----------GVGQAVVIAR 1909
Cdd:PRK07470 393 -DG----WFRTGDLGHLDARGFLYITGRASD-MYISGgsnvYPREIEEkllTHPAVSEVAvlgvpdpvwgEVGVAVCVAR 466
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 1910 EdrpgdkrlvgyateiaPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:PRK07470 467 D----------------GAPVDEAELLAWLDGKVARYKLPKRFFFWDALPKSGYGKI 507
|
|
| PRK08276 |
PRK08276 |
long-chain-fatty-acid--CoA ligase; Validated |
1515-1971 |
4.10e-21 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236215 [Multi-domain] Cd Length: 502 Bit Score: 99.59 E-value: 4.10e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1515 DASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAV 1594
Cdd:PRK08276 9 GEVVTYGELEARSNRLAHGLRALGLREGDVVAILLENNPEFFEVYWAARRSGLYYTPINWHLTAAEIAYIVDDSGAKVLI 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1595 TTAGLRSRLAG------HDLPIIDVVD-----------ALAAYPGTPPPMPAAVnlAYILYTSGTTGEPKGVgithrnVT 1657
Cdd:PRK08276 89 VSAALADTAAElaaelpAGVPLLLVVAgpvpgfrsyeeALAAQPDTPIADETAG--ADMLYSSGTTGRPKGI------KR 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1658 RLFASLPARLSAAQVWSQCHSYGFDA------------SAWEIWG--ALLGGGRLVIV----PESVAAspndfhglLVAE 1719
Cdd:PRK08276 161 PLPGLDPDEAPGMMLALLGFGMYGGPdsvylspaplyhTAPLRFGmsALALGGTVVVMekfdAEEALA--------LIER 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1720 HVSVLTQtpaavaMLPTQ---------------GLESVALVV-AGEACP----AALVDRWAPgrVMLNAYGPTE---TTI 1776
Cdd:PRK08276 233 YRVTHSQ------LVPTMfvrmlklpeevraryDVSSLRVAIhAAAPCPvevkRAMIDWWGP--IIHEYYASSEgggVTV 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1777 CAAISAPLRPGS-GMPPIGVpvsgaaLFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacpfggsGARMY 1855
Cdd:PRK08276 305 ITSEDWLAHPGSvGKAVLGE------VRILDEDGNELPPGEIGTVYFEMDGYPFEYHNDPEKTAAARN-------PHGWV 371
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1856 RTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGyATEIAPGAVDPAGL 1935
Cdd:PRK08276 372 TVGDVGYLDEDGYLYLTDRKSDMIISGGVNIYPQEIENLLVTHPKVADVAVFGVPDEEMGERVKA-VVQPADGADAGDAL 450
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 489495878 1936 RAQL----AQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK08276 451 AAELiawlRGRLAHYKCPRSIDFEDELPRTPTGKLYKRRL 490
|
|
| PRK13383 |
PRK13383 |
acyl-CoA synthetase; Provisional |
1497-1973 |
4.22e-21 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139531 [Multi-domain] Cd Length: 516 Bit Score: 100.07 E-value: 4.22e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1497 MLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPAN 1576
Cdd:PRK13383 40 LLAVTAARWPGRTAIIDDDGALSYRELQRATESLARRLTRDGVAPGRAVGVMCRNGRGFVTAVFAVGLLGADVVPISTEF 119
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1577 PPPRVAFMLGDAVPVAAVTTAGLRSRLAGHD--LPIIDVVDALAAYPGTPPPMPAAVNLayILYTSGTTGEPKGV----- 1649
Cdd:PRK13383 120 RSDALAAALRAHHISTVVADNEFAERIAGADdaVAVIDPATAGAEESGGRPAVAAPGRI--VLLTSGTTGKPKGVprapq 197
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1650 -----GITHRNVTRLFASLPARLSAAQvwSQCHSYGFDASAWEIwgaLLGGGRLV---IVPESVAASPNdfhgLLVAEHV 1721
Cdd:PRK13383 198 lrsavGVWVTILDRTRLRTGSRISVAM--PMFHGLGLGMLMLTI---ALGGTVLThrhFDAEAALAQAS----LHRADAF 268
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1722 SVLTQTPAAVAMLPTQ-----GLESVALVVA-GEACPAALVDRW--APGRVMLNAYGPTETTIcAAISAPLRPGSGMPPI 1793
Cdd:PRK13383 269 TAVPVVLARILELPPRvrarnPLPQLRVVMSsGDRLDPTLGQRFmdTYGDILYNGYGSTEVGI-GALATPADLRDAPETV 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1794 GVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYwrragltasrfvacpFGGSGAR----MYRTGDLVCWRADGQL 1869
Cdd:PRK13383 348 GKPVAGCPVRILDRNNRPVGPRVTGRIFVGGELAGTRY---------------TDGGGKAvvdgMTSTGDMGYLDNAGRL 412
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1870 EFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVP 1949
Cdd:PRK13383 413 FIVGREDDMIISGGENVYPRAVENALAAHPAVADNAVIGVPDERFGHRLAAFVVLHPGSGVDAAQLRDYLKDRVSRFEQP 492
|
490 500
....*....|....*....|....
gi 489495878 1950 AAVVVIDALPLTVNGKLDHRALPA 1973
Cdd:PRK13383 493 RDINIVSSIPRNPTGKVLRKELPG 516
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
1024-1343 |
6.03e-21 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 98.15 E-value: 6.03e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1024 PLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVD-GVPRQLViearRADLG-- 1100
Cdd:cd19547 3 PLAPMQEGMLFRGLFWPDSDAYFNQNVLELVGGTDEDVLREAWRRVADRYEILRTGFTWRDrAEPLQYV----RDDLApp 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1101 CDIVDATAWPADR----LQRAIEEAARHSFDLAtEIPL-RTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYAS 1175
Cdd:cd19547 79 WALLDWSGEDPDRraelLERLLADDRAAGLSLA-DCPLyRLTLVRLGGGRHYLLWSHHHILLDGWCLSLIWGDVFRVYEE 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1176 RCAGRAPDWAPLPvQYVDYTLWQREILGDLDDSDSpiaaqlaYWENALAGMPerlrlPTARPYPPvADQRGA--SLVVDW 1253
Cdd:cd19547 158 LAHGREPQLSPCR-PYRDYVRWIRARTAQSEESER-------FWREYLRDLT-----PSPFSTAP-ADREGEfdTVVHEF 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1254 PASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSdPAL---DNLVGFFVNTLVLRVNLAGDPSF 1330
Cdd:cd19547 224 PEQLTRLVNEAARGYGVTTNAISQAAWSMLLALQTGARDVVHGLTIAGRP-PELegsEHMVGIFINTIPLRIRLDPDQTV 302
|
330
....*....|...
gi 489495878 1331 AELLGQVRaRSLA 1343
Cdd:cd19547 303 TGLLETIH-RDLA 314
|
|
| PRK06164 |
PRK06164 |
acyl-CoA synthetase; Validated |
1488-1964 |
8.06e-21 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235722 [Multi-domain] Cd Length: 540 Bit Score: 99.05 E-value: 8.06e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1488 APTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGA 1567
Cdd:PRK06164 6 APRADTLASLLDAHARARPDAVALIDEDRPLSRAELRALVDRLAAWLAAQGVRRGDRVAVWLPNCIEWVVLFLACARLGA 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1568 AYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLR-----SRLAGHD------LPIIDVVD---------------ALAAYP 1621
Cdd:PRK06164 86 TVIAVNTRYRSHEVAHILGRGRARWLVVWPGFKgidfaAILAAVPpdalppLRAIAVVDdaadatpapapgarvQLFALP 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1622 GTPPP-----MPAAVNLAYILYT-SGTTGEPKGVGITHRNVTRLFASLPARLSAAQ------VWSQCHSYGFDASAweiw 1689
Cdd:PRK06164 166 DPAPPaaageRAADPDAGALLFTtSGTTSGPKLVLHRQATLLRHARAIARAYGYDPgavllaALPFCGVFGFSTLL---- 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1690 GALLGGGRLVIVPESVAA-------SPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVALVVAGEACPAALVDrwAPG 1762
Cdd:PRK06164 242 GALAGGAPLVCEPVFDAArtaralrRHRVTHTFGNDEMLRRILDTAGERADFPSARLFGFASFAPALGELAALAR--ARG 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1763 RVMLNAYGPTET-------TICAAISAPLRPGsgmppiGVPVSGAA-LFVLDSWLRPV-PAGVAGELYIAGAGVGVGYWR 1833
Cdd:PRK06164 320 VPLTGLYGSSEVqalvalqPATDPVSVRIEGG------GRPASPEArVRARDPQDGALlPDGESGEIEIRAPSLMRGYLD 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1834 RAGLTASRFVACPFggsgarmYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREdRP 1913
Cdd:PRK06164 394 NPDATARALTDDGY-------FRTGDLGYTRGDGQFVYQTRMGDSLRLGGFLVNPAEIEHALEALPGVAAAQVVGAT-RD 465
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 489495878 1914 GDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNG 1964
Cdd:PRK06164 466 GKTVPVAFVIPTDGASPDEAGLMAACREALAGFKVPARVQVVEAFPVTESA 516
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
574-911 |
1.22e-20 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 97.90 E-value: 1.22e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDla 653
Cdd:cd05922 119 LALLLYTSGSTGSPKLVRLSHQNLLANARSIAEYLGITADDRALTVLPLSYDYGLSVLNTHLLRGATLVLTNDGVLDD-- 196
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 654 ALVDDLvaRETTIVDLP--TAVWQLLcaDGDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLEsaASQGISLLSSYGPTEAT 731
Cdd:cd05922 197 AFWEDL--REHGATGLAgvPSTYAML--TRLGFDPAKLPSLRYLTQAGGRLPQETIARLRE--LLPGAQVYVMYGQTEAT 270
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 732 VVATFLPivcdQTTMDGALLRLGRPIlPNTVFLAF------------GEVVIVGDLVADGYLG-----IDGDGFGTVtaa 794
Cdd:cd05922 271 RRMTYLP----PERILEKPGSIGLAI-PGGEFEILdddgtptppgepGEIVHRGPNVMKGYWNdppyrRKEGRGGGV--- 342
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 795 dgsrrraFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGVWFKSQRTREGEQ 874
Cdd:cd05922 343 -------LHTGDLARRDEDGFLFIVGRRDRMIKLFGNRISPTEIEAAARSIGLIIEAAAVGLPDPLGEKLALFVTAPDKI 415
|
330 340 350
....*....|....*....|....*....|....*..
gi 489495878 875 DAAAATRIRLVLVSLGVSSFFVVGVPNIPRKPNGKID 911
Cdd:cd05922 416 DPKDVLRSLAERLPPYKVPATVRVVDELPLTASGKVD 452
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
569-911 |
1.61e-20 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 97.15 E-value: 1.61e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 569 LLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDT-VLQCAPLTSDISVEEIFGGAACGARLVRSAAM 647
Cdd:cd17650 90 TQPEDLAYVIYTSGTTGKPKGVMVEHRNVAHAAHAWRREYELDSFPVrLLQMASFSFDVFAGDFARSLLNGGTLVICPDE 169
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 648 KTGDLAALVDDLVARETTIVD-LPTAVWQLLcaDGDAIDAIGRSRLRQIVIGGEAirCSAVD-KWLESAASQGISLLSSY 725
Cdd:cd17650 170 VKLDPAALYDLILKSRITLMEsTPALIRPVM--AYVYRNGLDLSAMRLLIVGSDG--CKAQDfKTLAARFGQGMRIINSY 245
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 726 GPTEATVVATFLpivcdQTTMD----GALLRLGRPiLPNTVFL------------AFGEVVIVGDLVADGYLG---IDGD 786
Cdd:cd17650 246 GVTEATIDSTYY-----EEGRDplgdSANVPIGRP-LPNTAMYvlderlqpqpvgVAGELYIGGAGVARGYLNrpeLTAE 319
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 787 GFGTVTAADGSRrrAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVEL------HSGSL 860
Cdd:cd17650 320 RFVENPFAPGER--MYRTGDLARWRADGNVELLGRVDHQVKIRGFRIELGEIESQLARHPAIDEAVVAVredkggEARLC 397
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|.
gi 489495878 861 GVWFKSQRTREGEQDAAAATRirlvLVSLGVSSFFVVgVPNIPRKPNGKID 911
Cdd:cd17650 398 AYVVAAATLNTAELRAFLAKE----LPSYMIPSYYVQ-LDALPLTPNGKVD 443
|
|
| PRK04319 |
PRK04319 |
acetyl-CoA synthetase; Provisional |
1519-1977 |
1.87e-20 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 235279 [Multi-domain] Cd Length: 570 Bit Score: 98.43 E-value: 1.87e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAG 1598
Cdd:PRK04319 75 TYKELKELSNKFANVLKELGVEKGDRVFIFMPRIPELYFALLGALKNGAIVGPLFEAFMEEAVRDRLEDSEAKVLITTPA 154
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1599 LRSRLAGHDLP-----------------IIDVVDALAAYPGTPPPMPAAVNLAYIL-YTSGTTGEPKGVGITHRNVTRLF 1660
Cdd:PRK04319 155 LLERKPADDLPslkhvllvgedveegpgTLDFNALMEQASDEFDIEWTDREDGAILhYTSGSTGKPKGVLHVHNAMLQHY 234
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1661 ASlpAR----LSAAQV--------WSQCHSYGfdasaweIWGALLGGGRLVIVPESVaaSPNDFHGLLVAEHVSVLTQTP 1728
Cdd:PRK04319 235 QT--GKyvldLHEDDVywctadpgWVTGTSYG-------IFAPWLNGATNVIDGGRF--SPERWYRILEDYKVTVWYTAP 303
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1729 AAVAMLPTQGLESVA----------LVVaGEAC-PAALvdRW---APGRVMLNAYGPTET---TICAAISAPLRPGSgmp 1791
Cdd:PRK04319 304 TAIRMLMGAGDDLVKkydlsslrhiLSV-GEPLnPEVV--RWgmkVFGLPIHDNWWMTETggiMIANYPAMDIKPGS--- 377
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1792 pIGVPVSGAALFVLDSWLRPVPAGVAGELYIAgAG---VGVGYWRraglTASRFVACPFGGsgarMYRTGDLVCWRADGQ 1868
Cdd:PRK04319 378 -MGKPLPGIEAAIVDDQGNELPPNRMGNLAIK-KGwpsMMRGIWN----NPEKYESYFAGD----WYVSGDSAYMDEDGY 447
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1869 LEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDrPgdkrLVGyatEIA-------PGAVDPAGLRAQLAQ 1941
Cdd:PRK04319 448 FWFQGRVDDVIKTSGERVGPFEVESKLMEHPAVAEAGVIGKPD-P----VRG---EIIkafvalrPGYEPSEELKEEIRG 519
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 489495878 1942 ----RLPGYLVPAAVVVIDALPLTVNGKLDHRALPAPEYG 1977
Cdd:PRK04319 520 fvkkGLGAHAAPREIEFKDKLPKTRSGKIMRRVLKAWELG 559
|
|
| PRK05852 |
PRK05852 |
fatty acid--CoA ligase family protein; |
1482-1971 |
2.44e-20 |
|
fatty acid--CoA ligase family protein;
Pssm-ID: 235625 [Multi-domain] Cd Length: 534 Bit Score: 97.65 E-value: 2.44e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1482 AVLTAPAPTPvSIPQMLAAQVARIPEAEAVCCGD--ASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAM 1559
Cdd:PRK05852 7 AAPMASDFGP-RIADLVEVAATRLPEAPALVVTAdrIAISYRDLARLVDDLAGQLTRSGLLPGDRVALRMGSNAEFVVAL 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1560 VAVLKTGAAYLPIDPANPPP-----------RVAFMLGD--------AVPVAAVTTAGLRSRLAGHDLPIIDVVDALAAY 1620
Cdd:PRK05852 86 LAASRADLVVVPLDPALPIAeqrvrsqaagaRVVLIDADgphdraepTTRWWPLTVNVGGDSGPSGGTLSVHLDAATEPT 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1621 PGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTrlfASLPARLSAAQVWSQ---------CHSYGFDASAWeiwgA 1691
Cdd:PRK05852 166 PATSTPEGLRPDDAMIMFTGGTTGLPKMVPWTHANIA---SSVRAIITGYRLSPRdatvavmplYHGHGLIAALL----A 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1692 LLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAML--------------PTQGLESVALVVAGEACPAALVD 1757
Cdd:PRK05852 239 TLASGGAVLLPARGRFSAHTFWDDIKAVGATWYTAVPTIHQILleraatepsgrkpaALRFIRSCSAPLTAETAQALQTE 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1758 RWAPgrvMLNAYGPTETTICAAISAPLRPGSGMPPIGVP-----VSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYW 1832
Cdd:PRK05852 319 FAAP---VVCAFGMTEATHQVTTTQIEGIGQTENPVVSTglvgrSTGAQIRIVGSDGLPLPAGAVGEVWLRGTTVVRGYL 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1833 RRAGLTASRFVACPFggsgarmyRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDR 1912
Cdd:PRK05852 396 GDPTITAANFTDGWL--------RTGDLGSLSAAGDLSIRGRIKELINRGGEKISPERVEGVLASHPNVMEAAVFGVPDQ 467
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1913 PGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK05852 468 LYGEAVAAVIVPRESAPPTAEELVQFCRERLAAFEIPASFQEASGLPHTAKGSLDRRAV 526
|
|
| WcaG |
COG0451 |
Nucleoside-diphosphate-sugar epimerase [Cell wall/membrane/envelope biogenesis]; |
2109-2417 |
3.41e-20 |
|
Nucleoside-diphosphate-sugar epimerase [Cell wall/membrane/envelope biogenesis];
Pssm-ID: 440220 [Multi-domain] Cd Length: 295 Bit Score: 93.50 E-value: 3.41e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2109 TVLLTGATGFLGRYLVLELLRRldvDGRLICLVRaesDEDARRRLEktfdsgdpellrhfkelAADRLEVVAGDksepdl 2188
Cdd:COG0451 1 RILVTGGAGFIGSHLARRLLAR---GHEVVGLDR---SPPGAANLA-----------------ALPGVEFVRGD------ 51
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2189 GLDQPMWRRLAETVDLIVDSAAM--VNAFPYHELFGPNVAGTAELIRIALTTKLKPFTYVSTADV-GAAIEPsaFTEDAD 2265
Cdd:COG0451 52 LRDPEALAAALAGVDAVVHLAAPagVGEEDPDETLEVNVEGTLNLLEAARAAGVKRFVYASSSSVyGDGEGP--IDEDTP 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2266 IRVISPtrtvdggwaggYGTSKWAGEVLLREANDLCALPVAVFRCGMILadtsyaGQlNMSDWVTRMVLSLMATGIAPrs 2345
Cdd:COG0451 130 LRPVSP-----------YGASKLAAELLARAYARRYGLPVTILRPGNVY------GP-GDRGVLPRLIRRALAGEPVP-- 189
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 489495878 2346 fYEPDSEGNRQRAHfdglpVTFVAEAIavlgARVAGSSLAGFATYHVMNphDDGIGLDEYVDWLIEA-GYPIR 2417
Cdd:COG0451 190 -VFGDGDQRRDFIH-----VDDVARAI----VLALEAPAAPGGVYNVGG--GEPVTLRELAEAIAEAlGRPPE 250
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
575-916 |
7.68e-20 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 95.62 E-value: 7.68e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARL--VRSAAMKtgDL 652
Cdd:cd17656 131 LYIIYTSGTTGKPKGVQLEHKNMVNLLHFEREKTNINFSDKVLQFATCSFDVCYQEIFSTLLSGGTLyiIREETKR--DV 208
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 653 AALVDDLVARETTIVDLPTAVWQLLCADGDAIDAIGRSrLRQIVIGGEAIRCSavDKWLESAASQGISLLSSYGPTEATV 732
Cdd:cd17656 209 EQLFDLVKRHNIEVVFLPVAFLKFIFSEREFINRFPTC-VKHIITAGEQLVIT--NEFKEMLHEHNVHLHNHYGPSETHV 285
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 733 VATFlpiVCDQTTMDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYLGID---GDGFgtVTAADGSR 798
Cdd:cd17656 286 VTTY---TINPEAEIPELPPIGKPISNTWIYIldqeqqlqpqgIVGELYISGASVARGYLNRQeltAEKF--FPDPFDPN 360
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 799 RRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLG-----VWFKSQRTREGE 873
Cdd:cd17656 361 ERMYRTGDLARYLPDGNIEFLGRADHQVKIRGYRIELGEIEAQLLNHPGVSEAVVLDKADDKGekylcAYFVMEQELNIS 440
|
330 340 350 360
....*....|....*....|....*....|....*....|...
gi 489495878 874 QdaaAATRIRLVLVSLGVSSFFvVGVPNIPRKPNGKIDSDNLP 916
Cdd:cd17656 441 Q---LREYLAKQLPEYMIPSFF-VPLDQLPLTPNGKVDRKALP 479
|
|
| PRK05677 |
PRK05677 |
long-chain-fatty-acid--CoA ligase; Validated |
1615-1971 |
7.89e-20 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 168170 [Multi-domain] Cd Length: 562 Bit Score: 96.37 E-value: 7.89e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1615 DALAAYPGTP--PPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPArLSAAQVWSQC----------HSYGFd 1682
Cdd:PRK05677 189 DALAKGAGQPvtEANPQADDVAVLQYTGGTTGVAKGAMLTHRNLVANMLQCRA-LMGSNLNEGCeiliaplplyHIYAF- 266
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1683 asAWEIWGALLGGGRLVIVPesvaaSPNDFHGLlvaehVSVLTQTPAA---------VAMLPTQG---LESVALVV---A 1747
Cdd:PRK05677 267 --TFHCMAMMLIGNHNILIS-----NPRDLPAM-----VKELGKWKFSgfvglntlfVALCNNEAfrkLDFSALKLtlsG 334
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1748 GEACPAALVDRW--APGRVMLNAYGPTETTICAAISAP--LRPGSgmppIGVPVSGAALFVLDSWLRPVPAGVAGELYIA 1823
Cdd:PRK05677 335 GMALQLATAERWkeVTGCAICEGYGMTETSPVVSVNPSqaIQVGT----IGIPVPSTLCKVIDDDGNELPLGEVGELCVK 410
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1824 GAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQ 1903
Cdd:PRK05677 411 GPQVMKGYWQRPEATDEILDSDGW-------LKTGDIALIQEDGYMRIVDRKKDMILVSGFNVYPNELEDVLAALPGVLQ 483
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1904 AVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK05677 484 CAAIGVPDEKSGEAIKVFVVVKPGETLTKEQVMEHMRANLTGYKVPKAVEFRDELPTTNVGKILRREL 551
|
|
| PRK13391 |
PRK13391 |
acyl-CoA synthetase; Provisional |
1502-1971 |
9.80e-20 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 184022 [Multi-domain] Cd Length: 511 Bit Score: 95.53 E-value: 9.80e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1502 VARIPEAEAVCCG--DASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPP 1579
Cdd:PRK13391 7 AQTTPDKPAVIMAstGEVVTYRELDERSNRLAHLFRSLGLKRGDHVAIFMENNLRYLEVCWAAERSGLYYTCVNSHLTPA 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1580 RVAFMLGDAVPVAAVTTA--------------GLRSRL---AGHDLP-IIDVVDALAAYPGTppPMPAAVNLAYILYTSG 1641
Cdd:PRK13391 87 EAAYIVDDSGARALITSAakldvarallkqcpGVRHRLvldGDGELEgFVGYAEAVAGLPAT--PIADESLGTDMLYSSG 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1642 TTGEPKGV-------------GITH--------RNVTRLFASLPARLSAAQVWSQ-CHSYG--------FDAsawEIWGA 1691
Cdd:PRK13391 165 TTGRPKGIkrplpeqppdtplPLTAflqrlwgfRSDMVYLSPAPLYHSAPQRAVMlVIRLGgtvivmehFDA---EQYLA 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1692 LLGGGRLVivpesvaaspndfHGLLVAEHVSVLTQTPAAVAMlpTQGLESVALVVAGEA-CPA----ALVDRWAPgrVML 1766
Cdd:PRK13391 242 LIEEYGVT-------------HTQLVPTMFSRMLKLPEEVRD--KYDLSSLEVAIHAAApCPPqvkeQMIDWWGP--IIH 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1767 NAYGPTE---TTICAAISAPLRPGS-GMPPIGVPVsgaalfVLDSWLRPVPAGVAGELYIAGaGVGVGYWRRAGLTA-SR 1841
Cdd:PRK13391 305 EYYAATEglgFTACDSEEWLAHPGTvGRAMFGDLH------ILDDDGAELPPGEPGTIWFEG-GRPFEYLNDPAKTAeAR 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1842 fvaCPFGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRP-GD--KRL 1918
Cdd:PRK13391 378 ---HPDGT----WSTVGDIGYVDEDGYLYLTDRAAFMIISGGVNIYPQEAENLLITHPKVADAAVFGVPNEDlGEevKAV 450
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|...
gi 489495878 1919 VGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK13391 451 VQPVDGVDPGPALAAELIAFCRQRLSRQKCPRSIDFEDELPRLPTGKLYKRLL 503
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
1501-1971 |
1.39e-19 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 94.64 E-value: 1.39e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1501 QVARI-PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPP 1579
Cdd:PRK03640 10 QRAFLtPDRTAIEFEEKKVTFMELHEAVVSVAGKLAALGVKKGDRVALLMKNGMEMILVIHALQQLGAVAVLLNTRLSRE 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1580 RVAFMLGDAVPVAAVTTAGLRSRLAGHdlpIIDVVDALAAYPGTPPPMPAAVNL---AYILYTSGTTGEPKGVGITHRNv 1656
Cdd:PRK03640 90 ELLWQLDDAEVKCLITDDDFEAKLIPG---ISVKFAELMNGPKEEAEIQEEFDLdevATIMYTSGTTGKPKGVIQTYGN- 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1657 trLFAS-----LPARLSAAQVWSQC----HSYGFDAsaweIWGALLGGGRLVIVPesvAASPNDFHGLLVAEHVSVLTQT 1727
Cdd:PRK03640 166 --HWWSavgsaLNLGLTEDDCWLAAvpifHISGLSI----LMRSVIYGMRVVLVE---KFDAEKINKLLQTGGVTIISVV 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1728 PaavAMLpTQGLEsvalVVAGEACPAALvdrwapgRVML----------------------NAYGPTETtiCAAISApLR 1785
Cdd:PRK03640 237 S---TML-QRLLE----RLGEGTYPSSF-------RCMLlgggpapkplleqckekgipvyQSYGMTET--ASQIVT-LS 298
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1786 PGSGMPPIGvpVSGAALF-----VLDSwLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmyRTGDL 1860
Cdd:PRK03640 299 PEDALTKLG--SAGKPLFpcelkIEKD-GVVVPPFEEGEIVVKGPNVTKGYLNREDATRETFQDGWF--------KTGDI 367
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1861 VCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKrlVGYATEIAPGAVDPAGLRAQLA 1940
Cdd:PRK03640 368 GYLDEEGFLYVLDRRSDLIISGGENIYPAEIEEVLLSHPGVAEAGVVGVPDDKWGQ--VPVAFVVKSGEVTEEELRHFCE 445
|
490 500 510
....*....|....*....|....*....|.
gi 489495878 1941 QRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK03640 446 EKLAKYKVPKRFYFVEELPRNASGKLLRHEL 476
|
|
| PRK06839 |
PRK06839 |
o-succinylbenzoate--CoA ligase; |
1506-1971 |
2.26e-19 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 168698 [Multi-domain] Cd Length: 496 Bit Score: 94.16 E-value: 2.26e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLA----HRLagcGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRV 1581
Cdd:PRK06839 16 PDRIAIITEEEEMTYKQLHEYVSKVAayliYEL---NVKKGERIAILSQNSLEYIVLLFAIAKVECIAVPLNIRLTENEL 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1582 AFMLGD-------AVPVAAVTTAGLRSRLA-GHDLPIIDVVDALAAYP-GTPPPMPAAVNLayILYTSGTTGEPKGVGIT 1652
Cdd:PRK06839 93 IFQLKDsgttvlfVEKTFQNMALSMQKVSYvQRVISITSLKEIEDRKIdNFVEKNESASFI--ICYTSGTTGKPKGAVLT 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1653 HRN-----VTRLFA-SLPARLSAAQVWSQCHSYGFDASAWEIWgalLGGGRlVIVPESVaaSPNDFHGLLVAEHVSVLTQ 1726
Cdd:PRK06839 171 QENmfwnaLNNTFAiDLTMHDRSIVLLPLFHIGGIGLFAFPTL---FAGGV-IIVPRKF--EPTKALSMIEKHKVTVVMG 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1727 TPAAVAML------PTQGLESVALVVAGEA-CPAALVDRWAP-GRVMLNAYGPTETT----ICAAISAPLRPGSgmppIG 1794
Cdd:PRK06839 245 VPTIHQALincskfETTNLQSVRWFYNGGApCPEELMREFIDrGFLFGQGFGMTETSptvfMLSEEDARRKVGS----IG 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1795 VPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmyRTGDLVCWRADGQLEFLGR 1874
Cdd:PRK06839 321 KPVLFCDYELIDENKNKVEVGEVGELLIRGPNVMKEYWNRPDATEETIQDGWL--------CTGDLARVDEDGFVYIVGR 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1875 TDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVV 1954
Cdd:PRK06839 393 KKEMIISGGENIYPLEVEQVINKLSDVYEVAVVGRQHVKWGEIPIAFIVKKSSSVLIEKDVIEHCRLFLAKYKIPKEIVF 472
|
490
....*....|....*..
gi 489495878 1955 IDALPLTVNGKLDHRAL 1971
Cdd:PRK06839 473 LKELPKNATGKIQKAQL 489
|
|
| Firefly_Luc_like |
cd05911 |
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family ... |
472-910 |
2.45e-19 |
|
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341237 [Multi-domain] Cd Length: 486 Bit Score: 94.20 E-value: 2.45e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 472 VAWLVQRGAAPGDVLVFTDDDTDKTIDLLIACHLAGCGYSVCD---TADEIS-----VRTNAITEHGDGI---------- 533
Cdd:cd05911 24 AAGLRKLGLKKGDVVGIISPNSTYYPPVFLGCLFAGGIFSAANpiyTADELAhqlkiSKPKVIFTDPDGLekvkeaakel 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 534 ----LVTVVDVAATQLAVVGHDELRKVVDERVTQVTHDALLATKTAYIMPTSGTTGQPKLVRISHGSL-AVFCDAISRAY 608
Cdd:cd05911 104 gpkdKIIVLDDKPDGVLSIEDLLSPTLGEEDEDLPPPLKDGKDDTAAILYSSGTTGLPKGVCLSHRNLiANLSQVQTFLY 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 609 GW-GAHDTVLQCAPLTsdisveEIFG------GAACGARLVrsaAMKTGDLAALVDDLVARETTIVDL--PTAVWQLLCA 679
Cdd:cd05911 184 GNdGSNDVILGFLPLY------HIYGlfttlaSLLNGATVI---IMPKFDSELFLDLIEKYKITFLYLvpPIAAALAKSP 254
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 680 DGDAIDAigrSRLRQIVIGGeaircSAVDKWLESAASQGIS---LLSSYGPTEATVVATFLPIVCDQTTMDGALLR---- 752
Cdd:cd05911 255 LLDKYDL---SSLRVILSGG-----APLSKELQELLAKRFPnatIKQGYGMTETGGILTVNPDGDDKPGSVGRLLPnvea 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 753 -----LGRPIL-PNTVflafGEVVIVGDLVADGYLG--------IDGDGFgtvtaadgsrrraFATGDRVTVDAEGFPVF 818
Cdd:cd05911 327 kivddDGKDSLgPNEP----GEICVRGPQVMKGYYNnpeatketFDEDGW-------------LHTGDIGYFDEDGYLYI 389
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 819 SGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVelhsgsLGVW--FKSQRTR------EGEQDAAAatriRLV-LVSL 889
Cdd:cd05911 390 VDRKKELIKYKGFQVAPAELEAVLLEHPGVADAAV------IGIPdeVSGELPRayvvrkPGEKLTEK----EVKdYVAK 459
|
490 500
....*....|....*....|....*.
gi 489495878 890 GVSSFF-----VVGVPNIPRKPNGKI 910
Cdd:cd05911 460 KVASYKqlrggVVFVDEIPKSASGKI 485
|
|
| FACL_like_5 |
cd05924 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1635-1969 |
2.49e-19 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341248 [Multi-domain] Cd Length: 364 Bit Score: 92.45 E-value: 2.49e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1635 YILYTSGTTGEPKGVGITHRNVTRLFASLPARLSAAQVWSQCHS------------------YGfdASAWEIWGALLGGG 1696
Cdd:cd05924 7 YILYTGGTTGMPKGVMWRQEDIFRMLMGGADFGTGEFTPSEDAHkaaaaaagtvmfpapplmHG--TGSWTAFGGLLGGQ 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1697 RLVIVpeSVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLES---------VALVVAG----EACPAALVDRwAPGR 1763
Cdd:cd05924 85 TVVLP--DDRFDPEEVWRTIEKHKVTSMTIVGDAMARPLIDALRDagpydlsslFAISSGGallsPEVKQGLLEL-VPNI 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1764 VMLNAYGPTETTIcaaisaplrPGSGMPPIGVPVSGAALF------VLDSWLRPVPAGVAGELYIAGAG-VGVGYWRRAG 1836
Cdd:cd05924 162 TLVDAFGSSETGF---------TGSGHSAGSGPETGPFTRanpdtvVLDDDGRVVPPGSGGVGWIARRGhIPLGYYGDEA 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1837 LTASRFVACpfggSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDK 1916
Cdd:cd05924 233 KTAETFPEV----DGVRYAVPGDRATVEADGTVTLLGRGSVCINTGGEKVFPEEVEEALKSHPAVYDVLVVGRPDERWGQ 308
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|...
gi 489495878 1917 RLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHR 1969
Cdd:cd05924 309 EVVAVVQLREGAGVDLEELREHCRTRIARYKLPKQVVFVDEIERSPAGKADYR 361
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
1023-1231 |
4.69e-19 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 92.70 E-value: 4.69e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1023 IPLSFAQRrlWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADLGCD 1102
Cdd:cd19534 2 VPLTPIQR--WFFEQNLAGRHHFNQSVLLRVPQGLDPDALRQALRALVEHHDALRMRFRREDGGWQQRIRGDVEELFRLE 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1103 IVDATAWPADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADG--WSVapLTADLSAAYASRCAGR 1180
Cdd:cd19534 80 VVDLSSLAQAAAIEALAAEAQSSLDLEEGPLLAAALFDGTDGGDRLLLVIHHLVVDGvsWRI--LLEDLEAAYEQALAGE 157
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|...
gi 489495878 1181 APdwaPLP--VQYVDYTLWQREILGDLDDsdspiAAQLAYWENALAGMPERLR 1231
Cdd:cd19534 158 PI---PLPskTSFQTWAELLAEYAQSPAL-----LEELAYWRELPAADYWGLP 202
|
|
| FAA1 |
COG1022 |
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; |
1485-1913 |
5.74e-19 |
|
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism];
Pssm-ID: 440645 [Multi-domain] Cd Length: 603 Bit Score: 93.63 E-value: 5.74e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1485 TAPAPTPVSIPQMLAAQVARIPEAEAVCCGDA----SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMV 1560
Cdd:COG1022 4 FSDVPPADTLPDLLRRRAARFPDRVALREKEDgiwqSLTWAEFAERVRALAAGLLALGVKPGDRVAILSDNRPEWVIADL 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1561 AVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAV--------TTAGLRSRL------------AGHDLPIIDVVDALAA- 1619
Cdd:COG1022 84 AILAAGAVTVPIYPTSSAEEVAYILNDSGAKVLFvedqeqldKLLEVRDELpslrhivvldprGLRDDPRLLSLDELLAl 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1620 -----YPGTPPPMPAAVN---LAYILYTSGTTGEPKGVGITHRNVTRLFASLPARLSAAQVWSQ------CHSYGFdasA 1685
Cdd:COG1022 164 grevaDPAELEARRAAVKpddLATIIYTSGTTGRPKGVMLTHRNLLSNARALLERLPLGPGDRTlsflplAHVFER---T 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1686 WEIwGALLGGGRlVIVPESVAASPNDF-----HGLLV---------------AEHVSVLTQTPAAVAMlpTQGLESVALV 1745
Cdd:COG1022 241 VSY-YALAAGAT-VAFAESPDTLAEDLrevkpTFMLAvprvwekvyagiqakAEEAGGLKRKLFRWAL--AVGRRYARAR 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1746 VAGEACPAALVDRWAP--------------GRV------------------------MLNAYGPTETTICAAISAP--LR 1785
Cdd:COG1022 317 LAGKSPSLLLRLKHALadklvfsklrealgGRLrfavsggaalgpelarffralgipVLEGYGLTETSPVITVNRPgdNR 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1786 PGSgmppIGVPVSGAALFVLDSwlrpvpagvaGELYIAGAGVGVGYWRRAGLTASRFVAcpfGGSgarmYRTGDLVCWRA 1865
Cdd:COG1022 397 IGT----VGPPLPGVEVKIAED----------GEILVRGPNVMKGYYKNPEATAEAFDA---DGW----LHTGDIGELDE 455
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 489495878 1866 DGQLEFLGRTDDQVKIRGyrielGE-VA-----TALAELAGVGQAVVIArEDRP 1913
Cdd:COG1022 456 DGFLRITGRKKDLIVTSG-----GKnVApqpieNALKASPLIEQAVVVG-DGRP 503
|
|
| ttLC_FACS_AEE21_like |
cd12118 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This ... |
1490-1965 |
7.06e-19 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This family includes fatty acyl-CoA synthetases that can activate medium to long-chain fatty acids. These enzymes catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid. Also included in this family are acyl activating enzymes from Arabidopsis, which contains a large number of proteins from this family with up to 63 different genes, many of which are uncharacterized.
Pssm-ID: 341283 [Multi-domain] Cd Length: 486 Bit Score: 92.75 E-value: 7.06e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1490 TPVSIPQMlAAQVarIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAY 1569
Cdd:cd12118 5 TPLSFLER-AAAV--YPDRTSIVYGDRRYTWRQTYDRCRRLASALAALGISRGDTVAVLAPNTPAMYELHFGVPMAGAVL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1570 LPIDPANPPPRVAFMLGDAVPVAAVTTaglrSRLAGHDLpiidvvdaLAAYPGTPPPMPA-------AVNlayilYTSGT 1642
Cdd:cd12118 82 NALNTRLDAEEIAFILRHSEAKVLFVD----REFEYEDL--------LAEGDPDFEWIPPadewdpiALN-----YTSGT 144
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1643 TGEPKGVGITHRNvtrlfASLPArLSAAQVWSQCHSYG-------FDASAW-EIWGALLGGGRLVIVPESVAASPNDfhg 1714
Cdd:cd12118 145 TGRPKGVVYHHRG-----AYLNA-LANILEWEMKQHPVylwtlpmFHCNGWcFPWTVAAVGGTNVCLRKVDAKAIYD--- 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1715 LLVAEHVSVLTQTPAAVAML---PTQGLES----VALVVAGEACPAALVDRWAP-GRVMLNAYGPTETTICAAISAPLRP 1786
Cdd:cd12118 216 LIEKHKVTHFCGAPTVLNMLanaPPSDARPlphrVHVMTAGAPPPAAVLAKMEElGFDVTHVYGLTETYGPATVCAWKPE 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1787 GSGMPP---------IGVPVSGA-ALFVLD-SWLRPVPA-GV-AGELYIAGAGVGVGYWRRAGLTASRFVacpfGGsgar 1853
Cdd:cd12118 296 WDELPTeerarlkarQGVRYVGLeEVDVLDpETMKPVPRdGKtIGEIVFRGNIVMKGYLKNPEATAEAFR----GG---- 367
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1854 MYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYaTEIAPGA-VDP 1932
Cdd:cd12118 368 WFHSGDLAVIHPDGYIEIKDRSKDIIISGGENISSVEVEGVLYKHPAVLEAAVVARPDEKWGEVPCAF-VELKEGAkVTE 446
|
490 500 510
....*....|....*....|....*....|...
gi 489495878 1933 AGLRAQLAQRLPGYLVPAAVVVIDaLPLTVNGK 1965
Cdd:cd12118 447 EEIIAFCREHLAGFMVPKTVVFGE-LPKTSTGK 478
|
|
| VL_LC_FACS_like |
cd05907 |
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA ... |
574-853 |
2.47e-18 |
|
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA synthetases; This family includes long-chain fatty acid (C12-C20) CoA synthetases and Bubblegum-like very long-chain (>C20) fatty acid CoA synthetases. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Drosophila melanogaster mutant bubblegum (BGM) have elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene later named bubblegum. The human homolog (hsBG) of bubblegum has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341233 [Multi-domain] Cd Length: 452 Bit Score: 90.73 E-value: 2.47e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTsdISVEEIFG---GAACGARLVRSAAMKTg 650
Cdd:cd05907 89 LATIIYTSGTTGRPKGVMLSHRNILSNALALAERLPATEGDRHLSFLPLA--HVFERRAGlyvPLLAGARIYFASSAET- 165
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 651 dlaaLVDDL-VARETTIVDLPTaVWQLLCADGDAID-----------AIGrSRLRQIVIGGEAIRcSAVDKWLESAasqG 718
Cdd:cd05907 166 ----LLDDLsEVRPTVFLAVPR-VWEKVYAAIKVKAvpglkrklfdlAVG-GRLRFAASGGAPLP-AELLHFFRAL---G 235
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 719 ISLLSSYGPTEATvvatflPIVCDQTTMDGALLRLGRPILPNTVFLAF-GEVVIVGDLVADGYLGIDGDgfgtvTAADGS 797
Cdd:cd05907 236 IPVYEGYGLTETS------AVVTLNPPGDNRIGTVGKPLPGVEVRIADdGEILVRGPNVMLGYYKNPEA-----TAEALD 304
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 798 RRRAFATGDRVTVDAEGFPVFSGRKDAVVKIS-GKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd05907 305 ADGWLHTGDLGEIDEDGFLHITGRKKDLIITSgGKNISPEPIENALKASPLISQAVV 361
|
|
| FACL_like_2 |
cd05917 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1636-1965 |
3.12e-18 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341241 [Multi-domain] Cd Length: 349 Bit Score: 88.87 E-value: 3.12e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1636 ILYTSGTTGEPKGVGITHRNVTRLFASLPARLSAAQVWSQC------HSYGfdaSAWEIWGALLGGGRLVIVPESvaasp 1709
Cdd:cd05917 7 IQFTSGTTGSPKGATLTHHNIVNNGYFIGERLGLTEQDRLCipvplfHCFG---SVLGVLACLTHGATMVFPSPS----- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1710 ndFHGLLVAEHV-----SVLTQTPAA-VAMLPTQGLESVAL------VVAGEACPAALVDRwapgrvMLN---------A 1768
Cdd:cd05917 79 --FDPLAVLEAIekekcTALHGVPTMfIAELEHPDFDKFDLsslrtgIMAGAPCPPELMKR------VIEvmnmkdvtiA 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1769 YGPTETTICAAISAPLRP--------GSGMPPIGVPVsgaalfvLDSWLRPVPA-GVAGELYIAGAGVGVGYWRRAGLTA 1839
Cdd:cd05917 151 YGMTETSPVSTQTRTDDSiekrvntvGRIMPHTEAKI-------VDPEGGIVPPvGVPGELCIRGYSVMKGYWNDPEKTA 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1840 SRFvacpfggSGARMYRTGDLVCWRADGQLEFLGRTDDQVkIRG----YRIELGEVataLAELAGVGQAVVIA-REDRPG 1914
Cdd:cd05917 224 EAI-------DGDGWLHTGDLAVMDEDGYCRIVGRIKDMI-IRGgeniYPREIEEF---LHTHPKVSDVQVVGvPDERYG 292
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|..
gi 489495878 1915 DKrlVGYATEIAPGA-VDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGK 1965
Cdd:cd05917 293 EE--VCAWIRLKEGAeLTEEDIKAYCKGKIAHYKVPRYVFFVDEFPLTVSGK 342
|
|
| MACS_like_1 |
cd05974 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
1518-1911 |
4.17e-18 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341278 [Multi-domain] Cd Length: 432 Bit Score: 89.55 E-value: 4.17e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1518 MTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPidpanppprvafmlgdavPVAAVTTA 1597
Cdd:cd05974 1 VSFAEMSARSSRVANFLRSIGVGRGDRILLMLGNVVELWEAMLAAMKLGAVVIP------------------ATTLLTPD 62
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1598 GLRSRLAGHDLPIIDVVDALAAypgtPPPMpaavnLAYilYTSGTTGEPKGVGITHRN--VTRLFASLPARLSAAQVWSQ 1675
Cdd:cd05974 63 DLRDRVDRGGAVYAAVDENTHA----DDPM-----LLY--FTSGTTSKPKLVEHTHRSypVGHLSTMYWIGLKPGDVHWN 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1676 CHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVA-----LVVAGEA 1750
Cdd:cd05974 132 ISSPGWAKHAWSCFFAPWNAGATVFLFNYARFDAKRVLAALVRYGVTTLCAPPTVWRMLIQQDLASFDvklreVVGAGEP 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1751 CPAALVD--RWAPGRVMLNAYGPTETTICAAISA--PLRPGSgmppIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAG 1826
Cdd:cd05974 212 LNPEVIEqvRRAWGLTIRDGYGQTETTALVGNSPgqPVKAGS----MGRPLPGYRVALLDPDGAPATEGEVALDLGDTRP 287
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1827 VGV--GYWRRAGLTAsrfvacpfGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQA 1904
Cdd:cd05974 288 VGLmkGYAGDPDKTA--------HAMRGGYYRTGDIAMRDEDGYLTYVGRADDVFKSSDYRISPFELESVLIEHPAVAEA 359
|
....*..
gi 489495878 1905 VVIARED 1911
Cdd:cd05974 360 AVVPSPD 366
|
|
| FATP_FACS |
cd05940 |
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its ... |
1515-1965 |
4.22e-18 |
|
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its activation enzymes; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. At least five copies of FATPs are identified in mammalian cells. This family also includes prokaryotic FATPs. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341263 [Multi-domain] Cd Length: 449 Bit Score: 89.72 E-value: 4.22e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1515 DASMTYRELDEASNRLAHRLAGCGAGPGECVALLFErcapavvamvavlktgaaylpidpaNPPPRVAFMLGdAVPVAAV 1594
Cdd:cd05940 1 DEALTYAELDAMANRYARWLKSLGLKPGDVVALFME-------------------------NRPEYVLLWLG-LVKIGAV 54
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1595 TtAGLRSRLAGhdlpiidvvDALAAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHR---NVTRLFASLPARLSAAQ 1671
Cdd:cd05940 55 A-ALINYNLRG---------ESLAHCLNVSSAKHLVVDAALYIYTSGTTGLPKAAIISHRrawRGGAFFAGSGGALPSDV 124
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1672 VWSQCHSYGFDASAWEIWGALLGGGRLVIvPESVAASpnDFHGLLVAEHVSV----------LTQTPAAvamlPTQGLES 1741
Cdd:cd05940 125 LYTCLPLYHSTALIVGWSACLASGATLVI-RKKFSAS--NFWDDIRKYQATIfqyigelcryLLNQPPK----PTERKHK 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1742 VALVVAGEACPAA---LVDRWAPGRVmLNAYGPTETTiCAAISAPLRPGS--GMPPIGVPVSGAALFVLD---------- 1806
Cdd:cd05940 198 VRMIFGNGLRPDIweeFKERFGVPRI-AEFYAATEGN-SGFINFFGKPGAigRNPSLLRKVAPLALVKYDlesgepirda 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1807 -SWLRPVPAGVAGEL--YIAGAGVGVGYWRRAGLTASRFVACpFgGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRG 1883
Cdd:cd05940 276 eGRCIKVPRGEPGLLisRINPLEPFDGYTDPAATEKKILRDV-F-KKGDAWFNTGDLMRLDGEGFWYFVDRLGDTFRWKG 353
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1884 YRIELGEVATALAELAGVGQAVVIAREdRPGDKRLVGYATEI--APGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLT 1961
Cdd:cd05940 354 ENVSTTEVAAVLGAFPGVEEANVYGVQ-VPGTDGRAGMAAIVlqPNEEFDLSALAAHLEKNLPGYARPLFLRLQPEMEIT 432
|
....
gi 489495878 1962 VNGK 1965
Cdd:cd05940 433 GTFK 436
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
1632-1966 |
7.38e-18 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 87.56 E-value: 7.38e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1632 NLAYILYTSGTTGEPKGVGITHRNVTRLFASlparlsaaqvWSQC----------------HSYGFDASaweIWGALLGG 1695
Cdd:cd17638 1 DVSDIMFTSGTTGRSKGVMCAHRQTLRAAAA----------WADCadlteddryliinpffHTFGYKAG---IVACLLTG 67
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1696 GrlVIVPESVAASPNDFHgLLVAEHVSVLTQTPA------AVAMLPTQGLESVALVVAGEA-CPAALVDRWA---PGRVM 1765
Cdd:cd17638 68 A--TVVPVAVFDVDAILE-AIERERITVLPGPPTlfqsllDHPGRKKFDLSSLRAAVTGAAtVPVELVRRMRselGFETV 144
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1766 LNAYGPTEtTICAAISaplRPGSGMPPI----GVPVSGAALFVLDswlrpvpagvAGELYIAGAGVGVGYWRRAGLTASR 1841
Cdd:cd17638 145 LTAYGLTE-AGVATMC---RPGDDAETVattcGRACPGFEVRIAD----------DGEVLVRGYNVMQGYLDDPEATAEA 210
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1842 FVACPFggsgarmYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIARED-RPGDkrlVG 1920
Cdd:cd17638 211 IDADGW-------LHTGDVGELDERGYLRITDRLKDMYIVGGFNVYPAEVEGALAEHPGVAQVAVIGVPDeRMGE---VG 280
|
330 340 350 360
....*....|....*....|....*....|....*....|....*...
gi 489495878 1921 YATEIA--PGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:cd17638 281 KAFVVArpGVTLTEEDVIAWCRERLANYKVPRFVRFLDELPRNASGKV 328
|
|
| PRK08308 |
PRK08308 |
acyl-CoA synthetase; Validated |
1520-1975 |
8.80e-18 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236231 [Multi-domain] Cd Length: 414 Bit Score: 88.55 E-value: 8.80e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1520 YRELDEASNRLAHRLAGCGAGPGECVALLFercapavvamvAVLKTGAAYLPIDPANPpprvafmLGDAVPVAavTTAGL 1599
Cdd:PRK08308 21 YEEMEQFQEAAGNRFAVCLKDPFDIITLVF-----------FLKEKGASVLPIHPDTP-------KEAAIRMA--KRAGC 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1600 RSRLAGHDLPIIDVVDALAAYPGtpppmpaavnlAYILYTSGTTGEPKGVGITHRNVTRLFASLPARLSAAQVWS---QC 1676
Cdd:PRK08308 81 HGLLYGESDFTKLEAVNYLAEEP-----------SLLQYSSGTTGEPKLIRRSWTEIDREIEAYNEALNCEQDETpivAC 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1677 ---HSYGFdasaweIWGALLG---GGRLVIVpesVAASPNDFHGLLVAEHVSVLTQTPA---AVAMLPTQGLESVALVVA 1747
Cdd:PRK08308 150 pvtHSYGL------ICGVLAAltrGSKPVII---TNKNPKFALNILRNTPQHILYAVPLmlhILGRLLPGTFQFHAVMTS 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1748 GEACPAALVDRW-APGRVMLNAYGPTETTiCAAISAPLRPGSGMppiGVPVSGAALfvldswlrpvpagvagelyiaGAG 1826
Cdd:PRK08308 221 GTPLPEAWFYKLrERTTYMMQQYGCSEAG-CVSICPDMKSHLDL---GNPLPHVSV---------------------SAG 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1827 VGVGYWRRAGLTASRfvacpfggsgaRMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVV 1906
Cdd:PRK08308 276 SDENAPEEIVVKMGD-----------KEIFTKDLGYKSERGTLHFMGRMDDVINVSGLNVYPIEVEDVMLRLPGVQEAVV 344
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1907 IAREDRPGDKRLVgyATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAPE 1975
Cdd:PRK08308 345 YRGKDPVAGERVK--AKVISHEEIDPVQLREWCIQHLAPYQVPHEIESVTEIPKNANGKVSRKLLELGE 411
|
|
| A_NRPS_TubE_like |
cd05906 |
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) ... |
1519-1971 |
9.52e-18 |
|
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) synthesizing toxins and antitumor agents; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPSs that synthesize toxins and antitumor agents; for example, TubE for Tubulysine, CrpA for cryptophycin, TdiA for terrequinone A, KtzG for kutzneride, and Vlm1/Vlm2 for Valinomycin. Nonribosomal peptide synthetases are large multifunctional enzymes which synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341232 [Multi-domain] Cd Length: 540 Bit Score: 89.65 E-value: 9.52e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTG--AAYLPIDPANPPPRVAF--------MLGDA 1588
Cdd:cd05906 41 SYQDLLEDARRLAAGLRQLGLRPGDSVILQFDDNEDFIPAFWACVLAGfvPAPLTVPPTYDEPNARLrklrhiwqLLGSP 120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1589 VpvaAVTTAGLRSRLAG-------HDLPIIDVVDALAAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNV-TRLF 1660
Cdd:cd05906 121 V---VLTDAELVAEFAGletlsglPGIRVLSIEELLDTAADHDLPQSRPDDLALLMLTSGSTGFPKAVPLTHRNIlARSA 197
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1661 ASLPARLSAAQ----VWsqchsYGFD--ASAWE--IWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVlTQTPA-AV 1731
Cdd:cd05906 198 GKIQHNGLTPQdvflNW-----VPLDhvGGLVElhLRAVYLGCQQVHVPTEEILADPLRWLDLIDRYRVTI-TWAPNfAF 271
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1732 AMLpTQGLESVA-----------LVVAGEACPAALVDRW--------APGRVMLNAYGPTETtiCAAI-------SAPLR 1785
Cdd:cd05906 272 ALL-NDLLEEIEdgtwdlsslryLVNAGEAVVAKTIRRLlrllepygLPPDAIRPAFGMTET--CSGViysrsfpTYDHS 348
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1786 PGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVAcpfGGsgarMYRTGDLvCWRA 1865
Cdd:cd05906 349 QALEFVSLGRPIPGVSMRIVDDEGQLLPEGEVGRLQVRGPVVTKGYYNNPEANAEAFTE---DG----WFRTGDL-GFLD 420
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1866 DGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQ----AVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRA--QL 1939
Cdd:cd05906 421 NGNLTITGRTKDTIIVNGVNYYSHEIEAAVEEVPGVEPsftaAFAVRDPGAETEELAIFFVPEYDLQDALSETLRAirSV 500
|
490 500 510
....*....|....*....|....*....|....
gi 489495878 1940 AQRLPGyLVPAAVVVI--DALPLTVNGKLDHRAL 1971
Cdd:cd05906 501 VSREVG-VSPAYLIPLpkEEIPKTSLGKIQRSKL 533
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
535-853 |
1.71e-17 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 88.63 E-value: 1.71e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 535 VTVVDVAATQLAVVGHDELRKVVDERVTQVTHDALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRA-YGWGAH 613
Cdd:COG0365 147 VIVVGRTGADVPMEGDLDWDELLAAASAEFEPEPTDADDPLFILYTSGTTGKPKGVVHTHGGYLVHAATTAKYvLDLKPG 226
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 614 DTVLqCaplTSDI-------SVeeIFGGAACGARLV-RSAAMKTGDLAALVDdLVARE--TTIVDLPTAVWQLLCADGDA 683
Cdd:COG0365 227 DVFW-C---TADIgwatghsYI--VYGPLLNGATVVlYEGRPDFPDPGRLWE-LIEKYgvTVFFTAPTAIRALMKAGDEP 299
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 684 IDAIGRSRLRQIVIGGEAIRCSAVDKWLESAasqGISLLSSYGPTEAT-VVATFLPIV-----CDQTTMDGALLRL---- 753
Cdd:COG0365 300 LKKYDLSSLRLLGSAGEPLNPEVWEWWYEAV---GVPIVDGWGQTETGgIFISNLPGLpvkpgSMGKPVPGYDVAVvded 376
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 754 GRPILPNTVflafGEVVIVGDL--VADGYLGidgdgfgtvtaaDGSRRRA---------FATGDRVTVDAEGFPVFSGRK 822
Cdd:COG0365 377 GNPVPPGEE----GELVIKGPWpgMFRGYWN------------DPERYREtyfgrfpgwYRTGDGARRDEDGYFWILGRS 440
|
330 340 350
....*....|....*....|....*....|.
gi 489495878 823 DAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:COG0365 441 DDVINVSGHRIGTAEIESALVSHPAVAEAAV 471
|
|
| PRK06060 |
PRK06060 |
p-hydroxybenzoic acid--AMP ligase FadD22; |
1518-1989 |
1.73e-17 |
|
p-hydroxybenzoic acid--AMP ligase FadD22;
Pssm-ID: 180374 [Multi-domain] Cd Length: 705 Bit Score: 89.32 E-value: 1.73e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1518 MTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTA 1597
Cdd:PRK06060 31 VTHGQIHDGAARLGEVLRNRGLSSGDRVLLCLPDSPDLVQLLLACLARGVMAFLANPELHRDDHALAARNTEPALVVTSD 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1598 GLRSRLAGHDL--PIIDVVDALAAYPGTPPPMPAAVnLAYILYTSGTTGEPKGVGITH-----------RNVTRLfasLP 1664
Cdd:PRK06060 111 ALRDRFQPSRVaeAAELMSEAARVAPGGYEPMGGDA-LAYATYTSGTTGPPKAAIHRHadpltfvdamcRKALRL---TP 186
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1665 AR--LSAAQVWsqcHSYGFDASaweIWGALLGGGRLVIVPESVAAspnDFHGLLVAE-HVSVLTQTPA----AVAMLPTQ 1737
Cdd:PRK06060 187 EDtgLCSARMY---FAYGLGNS---VWFPLATGGSAVINSAPVTP---EAAAILSARfGPSVLYGVPNffarVIDSCSPD 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1738 GLESVALVV-AGEACPAALVDRWAP---GRVMLNAYGPTET--TICAAISAPLRPGS---GMPPIGVPV---SGAAlfvl 1805
Cdd:PRK06060 258 SFRSLRCVVsAGEALELGLAERLMEffgGIPILDGIGSTEVgqTFVSNRVDEWRLGTlgrVLPPYEIRVvapDGTT---- 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1806 dswlrpVPAGVAGELYIAGAGVGVGYWRRAGltasrfvacPFGGSGARMyRTGDLVCWRADGQLEFLGRTDDQVKIRGYR 1885
Cdd:PRK06060 334 ------AGPGVEGDLWVRGPAIAKGYWNRPD---------SPVANEGWL-DTRDRVCIDSDGWVTYRCRADDTEVIGGVN 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1886 IELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLR---AQLAQRLPGYLVPAAVVVIDALPLTV 1962
Cdd:PRK06060 398 VDPREVERLIIEDEAVAEAAVVAVRESTGASTLQAFLVATSGATIDGSVMRdlhRGLLNRLSAFKVPHRFAVVDRLPRTP 477
|
490 500
....*....|....*....|....*..
gi 489495878 1963 NGKLDHRALPApeygdtngyRAPAGPV 1989
Cdd:PRK06060 478 NGKLVRGALRK---------QSPTKPI 495
|
|
| BACL_like |
cd05929 |
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes ... |
1503-1971 |
1.73e-17 |
|
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes the formation of bile acid-CoA conjugates in a two-step reaction: the formation of a bile acid-AMP molecule as an intermediate, followed by the formation of a bile acid-CoA. This ligase requires a bile acid with a free carboxyl group, ATP, Mg2+, and CoA for synthesis of the final bile acid-CoA conjugate. The bile acid-CoA ligation is believed to be the initial step in the bile acid 7alpha-dehydroxylation pathway in the intestinal bacterium Eubacterium sp.
Pssm-ID: 341252 [Multi-domain] Cd Length: 473 Bit Score: 88.20 E-value: 1.73e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1503 ARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANP---PP 1579
Cdd:cd05929 3 ARDLDRAQVFHQRRLLLLDVYSIALNRNARAAAAEGVWIADGVYIYLINSILTVFAAAAAWKCGACPAYKSSRAPraeAC 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1580 RVAFMLGDAVPVAAVTTAGLRSRLAghdlpiiDVVDALAAYPGTPPPMPAAVNlaYILYTSGTTGEPKGV-----GITHR 1654
Cdd:cd05929 83 AIIEIKAAALVCGLFTGGGALDGLE-------DYEAAEGGSPETPIEDEAAGW--KMLYSGGTTGRPKGIkrglpGGPPD 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1655 NVTRLFASLPARLSAAQVW----SQCHSYGFDASAweiwGALLGGGRLVIVPEsvaASPNDFHGLLVAEHVSVLTQTPAA 1730
Cdd:cd05929 154 NDTLMAAALGFGPGADSVYlspaPLYHAAPFRWSM----TALFMGGTLVLMEK---FDPEEFLRLIERYRVTFAQFVPTM 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1731 -VAMLPTQG-------LESVALVV-AGEACPAALVDRWAP--GRVMLNAYGPTE---TTICAAISAPLRPGSgmppIGVP 1796
Cdd:cd05929 227 fVRLLKLPEavrnaydLSSLKRVIhAAAPCPPWVKEQWIDwgGPIIWEYYGGTEgqgLTIINGEEWLTHPGS----VGRA 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1797 VSGaALFVLDSWLRPVPAGVAGELYIAGAGvGVGYWRR-AGLTASRfvacpfggsGARMYRT-GDLVCWRADGQLEFLGR 1874
Cdd:cd05929 303 VLG-KVHILDEDGNEVPPGEIGEVYFANGP-GFEYTNDpEKTAAAR---------NEGGWSTlGDVGYLDEDGYLYLTDR 371
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1875 TDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRL---VGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAA 1951
Cdd:cd05929 372 RSDMIISGGVNIYPQEIENALIAHPKVLDAAVVGVPDEELGQRVhavVQPAPGADAGTALAEELIAFLRDRLSRYKCPRS 451
|
490 500
....*....|....*....|
gi 489495878 1952 VVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05929 452 IEFVAELPRDDTGKLYRRLL 471
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
501-853 |
2.00e-17 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 88.41 E-value: 2.00e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 501 IACHLAGCGYSVCDT--ADEisvRTNAITEHGDG---ILVTVVDVAATQLAVVGHDELRKVVDERVTQVTHDALLATKTA 575
Cdd:PRK04813 70 LGAVKAGHAYIPVDVssPAE---RIEMIIEVAKPsliIATEELPLEILGIPVITLDELKDIFATGNPYDFDHAVKGDDNY 146
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 576 YIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGarlvrsaamktGDLAAL 655
Cdd:PRK04813 147 YIIFTSGTTGKPKGVQISHDNLVSFTNWMLEDFALPEGPQFLNQAPYSFDLSVMDLYPTLASG-----------GTLVAL 215
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 656 VDDLVARE----TTIVDLPTAVWQL------LCADGDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLESAASQGIslLSSY 725
Cdd:PRK04813 216 PKDMTANFkqlfETLPQLPINVWVStpsfadMCLLDPSFNEEHLPNLTHFLFCGEELPHKTAKKLLERFPSATI--YNTY 293
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 726 GPTEATVVATFLPI---VCDQTTMdgalLRLGRP--------------ILPNTvflAFGEVVIVGDLVADGYLGIDgdgf 788
Cdd:PRK04813 294 GPTEATVAVTSIEItdeMLDQYKR----LPIGYAkpdsplliideegtKLPDG---EQGEIVISGPSVSKGYLNNP---- 362
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 489495878 789 gTVTAA-----DGsrRRAFATGDRVTVDaEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAV-SDVAV 853
Cdd:PRK04813 363 -EKTAEafftfDG--QPAYHTGDAGYLE-DGLLFYQGRIDFQIKLNGYRIELEEIEQNLRQSSYVeSAVVV 429
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
531-853 |
2.00e-17 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 88.46 E-value: 2.00e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 531 DGILVTVVDVAATQLAVVGH-----DELRKVVDERVTQVTHDALLAT------------KTAYIMP-TSGTTGQPKLVRI 592
Cdd:cd12119 104 DRDFLPLLEAIAPRLPTVEHvvvmtDDAAMPEPAGVGVLAYEELLAAespeydwpdfdeNTAAAICyTSGTTGNPKGVVY 183
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 593 SHGSLAVFCDAISRAYGWGAH--DTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLAAlvdDLVARE--TTIVD 668
Cdd:cd12119 184 SHRSLVLHAMAALLTDGLGLSesDVVLPVVPMFHVNAWGLPYAAAMVGAKLVLPGPYLDPASLA---ELIEREgvTFAAG 260
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 669 LPTaVWQLLCADGDAIDAiGRSRLRQIVIGGEAIRCSAVDKWLEsaasQGISLLSSYGPTEATVVATF--LPIVCDQTTM 746
Cdd:cd12119 261 VPT-VWQGLLDHLEANGR-DLSSLRRVVIGGSAVPRSLIEAFEE----RGVRVIHAWGMTETSPLGTVarPPSEHSNLSE 334
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 747 DGAL-LRL--GRPIL--------PNTVFL-----AFGEVVIVGDLVADGYLGIDGDgfGTVTAADGsrrrAFATGDRVTV 810
Cdd:cd12119 335 DEQLaLRAkqGRPVPgvelrivdDDGRELpwdgkAVGELQVRGPWVTKSYYKNDEE--SEALTEDG----WLRTGDVATI 408
|
330 340 350 360
....*....|....*....|....*....|....*....|....
gi 489495878 811 DAEGFPVFSGR-KDaVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd12119 409 DEDGYLTITDRsKD-VIKSGGEWISSVELENAIMAHPAVAEAAV 451
|
|
| PRK06814 |
PRK06814 |
acyl-[ACP]--phospholipid O-acyltransferase; |
1621-1971 |
2.66e-17 |
|
acyl-[ACP]--phospholipid O-acyltransferase;
Pssm-ID: 235865 [Multi-domain] Cd Length: 1140 Bit Score: 89.25 E-value: 2.66e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1621 PGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPAR--LSAAQVWSQC----HSYGFDAsaweiwGALL- 1693
Cdd:PRK06814 783 PLVYFCNRDPDDPAVILFTSGSEGTPKGVVLSHRNLLANRAQVAARidFSPEDKVFNAlpvfHSFGLTG------GLVLp 856
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1694 --GGGRLV---------IVPESV--------------------AASPNDFHgllvaehvsvltqtpaavamlptqgleSV 1742
Cdd:PRK06814 857 llSGVKVFlypsplhyrIIPELIydtnatilfgtdtflngyarYAHPYDFR---------------------------SL 909
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1743 ALVVAG-EACPAALVDRWAP--GRVMLNAYGPTETTICAAISAPL--RPGSgmppigvpvSGAALFVLDSWLRPVPaGV- 1816
Cdd:PRK06814 910 RYVFAGaEKVKEETRQTWMEkfGIRILEGYGVTETAPVIALNTPMhnKAGT---------VGRLLPGIEYRLEPVP-GId 979
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1817 -AGELYIAGAGVGVGYWRragLTASRFVACPFGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATAL 1895
Cdd:PRK06814 980 eGGRLFVRGPNVMLGYLR---AENPGVLEPPADG----WYDTGDIVTIDEEGFITIKGRAKRFAKIAGEMISLAAVEELA 1052
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 1896 AELAGVGQAVVIAREDRPGDKRLVGYATeiAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK06814 1053 AELWPDALHAAVSIPDARKGERIILLTT--ASDATRAAFLAHAKAAGASELMVPAEIITIDEIPLLGTGKIDYVAV 1126
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
575-918 |
3.36e-17 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 89.46 E-value: 3.36e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRIS-HGSLAvfcDAISRA--YGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGD 651
Cdd:PRK05691 3872 AYVIYTSGSTGLPKGVMVEqRGMLN---NQLSKVpyLALSEADVIAQTASQSFDISVWQFLAAPLFGARVEIVPNAIAHD 3948
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 652 LAALVDDLVARETTIVD-LPTAVWQLLCADGDAIDAigrsrLRQIVIGGEAIRCSAVDKWLESAAsqGISLLSSYGPTEA 730
Cdd:PRK05691 3949 PQGLLAHVQAQGITVLEsVPSLIQGMLAEDRQALDG-----LRWMLPTGEAMPPELARQWLQRYP--QIGLVNAYGPAEC 4021
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 731 TVVATFLPIvcDQTTMDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYLGidgDGFGTVTA------ 793
Cdd:PRK05691 4022 SDDVAFFRV--DLASTRGSYLPIGSPTDNNRLYLldealelvplgAVGELCVAGTGVGRGYVG---DPLRTALAfvphpf 4096
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 794 -ADGsrRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGVWFKSQRT-RE 871
Cdd:PRK05691 4097 gAPG--ERLYRTGDLARRRSDGVLEYVGRIDHQVKIRGYRIELGEIEARLHEQAEVREAAVAVQEGVNGKHLVGYLVpHQ 4174
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|..
gi 489495878 872 GEQDAAA-----ATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKIDSDNLPRL 918
Cdd:PRK05691 4175 TVLAQGAlleriKQRLRAELPDYMVPLHWLW-LDRLPLNANGKLDRKALPAL 4225
|
|
| PRK07059 |
PRK07059 |
Long-chain-fatty-acid--CoA ligase; Validated |
1493-1971 |
5.00e-17 |
|
Long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235923 [Multi-domain] Cd Length: 557 Bit Score: 87.38 E-value: 5.00e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1493 SIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPI 1572
Cdd:PRK07059 24 SLADLLEESFRQYADRPAFICMGKAITYGELDELSRALAAWLQSRGLAKGARVAIMMPNVLQYPVAIAAVLRAGYVVVNV 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1573 DPANPPPRVAFMLGD-----------------------AVPVAAVTTAGLRSRLAGHdlpIIDVV--------------- 1614
Cdd:PRK07059 104 NPLYTPRELEHQLKDsgaeaivvlenfattvqqvlaktAVKHVVVASMGDLLGFKGH---IVNFVvrrvkkmvpawslpg 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1615 -----DALAAYPGTP--PPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPARLSAA--------QVWSQC--- 1676
Cdd:PRK07059 181 hvrfnDALAEGARQTfkPVKLGPDDVAFLQYTGGTTGVSKGATLLHRNIVANVLQMEAWLQPAfekkprpdQLNFVCalp 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1677 --HSYGFDASAweiwgaLLG---GGRLVIVPesvaaSPNDFHGLLVAEHVSVLTQTPAAV----AMLPTQGLESV---AL 1744
Cdd:PRK07059 261 lyHIFALTVCG------LLGmrtGGRNILIP-----NPRDIPGFIKELKKYQVHIFPAVNtlynALLNNPDFDKLdfsKL 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1745 VVA---GEACPAALVDRW--APGRVMLNAYGPTETT---ICAAISAPLRPGSgmppIGVPVSGAALFVLDSWLRPVPAGV 1816
Cdd:PRK07059 330 IVAnggGMAVQRPVAERWleMTGCPITEGYGLSETSpvaTCNPVDATEFSGT----IGLPLPSTEVSIRDDDGNDLPLGE 405
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1817 AGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALA 1896
Cdd:PRK07059 406 PGEICIRGPQVMAGYWNRPDETAKVMTADGF-------FRTGDVGVMDERGYTKIVDRKKDMILVSGFNVYPNEIEEVVA 478
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 489495878 1897 ELAGVGQAVVIAREDRPGDKRLVGYATEIAPgAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK07059 479 SHPGVLEVAAVGVPDEHSGEAVKLFVVKKDP-ALTEEDVKAFCKERLTNYKRPKFVEFRTELPKTNVGKILRREL 552
|
|
| PRK07529 |
PRK07529 |
AMP-binding domain protein; Validated |
1491-1965 |
5.85e-17 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236043 [Multi-domain] Cd Length: 632 Bit Score: 87.32 E-value: 5.85e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1491 PVSIPQMLAAQVARIPEAEAVCC---GDA-----SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAV 1562
Cdd:PRK07529 24 PASTYELLSRAAARHPDAPALSFlldADPldrpeTWTYAELLADVTRTANLLHSLGVGPGDVVAFLLPNLPETHFALWGG 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1563 LKTGAAYlPIDPANPPP---------------------------RVAFMLGDAVPVAAVTTAGLRSRLAG---------- 1605
Cdd:PRK07529 104 EAAGIAN-PINPLLEPEqiaellraagakvlvtlgpfpgtdiwqKVAEVLAALPELRTVVEVDLARYLPGpkrlavplir 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1606 --HDLPIIDVVDALAAYPGT---PPPMPAAVNLAYILYTSGTTGEPKGVGITHRNvtrlfaslparlSAAQVWSQCHSYG 1680
Cdd:PRK07529 183 rkAHARILDFDAELARQPGDrlfSGRPIGPDDVAAYFHTGGTTGMPKLAQHTHGN------------EVANAWLGALLLG 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1681 FDASAWEIWG---------------ALLGGGRLVIVPESVAASPNDFHGL--LVAEH-VSVLTQTPAAVAML---PTQG- 1738
Cdd:PRK07529 251 LGPGDTVFCGlplfhvnallvtglaPLARGAHVVLATPQGYRGPGVIANFwkIVERYrINFLSGVPTVYAALlqvPVDGh 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1739 -LESVALVVAGEA-CPAALVDRW--APGRVMLNAYGPTETT---ICAAISAPLRPGSgmppIGVPVSGAALFVL-----D 1806
Cdd:PRK07529 331 dISSLRYALCGAApLPVEVFRRFeaATGVRIVEGYGLTEATcvsSVNPPDGERRIGS----VGLRLPYQRVRVVilddaG 406
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1807 SWLRPVPAGVAGELYIAGAGVGVGYwrragLTASRFVACPFGGsgaRMYRTGDLVCWRADGQLEFLGRTDDQVkIR-GYR 1885
Cdd:PRK07529 407 RYLRDCAVDEVGVLCIAGPNVFSGY-----LEAAHNKGLWLED---GWLNTGDLGRIDADGYFWLTGRAKDLI-IRgGHN 477
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1886 IELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYaTEIAPGA-VDPAGLRAQLAQRLPGYL-VPAAVVVIDALPLTVN 1963
Cdd:PRK07529 478 IDPAAIEEALLRHPAVALAAAVGRPDAHAGELPVAY-VQLKPGAsATEAELLAFARDHIAERAaVPKHVRILDALPKTAV 556
|
..
gi 489495878 1964 GK 1965
Cdd:PRK07529 557 GK 558
|
|
| PRK08279 |
PRK08279 |
long-chain-acyl-CoA synthetase; Validated |
1479-1961 |
1.94e-16 |
|
long-chain-acyl-CoA synthetase; Validated
Pssm-ID: 236217 [Multi-domain] Cd Length: 600 Bit Score: 85.70 E-value: 1.94e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1479 GNRAVLTAPAPTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVA 1558
Cdd:PRK08279 24 GLKRTALITPDSKRSLGDVFEEAAARHPDRPALLFEDQSISYAELNARANRYAHWAAARGVGKGDVVALLMENRPEYLAA 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1559 MVAVLKTGA----------------------------------AYLPIDPANPPPRVAFMLGDAVPVAAVTtaglrsrla 1604
Cdd:PRK08279 104 WLGLAKLGAvvallntqqrgavlahslnlvdakhlivgeelveAFEEARADLARPPRLWVAGGDTLDDPEG--------- 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1605 ghdlpIIDVVDALAAYPGTPPPMPAAVNL---AYILYTSGTTGEPKGVGITHRNVTRLFAS--LPARLSAAQVWSQC--- 1676
Cdd:PRK08279 175 -----YEDLAAAAAGAPTTNPASRSGVTAkdtAFYIYTSGTTGLPKAAVMSHMRWLKAMGGfgGLLRLTPDDVLYCClpl 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1677 -HSYGFDASaweiWGALLGGGRLVIVPESVAASpnDFHGLLVAEHVSV----------LTQTPAAvamlPTQGLESVALV 1745
Cdd:PRK08279 250 yHNTGGTVA----WSSVLAAGATLALRRKFSAS--RFWDDVRRYRATAfqyigelcryLLNQPPK----PTDRDHRLRLM 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1746 VAGEACP---AALVDRWAPGRVmLNAYGPTETTIcAAISAPLRPGS-------GMPPIGV---------PVSGAalfvlD 1806
Cdd:PRK08279 320 IGNGLRPdiwDEFQQRFGIPRI-LEFYAASEGNV-GFINVFNFDGTvgrvplwLAHPYAIvkydvdtgePVRDA-----D 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1807 SWLRPVPAGVAGELY--IAGAGVGVGYWRRAGlTASRFVACPFgGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGY 1884
Cdd:PRK08279 393 GRCIKVKPGEVGLLIgrITDRGPFDGYTDPEA-SEKKILRDVF-KKGDAWFNTGDLMRDDGFGHAQFVDRLGDTFRWKGE 470
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1885 RIELGEVATALAELAGVGQAVViaredrpgdkrlvgYATEIaPG----------------AVDPAGLRAQLAQRLPGYLV 1948
Cdd:PRK08279 471 NVATTEVENALSGFPGVEEAVV--------------YGVEV-PGtdgragmaaivladgaEFDLAALAAHLYERLPAYAV 535
|
570
....*....|...
gi 489495878 1949 PAAVVVIDALPLT 1961
Cdd:PRK08279 536 PLFVRLVPELETT 548
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
1057-1350 |
2.16e-16 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 84.08 E-value: 2.16e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1057 LDTEALGAAVADVVGRHESLRTVFPAvDGvprQLVIEARRADLGCDIVDATAWPADRLQRAIE---EAARHSFdLATEip 1133
Cdd:cd19535 37 LDPDRLERAWNKLIARHPMLRAVFLD-DG---TQQILPEVPWYGITVHDLRGLSEEEAEAALEelrERLSHRV-LDVE-- 109
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1134 lRTWLFRIA-----DDEHVLvavahHI-----AADGWSVAPLTADLSAAYASRCAGRAPdwapLPVQYVDYTLWQREilg 1203
Cdd:cd19535 110 -RGPLFDIRlsllpEGRTRL-----HLsidllVADALSLQILLRELAALYEDPGEPLPP----LELSFRDYLLAEQA--- 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1204 dldDSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQVRRIARQHNATSFMVVAAGLAVL 1283
Cdd:cd19535 177 ---LRETAYERARAYWQERLPTLPPAPQLPLAKDPEEIKEPRFTRREHRLSAEQWQRLKERARQHGVTPSMVLLTAYAEV 253
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1284 LSKLSGSPDVAVGFPIAGR--SDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRARSLAAYENQDV 1350
Cdd:cd19535 254 LARWSGQPRFLLNLTLFNRlpLHPDVNDVVGDFTSLLLLEVDGSEGQSFLERARRLQQQLWEDLDHSSY 322
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
575-853 |
2.28e-16 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 82.76 E-value: 2.28e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVrsaaMKTGDLAA 654
Cdd:cd17630 3 ATVILTSGSTGTPKAVVHTAANLLASAAGLHSRLGFGGGDSWLLSLPLYHVGGLAILVRSLLAGAELV----LLERNQAL 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 655 LVDDLVARETTIVDLPTAVWQLLCADGDAIDaigRSRLRQIVIGGEAIrcSAVDkwLESAASQGISLLSSYGPTE--ATV 732
Cdd:cd17630 79 AEDLAPPGVTHVSLVPTQLQRLLDSGQGPAA---LKSLRAVLLGGAPI--PPEL--LERAADRGIPLYTTYGMTEtaSQV 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 733 VATFLPIVCDQTT---MDGALLRLGRPilpntvflafGEVVIVGDLVADGYLGidgdgfgTVTAADGSRRRAFATGDRVT 809
Cdd:cd17630 152 ATKRPDGFGRGGVgvlLPGRELRIVED----------GEIWVGGASLAMGYLR-------GQLVPEFNEDGWFTTKDLGE 214
|
250 260 270 280
....*....|....*....|....*....|....*....|....
gi 489495878 810 VDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd17630 215 LHADGRLTVLGRADNMIISGGENIQPEEIEAALAAHPAVRDAFV 258
|
|
| FADD10 |
cd17635 |
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain ... |
1636-1966 |
2.29e-16 |
|
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain fatty acid CoA ligases, including FadD10 which is involved in the synthesis of a virulence-related lipopeptide. FadD10 is a fatty acyl-AMP ligase (FAAL) that transfers fatty acids to an acyl carrier protein. Structures of FadD10 in apo- and complexed form with dodecanoyl-AMP, show a novel open conformation, facilitated by its unique inter-domain and intermolecular interactions, which is critical for the enzyme to carry out the acyl transfer onto the acyl carrier protein (Rv0100) rather than coenzyme A.
Pssm-ID: 341290 [Multi-domain] Cd Length: 340 Bit Score: 83.08 E-value: 2.29e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1636 ILYTSGTTGEPKGVGITHRNvtrLFASLPARLSAAQVWSQ----------CHSYGfdaSAWEIWGALLGGGRLVIVPESV 1705
Cdd:cd17635 6 VIFTSGTTGEPKAVLLANKT---FFAVPDILQKEGLNWVVgdvtylplpaTHIGG---LWWILTCLIHGGLCVTGGENTT 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1706 AASpndFHGLLVAEHVSVLTQTPAAVAMLPT------QGLESVALVVAGEACPAALVDR---WAPGRVMLNAYGPTETTi 1776
Cdd:cd17635 80 YKS---LFKILTTNAVTTTCLVPTLLSKLVSelksanATVPSLRLIGYGGSRAIAADVRfieATGLTNTAQVYGLSETG- 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1777 cAAISAPLRPGSG-MPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacpfGGsgarMY 1855
Cdd:cd17635 156 -TALCLPTDDDSIeINAVGRPYPGVDVYLAATDGIAGPSASFGTIWIKSPANMLGYWNNPERTAEVLI----DG----WV 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1856 RTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKrLVGYATeIAPGAVDPAGL 1935
Cdd:cd17635 227 NTGDLGERREDGFLFITGRSSESINCGGVKIAPDEVERIAEGVSGVQECACYEISDEEFGE-LVGLAV-VASAELDENAI 304
|
330 340 350
....*....|....*....|....*....|....
gi 489495878 1936 RAQ---LAQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:cd17635 305 RALkhtIRRELEPYARPSTIVIVTDIPRTQSGKV 338
|
|
| PRK08751 |
PRK08751 |
long-chain fatty acid--CoA ligase; |
1493-1971 |
3.34e-16 |
|
long-chain fatty acid--CoA ligase;
Pssm-ID: 181546 [Multi-domain] Cd Length: 560 Bit Score: 84.54 E-value: 3.34e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1493 SIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAG-CGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLP 1571
Cdd:PRK08751 26 TVAEVFATSVAKFADRPAYHSFGKTITYREADQLVEQFAAYLLGeLQLKKGDRVALMMPNCLQYPIATFGVLRAGLTVVN 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1572 IDPANPPPRVAFMLGDA---------------------VPVAAVTTAGLRSRLAGHDLPIIDVV---------------- 1614
Cdd:PRK08751 106 VNPLYTPRELKHQLIDSgasvlvvidnfgttvqqviadTPVKQVITTGLGDMLGFPKAALVNFVvkyvkklvpeyringa 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1615 ----DALAAypGTPPPMP----AAVNLAYILYTSGTTGEPKGVGITHRNvtrlfasLPARLSAAQVWSQChSYGFDASAW 1686
Cdd:PRK08751 186 irfrEALAL--GRKHSMPtlqiEPDDIAFLQYTGGTTGVAKGAMLTHRN-------LVANMQQAHQWLAG-TGKLEEGCE 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1687 EIWGAL-------LGGGRLVIVP----ESVAASPNDFHGLlvaehVSVLTQTPAAV---------AMLPTQGLESVAL-- 1744
Cdd:PRK08751 256 VVITALplyhifaLTANGLVFMKiggcNHLISNPRDMPGF-----VKELKKTRFTAftgvntlfnGLLNTPGFDQIDFss 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1745 ----VVAGEACPAALVDRW--APGRVMLNAYGPTETTICAAISaPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAG 1818
Cdd:PRK08751 331 lkmtLGGGMAVQRSVAERWkqVTGLTLVEAYGLTETSPAACIN-PLTLKEYNGSIGLPIPSTDACIKDDAGTVLAIGEIG 409
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1819 ELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAEL 1898
Cdd:PRK08751 410 ELCIKGPQVMKGYWKRPEETAKVMDADGW-------LHTGDIARMDEQGFVYIVDRKKDMILVSGFNVYPNEIEDVIAMM 482
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 1899 AGVGQAVVIAREDRPGdkrlvGYATEIAPGAVDPA----GLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK08751 483 PGVLEVAAVGVPDEKS-----GEIVKVVIVKKDPAltaeDVKAHARANLTGYKQPRIIEFRKELPKTNVGKILRREL 554
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
1517-1971 |
3.48e-16 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 83.55 E-value: 3.48e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVaavtt 1596
Cdd:cd05912 1 SYTFAELFEEVSRLAEHLAALGVRKGDRVALLSKNSIEMILLIHALWLLGAEAVLLNTRLTPNELAFQLKDSDVK----- 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1597 aglrsrlaghdlpiidvVDALAAypgtpppmpaavnlayILYTSGTTGEPKGVGITHRNVtrlFASlpARLSAAQV---- 1672
Cdd:cd05912 76 -----------------LDDIAT----------------IMYTSGTTGKPKGVQQTFGNH---WWS--AIGSALNLglte 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1673 ---WSQC----HSYGFDAsaweIWGALLGGGRLVIVPesvAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVA-- 1743
Cdd:cd05912 118 ddnWLCAlplfHISGLSI----LMRSVIYGMTVYLVD---KFDAEQVLHLINSGKVTIISVVPTMLQRLLEILGEGYPnn 190
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1744 ---LVVAGEACPAALVDRWAP-GRVMLNAYGPTETT--ICAA--ISAPLRPGS-GMPPIGVPVSgaalFVLDSwlrpVPA 1814
Cdd:cd05912 191 lrcILLGGGPAPKPLLEQCKEkGIPVYQSYGMTETCsqIVTLspEDALNKIGSaGKPLFPVELK----IEDDG----QPP 262
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1815 GVAGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmyRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATA 1894
Cdd:cd05912 263 YEVGEILLKGPNVTKGYLNRPDATEESFENGWF--------KTGDIGYLDEEGFLYVLDRRSDLIISGGENIYPAEIEEV 334
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 1895 LAELAGVGQAVVIAREDRPGDKRLVGYAteIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05912 335 LLSHPAIKEAGVVGIPDDKWGQVPVAFV--VSERPISEEELIAYCSEKLAKYKVPKKIYFVDELPRTASGKLLRHEL 409
|
|
| PRK07867 |
PRK07867 |
acyl-CoA synthetase; Validated |
1594-1973 |
8.53e-16 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236120 [Multi-domain] Cd Length: 529 Bit Score: 83.19 E-value: 8.53e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1594 VTTAGLRSRLAGHD--LPIIDV-----VDALAAYPGTPPPM--PAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLP 1664
Cdd:PRK07867 106 LTESAHAELLDGLDpgVRVINVdspawADELAAHRDAEPPFrvADPDDLFMLIFTSGTSGDPKAVRCTHRKVASAGVMLA 185
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1665 AR--LSAAQVWSQC----HSYGFDAsAWEIwgALLGGGRLVIvPESVAASpndfhGLL-------------VAEHVSVLT 1725
Cdd:PRK07867 186 QRfgLGPDDVCYVSmplfHSNAVMA-GWAV--ALAAGASIAL-RRKFSAS-----GFLpdvrrygatyanyVGKPLSYVL 256
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1726 QTPAavamLPTQGLESVALVVAGEACPAAlVDRWAP--GRVMLNAYGPTETTICAAISAPLRPGSgmppIGVPVSGAALF 1803
Cdd:PRK07867 257 ATPE----RPDDADNPLRIVYGNEGAPGD-IARFARrfGCVVVDGFGSTEGGVAITRTPDTPPGA----LGPLPPGVAIV 327
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1804 VLDSwLRPVPAGVA------------GELY-IAGAGVGVGYWRRAGLTASRFVacpfGGsgarMYRTGDLVCWRADGQLE 1870
Cdd:PRK07867 328 DPDT-GTECPPAEDadgrllnadeaiGELVnTAGPGGFEGYYNDPEADAERMR----GG----VYWSGDLAYRDADGYAY 398
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1871 FLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRP-GDKrlVGYATEIAPGAV-DPAGLRAQLAQR--LPGY 1946
Cdd:PRK07867 399 FAGRLGDWMRVDGENLGTAPIERILLRYPDATEVAVYAVPDPVvGDQ--VMAALVLAPGAKfDPDAFAEFLAAQpdLGPK 476
|
410 420
....*....|....*....|....*..
gi 489495878 1947 LVPAAVVVIDALPLTVNGKLDHRALPA 1973
Cdd:PRK07867 477 QWPSYVRVCAELPRTATFKVLKRQLSA 503
|
|
| PRK13382 |
PRK13382 |
bile acid CoA ligase; |
1498-1974 |
8.78e-16 |
|
bile acid CoA ligase;
Pssm-ID: 172019 [Multi-domain] Cd Length: 537 Bit Score: 83.27 E-value: 8.78e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1498 LAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANP 1577
Cdd:PRK13382 49 FAIAAQRCPDRPGLIDELGTLTWRELDERSDALAAALQALPIGEPRVVGIMCRNHRGFVEALLAANRIGADILLLNTSFA 128
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1578 PPRVAFMLG--------------DAVPVAAVTTAGLRSRLAGHDLPIIDVVDALAAYPGTPPPMPAAVNLAYILYTSGTT 1643
Cdd:PRK13382 129 GPALAEVVTregvdtviydeefsATVDRALADCPQATRIVAWTDEDHDLTVEVLIAAHAGQRPEPTGRKGRVILLTSGTT 208
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1644 GEPKGV------------GITHRnvTRLFASLPARLSAAQVwsqcHSYGFdasAWEIWGALLgggRLVIV------PESV 1705
Cdd:PRK13382 209 GTPKGArrsgpggigtlkAILDR--TPWRAEEPTVIVAPMF----HAWGF---SQLVLAASL---ACTIVtrrrfdPEAT 276
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1706 AAspndfhglLVAEHvsvltqTPAAVAMLPT---QGLESVALV-------------VAGEACPAALV----DRWapGRVM 1765
Cdd:PRK13382 277 LD--------LIDRH------RATGLAVVPVmfdRIMDLPAEVrnrysgrslrfaaASGSRMRPDVViafmDQF--GDVI 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1766 LNAYGPTETT-ICAAISAPLR--PGSGmppiGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYwrragltasrf 1842
Cdd:PRK13382 341 YNNYNATEAGmIATATPADLRaaPDTA----GRPAEGTEIRILDQDFREVPTGEVGTIFVRNDTQFDGY----------- 405
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1843 vacpfgGSGAR------MYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDK 1916
Cdd:PRK13382 406 ------TSGSTkdfhdgFMASGDVGYLDENGRLFVVGRDDEMIVSGGENVYPIEVEKTLATHPDVAEAAVIGVDDEQYGQ 479
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1917 RLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAP 1974
Cdd:PRK13382 480 RLAAFVVLKPGASATPETLKQHVRDNLANYKVPRDIVVLDELPRGATGKILRRELQAR 537
|
|
| PtmA |
cd17636 |
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, ... |
1636-1967 |
1.37e-15 |
|
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341291 [Multi-domain] Cd Length: 331 Bit Score: 80.42 E-value: 1.37e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1636 ILYTSGTTGEPKGVGITHRNVtrlfasLPARLSAAQVWSQCHSYGFDASA--WEIwGALLG-------GGRLVIVPesvA 1706
Cdd:cd17636 5 AIYTAAFSGRPNGALLSHQAL------LAQALVLAVLQAIDEGTVFLNSGplFHI-GTLMFtlatfhaGGTNVFVR---R 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1707 ASPNDFHGLLVAEHVS---VLTQTPAAVAMLPTQGLESV----ALVVAGEACPAALVDRWAPGRVMlNAYGPTETTICAA 1779
Cdd:cd17636 75 VDAEEVLELIEAERCThafLLPPTIDQIVELNADGLYDLsslrSSPAAPEWNDMATVDTSPWGRKP-GGYGQTEVMGLAT 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1780 ISAPLRPGSGMppIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacpFGGsgarmYRTGD 1859
Cdd:cd17636 154 FAALGGGAIGG--AGRPSPLVQVRILDEDGREVPDGEVGEIVARGPTVMAGYWNRPEVNARRTR---GGW-----HHTND 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1860 LVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDrPGDKRLVGYATEIAPGA-VDPAGLRAQ 1938
Cdd:cd17636 224 LGRREPDGSLSFVGPKTRMIKSGAENIYPAEVERCLRQHPAVADAAVIGVPD-PRWAQSVKAIVVLKPGAsVTEAELIEH 302
|
330 340
....*....|....*....|....*....
gi 489495878 1939 LAQRLPGYLVPAAVVVIDALPLTVNGKLD 1967
Cdd:cd17636 303 CRARIASYKKPKSVEFADALPRTAGGADD 331
|
|
| AACS_like |
cd05968 |
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This ... |
1517-1985 |
1.41e-15 |
|
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This uncharacterized acyl-CoA synthetase family (EC 6.2.1.16, or acetoacetate#CoA ligase or acetoacetate:CoA ligase (AMP-forming)) is highly homologous to acetoacetyl-CoA synthetase. However, the proteins in this family exist in only bacteria and archaea. AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms.
Pssm-ID: 341272 [Multi-domain] Cd Length: 610 Bit Score: 82.92 E-value: 1.41e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTT 1596
Cdd:cd05968 91 TLTYGELLYEVKRLANGLRALGVGKGDRVGIYLPMIPEIVPAFLAVARIGGIVVPIFSGFGKEAAATRLQDAEAKALITA 170
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1597 AGLRSRlaGHDLPIIDVVD-ALAAYP-----------GTPPPMPAAVNLAY---------------------ILYTSGTT 1643
Cdd:cd05968 171 DGFTRR--GREVNLKEEADkACAQCPtvekvvvvrhlGNDFTPAKGRDLSYdeeketagdgaertesedplmIIYTSGTT 248
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1644 GEPKGVGITHrnvtrlfASLParLSAAQVWSQCHS------------YGFDASAWEIWGALLGGGRLVI---VPESVAAs 1708
Cdd:cd05968 249 GKPKGTVHVH-------AGFP--LKAAQDMYFQFDlkpgdlltwftdLGWMMGPWLIFGGLILGATMVLydgAPDHPKA- 318
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1709 pnDFHGLLVAEH-VSVLTQTPAAVAMLPTQGLESVA------LVVAGEACPAALVDRW-------APGRV-MLNAYGPTE 1773
Cdd:cd05968 319 --DRLWRMVEDHeITHLGLSPTLIRALKPRGDAPVNahdlssLRVLGSTGEPWNPEPWnwlfetvGKGRNpIINYSGGTE 396
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1774 TT---ICAAISAPLRPGSgmppIGVPVSGAALFVLDSWLRPVPAGVaGELYIAGAGVGV--GYWRraglTASRFVACPFg 1848
Cdd:cd05968 397 ISggiLGNVLIKPIKPSS----FNGPVPGMKADVLDESGKPARPEV-GELVLLAPWPGMtrGFWR----DEDRYLETYW- 466
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1849 gsgARM---YRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATeI 1925
Cdd:cd05968 467 ---SRFdnvWVHGDFAYYDEEGYFYILGRSDDTINVAGKRVGPAEIESVLNAHPAVLESAAIGVPHPVKGEAIVCFVV-L 542
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1926 APGAVDPAGLRAQLAQR----LPGYLVPAAVVVIDALPLTVNGKLDHRALPA----PEYGDTNGYRAP 1985
Cdd:cd05968 543 KPGVTPTEALAEELMERvadeLGKPLSPERILFVKDLPKTRNAKVMRRVIRAaylgKELGDLSSLENP 610
|
|
| PRK12583 |
PRK12583 |
acyl-CoA synthetase; Provisional |
1494-1966 |
2.13e-15 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237145 [Multi-domain] Cd Length: 558 Bit Score: 82.13 E-value: 2.13e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1494 IPQMLAAQVARIPEAEAVCCG--DASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLP 1571
Cdd:PRK12583 20 IGDAFDATVARFPDREALVVRhqALRYTWRQLADAVDRLARGLLALGVQPGDRVGIWAPNCAEWLLTQFATARIGAILVN 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1572 IDPANPPPRVAFMLGDAVPVAAVTTAGLRS--------------------RLAGHDLPIIDVVDALAaypGTPPP----- 1626
Cdd:PRK12583 100 INPAYRASELEYALGQSGVRWVICADAFKTsdyhamlqellpglaegqpgALACERLPELRGVVSLA---PAPPPgflaw 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1627 -----MPAAVNLA---------------YILYTSGTTGEPKGVGITHRNVTRLFASLPARLSAAQVWSQC------HSYG 1680
Cdd:PRK12583 177 helqaRGETVSREalaerqasldrddpiNIQYTSGTTGFPKGATLSHHNILNNGYFVAESLGLTEHDRLCvpvplyHCFG 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1681 FDASaweIWGALLGGGRLVIvpesvaasPND-FHGLLVAEHVSVLTQTpaAVAMLPTQGLESV-----------AL---V 1745
Cdd:PRK12583 257 MVLA---NLGCMTVGACLVY--------PNEaFDPLATLQAVEEERCT--ALYGVPTMFIAELdhpqrgnfdlsSLrtgI 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1746 VAGEACPAALVDrwapgRVM--------LNAYGPTETT-----ICAAISAPLRPGSgmppIGVPVSGAALFVLDSWLRPV 1812
Cdd:PRK12583 324 MAGAPCPIEVMR-----RVMdemhmaevQIAYGMTETSpvslqTTAADDLERRVET----VGRTQPHLEVKVVDPDGATV 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1813 PAGVAGELYIAGAGVGVGYWRRAGLTASRFvacpfgGSGARMYrTGDLVCWRADGQLEFLGRTDDQVkIRG----YRIEL 1888
Cdd:PRK12583 395 PRGEIGELCTRGYSVMKGYWNNPEATAESI------DEDGWMH-TGDLATMDEQGYVRIVGRSKDMI-IRGgeniYPREI 466
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1889 GEVataLAELAGVGQAVVIAREDRPGDKRLVGYaTEIAPG-AVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:PRK12583 467 EEF---LFTHPAVADVQVFGVPDEKYGEEIVAW-VRLHPGhAASEEELREFCKARIAHFKVPRYFRFVDEFPMTVTGKV 541
|
|
| entE |
PRK10946 |
(2,3-dihydroxybenzoyl)adenylate synthase; |
1497-1971 |
3.17e-15 |
|
(2,3-dihydroxybenzoyl)adenylate synthase;
Pssm-ID: 236803 [Multi-domain] Cd Length: 536 Bit Score: 81.57 E-value: 3.17e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1497 MLAAQVAriPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGEC-------VALLFercapavVAMVAVLKTGAAy 1569
Cdd:PRK10946 30 ILTRHAA--SDAIAVICGERQFSYRELNQASDNLACSLRRQGIKPGDTalvqlgnVAEFY-------ITFFALLKLGVA- 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1570 lpidPAN------------------PPPRVA------FMLGDAVPVAAVTTAGLRSRLAGHDLPIIDVVDALAAYPGTPP 1625
Cdd:PRK10946 100 ----PVNalfshqrselnayasqiePALLIAdrqhalFSDDDFLNTLVAEHSSLRVVLLLNDDGEHSLDDAINHPAEDFT 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1626 PMP-AAVNLAYILYTSGTTGEPKGVGITH--------RNV--------TRLFASLPArlsaaqvwsqCHSYGFdaSAWEI 1688
Cdd:PRK10946 176 ATPsPADEVAFFQLSGGSTGTPKLIPRTHndyyysvrRSVeicgftpqTRYLCALPA----------AHNYPM--SSPGA 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1689 WGALLGGGRLVIVPESVAAS--PndfhglLVAEH-VSVLTQTPAAVAM------LPT--QGLESVALV-VAGEACPAALV 1756
Cdd:PRK10946 244 LGVFLAGGTVVLAPDPSATLcfP------LIEKHqVNVTALVPPAVSLwlqaiaEGGsrAQLASLKLLqVGGARLSETLA 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1757 DRwapgrvmlnaygptettICAAISAPLRPGSGM------------PPI------GVPVSGA-ALFVLDSWLRPVPAGVA 1817
Cdd:PRK10946 318 RR-----------------IPAELGCQLQQVFGMaeglvnytrlddSDErifttqGRPMSPDdEVWVADADGNPLPQGEV 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1818 GELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAE 1897
Cdd:PRK10946 381 GRLMTRGPYTFRGYYKSPQHNASAFDANGF-------YCSGDLVSIDPDGYITVVGREKDQINRGGEKIAAEEIENLLLR 453
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 1898 LAGVGQAVVIARED-RPGDKrlvGYATEIAPGAVDPAGLRAQL-AQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK10946 454 HPAVIHAALVSMEDeLMGEK---SCAFLVVKEPLKAVQLRRFLrEQGIAEFKLPDRVECVDSLPLTAVGKVDKKQL 526
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
540-910 |
7.73e-15 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 79.43 E-value: 7.73e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 540 VAATQLAVVGHDELRKVVDERVTQVTHDALL---ATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAY-GWGAHDT 615
Cdd:cd05919 56 LARGAIAVVINPLLHPDDYAYIARDCEARLVvtsADDIAYLLYSSGTTGPPKGVMHAHRDPLLFADAMAREAlGLTPGDR 135
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 616 VLQCAPLTSDISV-EEIFGGAACGARLVRSAAMKTGDlAALVDDLVARETTIVDLPTAVWQLLCADGDAIDAIgrSRLRQ 694
Cdd:cd05919 136 VFSSAKMFFGYGLgNSLWFPLAVGASAVLNPGWPTAE-RVLATLARFRPTVLYGVPTFYANLLDSCAGSPDAL--RSLRL 212
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 695 IVIGGEAIRCSAVDKWLESAasqGISLLSSYGPTEatVVATFLPIVCDQTTMD-------GALLRL----GRPILPNTVf 763
Cdd:cd05919 213 CVSAGEALPRGLGERWMEHF---GGPILDGIGATE--VGHIFLSNRPGAWRLGstgrpvpGYEIRLvdeeGHTIPPGEE- 286
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 764 lafGEVVIVGDLVADGYLgidgdgfgtvTAADGSRRRA----FATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVT 839
Cdd:cd05919 287 ---GDLLVRGPSAAVGYW----------NNPEKSRATFnggwYRTGDKFCRDADGWYTHAGRADDMLKVGGQWVSPVEVE 353
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 840 RRIAEDPAVSDVAV----ELHSGS---LGVWFKSQRTREGEQDAAAATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKI 910
Cdd:cd05919 354 SLIIQHPAVAEAAVvavpESTGLSrltAFVVLKSPAAPQESLARDIHRHLLERLSAHKVPRRIAF-VDELPRTATGKL 430
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
1626-1971 |
8.01e-15 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 80.25 E-value: 8.01e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1626 PMPAAV-NLAYILYTSGTTGEPKGVGITHRNVTRLFASLPARLS-----AAQVWSQC-----------HSYGFDASAWEI 1688
Cdd:PRK12492 201 PVPVGLdDIAVLQYTGGTTGLAKGAMLTHGNLVANMLQVRACLSqlgpdGQPLMKEGqevmiaplplyHIYAFTANCMCM 280
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1689 wgaLLGGGRLVIVpesvaASPNDFHGLLVA----EHVSVLTQTPAAVAMLPTQGLESV---ALVV---AGEACPAALVDR 1758
Cdd:PRK12492 281 ---MVSGNHNVLI-----TNPRDIPGFIKElgkwRFSALLGLNTLFVALMDHPGFKDLdfsALKLtnsGGTALVKATAER 352
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1759 WA--PGRVMLNAYGPTETTICAAiSAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAG 1836
Cdd:PRK12492 353 WEqlTGCTIVEGYGLTETSPVAS-TNPYGELARLGTVGIPVPGTALKVIDDDGNELPLGERGELCIKGPQVMKGYWQQPE 431
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1837 LTASRFVAcpfggsgARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRI---ELGEVATALAELAGVgqAVVIAREDRP 1913
Cdd:PRK12492 432 ATAEALDA-------EGWFKTGDIAVIDPDGFVRIVDRKKDLIIVSGFNVypnEIEDVVMAHPKVANC--AAIGVPDERS 502
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1914 GDK-RLVGYATEiapGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK12492 503 GEAvKLFVVARD---PGLSVEELKAYCKENFTGYKVPKHIVLRDSLPMTPVGKILRREL 558
|
|
| PRK08162 |
PRK08162 |
acyl-CoA synthetase; Validated |
1499-1966 |
8.36e-15 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236169 [Multi-domain] Cd Length: 545 Bit Score: 79.99 E-value: 8.36e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1499 AAQVAriPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPP 1578
Cdd:PRK08162 27 AAEVY--PDRPAVIHGDRRRTWAETYARCRRLASALARRGIGRGDTVAVLLPNIPAMVEAHFGVPMAGAVLNTLNTRLDA 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1579 PRVAFML--GDAVPV------AAVTTAGLRsRLAGHDLPIIDVVDAlaAYPGTPP-------------------PMPA-- 1629
Cdd:PRK08162 105 ASIAFMLrhGEAKVLivdtefAEVAREALA-LLPGPKPLVIDVDDP--EYPGGRFigaldyeaflasgdpdfawTLPAde 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1630 --AVNLAYilyTSGTTGEPKGVGITHR--------NVtrLFASLPARlsAAQVWS----QCHSYGFdasAWEIwgALLGG 1695
Cdd:PRK08162 182 wdAIALNY---TSGTTGNPKGVVYHHRgaylnalsNI--LAWGMPKH--PVYLWTlpmfHCNGWCF---PWTV--AARAG 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1696 grlVIV------PESVaaspndfHGLLVAEHVSVLTQTPAAVAML------PTQGLE-SVALVVAGEACPAALVDRWAP- 1761
Cdd:PRK08162 250 ---TNVclrkvdPKLI-------FDLIREHGVTHYCGAPIVLSALinapaeWRAGIDhPVHAMVAGAAPPAAVIAKMEEi 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1762 GRVMLNAYGPTET----TICAAisaplRPGSGMPPI----------GVP-VSGAALFVLDS-WLRPVPAG--VAGELYIA 1823
Cdd:PRK08162 320 GFDLTHVYGLTETygpaTVCAW-----QPEWDALPLderaqlkarqGVRyPLQEGVTVLDPdTMQPVPADgeTIGEIMFR 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1824 GAGVGVGYWRRAGLTASRFVacpfGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQ 1903
Cdd:PRK08162 395 GNIVMKGYLKNPKATEEAFA----GG----WFHTGDLAVLHPDGYIKIKDRSKDIIISGGENISSIEVEDVLYRHPAVLV 466
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 1904 AVVIARED-RPGDkrlVGYA-TEIAPGA-VDPAGLRAQLAQRLPGYLVPAAvVVIDALPLTVNGKL 1966
Cdd:PRK08162 467 AAVVAKPDpKWGE---VPCAfVELKDGAsATEEEIIAHCREHLAGFKVPKA-VVFGELPKTSTGKI 528
|
|
| ACLS-CaiC |
cd17637 |
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ... |
1636-1967 |
8.48e-15 |
|
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized, but may be similar to Carnitine-CoA ligase (CaiC) which catalyzes the transfer of CoA to carnitine. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341292 [Multi-domain] Cd Length: 333 Bit Score: 78.08 E-value: 8.48e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1636 ILYTSGTTGEPKGVGITHRNVtrlfasLPARLSAAQVWSQCHSygfDASA-----WEIWGALLG------GGRLVIV--- 1701
Cdd:cd17637 5 IIHTAAVAGRPRGAVLSHGNL------IAANLQLIHAMGLTEA---DVYLnmlplFHIAGLNLAlatfhaGGANVVMekf 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1702 -PESVAAspndfhgLLVAEHVSVLTQTPAAVAM-LPTQGLESVAL----VVAGEACPAAlVDRW---APGRvMLNAYGPT 1772
Cdd:cd17637 76 dPAEALE-------LIEEEKVTLMGSFPPILSNlLDAAEKSGVDLsslrHVLGLDAPET-IQRFeetTGAT-FWSLYGQT 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1773 ETTICAAIS-APLRPGSGmppiGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVacpfGGsg 1851
Cdd:cd17637 147 ETSGLVTLSpYRERPGSA----GRPGPLVRVRIVDDNDRPVPAGETGEIVVRGPLVFQGYWNLPELTAYTFR----NG-- 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1852 arMYRTGDLVCWRADGQLEFLGRT--DDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDrPGDKRLVGYATEIAPGA 1929
Cdd:cd17637 217 --WHHTGDLGRFDEDGYLWYAGRKpeKELIKPGGENVYPAEVEKVILEHPAIAEVCVIGVPD-PKWGEGIKAVCVLKPGA 293
|
330 340 350
....*....|....*....|....*....|....*....
gi 489495878 1930 -VDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLD 1967
Cdd:cd17637 294 tLTADELIEFVGSRIARYKKPRYVVFVEALPKTADGSID 332
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
575-911 |
9.38e-15 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 79.19 E-value: 9.38e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLT-SDISVEEIFGGAACGARLVRSAAMKTGDLA 653
Cdd:cd17631 101 ALLMYTSGTTGRPKGAMLTHRNLLWNAVNALAALDLGPDDVLLVVAPLFhIGGLGVFTLPTLLRGGTVVILRKFDPETVL 180
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 654 ALVDDlvARETTIVDLPTaVWQLLCADGDAiDAIGRSRLRQIVIGGEAIRCSAVDKWLEsaasQGISLLSSYGPTEATVV 733
Cdd:cd17631 181 DLIER--HRVTSFFLVPT-MIQALLQHPRF-ATTDLSSLRAVIYGGAPMPERLLRALQA----RGVKFVQGYGMTETSPG 252
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 734 ATFLPIVCDQTTMDGAllrlGRPIL---------------PNTVflafGEVVIVGDLVADGYLGIDgdgfgtVTAADGSR 798
Cdd:cd17631 253 VTFLSPEDHRRKLGSA----GRPVFfvevrivdpdgrevpPGEV----GEIVVRGPHVMAGYWNRP------EATAAAFR 318
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 799 RRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV----ELHSGSLGVWFKSQR--TREG 872
Cdd:cd17631 319 DGWFHTGDLGRLDEDGYLYIVDRKKDMIISGGENVYPAEVEDVLYEHPAVAEVAVigvpDEKWGEAVVAVVVPRpgAELD 398
|
330 340 350
....*....|....*....|....*....|....*....
gi 489495878 873 EQDAAAATRIRLVLVSLGVSSFFvvgVPNIPRKPNGKID 911
Cdd:cd17631 399 EDELIAHCRERLARYKIPKSVEF---VDALPRNATGKIL 434
|
|
| FACL_like_4 |
cd05944 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1632-1971 |
1.10e-14 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341266 [Multi-domain] Cd Length: 359 Bit Score: 78.29 E-value: 1.10e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1632 NLAYILYTSGTTGEPKGVGITHRNVTrlfaslparlsaAQVWSQCHSYGFD---------------ASAWEIWGALLGGG 1696
Cdd:cd05944 3 DVAAYFHTGGTTGTPKLAQHTHSNEV------------YNAWMLALNSLFDpddvllcglplfhvnGSVVTLLTPLASGA 70
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1697 RLVIVPESVAASPN---DFHGLLVAEHVSVLTQTPAAVAML---PTQG-LESVALVVAGEA-CPAALVDRW--APGRVML 1766
Cdd:cd05944 71 HVVLAGPAGYRNPGlfdNFWKLVERYRITSLSTVPTVYAALlqvPVNAdISSLRFAMSGAApLPVELRARFedATGLPVV 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1767 NAYGPTETTICAAIS---APLRPGS-GMPpigVPVSGAALFVLD---SWLRPVPAGVAGELYIAGAGVGVGYwrraglTA 1839
Cdd:cd05944 151 EGYGLTEATCLVAVNppdGPKRPGSvGLR---LPYARVRIKVLDgvgRLLRDCAPDEVGEICVAGPGVFGGY------LY 221
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1840 SRFVACPFGGSGarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLV 1919
Cdd:cd05944 222 TEGNKNAFVADG--WLNTGDLGRLDADGYLFITGRAKDLIIRGGHNIDPALIEEALLRHPAVAFAGAVGQPDAHAGELPV 299
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....
gi 489495878 1920 GYaTEIAPGA-VDPAGLRAQLAQRLPGY-LVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05944 300 AY-VQLKPGAvVEEEELLAWARDHVPERaAVPKHIEVLEELPVTAVGKVFKPAL 352
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
1776-2063 |
1.29e-14 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 77.10 E-value: 1.29e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1776 ICAAISAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPF--GGSGAR 1853
Cdd:COG3433 1 IAIATPPPAPPTPDEPPPVIPPAIVQARALLLIVDLQGYFGGFGGEGGLLGAGLLLRIRLLAAAARAPFIPVpyPAQPGR 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1854 MYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRpGDKRLVGYATEIAPGAVDPA 1933
Cdd:COG3433 81 QADDLRLLLRRGLGPGGGLERLVQQVVIRAERGEEEELLLVLRAAAVVRVAVLAALRGA-GVGLLLIVGAVAALDGLAAA 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1934 GLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAPEYGDTNGYRAPAGPVEKT-----VAGIFARVLGL--ERV 2006
Cdd:COG3433 160 AALAALDKVPPDVVAASAVVALDALLLLALKVVARAAPALAAAEALLAAASPAPALETAlteeeLRADVAELLGVdpEEI 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 2007 GVDDSFFELGGDSLAAMRVIAAINTTlNADLPVRALLHASSTRGLSQLLGRDARPTS 2063
Cdd:COG3433 240 DPDDNLFDLGLDSIRLMQLVERWRKA-GLDVSFADLAEHPTLAAWWALLAAAQAAAA 295
|
|
| PRK13390 |
PRK13390 |
acyl-CoA synthetase; Provisional |
1500-1966 |
2.58e-14 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139538 [Multi-domain] Cd Length: 501 Bit Score: 78.51 E-value: 2.58e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1500 AQVAriPEAEAVCCGDA--SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANP 1577
Cdd:PRK13390 7 AQIA--PDRPAVIVAETgeQVSYRQLDDDSAALARVLYDAGLRTGDVVALLSDNSPEALVVLWAALRSGLYITAINHHLT 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1578 PPRVAFMLGDAVPVAAVTTAGLRSRLA--GHDLPI-------ID-VVDALAAYPGTPPPMPAAVNLAYILYTSGTTGEPK 1647
Cdd:PRK13390 85 APEADYIVGDSGARVLVASAALDGLAAkvGADLPLrlsfggeIDgFGSFEAALAGAGPRLTEQPCGAVMLYSSGTTGFPK 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1648 GV------------------------GITHRNVtrLFASLPARLSAAQVW-SQCHSYgfdasaweiwgallgGGRLVIVP 1702
Cdd:PRK13390 165 GIqpdlpgrdvdapgdpivaiarafyDISESDI--YYSSAPIYHAAPLRWcSMVHAL---------------GGTVVLAK 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1703 ESVAAspnDFHGLLVAEHVSVLTQTPAA-VAMLPTQG-------LESV-ALVVAGEACPA----ALVDRWAPgrVMLNAY 1769
Cdd:PRK13390 228 RFDAQ---ATLGHVERYRITVTQMVPTMfVRLLKLDAdvrtrydVSSLrAVIHAAAPCPVdvkhAMIDWLGP--IVYEYY 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1770 GPTETTICAAISAP---LRPGSgmppIGVPVSGaALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTA-SRFVAC 1845
Cdd:PRK13390 303 SSTEAHGMTFIDSPdwlAHPGS----VGRSVLG-DLHICDDDGNELPAGRIGTVYFERDRLPFRYLNDPEKTAaAQHPAH 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1846 PFGGSgarmyrTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDrPGDKRLVGYATEI 1925
Cdd:PRK13390 378 PFWTT------VGDLGSVDEDGYLYLADRKSFMIISGGVNIYPQETENALTMHPAVHDVAVIGVPD-PEMGEQVKAVIQL 450
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 489495878 1926 APGaVDPAGLRAQ-----LAQRLPGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:PRK13390 451 VEG-IRGSDELARelidyTRSRIAHYKAPRSVEFVDELPRTPTGKL 495
|
|
| prpE |
PRK10524 |
propionyl-CoA synthetase; Provisional |
1635-1973 |
2.95e-14 |
|
propionyl-CoA synthetase; Provisional
Pssm-ID: 182517 [Multi-domain] Cd Length: 629 Bit Score: 78.84 E-value: 2.95e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1635 YILYTSGTTGEPKGVgitHRNV----TRLFASLP---------ARLSAAQV-WSQCHSYgfdasawEIWGALLGGgRLVI 1700
Cdd:PRK10524 237 YILYTSGTTGKPKGV---QRDTggyaVALATSMDtifggkageTFFCASDIgWVVGHSY-------IVYAPLLAG-MATI 305
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1701 VPESVAASPNDfhGL---LVAEH-VSVLTQTPAAVAMLPTQG--------LESV-ALVVAGEAC--PAAlvdRW---APG 1762
Cdd:PRK10524 306 MYEGLPTRPDA--GIwwrIVEKYkVNRMFSAPTAIRVLKKQDpallrkhdLSSLrALFLAGEPLdePTA---SWiseALG 380
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1763 RVMLNAYGPTET-----TICAAISA-PLRPGSgmpPiGVPVSGAALFVLDSWL-RPVPAGVAGELYIAGA---GVGVGYW 1832
Cdd:PRK10524 381 VPVIDNYWQTETgwpilAIARGVEDrPTRLGS---P-GVPMYGYNVKLLNEVTgEPCGPNEKGVLVIEGPlppGCMQTVW 456
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1833 RraglTASRFVACPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDR 1912
Cdd:PRK10524 457 G----DDDRFVKTYWSLFGRQVYSTFDWGIRDADGYYFILGRTDDVINVAGHRLGTREIEESISSHPAVAEVAVVGVKDA 532
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1913 PGDKRLVGYATEIAPGAVDPAGLRAQL--------AQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPA 1973
Cdd:PRK10524 533 LKGQVAVAFVVPKDSDSLADREARLALekeimalvDSQLGAVARPARVWFVSALPKTRSGKLLRRAIQA 601
|
|
| LC_FACS_like |
cd17640 |
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA ... |
1519-1912 |
6.52e-14 |
|
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA synthetases, including an Arabidopsis gene At4g14070 that plays a role in activation and elongation of exogenous fatty acids. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341295 [Multi-domain] Cd Length: 468 Bit Score: 77.01 E-value: 6.52e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAylpidpanppprvafmlgDAVPVAAVTTAG 1598
Cdd:cd17640 7 TYKDLYQEILDFAAGLRSLGVKAGEKVALFADNSPRWLIADQGIMALGAV------------------DVVRGSDSSVEE 68
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1599 LRSRLAgHDLPIIDVVDAlaaypgtpppmpAAVNLAYILYTSGTTGEPKGVGITHRN----VTRLFASLPAR-----LSA 1669
Cdd:cd17640 69 LLYILN-HSESVALVVEN------------DSDDLATIIYTSGTTGNPKGVMLTHANllhqIRSLSDIVPPQpgdrfLSI 135
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1670 AQVWsqcHSYgfdASAWEIWGALLGGGRLV------------IVPESVAASPNDFHGLLVAEHVSVLTQTPA--AVAMLP 1735
Cdd:cd17640 136 LPIW---HSY---ERSAEYFIFACGCSQAYtsirtlkddlkrVKPHYIVSVPRLWESLYSGIQKQVSKSSPIkqFLFLFF 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1736 TQGLESVALVVAGEACPAAlVDRW--APGRVMLNAYGPTETTICAAISAPLRPGSGmpPIGVPVSGAALFVLDSWLR-PV 1812
Cdd:cd17640 210 LSGGIFKFGISGGGALPPH-VDTFfeAIGIEVLNGYGLTETSPVVSARRLKCNVRG--SVGRPLPGTEIKIVDPEGNvVL 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1813 PAGVAGELYIAGAGVGVGYWRRAGLTASrfvacPFGGSGarMYRTGDLVCWRADGQLEFLGRTDDQVKIR-GYRIELGEV 1891
Cdd:cd17640 287 PPGEKGIVWVRGPQVMKGYYKNPEATSK-----VLDSDG--WFNTGDLGWLTCGGELVLTGRAKDTIVLSnGENVEPQPI 359
|
410 420
....*....|....*....|.
gi 489495878 1892 ATALAELAGVGQAVVIAREDR 1912
Cdd:cd17640 360 EEALMRSPFIEQIMVVGQDQK 380
|
|
| PRK05857 |
PRK05857 |
fatty acid--CoA ligase; |
1491-1973 |
6.53e-14 |
|
fatty acid--CoA ligase;
Pssm-ID: 180293 [Multi-domain] Cd Length: 540 Bit Score: 77.36 E-value: 6.53e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1491 PVSIPQMLAAQVARIPEAEAV--CCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAA 1568
Cdd:PRK05857 13 PSTVLDRVFEQARQQPEAIALrrCDGTSALRYRELVAEVGGLAADLRAQSVSRGSRVLVISDNGPETYLSVLACAKLGAI 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1569 YLPIDPANPPPRVAFMLGDAVPVAAVTTAGLR---SRLAG--HDLPIIDVVDALAA----------YPGTPPPMPAAVNL 1633
Cdd:PRK05857 93 AVMADGNLPIAAIERFCQITDPAAALVAPGSKmasSAVPEalHSIPVIAVDIAAVTresehsldaaSLAGNADQGSEDPL 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1634 AYIlYTSGTTGEPKGVGITHRNvtrlFASLPARLSAAQV-W-------------SQCHSYGFdasaWEIWGALLGGGRLV 1699
Cdd:PRK05857 173 AMI-FTSGTTGEPKAVLLANRT----FFAVPDILQKEGLnWvtwvvgettysplPATHIGGL----WWILTCLMHGGLCV 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1700 IVPESVAAspndFHGLLVAEHVSVLTQTPAAVAMLPTQgLESVALVV--------AGEACPAALVdRW--APGRVMLNAY 1769
Cdd:PRK05857 244 TGGENTTS----LLEILTTNAVATTCLVPTLLSKLVSE-LKSANATVpslrlvgyGGSRAIAADV-RFieATGVRTAQVY 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1770 GPTETTiCAAISAPLRPGS---------GMPPIGV-----PVSGAALFVLDSwlrpVPAGVAGELYIAGAGVGVGYWRRA 1835
Cdd:PRK05857 318 GLSETG-CTALCLPTDDGSivkieagavGRPYPGVdvylaATDGIGPTAPGA----GPSASFGTLWIKSPANMLGYWNNP 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1836 GLTASRFVacpfggsgARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDrPGD 1915
Cdd:PRK05857 393 ERTAEVLI--------DGWVNTGDLLERREDGFFYIKGRSSEMIICGGVNIAPDEVDRIAEGVSGVREAACYEIPD-EEF 463
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 1916 KRLVGYATeIAPGAVDPAGLRAqLAQRLPGYL--------VPAAVVVIDALPLTVNGKLDHRALPA 1973
Cdd:PRK05857 464 GALVGLAV-VASAELDESAARA-LKHTIAARFrresepmaRPSTIVIVTDIPRTQSGKVMRASLAA 527
|
|
| ACS |
cd05966 |
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); ... |
1615-1979 |
7.58e-14 |
|
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); Acetyl-CoA synthetase (ACS, EC 6.2.1.1, acetate#CoA ligase or acetate:CoA ligase (AMP-forming)) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is widely present in all living organisms. The activity of this enzyme is crucial for maintaining the required levels of acetyl-CoA, a key intermediate in many important biosynthetic and catabolic processes. Acetyl-CoA is used in the biosynthesis of glucose, fatty acids, and cholesterol. It can also be used in the production of energy in the citric acid cycle. Eukaryotes typically have two isoforms of acetyl-CoA synthetase, a cytosolic form involved in biosynthetic processes and a mitochondrial form primarily involved in energy generation.
Pssm-ID: 341270 [Multi-domain] Cd Length: 608 Bit Score: 77.22 E-value: 7.58e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1615 DALAAYPGTPPPMP-AAVNLAYILYTSGTTGEPKGV-----------GITHRNV-----TRLFASlparlsAAQV-WSQC 1676
Cdd:cd05966 214 DLMAKQSPECEPEWmDSEDPLFILYTSGSTGKPKGVvhttggyllyaATTFKYVfdyhpDDIYWC------TADIgWITG 287
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1677 HSYGfdasaweIWGALLGGGRLVIVpESVAASPN-DFHGLLVAEH-VSVLTQTPAAVAMLPTQG--------LESVAL-- 1744
Cdd:cd05966 288 HSYI-------VYGPLANGATTVMF-EGTPTYPDpGRYWDIVEKHkVTIFYTAPTAIRALMKFGdewvkkhdLSSLRVlg 359
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1745 ----------------VVAGEACPaaLVDRWapgrvmlnayGPTET-TIC---AAISAPLRPGSGMPPI-GVPVSgaalf 1803
Cdd:cd05966 360 svgepinpeawmwyyeVIGKERCP--IVDTW----------WQTETgGIMitpLPGATPLKPGSATRPFfGIEPA----- 422
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1804 VLDSWLRPVPAGVAGELYIAGAGVGV-------------GYWRragltasrfvacPFGGsgarMYRTGDlVCWR-ADGQL 1869
Cdd:cd05966 423 ILDEEGNEVEGEVEGYLVIKRPWPGMartiygdheryedTYFS------------KFPG----YYFTGD-GARRdEDGYY 485
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1870 EFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYAT---EIAPGAVDPAGLRAQLAQRLPGY 1946
Cdd:cd05966 486 WITGRVDDVINVSGHRLGTAEVESALVAHPAVAEAAVVGRPHDIKGEAIYAFVTlkdGEEPSDELRKELRKHVRKEIGPI 565
|
410 420 430
....*....|....*....|....*....|....*...
gi 489495878 1947 LVPAAVVVIDALPLTVNGK-----LDHRALPAPEYGDT 1979
Cdd:cd05966 566 ATPDKIQFVPGLPKTRSGKimrriLRKIAAGEEELGDT 603
|
|
| PrpE |
cd05967 |
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or ... |
1635-1971 |
8.45e-14 |
|
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or propionate#CoA ligase (PrpE) catalyzes the first step of the 2-methylcitric acid cycle for propionate catabolism. It activates propionate to propionyl-CoA in a two-step reaction, which proceeds through a propionyl-AMP intermediate and requires ATP and Mg2+. In Salmonella enterica, the PrpE protein is required for growth of Salmonella enterica on propionate and can substitute for the acetyl-CoA synthetase (Acs) enzyme during growth on acetate. PrpE can also activate acetate, 3HP, and butyrate to their corresponding CoA-thioesters, although with less efficiency.
Pssm-ID: 341271 [Multi-domain] Cd Length: 617 Bit Score: 76.97 E-value: 8.45e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1635 YILYTSGTTGEPKGVgitHRNVtrlfaslpARLSAAQVWSQCHSYG-------FDAS--AWEI------WGALLGG---- 1695
Cdd:cd05967 234 YILYTSGTTGKPKGV---VRDN--------GGHAVALNWSMRNIYGikpgdvwWAASdvGWVVghsyivYGPLLHGattv 302
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1696 ---GRLVIVPEsvaasPNDFHGLlVAEH-VSVLTQTPAAVAML---PTQG-------LESV-ALVVAGEACPAALVDrWA 1760
Cdd:cd05967 303 lyeGKPVGTPD-----PGAFWRV-IEKYqVNALFTAPTAIRAIrkeDPDGkyikkydLSSLrTLFLAGERLDPPTLE-WA 375
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1761 P---GRVMLNAYGPTET-----TICAAI-SAPLRPGSGmppiGVPVSGAALFVLDSWLRPVPAGVAGELYIAGA---GVG 1828
Cdd:cd05967 376 EntlGVPVIDHWWQTETgwpitANPVGLePLPIKAGSP----GKPVPGYQVQVLDEDGEPVGPNELGNIVIKLPlppGCL 451
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1829 VGYWRRAGltasRFVACPFGGSGArMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIA 1908
Cdd:cd05967 452 LTLWKNDE----RFKKLYLSKFPG-YYDTGDAGYKDEDGYLFIMGRTDDVINVAGHRLSTGEMEESVLSHPAVAECAVVG 526
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 1909 REDRPGDKRLVGYATEIAPGAVDPA----GLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05967 527 VRDELKGQVPLGLVVLKEGVKITAEelekELVALVREQIGPVAAFRLVIFVKRLPKTRSGKILRRTL 593
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
567-853 |
8.98e-14 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 76.17 E-value: 8.98e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 567 DALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLtsdISVEEIFGGAAC----GARLV 642
Cdd:cd05941 84 EPSLVLDPALILYTSGTTGRPKGVVLTHANLAANVRALVDAWRWTEDDVLLHVLPL---HHVHGLVNALLCplfaGASVE 160
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 643 rsaaMKTGDLAALVD--DLVARETTIVDLPT------AVWQLLCADGDAIDAIGRSRLRQIVIGGEAIRCSAVDKWlesA 714
Cdd:cd05941 161 ----FLPKFDPKEVAisRLMPSITVFMGVPTiytrllQYYEAHFTDPQFARAAAAERLRLMVSGSAALPVPTLEEW---E 233
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 715 ASQGISLLSSYGPTEATV--------------VATFLPIVCDQTTMDGAllrlGRPILPNTVflafGEVVIVGDLVADGY 780
Cdd:cd05941 234 AITGHTLLERYGMTEIGMalsnpldgerrpgtVGMPLPGVQARIVDEET----GEPLPRGEV----GEIQVRGPSVFKEY 305
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 781 L--------GIDGDGFgtvtaadgsrrraFATGDRVTVDAEGFPVFSGR-KDAVVKISGKRVDIAEVTRRIAEDPAVSDV 851
Cdd:cd05941 306 WnkpeatkeEFTDDGW-------------FKTGDLGVVDEDGYYWILGRsSVDIIKSGGYKVSALEIERVLLAHPGVSEC 372
|
..
gi 489495878 852 AV 853
Cdd:cd05941 373 AV 374
|
|
| PRK13388 |
PRK13388 |
acyl-CoA synthetase; Provisional |
1594-1973 |
1.02e-13 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237374 [Multi-domain] Cd Length: 540 Bit Score: 76.60 E-value: 1.02e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1594 VTTAGLRSRLAGHDLPIIDVVDA-LAAYPG--------TPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLP 1664
Cdd:PRK13388 104 VTDAEHRPLLDGLDLPGVRVLDVdTPAYAElvaaagalTPHREVDAMDPFMLIFTSGTTGAPKAVRCSHGRLAFAGRALT 183
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1665 AR--LSAAQVWSQC----HSYGFDASaweiWGALLGGGRLVIVPESVAASpndfhGLL-------------VAEHVSVLT 1725
Cdd:PRK13388 184 ERfgLTRDDVCYVSmplfHSNAVMAG----WAPAVASGAAVALPAKFSAS-----GFLddvrrygatyfnyVGKPLAYIL 254
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1726 QTPAAvamlPTQGLESVALVVAGEACP---AALVDRWapGRVMLNAYGPTETticaAISAPLRPGSgmPP--IGVPVSGA 1800
Cdd:PRK13388 255 ATPER----PDDADNPLRVAFGNEASPrdiAEFSRRF--GCQVEDGYGSSEG----AVIVVREPGT--PPgsIGRGAPGV 322
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1801 ALFVLDSwLRPVPAGV-------------AGELY-IAGAGVGVGYWRRAGLTASRFVacpfGGsgarMYRTGDLVCWRAD 1866
Cdd:PRK13388 323 AIYNPET-LTECAVARfdahgallnadeaIGELVnTAGAGFFEGYYNNPEATAERMR----HG----MYWSGDLAYRDAD 393
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1867 GQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIARED-RPGDKrlVGYATEIAPGA-VDPAGLRAQL-AQR- 1942
Cdd:PRK13388 394 GWIYFAGRTADWMRVDGENLSAAPIERILLRHPAINRVAVYAVPDeRVGDQ--VMAALVLRDGAtFDPDAFAAFLaAQPd 471
|
410 420 430
....*....|....*....|....*....|.
gi 489495878 1943 LPGYLVPAAVVVIDALPLTVNGKLDHRALPA 1973
Cdd:PRK13388 472 LGTKAWPRYVRIAADLPSTATNKVLKRELIA 502
|
|
| FAA1 |
COG1022 |
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; |
557-853 |
2.00e-13 |
|
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism];
Pssm-ID: 440645 [Multi-domain] Cd Length: 603 Bit Score: 75.91 E-value: 2.00e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 557 VDERVTQVTHDALlATktayIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLtsdisveeifggAA 636
Cdd:COG1022 173 LEARRAAVKPDDL-AT----IIYTSGTTGRPKGVMLTHRNLLSNARALLERLPLGPGDRTLSFLPL------------AH 235
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 637 CGARLVRSAAMKTG-------DLAALVDDL-------------------------VARETTI--------VDL------- 669
Cdd:COG1022 236 VFERTVSYYALAAGatvafaeSPDTLAEDLrevkptfmlavprvwekvyagiqakAEEAGGLkrklfrwaLAVgrryara 315
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 670 ------PTAVWQLLCADGDAI------DAIGrSRLRQIVIGGEAIRcSAVDKWLESAasqGISLLSSYGPTEATVVATFl 737
Cdd:COG1022 316 rlagksPSLLLRLKHALADKLvfsklrEALG-GRLRFAVSGGAALG-PELARFFRAL---GIPVLEGYGLTETSPVITV- 389
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 738 pivcdqtTMDGALLR--LGRPILPNTVFLAF-GEVVIVGDLVADGYLG--------IDGDGFgtvtaadgsrrraFATGD 806
Cdd:COG1022 390 -------NRPGDNRIgtVGPPLPGVEVKIAEdGEILVRGPNVMKGYYKnpeataeaFDADGW-------------LHTGD 449
|
330 340 350 360
....*....|....*....|....*....|....*....|....*...
gi 489495878 807 RVTVDAEGFPVFSGRKDAVVKIS-GKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:COG1022 450 IGELDEDGFLRITGRKKDLIVTSgGKNVAPQPIENALKASPLIEQAVV 497
|
|
| ACS-like |
cd17634 |
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the ... |
568-853 |
4.28e-13 |
|
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases. The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341289 [Multi-domain] Cd Length: 587 Bit Score: 74.92 E-value: 4.28e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 568 ALLATKTAYIMPTSGTTGQPKLVRISHGSLAVF-CDAISRAYGWGAHDTVLqcapLTSDISVEE-----IFGGAACGARL 641
Cdd:cd17634 228 AMNAEDPLFILYTSGTTGKPKGVLHTTGGYLVYaATTMKYVFDYGPGDIYW----CTADVGWVTghsylLYGPLACGATT 303
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 642 VRSAAMKTGDLAALVDDLVARE--TTIVDLPTAVWQLLCADGDAIDAIGRSRLRQIVIGGEAI---------------RC 704
Cdd:cd17634 304 LLYEGVPNWPTPARMWQVVDKHgvNILYTAPTAIRALMAAGDDAIEGTDRSSLRILGSVGEPInpeayewywkkigkeKC 383
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 705 SAVDKWLESAASQG-ISLLSSYGPTEATvvATFLPIVCDQTTMdgaLLRLGRPILPNTVflafGEVVIvGDLVADGYLGI 783
Cdd:cd17634 384 PVVDTWWQTETGGFmITPLPGAIELKAG--SATRPVFGVQPAV---VDNEGHPQPGGTE----GNLVI-TDPWPGQTRTL 453
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 784 DGDGFGTVTAADGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd17634 454 FGDHERFEQTYFSTFKGMYFSGDGARRDEDGYYWITGRSDDVINVAGHRLGTAEIESVLVAHPKVAEAAV 523
|
|
| MACS_like |
cd05972 |
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of ... |
574-910 |
6.74e-13 |
|
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes.
Pssm-ID: 341276 [Multi-domain] Cd Length: 428 Bit Score: 73.53 E-value: 6.74e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFcdaISRAYGW---GAHDTVLQCAP------LTSDIsveeiFGGAACGARLVrs 644
Cdd:cd05972 83 PALIYFTSGTTGLPKGVLHTHSYPLGH---IPTAAYWlglRPDDIHWNIADpgwakgAWSSF-----FGPWLLGATVF-- 152
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 645 aaMKTGD--LAALVDDLVARE--TTIVDLPTAVWQLLCADGDAIDaigRSRLRQIVIGGEAIRCSAVDKWLESAasqGIS 720
Cdd:cd05972 153 --VYEGPrfDAERILELLERYgvTSFCGPPTAYRMLIKQDLSSYK---FSHLRLVVSAGEPLNPEVIEWWRAAT---GLP 224
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 721 LLSSYGPTEAT-VVATFLPIVCDQTTMdgallrlGRPILPNTVFL--AFGEVVIVGDlvaDGYLGIDGD------GFGTV 791
Cdd:cd05972 225 IRDGYGQTETGlTVGNFPDMPVKPGSM-------GRPTPGYDVAIidDDGRELPPGE---EGDIAIKLPppglflGYVGD 294
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 792 TAADGSRRRA--FATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHS----GSLGVWFK 865
Cdd:cd05972 295 PEKTEASIRGdyYLTGDRAYRDEDGYFWFVGRADDIIKSSGYRIGPFEVESALLEHPAVAEAAVVGSPdpvrGEVVKAFV 374
|
330 340 350 360
....*....|....*....|....*....|....*....|....*..
gi 489495878 866 SQRTREGEQDAAAATRIRLVLVSLG--VSSFFVVGVPNIPRKPNGKI 910
Cdd:cd05972 375 VLTSGYEPSEELAEELQGHVKKVLApyKYPREIEFVEELPKTISGKI 421
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
573-853 |
2.21e-12 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 71.61 E-value: 2.21e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 573 KTAYIMPTSGTTGQPKLVRISHGSlaVFCDAISRAYGWGAH--DTVLQCAPL--TSDISVeeIFGGA--ACGARLVRSAa 646
Cdd:cd05912 78 DIATIMYTSGTTGKPKGVQQTFGN--HWWSAIGSALNLGLTedDNWLCALPLfhISGLSI--LMRSViyGMTVYLVDKF- 152
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 647 mktgDLAALVDDLVARETTIVDL-PTAVWQLLCADGDAIDaigrSRLRQIVIGGEAIRCSAvdkwLESAASQGISLLSSY 725
Cdd:cd05912 153 ----DAEQVLHLINSGKVTIISVvPTMLQRLLEILGEGYP----NNLRCILLGGGPAPKPL----LEQCKEKGIPVYQSY 220
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 726 GPTE-ATVVATFLPivcdqttmDGALLRL---GRPILPNTVFLA--------FGEVVIVGDLVADGYLGiDGDGFGTVTA 793
Cdd:cd05912 221 GMTEtCSQIVTLSP--------EDALNKIgsaGKPLFPVELKIEddgqppyeVGEILLKGPNVTKGYLN-RPDATEESFE 291
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 794 ADgsrrrAFATGDRVTVDAEGFP-VFSGRKDAVvkIS-GKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd05912 292 NG-----WFKTGDIGYLDEEGFLyVLDRRSDLI--ISgGENIYPAEIEEVLLSHPAIKEAGV 346
|
|
| PRK07768 |
PRK07768 |
long-chain-fatty-acid--CoA ligase; Validated |
539-910 |
2.57e-12 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236091 [Multi-domain] Cd Length: 545 Bit Score: 72.34 E-value: 2.57e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 539 DVAATQLAVVGH-----DELRKVVDERVTQVTHDALlatktAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGA- 612
Cdd:PRK07768 119 LAAAPVLEEKGIrvltvADLLAADPIDPVETGEDDL-----ALMQLTSGSTGSPKAVQITHGNLYANAEAMFVAAEFDVe 193
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 613 HDTVLQCAPLTSDIS-VEEIFGGAACGARLVRSAAMKTGDLAALVDDLVAR-ETTIVDLPTAVWQLLC------ADGDAI 684
Cdd:PRK07768 194 TDVMVSWLPLFHDMGmVGFLTVPMYFGAELVKVTPMDFLRDPLLWAELISKyRGTMTAAPNFAYALLArrlrrqAKPGAF 273
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 685 DAigrSRLRQIVIGGEAIRCSAVDKWLESAASQGI---SLLSSYGPTEATVVATFLPIVCDQT--TMDGALL-------- 751
Cdd:PRK07768 274 DL---SSLRFALNGAEPIDPADVEDLLDAGARFGLrpeAILPAYGMAEATLAVSFSPCGAGLVvdEVDADLLaalrravp 350
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 752 ----------RLGRPILPNTVFL-----------AFGEVVIVGDLVADGYLgiDGDGFGTVTAADGsrrrAFATGDRVTV 810
Cdd:PRK07768 351 atkgntrrlaTLGPPLPGLEVRVvdedgqvlpprGVGVIELRGESVTPGYL--TMDGFIPAQDADG----WLDTGDLGYL 424
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 811 DAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAV---SDVAVELHSGSLGVWFKSQRTREGEQDAAAATRIRL--- 884
Cdd:PRK07768 425 TEEGEVVVCGRVKDVIIMAGRNIYPTDIERAAARVEGVrpgNAVAVRLDAGHSREGFAVAVESNAFEDPAEVRRIRHqva 504
|
410 420 430
....*....|....*....|....*....|
gi 489495878 885 --VLVSLGVSSFFVVGVP--NIPRKPNGKI 910
Cdd:PRK07768 505 heVVAEVGVRPRNVVVLGpgSIPKTPSGKL 534
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
574-853 |
3.26e-12 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 71.76 E-value: 3.26e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLtsdisveeiFGGAACGARLVRSAAMKTGDLA 653
Cdd:PRK06187 169 AAAMLYTSGTTGHPKGVVLSHRNLFLHSLAVCAWLKLSRDDVYLVIVPM---------FHVHAWGLPYLALMAGAKQVIP 239
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 654 ALVD-----DLVARE--TTIVDLPTaVWQLLcadGDAIDAIGR--SRLRQIVIGGEAIRCSAVDKWLESAasqGISLLSS 724
Cdd:PRK06187 240 RRFDpenllDLIETErvTFFFAVPT-IWQML---LKAPRAYFVdfSSLRLVIYGGAALPPALLREFKEKF---GIDLVQG 312
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 725 YGPTEATVVATFLPIVcDQTTMDGALLRL-GRPIL--------PNTVFL-----AFGEVVIVGDLVADGYLGIDGDGfgt 790
Cdd:PRK06187 313 YGMTETSPVVSVLPPE-DQLPGQWTKRRSaGRPLPgvearivdDDGDELppdggEVGEIIVRGPWLMQGYWNRPEAT--- 388
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 791 vtaadgsrRRAFA-----TGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK06187 389 --------AETIDggwlhTGDVGYIDEDGYLYITDRIKDVIISGGENIYPRELEDALYGHPAVAEVAV 448
|
|
| caiC |
PRK08008 |
putative crotonobetaine/carnitine-CoA ligase; Validated |
1512-1971 |
3.79e-12 |
|
putative crotonobetaine/carnitine-CoA ligase; Validated
Pssm-ID: 181195 [Multi-domain] Cd Length: 517 Bit Score: 71.64 E-value: 3.79e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1512 CCGDAS-MTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVP 1590
Cdd:PRK08008 31 SGGVVRrYSYLELNEEINRTANLFYSLGIRKGDKVALHLDNCPEFIFCWFGLAKIGAIMVPINARLLREESAWILQNSQA 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1591 VAAVTTAG---------------LRSRL-----AGHDLPIIDVVDALAAYPGT---PPPMpAAVNLAYILYTSGTTGEPK 1647
Cdd:PRK08008 111 SLLVTSAQfypmyrqiqqedatpLRHICltrvaLPADDGVSSFTQLKAQQPATlcyAPPL-STDDTAEILFTSGTTSRPK 189
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1648 GVGITHRNVtrLFA----SLPARLSAAQVWSQCH-SYGFDASAWEIWGALLGGGRLVIVpESVAASPndFHGlLVAEHVS 1722
Cdd:PRK08008 190 GVVITHYNL--RFAgyysAWQCALRDDDVYLTVMpAFHIDCQCTAAMAAFSAGATFVLL-EKYSARA--FWG-QVCKYRA 263
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1723 VLTQtpAAVAMLPTQGLESVA--------------LVVAgEACPAALVDRWapGRVMLNAYGPTEtTICAAISAplRPGS 1788
Cdd:PRK08008 264 TITE--CIPMMIRTLMVQPPSandrqhclrevmfyLNLS-DQEKDAFEERF--GVRLLTSYGMTE-TIVGIIGD--RPGD 335
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1789 G--MPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAG-AGVGV--GYWRRAGLTASRFVAcpfGGsgarMYRTGDLVCW 1863
Cdd:PRK08008 336 KrrWPSIGRPGFCYEAEIRDDHNRPLPAGEIGEICIKGvPGKTIfkEYYLDPKATAKVLEA---DG----WLHTGDTGYV 408
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1864 RADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATeIAPGA-VDPAGLRAQLAQR 1942
Cdd:PRK08008 409 DEEGFFYFVDRRCNMIKRGGENVSCVELENIIATHPKIQDIVVVGIKDSIRDEAIKAFVV-LNEGEtLSEEEFFAFCEQN 487
|
490 500
....*....|....*....|....*....
gi 489495878 1943 LPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK08008 488 MAKFKVPSYLEIRKDLPRNCSGKIIKKNL 516
|
|
| LC_FACS_euk1 |
cd17639 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The ... |
1633-1956 |
5.87e-12 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The members of this family are eukaryotic fatty acid CoA synthetases (EC 6.2.1.3) that activate fatty acids with chain lengths of 12 to 20 and includes fungal proteins. They act on a wide range of long-chain saturated and unsaturated fatty acids, but the enzymes from different tissues show some variation in specificity. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. In Schizosaccharomyces pombe, lcf1 gene encodes a new fatty acyl-CoA synthetase that preferentially recognizes myristic acid as a substrate.
Pssm-ID: 341294 [Multi-domain] Cd Length: 507 Bit Score: 70.71 E-value: 5.87e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1633 LAYILYTSGTTGEPKGVGITHRNVT------------------RLFASLParlsaaqvwsQCHSYGFDAsawEI----WG 1690
Cdd:cd17639 90 LACIMYTSGSTGNPKGVMLTHGNLVagiaglgdrvpellgpddRYLAYLP----------LAHIFELAA---ENvclyRG 156
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1691 ALLGGGR-LVIVPESVAASpndfHGLLVAEHVSVLTQTPA-------AV-AMLPTQGLES-----------VALVVAGEA 1750
Cdd:cd17639 157 GTIGYGSpRTLTDKSKRGC----KGDLTEFKPTLMVGVPAiwdtirkGVlAKLNPMGGLKrtlfwtayqskLKALKEGPG 232
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1751 CPA------ALVDRWAPGRV------------------------MLNAYGPTETTICAAISAP--LRPGSgmppIGVPVS 1798
Cdd:cd17639 233 TPLldelvfKKVRAALGGRLrymlsggaplsadtqeflnivlcpVIQGYGLTETCAGGTVQDPgdLETGR----VGPPLP 308
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1799 GAALFVLD------SWLRPVPAGvagELYIAGAGVGVGYWRRAGLTASRFvacpfggSGARMYRTGDLVCWRADGQLEFL 1872
Cdd:cd17639 309 CCEIKLVDweeggySTDKPPPRG---EILIRGPNVFKGYYKNPEKTKEAF-------DGDGWFHTGDIGEFHPDGTLKII 378
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1873 GRTDDQVKIR-GYRIELGEVATALAELAGVGQAVVIAREDR--------PGDKRLVGYATE-IAPGAVDPAGL------- 1935
Cdd:cd17639 379 DRKKDLVKLQnGEYIALEKLESIYRSNPLVNNICVYADPDKsypvaivvPNEKHLTKLAEKhGVINSEWEELCedkklqk 458
|
410 420
....*....|....*....|....*...
gi 489495878 1936 -------RAQLAQRLPGYLVPAAVVVID 1956
Cdd:cd17639 459 avlkslaETARAAGLEKFEIPQGVVLLD 486
|
|
| PRK08180 |
PRK08180 |
feruloyl-CoA synthase; Reviewed |
1485-1943 |
7.08e-12 |
|
feruloyl-CoA synthase; Reviewed
Pssm-ID: 236175 [Multi-domain] Cd Length: 614 Bit Score: 71.06 E-value: 7.08e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1485 TAPAPTPVSIPQMLAAQVARIPEAEAVCCGDAS-----MTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAM 1559
Cdd:PRK08180 32 EPLGDYPRRLTDRLVHWAQEAPDRVFLAERGADggwrrLTYAEALERVRAIAQALLDRGLSAERPLMILSGNSIEHALLA 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1560 VAVLKTGAAYLPIDPAN-----PPPRVAFMLG-------------------DAVPVAAVTTAGLRSRLAGHD-LPIidvv 1614
Cdd:PRK08180 112 LAAMYAGVPYAPVSPAYslvsqDFGKLRHVLElltpglvfaddgaafaralAAVVPADVEVVAVRGAVPGRAaTPF---- 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1615 DALAAYPGTPPPMPA--AVN---LAYILYTSGTTGEPKGVGITHR----NVTRLFASLPARLSAAQV------WSqcHSY 1679
Cdd:PRK08180 188 AALLATPPTAAVDAAhaAVGpdtIAKFLFTSGSTGLPKAVINTHRmlcaNQQMLAQTFPFLAEEPPVlvdwlpWN--HTF 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1680 GfdASAweIWG-ALLGGGRLVI-----VPESVAASPNDFHGLLVAEHVSVltqtPAAVAMLpTQGLES------------ 1741
Cdd:PRK08180 266 G--GNH--NLGiVLYNGGTLYIddgkpTPGGFDETLRNLREISPTVYFNV----PKGWEML-VPALERdaalrrrffsrl 336
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1742 VALVVAGEACPAALVDRW------APGR--VMLNAYGPTETTICAAISAPLRPGSGMppIGVPVSGAALfvldswlRPVP 1813
Cdd:PRK08180 337 KLLFYAGAALSQDVWDRLdrvaeaTCGEriRMMTGLGMTETAPSATFTTGPLSRAGN--IGLPAPGCEV-------KLVP 407
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1814 AGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCWrADGQ-----LEFLGRTDDQVKI-RGYRIE 1887
Cdd:PRK08180 408 VGGKLEVRVKGPNVTPGYWRAPELTAEAFDEEGY-------YRSGDAVRF-VDPAdpergLMFDGRIAEDFKLsSGTWVS 479
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1888 LGEV-ATALAELAGVGQAVVIAREDR-----------PGDKRLVGYATEIAPGAV-DPAGLRAQLAQRL 1943
Cdd:PRK08180 480 VGPLrARAVSAGAPLVQDVVITGHDRdeigllvfpnlDACRRLAGLLADASLAEVlAHPAVRAAFRERL 548
|
|
| PRK06018 |
PRK06018 |
putative acyl-CoA synthetase; Provisional |
580-853 |
8.36e-12 |
|
putative acyl-CoA synthetase; Provisional
Pssm-ID: 235673 [Multi-domain] Cd Length: 542 Bit Score: 70.55 E-value: 8.36e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 580 TSGTTGQPKLVRISHGS--LAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGdlaALVD 657
Cdd:PRK06018 185 TSGTTGDPKGVLYSHRSnvLHALMANNGDALGTSAADTMLPVVPLFHANSWGIAFSAPSMGTKLVMPGAKLDG---ASVY 261
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 658 DLVARE--TTIVDLPTaVWQLLCADGDAIDAiGRSRLRQIVIGGEAIRCSAVDKWLEsaasQGISLLSSYGPTEATVVAT 735
Cdd:PRK06018 262 ELLDTEkvTFTAGVPT-VWLMLLQYMEKEGL-KLPHLKMVVCGGSAMPRSMIKAFED----MGVEVRHAWGMTEMSPLGT 335
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 736 F--LPIVCDQTTMDGAL---LRLGRPilPNTVFL---------------AFGEVVIVGDLVADGYLGIDGDgfgtVTAAD 795
Cdd:PRK06018 336 LaaLKPPFSKLPGDARLdvlQKQGYP--PFGVEMkitddagkelpwdgkTFGRLKVRGPAVAAAYYRVDGE----ILDDD 409
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 796 GsrrrAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK06018 410 G----FFDTGDVATIDAYGYMRITDRSKDVIKSGGEWISSIDLENLAVGHPKVAEAAV 463
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
575-853 |
8.56e-12 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 69.82 E-value: 8.56e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLtsdISVEEIFG----GAACGARLVRSAAMKTG 650
Cdd:cd05935 87 ALIPYTSGTTGLPKGCMHTHFSAAANALQSAVWTGLTPSDVILACLPL---FHVTGFVGslntAVYVGGTYVLMARWDRE 163
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 651 DLAALVDDLvaRETTIVDLPTAVWQLLCADGdaIDAIGRSRLRQIVIGGEAIRCSAVDKWLESAasqGISLLSSYGPTEA 730
Cdd:cd05935 164 TALELIEKY--KVTFWTNIPTMLVDLLATPE--FKTRDLSSLKVLTGGGAPMPPAVAEKLLKLT---GLRFVEGYGLTET 236
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 731 TVVATFLP-----IVCDQTTMDGALLRL-----GRPILPNTVflafGEVVIVGDLVADGYLGIDGDGFGTVTAADGsrRR 800
Cdd:cd05935 237 MSQTHTNPplrpkLQCLGIP*FGVDARVidietGRELPPNEV----GEIVVRGPQIFKGYWNRPEETEESFIEIKG--RR 310
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|...
gi 489495878 801 AFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd05935 311 FFRTGDLGYMDEEGYFFFVDRVKRMINVSGFKVWPAEVEAKLYKHPAI*EVCV 363
|
|
| FACL_like_1 |
cd05910 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1516-1874 |
9.40e-12 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341236 [Multi-domain] Cd Length: 457 Bit Score: 70.18 E-value: 9.40e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1516 ASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVT 1595
Cdd:cd05910 1 SRLSFRELDERSDRIAQGLTAYGIRRGMRAVLMVPPGPDFFALTFALFKAGAVPVLIDPGMGRKNLKQCLQEAEPDAFIG 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1596 taglrsrlaghdlpiidvvdalaaypgtpppMPAAVNLAYILYTSGTTGEPKGVGITHRNVtrlfaslparlsAAQVWSQ 1675
Cdd:cd05910 81 -------------------------------IPKADEPAAILFTSGSTGTPKGVVYRHGTF------------AAQIDAL 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1676 CHSYGFDASAWEIWG----ALLGG--GRLVIVPE-----SVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQG------ 1738
Cdd:cd05910 118 RQLYGIRPGEVDLATfplfALFGPalGLTSVIPDmdptrPARADPQKLVGAIRQYGVSIVFGSPALLERVARYCaqhgit 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1739 LESVALVV-AGEACPAALVDRW----APGRVMLNAYGPTETTICAAI-SAPLRPGSGMPP-------IGVPVSGAALFVL 1805
Cdd:cd05910 198 LPSLRRVLsAGAPVPIALAARLrkmlSDEAEILTPYGATEALPVSSIgSRELLATTTAATsggagtcVGRPIPGVRVRII 277
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1806 D-------SW--LRPVPAGVAGELYIAGAGVGVGYWRRAglTASRFVACPFGGSGARmYRTGDLVCWRADGQLEFLGR 1874
Cdd:cd05910 278 EiddepiaEWddTLELPRGEIGEITVTGPTVTPTYVNRP--VATALAKIDDNSEGFW-HRMGDLGYLDDEGRLWFCGR 352
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
551-853 |
1.04e-11 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 69.63 E-value: 1.04e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 551 DELRKVVDERVTQvthdaLLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLT-SDISVE 629
Cdd:cd05934 65 DELAYIIDHSGAQ-----LVVVDPASILYTSGTTGPPKGVVITHANLTFAGYYSARRFGLGEDDVYLTVLPLFhINAQAV 139
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 630 EIFGGAACGARLVRSAAMKTGDLAALVDDLVARETTIVDLPTAVwqLLCADGDAIDAIGRSRlrqiviggeAIRCSAVDK 709
Cdd:cd05934 140 SVLAALSVGATLVLLPRFSASRFWSDVRRYGATVTNYLGAMLSY--LLAQPPSPDDRAHRLR---------AAYGAPNPP 208
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 710 WLESAASQ--GISLLSSYGPTEaTVVATFLPIvcDQTTMDGALlrlGRPilpntvflAFG-EVVIVGD---LVADGYLG- 782
Cdd:cd05934 209 ELHEEFEErfGVRLLEGYGMTE-TIVGVIGPR--DEPRRPGSI---GRP--------APGyEVRIVDDdgqELPAGEPGe 274
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 783 -----IDGDGFGT----VTAADGSRRRA--FATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDV 851
Cdd:cd05934 275 lvirgLRGWGFFKgyynMPEATAEAMRNgwFHTGDLGYRDADGFFYFVDRKKDMIRRRGENISSAEVERAILRHPAVREA 354
|
..
gi 489495878 852 AV 853
Cdd:cd05934 355 AV 356
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
1984-2055 |
1.53e-11 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 62.18 E-value: 1.53e-11
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 489495878 1984 APAGPVEKTVAGIFARVLGL--ERVGVDDSFF-ELGGDSLAAMRVIAAINTTLNADLPVRALLHASSTRGLSQLL 2055
Cdd:COG0236 1 MPREELEERLAEIIAEVLGVdpEEITPDDSFFeDLGLDSLDAVELIAALEEEFGIELPDTELFEYPTVADLADYL 75
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
1991-2047 |
1.83e-11 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 61.43 E-value: 1.83e-11
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1991 KTVAGIFARVLGL--ERVGVDDSFFELGGDSLAAMRVIAAINTTLNADLPVRALLHASS 2047
Cdd:pfam00550 1 ERLRELLAEVLGVpaEEIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPT 59
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
1632-1967 |
2.30e-11 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 67.43 E-value: 2.30e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1632 NLAYILYTSGTTGEPKGVGITHR--------NVTRLFASLPARLSAAQVWSQCHS-YGfdasaweIWGALLGGGRLVIvp 1702
Cdd:cd17633 1 NPFYIGFTSGTTGLPKAYYRSERswiesfvcNEDLFNISGEDAILAPGPLSHSLFlYG-------AISALYLGGTFIG-- 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1703 eSVAASPNDFHGLLVAEHVSVLTQTPAAV-AMLPTQGLES--VALVVAGEACPAAL---VDRWAPGRVMLNAYGPTETTI 1776
Cdd:cd17633 72 -QRKFNPKSWIRKINQYNATVIYLVPTMLqALARTLEPESkiKSIFSSGQKLFESTkkkLKNIFPKANLIEFYGTSELSF 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1777 CAAISaplrPGSGMPP--IGVPVSGaalfvLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFvacpfggsgarm 1854
Cdd:cd17633 151 ITYNF----NQESRPPnsVGRPFPN-----VEIEIRNADGGEIGKIFVKSEMVFSGYVRGGFSNPDGW------------ 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1855 YRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVgyATEIAPGAVDPAg 1934
Cdd:cd17633 210 MSVGDIGYVDEEGYLYLVGRESDMIIIGGINIFPTEIESVLKAIPGIEEAIVVGIPDARFGEIAV--ALYSGDKLTYKQ- 286
|
330 340 350
....*....|....*....|....*....|...
gi 489495878 1935 LRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLD 1967
Cdd:cd17633 287 LKRFLKQKLSRYEIPKKIIFVDSLPYTSSGKIA 319
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
575-853 |
2.48e-11 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 68.88 E-value: 2.48e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLtsdISVEEIFGGA----ACGARLVRSAAMKTG 650
Cdd:cd05926 152 ALILHTSGTTGRPKGVPLTHRNLAASATNITNTYKLTPDDRTLVVMPL---FHVHGLVASLlstlAAGGSVVLPPRFSAS 228
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 651 DLAALVDDLVARETTIVdlPTaVWQLLCADGDAIDAIGRSRLRqiviggeAIR-CSA---VDKWLESAASQGISLLSSYG 726
Cdd:cd05926 229 TFWPDVRDYNATWYTAV--PT-IHQILLNRPEPNPESPPPKLR-------FIRsCSAslpPAVLEALEATFGAPVLEAYG 298
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 727 PTEAT--VVATFLPIVCDQTTMDG--------ALLRLGRPILPNTVflafGEVVIVGDLVADGYLGIDgdgfgTVTAADG 796
Cdd:cd05926 299 MTEAAhqMTSNPLPPGPRKPGSVGkpvgvevrILDEDGEILPPGVV----GEICLRGPNVTRGYLNNP-----EANAEAA 369
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 797 SRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd05926 370 FKDGWFRTGDLGYLDADGYLFLTGRIKELINRGGEKISPLEVDGVLLSHPAVLEAVA 426
|
|
| PRK09029 |
PRK09029 |
O-succinylbenzoic acid--CoA ligase; Provisional |
1506-1913 |
2.77e-11 |
|
O-succinylbenzoic acid--CoA ligase; Provisional
Pssm-ID: 236363 [Multi-domain] Cd Length: 458 Bit Score: 68.36 E-value: 2.77e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML 1585
Cdd:PRK09029 17 PQAIALRLNDEVLTWQQLCARIDQLAAGFAQQGVVEGSGVALRGKNSPETLLAYLALLQCGARVLPLNPQLPQPLLEELL 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1586 gdavpvaavTTAGLRSRLAGHDLPIIDVVDAL--AAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRN-------V 1656
Cdd:PRK09029 97 ---------PSLTLDFALVLEGENTFSALTSLhlQLVEGAHAVAWQPQRLATMTLTSGSTGLPKAAVHTAQAhlasaegV 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1657 TRLFA---------SLPArlsaaqvwsqchsygFDASAWEI-WGALLGGGRLViVPESvaaspNDF-HGLLVAEHVS-VL 1724
Cdd:PRK09029 168 LSLMPftaqdswllSLPL---------------FHVSGQGIvWRWLYAGATLV-VRDK-----QPLeQALAGCTHASlVP 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1725 TQtpaaVAMLPTQGLESVAL---VVAGEACPAALVDR--------WApgrvmlnAYGPTE--TTICAaisaplRPGSGMP 1791
Cdd:PRK09029 227 TQ----LWRLLDNRSEPLSLkavLLGGAAIPVELTEQaeqqgircWC-------GYGLTEmaSTVCA------KRADGLA 289
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1792 PIGVPVSGAALFVldswlrpvpagVAGELYIAGAGVGVGYWRRAGLTasrfvacPF-GGSGarMYRTGDLVCWRaDGQLE 1870
Cdd:PRK09029 290 GVGSPLPGREVKL-----------VDGEIWLRGASLALGYWRQGQLV-------PLvNDEG--WFATRDRGEWQ-NGELT 348
|
410 420 430 440
....*....|....*....|....*....|....*....|....*...
gi 489495878 1871 FLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIARED-----RP 1913
Cdd:PRK09029 349 ILGRLDNLFFSGGEGIQPEEIERVINQHPLVQQVFVVPVADaefgqRP 396
|
|
| PLN02479 |
PLN02479 |
acetate-CoA ligase |
1638-1992 |
3.74e-11 |
|
acetate-CoA ligase
Pssm-ID: 178097 [Multi-domain] Cd Length: 567 Bit Score: 68.33 E-value: 3.74e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1638 YTSGTTGEPKGVGITHRNvtrlfASLPArLSAAQVWS--------------QCHSYGFdasAWEIwGALLGGG---RLVI 1700
Cdd:PLN02479 202 YTSGTTASPKGVVLHHRG-----AYLMA-LSNALIWGmnegavylwtlpmfHCNGWCF---TWTL-AALCGTNiclRQVT 271
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1701 VPESVAASPNDFHGLLVAEHV--SVLTQTPAAVAMLPTQglESVALVVAGEACPAALVDRWAP-GRVMLNAYGPTET--- 1774
Cdd:PLN02479 272 AKAIYSAIANYGVTHFCAAPVvlNTIVNAPKSETILPLP--RVVHVMTAGAAPPPSVLFAMSEkGFRVTHTYGLSETygp 349
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1775 -TICA----------AISAPLRPGSGMPPIGVpvsgAALFVLDS-WLRPVPA--GVAGELYIAGAGVGVGYWRRAGLTAS 1840
Cdd:PLN02479 350 sTVCAwkpewdslppEEQARLNARQGVRYIGL----EGLDVVDTkTMKPVPAdgKTMGEIVMRGNMVMKGYLKNPKANEE 425
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1841 RFVacpfGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVG 1920
Cdd:PLN02479 426 AFA----NG----WFHSGDLGVKHPDGYIEIKDRSKDIIISGGENISSLEVENVVYTHPAVLEASVVARPDERWGESPCA 497
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1921 YATeIAPGA--VDPAGLRAQLAQ----RLPGYLVPAAvVVIDALPLTVNGKLDHRALpapeygdtngyRAPA---GPVEK 1991
Cdd:PLN02479 498 FVT-LKPGVdkSDEAALAEDIMKfcreRLPAYWVPKS-VVFGPLPKTATGKIQKHVL-----------RAKAkemGPVKK 564
|
.
gi 489495878 1992 T 1992
Cdd:PLN02479 565 S 565
|
|
| MACS_euk |
cd05928 |
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step ... |
1636-1976 |
5.33e-11 |
|
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes. MACS enzymes are localized to mitochondria. Two murine MACS family proteins are found in liver and kidney. In rodents, a MACS member is detected particularly in the olfactory epithelium and is called O-MACS. O-MACS demonstrates substrate preference for the fatty acid lengths of C6-C12.
Pssm-ID: 341251 [Multi-domain] Cd Length: 530 Bit Score: 67.88 E-value: 5.33e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1636 ILYTSGTTGEPKGVGITHRNVTrLFASLPAR----LSAAQVWSQCHSYGFDASAW----EIWGAllggGRLVIVPESVAA 1707
Cdd:cd05928 179 IYFTSGTTGSPKMAEHSHSSLG-LGLKVNGRywldLTASDIMWNTSDTGWIKSAWsslfEPWIQ----GACVFVHHLPRF 253
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1708 SPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVAL------VVAGEACPAALVDRWA--PGRVMLNAYGPTETT-ICA 1778
Cdd:cd05928 254 DPLVILKTLSSYPITTFCGAPTVYRMLVQQDLSSYKFpslqhcVTGGEPLNPEVLEKWKaqTGLDIYEGYGQTETGlICA 333
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1779 AISA-PLRPGSgmppIGVPVSGAALFVLDSWLRPVPAGVAGELyiagaGVGVGYWRRAGLTaSRFVACPFGGSGAR---M 1854
Cdd:cd05928 334 NFKGmKIKPGS----MGKASPPYDVQIIDDNGNVLPPGTEGDI-----GIRVKPIRPFGLF-SGYVDNPEKTAATIrgdF 403
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1855 YRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDrPGDKRLVGYATEIAPG--AVDP 1932
Cdd:cd05928 404 YLTGDRGIMDEDGYFWFMGRADDVINSSGYRIGPFEVESALIEHPAVVESAVVSSPD-PIRGEVVKAFVVLAPQflSHDP 482
|
330 340 350 360
....*....|....*....|....*....|....*....|....*...
gi 489495878 1933 AGLRAQLAQRLPG----YLVPAAVVVIDALPLTVNGKLDHRALPAPEY 1976
Cdd:cd05928 483 EQLTKELQQHVKSvtapYKYPRKVEFVQELPKTVTGKIQRNELRDKEW 530
|
|
| PRK07008 |
PRK07008 |
long-chain-fatty-acid--CoA ligase; Validated |
1519-1966 |
7.24e-11 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235908 [Multi-domain] Cd Length: 539 Bit Score: 67.42 E-value: 7.24e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDA---------- 1588
Cdd:PRK07008 41 TYRDCERRAKQLAQALAALGVEPGDRVGTLAWNGYRHLEAYYGVSGSGAVCHTINPRLFPEQIAYIVNHAedryvlfdlt 120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1589 -VPVAAVTTAGL-----------RSRLAGHDLPIIDVVDALAAYPGTPPPMPAAVNLA-YILYTSGTTGEPKGVGITHRN 1655
Cdd:PRK07008 121 fLPLVDALAPQCpnvkgwvamtdAAHLPAGSTPLLCYETLVGAQDGDYDWPRFDENQAsSLCYTSGTTGNPKGALYSHRS 200
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1656 vTRLFA---SLP------ARLSAAQVWSQCHsygfdASAWEI-WGALLGGGRLVIV-PESVAASpndFHGLLVAEHVSVL 1724
Cdd:PRK07008 201 -TVLHAygaALPdamglsARDAVLPVVPMFH-----VNAWGLpYSAPLTGAKLVLPgPDLDGKS---LYELIEAERVTFS 271
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1725 TQTPAAVAMLPTQ----GLESVAL---VVAGEACPAALVDRW--APGRVMLNAYGPTETTICAAISAPLRPGSGMPP--- 1792
Cdd:PRK07008 272 AGVPTVWLGLLNHmreaGLRFSTLrrtVIGGSACPPAMIRTFedEYGVEVIHAWGMTEMSPLGTLCKLKWKHSQLPLdeq 351
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1793 ------IGVPVSGAALFVLDSWLRPVP-AGVA-GELYIAGAGVGVGYWRRaglTASRFVACPFggsgarmyRTGDLVCWR 1864
Cdd:PRK07008 352 rkllekQGRVIYGVDMKIVGDDGRELPwDGKAfGDLQVRGPWVIDRYFRG---DASPLVDGWF--------PTGDVATID 420
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1865 ADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVgYATEIAPGA-VDPAGLRAQLAQRL 1943
Cdd:PRK07008 421 ADGFMQITDRSKDVIKSGGEWISSIDIENVAVAHPAVAEAACIACAHPKWDERPL-LVVVKRPGAeVTREELLAFYEGKV 499
|
490 500
....*....|....*....|...
gi 489495878 1944 PGYLVPAAVVVIDALPLTVNGKL 1966
Cdd:PRK07008 500 AKWWIPDDVVFVDAIPHTATGKL 522
|
|
| FATP_chFAT1_like |
cd05937 |
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA ... |
1519-1965 |
7.77e-11 |
|
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA synthetase in fungi; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis. Members of this family are fungal FATPs, including FAT1 from Cochliobolus heterostrophus.
Pssm-ID: 341260 [Multi-domain] Cd Length: 468 Bit Score: 67.07 E-value: 7.77e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGC-GAGPGECVALLFERCAPAVVAMVAVLKTGAAylpidpanpPPRVAFMLGDAVPVAAVTTA 1597
Cdd:cd05937 7 TYSETYDLVLRYAHWLHDDlGVQAGDFVAIDLTNSPEFVFLWLGLWSIGAA---------PAFINYNLSGDPLIHCLKLS 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1598 GLRsrlaghdLPIIDVVDalaaypgtpppmpaavnLAYILYTSGTTGEPKGVGITHRN--VTRLFASLPARLSAAQVWSQ 1675
Cdd:cd05937 78 GSR-------FVIVDPDD-----------------PAILIYTSGTTGLPKAAAISWRRtlVTSNLLSHDLNLKNGDRTYT 133
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1676 C----HSYGFDASAWEIwgaLLGGGRLVIV---------PESVAASPNDFhgLLVAEHVSVLTQTPAAvamlPTQGLESV 1742
Cdd:cd05937 134 CmplyHGTAAFLGACNC---LMSGGTLALSrkfsasqfwKDVRDSGATII--QYVGELCRYLLSTPPS----PYDRDHKV 204
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1743 ALVVAGEACPaalvDRWAPGRVMLNA------YGPTEtticaAISAPLRPGSGMPPIG-VPVSGAAL-------FVL--- 1805
Cdd:cd05937 205 RVAWGNGLRP----DIWERFRERFNVpeigefYAATE-----GVFALTNHNVGDFGAGaIGHHGLIRrwkfenqVVLvkm 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1806 -----DSWLRP-------VPAGVAGELYIA----GAGVGVGYWRRAGLTASRFVACPFGgSGARMYRTGDLVCWRADGQL 1869
Cdd:cd05937 276 dpetdDPIRDPktgfcvrAPVGEPGEMLGRvpfkNREAFQGYLHNEDATESKLVRDVFR-KGDIYFRTGDLLRQDADGRW 354
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1870 EFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIA-----REDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLP 1944
Cdd:cd05937 355 YFLDRLGDTFRWKSENVSTTEVADVLGAHPDIAEANVYGvkvpgHDGRAGCAAITLEESSAVPTEFTKSLLASLARKNLP 434
|
490 500
....*....|....*....|.
gi 489495878 1945 GYLVPAAVVVIDALPLTVNGK 1965
Cdd:cd05937 435 SYAVPLFLRLTEEVATTDNHK 455
|
|
| PRK07824 |
PRK07824 |
o-succinylbenzoate--CoA ligase; |
1565-1971 |
8.00e-11 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 236108 [Multi-domain] Cd Length: 358 Bit Score: 66.22 E-value: 8.00e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1565 TGAAYLPIdPANPPPRVAFMlgdavpvaavtTAGLRsrlAGHdlPIIDVVdalaaypgtpppmpaavnlAYILYTSGTTG 1644
Cdd:PRK07824 5 RAPALLPV-PAQDERRAALL-----------RDALR---VGE--PIDDDV-------------------ALVVATSGTTG 48
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1645 EPKGVGITHRNVTRLFASLPARLSAAQVWSqchsygFDASAWEIWG------ALLGGGRLVIVPESVAASPNDF----HG 1714
Cdd:PRK07824 49 TPKGAMLTAAALTASADATHDRLGGPGQWL------LALPAHHIAGlqvlvrSVIAGSEPVELDVSAGFDPTALpravAE 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1715 LLVAEHVSVLTQTPAAVAMLPTQGLESV----ALVVAGEACPAALVDRWAPGRVML-NAYGPTETTicaaisaplrpgSG 1789
Cdd:PRK07824 123 LGGGRRYTSLVPMQLAKALDDPAATAALaeldAVLVGGGPAPAPVLDAAAAAGINVvRTYGMSETS------------GG 190
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1790 MPPIGVPVSGAALFVLDswlrpvpagvaGELYIAGAGVGVGYwrRAGLTASrfvacPFGGSGarMYRTGDLVCWrADGQL 1869
Cdd:PRK07824 191 CVYDGVPLDGVRVRVED-----------GRIALGGPTLAKGY--RNPVDPD-----PFAEPG--WFRTDDLGAL-DDGVL 249
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1870 EFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIARED-RPGDKRLVGYATEIAPgAVDPAGLRAQLAQRLPGYLV 1948
Cdd:PRK07824 250 TVLGRADDAISTGGLTVLPQVVEAALATHPAVADCAVFGLPDdRLGQRVVAAVVGDGGP-APTLEALRAHVARTLDRTAA 328
|
410 420
....*....|....*....|...
gi 489495878 1949 PAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK07824 329 PRELHVVDELPRRGIGKVDRRAL 351
|
|
| PLN02503 |
PLN02503 |
fatty acyl-CoA reductase 2 |
2111-2251 |
8.29e-11 |
|
fatty acyl-CoA reductase 2
Pssm-ID: 215279 [Multi-domain] Cd Length: 605 Bit Score: 67.58 E-value: 8.29e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2111 LLTGATGFLGRYLVLELLRRLDVDGRLICLVRAESDEDARRRLEKtfDSGDPELLRHFKE--------LAADRLEVVAGD 2182
Cdd:PLN02503 123 LITGATGFLAKVLIEKILRTNPDVGKIYLLIKAKDKEAAIERLKN--EVIDAELFKCLQEthgksyqsFMLSKLVPVVGN 200
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 2183 KSEPDLGLDQPMWRRLAETVDLIVDSAAMvNAFP--YHELFGPNVAGTAELIRIALT-TKLKPFTYVSTADV 2251
Cdd:PLN02503 201 VCESNLGLEPDLADEIAKEVDVIINSAAN-TTFDerYDVAIDINTRGPCHLMSFAKKcKKLKLFLQVSTAYV 271
|
|
| hsFATP4_like |
cd05939 |
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty ... |
1515-1971 |
8.99e-11 |
|
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes FATP4, FATP1, and homologous proteins. Each FATP has unique patterns of tissue distribution. FATP4 is mainly expressed in the brain, testis, colon and kidney. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341262 [Multi-domain] Cd Length: 474 Bit Score: 67.06 E-value: 8.99e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1515 DASMTYRELDEASNRLAHRLAGCGAGPGECVALLFErcapavvamvavlktgaaylpidpaNPPPRVAFMLGDAvpVAAV 1594
Cdd:cd05939 1 DRHWTFRELNEYSNKVANFFQAQGYRSGDVVALFME-------------------------NRLEFVALWLGLA--KIGV 53
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1595 TTAGLRSRLAGHDLP-----------IIDVVDALAAYPGTPPPMPAAVN----LAYIlYTSGTTGEPKGVGITHRNVTRL 1659
Cdd:cd05939 54 ETALINSNLRLESLLhcitvskakalIFNLLDPLLTQSSTEPPSQDDVNfrdkLFYI-YTSGTTGLPKAAVIVHSRYYRI 132
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1660 --FASLPARLSAAQVWSQC----HSYGfdasawEIWG---ALLGGGRLVIVPEsvaASPNDF------HGLLVAEHVSVL 1724
Cdd:cd05939 133 aaGAYYAFGMRPEDVVYDClplyHSAG------GIMGvgqALLHGSTVVIRKK---FSASNFwddcvkYNCTIVQYIGEI 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1725 TQTPAAVAMLPTQGLESVALVVAGEACPA---ALVDRWAPGRVMlNAYGPTE--------TTICAAISAPLRPGSGMPPI 1793
Cdd:cd05939 204 CRYLLAQPPSEEEQKHNVRLAVGNGLRPQiweQFVRRFGIPQIG-EFYGATEgnsslvniDNHVGACGFNSRILPSVYPI 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1794 GV----PVSGAALFVLDSWLRPVPAGVAGELyiagagVGV-----------GYWRRaGLTASRFVACPFgGSGARMYRTG 1858
Cdd:cd05939 283 RLikvdEDTGELIRDSDGLCIPCQPGEPGLL------VGKiiqndplrrfdGYVNE-GATNKKIARDVF-KKGDSAFLSG 354
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1859 DLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREdRPGDKRLVGYATEIAP-GAVDPAGLRA 1937
Cdd:cd05939 355 DVLVMDELGYLYFKDRTGDTFRWKGENVSTTEVEGILSNVLGLEDVVVYGVE-VPGVEGRAGMAAIVDPeRKVDLDRFSA 433
|
490 500 510
....*....|....*....|....*....|....
gi 489495878 1938 QLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:cd05939 434 VLAKSLPPYARPQFIRLLPEVDKTGTFKLQKTDL 467
|
|
| AACS |
cd05943 |
Acetoacetyl-CoA synthetase (acetoacetate-CoA ligase, AACS); AACS is a cytosolic ligase that ... |
1606-1965 |
1.28e-10 |
|
Acetoacetyl-CoA synthetase (acetoacetate-CoA ligase, AACS); AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms. AACS is widely distributed in bacteria, archaea and eukaryotes. In bacteria, AACS is known to exhibit an important role in the metabolism of poly-b-hydroxybutyrate, an intracellular reserve of organic carbon and chemical energy by some microorganisms. In mammals, AACS influences the rate of ketone body utilization for the formation of physiologically important fatty acids and cholesterol.
Pssm-ID: 341265 [Multi-domain] Cd Length: 629 Bit Score: 66.91 E-value: 1.28e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1606 HDLPIIDVV----DALAAYPGTPP---PMPAAVNLaYILYTSGTTGEPKGvgITHRNVTRLFASLPARLSAAQVWSQCHS 1678
Cdd:cd05943 218 PDLSKIAKAltleDFLATGAAGELefePLPFDHPL-YILYSSGTTGLPKC--IVHGAGGTLLQHLKEHILHCDLRPGDRL 294
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1679 YGFDASAWEIW----GALLGGGRLVIVPES-VAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESV---------AL 1744
Cdd:cd05943 295 FYYTTCGWMMWnwlvSGLAVGATIVLYDGSpFYPDTNALWDLADEEGITVFGTSAKYLDALEKAGLKPAethdlsslrTI 374
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1745 VVAGEACPA---ALVDRWAPGRVMLNAYGpTETTICAA-----ISAPLRPGsgmpPIGVPVSGAALFVLDSWLRPVPaGV 1816
Cdd:cd05943 375 LSTGSPLKPesfDYVYDHIKPDVLLASIS-GGTDIISCfvggnPLLPVYRG----EIQCRGLGMAVEAFDEEGKPVW-GE 448
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1817 AGELYIAGA--GVGVGYWRRAGltASRFVACPFggsgAR---MYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEV 1891
Cdd:cd05943 449 KGELVCTKPfpSMPVGFWNDPD--GSRYRAAYF----AKypgVWAHGDWIEITPRGGVVILGRSDGTLNPGGVRIGTAEI 522
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1892 ATALAELAGVGQAVVIAREDRPGDKRLVGYaTEIAPGAVDPAGLRAQLAQRLPGYL----VPAAVVVIDALPLTVNGK 1965
Cdd:cd05943 523 YRVVEKIPEVEDSLVVGQEWKDGDERVILF-VKLREGVELDDELRKRIRSTIRSALsprhVPAKIIAVPDIPRTLSGK 599
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
473-910 |
1.67e-10 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 65.86 E-value: 1.67e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 473 AWLVQRGAAPGDVLVFTDDDTDKTIDLLIACHLAGcgysvcdtadeiSVRTNAITEHGDGILVTVVDVAATQLAVVghde 552
Cdd:cd05903 16 AGLAALGVGPGDVVAFQLPNWWEFAVLYLACLRIG------------AVTNPILPFFREHELAFILRRAKAKVFVV---- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 553 lrkvvDERVTQVTHDALLAtKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISveeiF 632
Cdd:cd05903 80 -----PERFRQFDPAAMPD-AVALLLFTSGTTGEPKGVMHSHNTLSASIRQYAERLGLGPGDVFLVASPMAHQTG----F 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 633 GGAACGARLVRSAA--MKTGDLAALVDDLVARETTIVDLPTAVWQLLCadgDAIDAIGR--SRLRQIVIGGEAIRCSAVD 708
Cdd:cd05903 150 VYGFTLPLLLGAPVvlQDIWDPDKALALMREHGVTFMMGATPFLTDLL---NAVEEAGEplSRLRTFVCGGATVPRSLAR 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 709 kwlESAASQGISLLSSYGPTEATVVATFLP-------IVCDQTTMDGALLRLGRPILPNTVFLAFGEVVIVGDLVADGYL 781
Cdd:cd05903 227 ---RAAELLGAKVCSAYGSTECPGAVTSITpapedrrLYTDGRPLPGVEIKVVDDTGATLAPGVEGELLSRGPSVFLGYL 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 782 GiDGDgfgtvTAADGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVelhsgslg 861
Cdd:cd05903 304 D-RPD-----LTADAAPEGWFRTGDLARLDEDGYLRITGRSKDIIIRGGENIPVLEVEDLLLGHPGVIEAAV-------- 369
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 489495878 862 VWFKSQRTreGEQDAA-AATR---------IRLVLVSLGVSSFF----VVGVPNIPRKPNGKI 910
Cdd:cd05903 370 VALPDERL--GERACAvVVTKsgalltfdeLVAYLDRQGVAKQYwperLVHVDDLPRTPSGKV 430
|
|
| PLN02574 |
PLN02574 |
4-coumarate--CoA ligase-like |
1624-1971 |
1.68e-10 |
|
4-coumarate--CoA ligase-like
Pssm-ID: 215312 [Multi-domain] Cd Length: 560 Bit Score: 66.40 E-value: 1.68e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1624 PPPMPAAVNLAYILYTSGTTGEPKGVGITHRNV-------TRLFASLPARLSAAQVW----SQCHSYGFDASAWeiwgAL 1692
Cdd:PLN02574 191 PKPVIKQDDVAAIMYSSGTTGASKGVVLTHRNLiamvelfVRFEASQYEYPGSDNVYlaalPMFHIYGLSLFVV----GL 266
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1693 LGGGRLVIVPESVAASP-----NDF---HGLLVAEHVSVLTQTPAAVAMLPtqgLESVALVVAGeACPAA--LVDRWA-- 1760
Cdd:PLN02574 267 LSLGSTIVVMRRFDASDmvkviDRFkvtHFPVVPPILMALTKKAKGVCGEV---LKSLKQVSCG-AAPLSgkFIQDFVqt 342
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1761 -PGRVMLNAYGPTETTICAAISAPLRPGSGMPPIGVPVSGAALFVLDsWLRP--VPAGVAGELYIAGAGVGVGYWRRAGL 1837
Cdd:PLN02574 343 lPHVDFIQGYGMTESTAVGTRGFNTEKLSKYSSVGLLAPNMQAKVVD-WSTGclLPPGNCGELWIQGPGVMKGYLNNPKA 421
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1838 TASRFVACPFggsgarmYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKR 1917
Cdd:PLN02574 422 TQSTIDKDGW-------LRTGDIAYFDEDGYLYIVDRLKEIIKYKGFQIAPADLEAVLISHPEIIDAAVTAVPDKECGEI 494
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....
gi 489495878 1918 LVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PLN02574 495 PVAFVVRRQGSTLSQEAVINYVAKQVAPYKKVRKVVFVQSIPKSPAGKILRREL 548
|
|
| FCS |
cd05921 |
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl ... |
1519-1943 |
2.70e-10 |
|
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl acid degradation pathway and enables some proteobacteria to grow on media containing feruloyl acid as the sole carbon source. It catalyzes the transfer of CoA to the carboxyl group of ferulic acid, which then forms feruloyl-CoA in the presence of ATP and Mg2. The resulting feruloyl-CoA is further degraded to vanillin and acetyl-CoA. Feruloyl-CoA synthetase (FCS) is a subfamily of the adenylate-forming enzymes superfamily.
Pssm-ID: 341245 [Multi-domain] Cd Length: 561 Bit Score: 65.53 E-value: 2.70e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANP----------------PPRVA 1582
Cdd:cd05921 27 TYAEALRQVRAIAQGLLDLGLSAERPLLILSGNSIEHALMALAAMYAGVPAAPVSPAYSlmsqdlaklkhlfellKPGLV 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1583 F-----MLGDAVpvAAVTTAGLRSRLAGHDLPIIDVV--DALAAYPGTP--PPMPAAV---NLAYILYTSGTTGEPKGVG 1650
Cdd:cd05921 107 FaqdaaPFARAL--AAIFPLGTPLVVSRNAVAGRGAIsfAELAATPPTAavDAAFAAVgpdTVAKFLFTSGSTGLPKAVI 184
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1651 ITHRNVTR----------LFASLPARLSAAQVWSqcHSYGFDAsaweIWGALL-GGGRLVI-----VPESVAASPNDFHG 1714
Cdd:cd05921 185 NTQRMLCAnqamleqtypFFGEEPPVLVDWLPWN--HTFGGNH----NFNLVLyNGGTLYIddgkpMPGGFEETLRNLRE 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1715 LLVAEHVSVltqtPAAVAMLpTQGLES------------VALVVAGEACPAALVDRWAP------GR--VMLNAYGPTET 1774
Cdd:cd05921 259 ISPTVYFNV----PAGWEML-VAALEKdealrrrffkrlKLMFYAGAGLSQDVWDRLQAlavatvGEriPMMAGLGATET 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1775 TICAAISAPLRPGSGMppIGVPVSGAALfvldswlRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarm 1854
Cdd:cd05921 334 APTATFTHWPTERSGL--IGLPAPGTEL-------KLVPSGGKYEVRVKGPNVTPGYWRQPELTAQAFDEEGF------- 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1855 YRTGDLVCWRADGQ----LEFLGRTDDQVKIR-GYRIELGEVATAL-AELAGVGQAVVIAREDR-----------PGDKR 1917
Cdd:cd05921 398 YCLGDAAKLADPDDpakgLVFDGRVAEDFKLAsGTWVSVGPLRARAvAACAPLVHDAVVAGEDRaevgalvfpdlLACRR 477
|
490 500
....*....|....*....|....*.
gi 489495878 1918 LVGYATEIAPGAVDPAGLRAQLAQRL 1943
Cdd:cd05921 478 LVGLQEASDAEVLRHAKVRAAFRDRL 503
|
|
| PRK12476 |
PRK12476 |
putative fatty-acid--CoA ligase; Provisional |
1514-1970 |
3.37e-10 |
|
putative fatty-acid--CoA ligase; Provisional
Pssm-ID: 171527 [Multi-domain] Cd Length: 612 Bit Score: 65.53 E-value: 3.37e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1514 GDaSMTYRELDEASNRLAH-----------RLAGCGA------GPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPAN 1576
Cdd:PRK12476 48 GD-TVAYRYLDHSHSAAGCaveltwtqlgvRLRAVGArlqqvaGPGDRVAILAPQGIDYVAGFFAAIKAGTIAVPLFAPE 126
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1577 PP---PRVAFMLGDAVPVAAVTTAGLR-------SRLAGHDLPIIDVVDALAAYPG---TPPPMPAAvNLAYILYTSGTT 1643
Cdd:PRK12476 127 LPghaERLDTALRDAEPTVVLTTTAAAeavegflRNLPRLRRPRVIAIDAIPDSAGesfVPVELDTD-DVSHLQYTSGST 205
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1644 GEPKGVGITHRNV-TRLfasLPARLSAAQVWSQCHSYGF-----DASAWEI-WGALLGGGRLVIVPESVAASPNDFHGLL 1716
Cdd:PRK12476 206 RPPVGVEITHRAVgTNL---VQMILSIDLLDRNTHGVSWlplyhDMGLSMIgFPAVYGGHSTLMSPTAFVRRPQRWIKAL 282
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1717 VAE--HVSVLTQTP------AAVAMLPTQG----LESVALVVAGEACPAALVDRWA--------PGRVMLNAYGPTETTI 1776
Cdd:PRK12476 283 SEGsrTGRVVTAAPnfayewAAQRGLPAEGddidLSNVVLIIGSEPVSIDAVTTFNkafapyglPRTAFKPSYGIAEATL 362
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1777 CAAISAP-------------------LRPGSGMPPIGVPVSGA-------ALFVLDSWLRPVPAGVAGELYIAGAGVGVG 1830
Cdd:PRK12476 363 FVATIAPdaepsvvyldreqlgagraVRVAADAPNAVAHVSCGqvarsqwAVIVDPDTGAELPDGEVGEIWLHGDNIGRG 442
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1831 YWRRAGLTASRFVA-----CPFGG------SGARMYRTGDLVCWRaDGQLEFLGRTDDQVKIRGYRIELGEVATALAELA 1899
Cdd:PRK12476 443 YWGRPEETERTFGAklqsrLAEGShadgaaDDGTWLRTGDLGVYL-DGELYITGRIADLIVIDGRNHYPQDIEATVAEAS 521
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1900 GVGQAVVIAREDRPGD--KRLVGYAtEIAPGA--VDPA----GLRAQLAQRlpgYLVPAA---VVVIDALPLTVNGKLDH 1968
Cdd:PRK12476 522 PMVRRGYVTAFTVPAEdnERLVIVA-ERAAGTsrADPApaidAIRAAVSRR---HGLAVAdvrLVPAGAIPRTTSGKLAR 597
|
..
gi 489495878 1969 RA 1970
Cdd:PRK12476 598 RA 599
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
574-853 |
3.59e-10 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 64.89 E-value: 3.59e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSL---AVFCDAISRAYGWGaHDTVLQCAPLTsdisveEIFGGAACGARLVRSAA---- 646
Cdd:cd05936 127 VAVLQYTSGTTGVPKGAMLTHRNLvanALQIKAWLEDLLEG-DDVVLAALPLF------HVFGLTVALLLPLALGAtivl 199
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 647 MKTGDLAALVDDLVA-RETTIVDLPTAVWQLLCAdgDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLESAasqGISLLSSY 725
Cdd:cd05936 200 IPRFRPIGVLKEIRKhRVTIFPGVPTMYIALLNA--PEFKKRDFSSLRLCISGGAPLPVEVAERFEELT---GVPIVEGY 274
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 726 GPTEATVVATFLPIvcDQTTMDGAllrLGRPIL--------PNTVFLA---FGEVVIVGDLVADGYLGIDGDgfgtvTAA 794
Cdd:cd05936 275 GLTETSPVVAVNPL--DGPRKPGS---IGIPLPgtevkivdDDGEELPpgeVGELWVRGPQVMKGYWNRPEE-----TAE 344
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 795 ---DGsrrrAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd05936 345 afvDG----WLRTGDIGYMDEDGYFFIVDRKKDMIIVGGFNVYPREVEEVLYEHPAVAEAAV 402
|
|
| AAS_C |
cd05909 |
C-terminal domain of the acyl-acyl carrier protein synthetase (also called ... |
573-833 |
3.64e-10 |
|
C-terminal domain of the acyl-acyl carrier protein synthetase (also called 2-acylglycerophosphoethanolamine acyltransferase, Aas); Acyl-acyl carrier protein synthase (Aas) is a membrane protein responsible for a minor pathway of incorporating exogenous fatty acids into membrane phospholipids. Its in vitro activity is characterized by the ligation of free fatty acids between 8 and 18 carbons in length to the acyl carrier protein sulfydryl group (ACP-SH) in the presence of ATP and Mg2+. However, its in vivo function is as a 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase. The reaction occurs in two steps: the acyl chain is first esterified to acyl carrier protein (ACP) via a thioester bond, followed by a second step where the acyl chain is transferred to a 2-acyllysophospholipid, thus completing the transacylation reaction. This model represents the C-terminal domain of the enzyme, which belongs to the class I adenylate-forming enzyme family, including acyl-CoA synthetases.
Pssm-ID: 341235 [Multi-domain] Cd Length: 490 Bit Score: 65.05 E-value: 3.64e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 573 KTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTsdisveEIFGGAAC-------GARLV-RS 644
Cdd:cd05909 148 DPAVILFTSGSEGLPKGVVLSHKNLLANVEQITAIFDPNPEDVVFGALPFF------HSFGLTGClwlpllsGIKVVfHP 221
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 645 AAMKTGDLAALVDDlvARETTIVDLPTAVWQLLcadgDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLESaasQGISLLSS 724
Cdd:cd05909 222 NPLDYKKIPELIYD--KKATILLGTPTFLRGYA----RAAHPEDFSSLRLVVAGAEKLKDTLRQEFQEK---FGIRILEG 292
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 725 YGPTEATVVatflpIVCDQTTMDGALLRLGRPiLPNTVF----------LAFGE---VVIVGDLVADGYLGIDGdgfGTV 791
Cdd:cd05909 293 YGTTECSPV-----ISVNTPQSPNKEGTVGRP-LPGMEVkivsvetheeVPIGEgglLLVRGPNVMLGYLNEPE---LTS 363
|
250 260 270 280
....*....|....*....|....*....|....*....|..
gi 489495878 792 TAAdgsRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRV 833
Cdd:cd05909 364 FAF---GDGWYDTGDIGKIDGEGFLTITGRLSRFAKIAGEMV 402
|
|
| LC_FACS_bac |
cd05932 |
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter ... |
1519-1880 |
5.95e-10 |
|
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase. Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase in this family is involved in the synthesis of isoprenoid wax ester storage compounds when grown on phytol as the sole carbon source. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341255 [Multi-domain] Cd Length: 508 Bit Score: 64.41 E-value: 5.95e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFML----GDAVPVA-- 1592
Cdd:cd05932 8 TWGEVADKARRLAAALRALGLEPGSKIALISKNCAEWFITDLAIWMAGHISVPLYPTLNPDTIRYVLehseSKALFVGkl 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1593 ---AVTTAGLRSRLAGHDLPIIDVV-------DALAAYP---GTPPPMPAavNLAYILYTSGTTGEPKGV---------- 1649
Cdd:cd05932 88 ddwKAMAPGVPEGLISISLPPPSAAncqyqwdDLIAQHPpleERPTRFPE--QLATLIYTSGTTGQPKGVmltfgsfawa 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1650 ---GITHRNVT---RLFASLPARLSAAQVWsqchsygfdasaweIWGALLGGGRLVIVPESV--------AASPNDFHG- 1714
Cdd:cd05932 166 aqaGIEHIGTEendRMLSYLPLAHVTERVF--------------VEGGSLYGGVLVAFAESLdtfvedvqRARPTLFFSv 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1715 --LLVAEHVSVLTQTPAAV----------------AMLPTQGLESVALVVAGEA-CPAALVDrW--APGRVMLNAYGPTE 1773
Cdd:cd05932 232 prLWTKFQQGVQDKIPQQKlnlllkipvvnslvkrKVLKGLGLDQCRLAGCGSApVPPALLE-WyrSLGLNILEAYGMTE 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1774 TTICAAISAPLRPGSGMppIGVPVSGAALFVLDSwlrpvpagvaGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgar 1853
Cdd:cd05932 311 NFAYSHLNYPGRDKIGT--VGNAGPGVEVRISED----------GEILVRSPALMMGYYKDPEATAEAFTADGF------ 372
|
410 420
....*....|....*....|....*..
gi 489495878 1854 mYRTGDLVCWRADGQLEFLGRTDDQVK 1880
Cdd:cd05932 373 -LRTGDKGELDADGNLTITGRVKDIFK 398
|
|
| LC_FACS_like |
cd17640 |
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA ... |
574-853 |
6.22e-10 |
|
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA synthetases, including an Arabidopsis gene At4g14070 that plays a role in activation and elongation of exogenous fatty acids. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341295 [Multi-domain] Cd Length: 468 Bit Score: 64.30 E-value: 6.22e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPL--TSDISVEEIFggAACGArlvrsaAMKTGD 651
Cdd:cd17640 90 LATIIYTSGTTGNPKGVMLTHANLLHQIRSLSDIVPPQPGDRFLSILPIwhSYERSAEYFI--FACGC------SQAYTS 161
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 652 LAALVDDLV-ARETTIVDLPTaVWQLL-------CADGDAID------AIGRSRLRQIVIGGEAIrCSAVDKWLESAasq 717
Cdd:cd17640 162 IRTLKDDLKrVKPHYIVSVPR-LWESLysgiqkqVSKSSPIKqflflfFLSGGIFKFGISGGGAL-PPHVDTFFEAI--- 236
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 718 GISLLSSYGPTEATvvatflPIVCDQTTMDGALLRLGRPIlPNTVF----------LAFGE---VVIVGDLVADGYLG-- 782
Cdd:cd17640 237 GIEVLNGYGLTETS------PVVSARRLKCNVRGSVGRPL-PGTEIkivdpegnvvLPPGEkgiVWVRGPQVMKGYYKnp 309
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 783 ------IDGDGFgtvtaadgsrrraFATGDRVTVDAEGFPVFSGR-KDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd17640 310 eatskvLDSDGW-------------FNTGDLGWLTCGGELVLTGRaKDTIVLSNGENVEPQPIEEALMRSPFIEQIMV 374
|
|
| PRK07768 |
PRK07768 |
long-chain-fatty-acid--CoA ligase; Validated |
1519-1970 |
1.01e-09 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236091 [Multi-domain] Cd Length: 545 Bit Score: 63.86 E-value: 1.01e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1519 TYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAA--YLPidpaNPPPR------------VAFM 1584
Cdd:PRK07768 31 TWGEVHERARRIAGGLAAAGVGPGDAVAVLAGAPVEIAPTAQGLWMRGASltMLH----QPTPRtdlavwaedtlrVIGM 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1585 LGDAVPVAAVTTAGLRSRLAGHDLPIIDVVDALAAYPGTPPPMPAAvNLAYILYTSGTTGEPKGVGITHRNvtrLFASLP 1664
Cdd:PRK07768 107 IGAKAVVVGEPFLAAAPVLEEKGIRVLTVADLLAADPIDPVETGED-DLALMQLTSGSTGSPKAVQITHGN---LYANAE 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1665 ARLSAAQV---------WSQC-HSYGfdasaweiwgaLLGGgrlVIVP-----ESVAASPNDFHG------LLVAEHVSV 1723
Cdd:PRK07768 183 AMFVAAEFdvetdvmvsWLPLfHDMG-----------MVGF---LTVPmyfgaELVKVTPMDFLRdpllwaELISKYRGT 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1724 LTQTPA-AVAML-------PTQG---LESVALVVAG-EACPAALVDRWA--------PGRVMLNAYGPTETTIcaAISAP 1783
Cdd:PRK07768 249 MTAAPNfAYALLarrlrrqAKPGafdLSSLRFALNGaEPIDPADVEDLLdagarfglRPEAILPAYGMAEATL--AVSFS 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1784 lRPGSGM---------------------------PPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYwrrag 1836
Cdd:PRK07768 327 -PCGAGLvvdevdadllaalrravpatkgntrrlATLGPPLPGLEVRVVDEDGQVLPPRGVGVIELRGESVTPGY----- 400
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1837 LTASRFVAC--PFGgsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGV--GQAVVIaREDR 1912
Cdd:PRK07768 401 LTMDGFIPAqdADG-----WLDTGDLGYLTEEGEVVVCGRVKDVIIMAGRNIYPTDIERAAARVEGVrpGNAVAV-RLDA 474
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 489495878 1913 PGDKRLVGYATEIApGAVDPAG---LRAQLAQRLPGYL--VPAAVVVIDA--LPLTVNGKLDHRA 1970
Cdd:PRK07768 475 GHSREGFAVAVESN-AFEDPAEvrrIRHQVAHEVVAEVgvRPRNVVVLGPgsIPKTPSGKLRRAN 538
|
|
| PRK06710 |
PRK06710 |
long-chain-fatty-acid--CoA ligase; Validated |
1489-1975 |
1.24e-09 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 180666 [Multi-domain] Cd Length: 563 Bit Score: 63.51 E-value: 1.24e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1489 PTPVSIPQMlaaqVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAA 1568
Cdd:PRK06710 25 PLHKYVEQM----ASRYPEKKALHFLGKDITFSVFHDKVKRFANYLQKLGVEKGDRVAIMLPNCPQAVIGYYGTLLAGGI 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1569 YLPIDPANPPPRVAFMLGDA-----------VP-VAAVTTAG-----LRSRLAGHdLP-----------------IIDVV 1614
Cdd:PRK06710 101 VVQTNPLYTERELEYQLHDSgakvilcldlvFPrVTNVQSATkiehvIVTRIADF-LPfpknllypfvqkkqsnlVVKVS 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1615 DALAAY----------PGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTR--------LFASLPARLSAAQVWSQC 1676
Cdd:PRK06710 180 ESETIHlwnsvekevnTGVEVPCDPENDLALLQYTGGTTGFPKGVMLTHKNLVSntlmgvqwLYNCKEGEEVVLGVLPFF 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1677 HSYGFDASaweIWGALLGGGRLVIVPEsvaaspndFHGLLVAEHVS--VLTQTPAA----VAMLPTQGLE-----SVALV 1745
Cdd:PRK06710 260 HVYGMTAV---MNLSIMQGYKMVLIPK--------FDMKMVFEAIKkhKVTLFPGAptiyIALLNSPLLKeydisSIRAC 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1746 VAGEA-CPAALVDRW--APGRVMLNAYGPTET---TICAAISAPLRPGSgmppIGVPV--SGAALFVLDSWlRPVPAGVA 1817
Cdd:PRK06710 329 ISGSApLPVEVQEKFetVTGGKLVEGYGLTESspvTHSNFLWEKRVPGS----IGVPWpdTEAMIMSLETG-EALPPGEI 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1818 GELYIAGAGVGVGYWRRAGLTASRFvacpfggsGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAE 1897
Cdd:PRK06710 404 GEIVVKGPQIMKGYWNKPEETAAVL--------QDGWLHTGDVGYMDEDGFFYVKDRKKDMIVASGFNVYPREVEEVLYE 475
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1898 LAGVGQAVVIAREDrPGDKRLVGYATEIAPGAVDPAGLRAQLAQR-LPGYLVPAAVVVIDALPLTVNGKLDHRALPAPE 1975
Cdd:PRK06710 476 HEKVQEVVTIGVPD-PYRGETVKAFVVLKEGTECSEEELNQFARKyLAAYKVPKVYEFRDELPKTTVGKILRRVLIEEE 553
|
|
| PRK09274 |
PRK09274 |
peptide synthase; Provisional |
1488-1880 |
1.34e-09 |
|
peptide synthase; Provisional
Pssm-ID: 236443 [Multi-domain] Cd Length: 552 Bit Score: 63.38 E-value: 1.34e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1488 APTPVSIPQMLAAQVARIPEAEAVCCGDA----------SMTYRELDEASNRLAHRLAGCGAGPG-----------ECVA 1546
Cdd:PRK09274 2 MASMANIARHLPRAAQERPDQLAVAVPGGrgadgklaydELSFAELDARSDAIAHGLNAAGIGRGmravlmvtpslEFFA 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1547 LLFercapavvamvAVLKTGAAYLPIDPA--------------------NPPPRVA-FMLGDAVP-VAAVTTAGLRSRLA 1604
Cdd:PRK09274 82 LTF-----------ALFKAGAVPVLVDPGmgiknlkqclaeaqpdafigIPKAHLArRLFGWGKPsVRRLVTVGGRLLWG 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1605 GHDLPIIDVVDALAAYPG--TPPPMPAAvnlayILYTSGTTGEPKGVGITHRNvtrlFAslpARLSAAQvwsqcHSYGFD 1682
Cdd:PRK09274 151 GTTLATLLRDGAAAPFPMadLAPDDMAA-----ILFTSGSTGTPKGVVYTHGM----FE---AQIEALR-----EDYGIE 213
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1683 ASawEI----------WGALLGGGrlVIVPESVA-----ASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQG------LES 1741
Cdd:PRK09274 214 PG--EIdlptfplfalFGPALGMT--SVIPDMDPtrpatVDPAKLFAAIERYGVTNLFGSPALLERLGRYGeangikLPS 289
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1742 VALV-VAGEACPAALVDRW----APGRVMLNAYGPTE---------TTICAAISAPLRPGSGMpPIGVPVSGAALFV--- 1804
Cdd:PRK09274 290 LRRViSAGAPVPIAVIERFramlPPDAEILTPYGATEalpissiesREILFATRAATDNGAGI-CVGRPVDGVEVRIiai 368
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1805 ----LDSW--LRPVPAGVAGELYIAGAGVGVGYWRRAGLTAsrfVACPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQ 1878
Cdd:PRK09274 369 sdapIPEWddALRLATGEIGEIVVAGPMVTRSYYNRPEATR---LAKIPDGQGDVWHRMGDLGYLDAQGRLWFCGRKAHR 445
|
..
gi 489495878 1879 VK 1880
Cdd:PRK09274 446 VE 447
|
|
| E-C_NRPS |
cd19544 |
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); ... |
1052-1346 |
2.24e-09 |
|
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); Dual function Epimerization/Condensation (E/C) domains have both an epimerization and a DCL condensation activity. Dual E/C domains first epimerize the substrate amino acid to produce a D-configuration, then catalyze the condensation between the D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. They are D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. These Dual E/C domains contain an extended His-motif (HHx(N)GD) near the N-terminus of the domain in addition to the standard Condensation (C) domain active site motif (HHxxxD). C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains, these include the DCL-type, LCL-type, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C domains, and the X-domain.
Pssm-ID: 380466 [Multi-domain] Cd Length: 413 Bit Score: 62.07 E-value: 2.24e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1052 RLRGYLDteALGAavadVVGRHESLRTVFpAVDGVPR--QLVIeaRRADLGCDIV--DATAWPADRLQRAIEeAARHSFD 1127
Cdd:cd19544 37 RLDAFLA--ALQQ----VIDRHDILRTAI-LWEGLSEpvQVVW--RQAELPVEELtlDPGDDALAQLRARFD-PRRYRLD 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1128 LaTEIPLrtWLFRIADDEH----VLVAVAHHIAADGWSVAPLTADLSAayasRCAGRAPDWAPlPVQYVDYTLWQReilg 1203
Cdd:cd19544 107 L-RQAPL--LRAHVAEDPAngrwLLLLLFHHLISDHTSLELLLEEIQA----ILAGRAAALPP-PVPYRNFVAQAR---- 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1204 dlddSDSPIAAQLAYWENALAGMPErlrlPTArPYPpVADQRG-------ASLVVDwpASVQQQVRRIARQHNAT--SFM 1274
Cdd:cd19544 175 ----LGASQAEHEAFFREMLGDVDE----PTA-PFG-LLDVQGdgsditeARLALD--AELAQRLRAQARRLGVSpaSLF 242
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 1275 VVAAGLavLLSKLSGSPDVAVGFPIAGR--SDPALDNLVGFFVNTLVLRVNLAGDpSFAELLGQVRAR--SLAAYE 1346
Cdd:cd19544 243 HLAWAL--VLARCSGRDDVVFGTVLSGRmqGGAGADRALGMFINTLPLRVRLGGR-SVREAVRQTHARlaELLRHE 315
|
|
| PRK07787 |
PRK07787 |
acyl-CoA synthetase; Validated |
574-853 |
2.46e-09 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236096 [Multi-domain] Cd Length: 471 Bit Score: 62.31 E-value: 2.46e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDIS-VEEIFGGAACGARLVRSAAMKTGDL 652
Cdd:PRK07787 130 PALIVYTSGTTGPPKGVVLSRRAIAADLDALAEAWQWTADDVLVHGLPLFHVHGlVLGVLGPLRIGNRFVHTGRPTPEAY 209
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 653 AAlvdDLVARETTIVDLPTaVWQLLCADGDAIDAIGRSRLrqIVIGGEAIRCSAVDKWlesAASQGISLLSSYGPTEaTV 732
Cdd:PRK07787 210 AQ---ALSEGGTLYFGVPT-VWSRIAADPEAARALRGARL--LVSGSAALPVPVFDRL---AALTGHRPVERYGMTE-TL 279
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 733 VATFLPIVCDQ------TTMDGALLRL----GRPILPNTVflAFGEVVIVGDLVADGYLG--------IDGDGFgtvtaa 794
Cdd:PRK07787 280 ITLSTRADGERrpgwvgLPLAGVETRLvdedGGPVPHDGE--TVGELQVRGPTLFDGYLNrpdataaaFTADGW------ 351
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 795 dgsrrraFATGDRVTVDAEGFPVFSGRKDA-VVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK07787 352 -------FRTGDVAVVDPDGMHRIVGRESTdLIKSGGYRIGAGEIETALLGHPGVREAAV 404
|
|
| AMP-binding_C |
pfam13193 |
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to ... |
1890-1965 |
2.85e-09 |
|
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to pfam00501. It has a central beta sheet core that is flanked by alpha helices.
Pssm-ID: 463804 [Multi-domain] Cd Length: 76 Bit Score: 55.63 E-value: 2.85e-09
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 1890 EVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGK 1965
Cdd:pfam13193 1 EVESALVSHPAVAEAAVVGVPDELKGEAPVAFVVLKPGVELLEEELVAHVREELGPYAVPKEVVFVDELPKTRSGK 76
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
442-853 |
3.05e-09 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 62.31 E-value: 3.05e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 442 ARQPSTPAWFLDSARGVHQFLGRR--RFVYPWVAWlvqrGAAPGDVLVFTDDDTDKTIDLLIACHLAGCGY-------SV 512
Cdd:PRK06188 23 KRYPDRPALVLGDTRLTYGQLADRisRYIQAFEAL----GLGTGDAVALLSLNRPEVLMAIGAAQLAGLRRtalhplgSL 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 513 CDTADEIS--------VRTNAITEHGDGILvtvvDVAATQLAVVGHDELRKVVD--ERVTQVTH----DALLATKTAYIM 578
Cdd:PRK06188 99 DDHAYVLEdagistliVDPAPFVERALALL----ARVPSLKHVLTLGPVPDGVDllAAAAKFGPaplvAAALPPDIAGLA 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 579 PTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSdisveeifggaaCGARLVRSAAMKTGDL------ 652
Cdd:PRK06188 175 YTGGTTGKPKGVMGTHRSIATMAQIQLAEWEWPADPRFLMCTPLSH------------AGGAFFLPTLLRGGTVivlakf 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 653 -AALVDDLVARE----TTIVdlPTAVWQLLcaDGDAIDAIGRSRLRQIVIGGEAIrcsAVDKWLESAASQGISLLSSYGP 727
Cdd:PRK06188 243 dPAEVLRAIEEQritaTFLV--PTMIYALL--DHPDLRTRDLSSLETVYYGASPM---SPVRLAEAIERFGPIFAQYYGQ 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 728 TEATVVATFLPIVCDQTTMDGALLRLGRPILPNTVFL-----------AFGEVVIVGDLVADGYLGIDGDgfgtvTAadg 796
Cdd:PRK06188 316 TEAPMVITYLRKRDHDPDDPKRLTSCGRPTPGLRVALldedgrevaqgEVGEICVRGPLVMDGYWNRPEE-----TA--- 387
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 797 srrRAFA-----TGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK06188 388 ---EAFRdgwlhTGDVAREDEDGFYYIVDRKKDMIVTGGFNVFPREVEDVLAEHPAVAQVAV 446
|
|
| PRK07769 |
PRK07769 |
long-chain-fatty-acid--CoA ligase; Validated |
1514-1988 |
3.79e-09 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 181109 [Multi-domain] Cd Length: 631 Bit Score: 62.05 E-value: 3.79e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1514 GDaSMTYRELDEASNR-----------LAHRLAGCGA------GPGECVALLFERCAPAVVAMVAVLKTGAAYLPI-DPA 1575
Cdd:PRK07769 35 GD-KLAYRFLDFSTERdgvardltwsqFGARNRAVGArlqqvtKPGDRVAILAPQNLDYLIAFFGALYAGRIAVPLfDPA 113
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1576 NP--PPRVAFMLGDAVPVAAVTTAG--------LRSRLAgHDLPIIDVVDALAAYPGTP--PPMPAAVNLAYILYTSGTT 1643
Cdd:PRK07769 114 EPghVGRLHAVLDDCTPSAILTTTDsaegvrkfFRARPA-KERPRVIAVDAVPDEVGATwvPPEANEDTIAYLQYTSGST 192
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1644 GEPKGVGITHR----NVTRLFASLPARLSAAQV-W-SQCHSYGFDASaweIWGALLGGGRLVIVPES-----------VA 1706
Cdd:PRK07769 193 RIPAGVQITHLnlptNVLQVIDALEGQEGDRGVsWlPFFHDMGLITV---LLPALLGHYITFMSPAAfvrrpgrwireLA 269
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1707 ASPNDFHGLLVA------EHvsvltqtpAAVAMLPTQG-----LESVALVVAG-EACPAALV----DRWAPgrvmlnaYG 1770
Cdd:PRK07769 270 RKPGGTGGTFSAapnfafEH--------AAARGLPKDGeppldLSNVKGLLNGsEPVSPASMrkfnEAFAP-------YG 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1771 PTETTIcaaisaplRPGSGMP-------------------------------------PIGVPVSGAALFVLDSWL---- 1809
Cdd:PRK07769 335 LPPTAI--------KPSYGMAeatlfvsttpmdeeptviyvdrdelnagrfvevpadaPNAVAQVSAGKVGVSEWAvivd 406
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1810 ----RPVPAGVAGELYIAGAGVGVGYWRRAGLTASRF---VACPFGGS-------GARMYRTGDLVCWrADGQLEFLGRT 1875
Cdd:PRK07769 407 petaSELPDGQIGEIWLHGNNIGTGYWGKPEETAATFqniLKSRLSEShaegapdDALWVRTGDYGVY-FDGELYITGRV 485
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1876 DDQVKIRG---YRIEL-------------GEVAtALAELAGVGQAVV-------IAREDRPGDKRLVGYAtEIAPGA--V 1930
Cdd:PRK07769 486 KDLVIIDGrnhYPQDLeytaqeatkalrtGYVA-AFSVPANQLPQVVfddshagLKFDPEDTSEQLVIVA-ERAPGAhkL 563
|
570 580 590 600 610 620 630
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1931 DPA----GLRAQLAQR--LPG---YLVPAAvvvidALPLTVNGKLDHRALPApEYGDTN---GYRAPAGP 1988
Cdd:PRK07769 564 DPQpiadDIRAAIAVRhgVTVrdvLLVPAG-----SIPRTSSGKIARRACRA-AYLDGSlrsGYGQPAFP 627
|
|
| MACS_like_1 |
cd05974 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
534-853 |
5.78e-09 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341278 [Multi-domain] Cd Length: 432 Bit Score: 61.04 E-value: 5.78e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 534 LVTVVDVAATQLavvGHDELRKVVDE------RVTQVTHdallATKTAYIMPTSGTTGQPKLVRISHGSLAVfcDAISRA 607
Cdd:cd05974 48 LGAVVIPATTLL---TPDDLRDRVDRggavyaAVDENTH----ADDPMLLYFTSGTTSKPKLVEHTHRSYPV--GHLSTM 118
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 608 Y----------------GWGAHDTVLQCAPLTSDISVeEIFGGAACGARLVrsaamktgdLAALVDdlvARETTIVDLPT 671
Cdd:cd05974 119 YwiglkpgdvhwnisspGWAKHAWSCFFAPWNAGATV-FLFNYARFDAKRV---------LAALVR---YGVTTLCAPPT 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 672 aVWQLLCADGDAIDAIGrsrLRQIVIGGEAIRCSAVDKwleSAASQGISLLSSYGPTEATVVATFLPivcDQTTMDGAll 751
Cdd:cd05974 186 -VWRMLIQQDLASFDVK---LREVVGAGEPLNPEVIEQ---VRRAWGLTIRDGYGQTETTALVGNSP---GQPVKAGS-- 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 752 rLGRPIL--------PNTVFLAFGEVVIV-GDLVADGYL-GIDGDGFGTVTAADGSRRRafaTGDRVTVDAEGFPVFSGR 821
Cdd:cd05974 254 -MGRPLPgyrvalldPDGAPATEGEVALDlGDTRPVGLMkGYAGDPDKTAHAMRGGYYR---TGDIAMRDEDGYLTYVGR 329
|
330 340 350
....*....|....*....|....*....|..
gi 489495878 822 KDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd05974 330 ADDVFKSSDYRISPFELESVLIEHPAVAEAAV 361
|
|
| Epimerase |
pfam01370 |
NAD dependent epimerase/dehydratase family; This family of proteins utilize NAD as a cofactor. ... |
2110-2310 |
5.89e-09 |
|
NAD dependent epimerase/dehydratase family; This family of proteins utilize NAD as a cofactor. The proteins in this family use nucleotide-sugar substrates for a variety of chemical reactions.
Pssm-ID: 396097 [Multi-domain] Cd Length: 238 Bit Score: 59.23 E-value: 5.89e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2110 VLLTGATGFLGRYLVLELLRRldvDGRLICLVRAESDEDARRRLEKTFDSGD----PELLRHFKELAADrlEVV-AGDKS 2184
Cdd:pfam01370 1 ILVTGATGFIGSHLVRRLLEK---GYEVIGLDRLTSASNTARLADLRFVEGDltdrDALEKLLADVRPD--AVIhLAAVG 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2185 EPDLGLDQPmwrrlaetVDLIVDsaamvnafpyhelfgpNVAGTAELIRIALTTKLKPFTYVSTADVGAAIEPSAFTEDA 2264
Cdd:pfam01370 76 GVGASIEDP--------EDFIEA----------------NVLGTLNLLEAARKAGVKRFLFASSSEVYGDGAEIPQEETT 131
|
170 180 190 200
....*....|....*....|....*....|....*....|....*.
gi 489495878 2265 DIRVISPTRtvdggwagGYGTSKWAGEVLLREANDLCALPVAVFRC 2310
Cdd:pfam01370 132 LTGPLAPNS--------PYAAAKLAGEWLVLAYAAAYGLRAVILRL 169
|
|
| PRK08315 |
PRK08315 |
AMP-binding domain protein; Validated |
1494-1965 |
6.16e-09 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236236 [Multi-domain] Cd Length: 559 Bit Score: 61.37 E-value: 6.16e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1494 IPQMLAAQVARIPEAEAV--CCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLP 1571
Cdd:PRK08315 18 IGQLLDRTAARYPDREALvyRDQGLRWTYREFNEEVDALAKGLLALGIEKGDRVGIWAPNVPEWVLTQFATAKIGAILVT 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1572 IDPANPPPRVAF-----------------------MLGDAVPVAAVTTAG-LRS----------RLAGHDLPIIDVVDAL 1617
Cdd:PRK08315 98 INPAYRLSELEYalnqsgckaliaadgfkdsdyvaMLYELAPELATCEPGqLQSarlpelrrviFLGDEKHPGMLNFDEL 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1618 AAYPGTPPPMPAA-----------VNlayILYTSGTTGEPKGVGITHRNVtrlfaslparlsaaqvwsqchsygfdasaw 1686
Cdd:PRK08315 178 LALGRAVDDAELAarqatldpddpIN---IQYTSGTTGFPKGATLTHRNI------------------------------ 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1687 eiwgalLGGGRLviVPESVAASPND--------FH------GLLVAehvsvLTQTPAAVAML----PTQGLESV------ 1742
Cdd:PRK08315 225 ------LNNGYF--IGEAMKLTEEDrlcipvplYHcfgmvlGNLAC-----VTHGATMVYPGegfdPLATLAAVeeerct 291
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1743 AL---------------------------VVAGEACPAALVDrwapgRVM--LN------AYGPTETT--ICA-AISAPL 1784
Cdd:PRK08315 292 ALygvptmfiaeldhpdfarfdlsslrtgIMAGSPCPIEVMK-----RVIdkMHmsevtiAYGMTETSpvSTQtRTDDPL 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1785 RP-----GSGMPPIGV----PVSGaalfvldswlRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVAcpfggsgARMY 1855
Cdd:PRK08315 367 EKrvttvGRALPHLEVkivdPETG----------ETVPRGEQGELCTRGYSVMKGYWNDPEKTAEAIDA-------DGWM 429
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1856 RTGDLVCWRADGQLEFLGRTDDQVkIRG----YRIELGEV-----ATALAELAGV-----GQAV---VIAREDRPgdkrl 1918
Cdd:PRK08315 430 HTGDLAVMDEEGYVNIVGRIKDMI-IRGgeniYPREIEEFlythpKIQDVQVVGVpdekyGEEVcawIILRPGAT----- 503
|
570 580 590 600
....*....|....*....|....*....|....*....|....*..
gi 489495878 1919 vgyateiapgaVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGK 1965
Cdd:PRK08315 504 -----------LTEEDVRDFCRGKIAHYKIPRYIRFVDEFPMTVTGK 539
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
574-910 |
8.81e-09 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 59.82 E-value: 8.81e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSlavfcdAISRAYGWGAhdtvlqCAPLTSDISVEEI------FG-GAACGARLVRSAA 646
Cdd:cd17638 2 VSDIMFTSGTTGRSKGVMCAHRQ------TLRAAAAWAD------CADLTEDDRYLIInpffhtFGyKAGIVACLLTGAT 69
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 647 ---MKTGDLAALVDDLVARETTIVDLPTAVWQLLCADGDAIDAiGRSRLRQIVIGGEAIRCSAVDKWLESAASQGIslLS 723
Cdd:cd17638 70 vvpVAVFDVDAILEAIERERITVLPGPPTLFQSLLDHPGRKKF-DLSSLRAAVTGAATVPVELVRRMRSELGFETV--LT 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 724 SYGPTEATVVATFLP---IVCDQTT----MDGALLRLGRPilpntvflafGEVVIVGDLVADGYL--------GIDGDGF 788
Cdd:cd17638 147 AYGLTEAGVATMCRPgddAETVATTcgraCPGFEVRIADD----------GEVLVRGYNVMQGYLddpeataeAIDADGW 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 789 gtvtaadgsrrraFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV----ELHSGSLGVWF 864
Cdd:cd17638 217 -------------LHTGDVGELDERGYLRITDRLKDMYIVGGFNVYPAEVEGALAEHPGVAQVAVigvpDERMGEVGKAF 283
|
330 340 350 360
....*....|....*....|....*....|....*....|....*...
gi 489495878 865 KSQRTREG--EQDAAAATRIRLVLVSLgvsSFFVVGVPNIPRKPNGKI 910
Cdd:cd17638 284 VVARPGVTltEEDVIAWCRERLANYKV---PRFVRFLDELPRNASGKV 328
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
537-853 |
9.93e-09 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 60.46 E-value: 9.93e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 537 VVDVAATQLAVVGHDELRKVVDERVTQVTHDALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTV 616
Cdd:cd05959 128 VLIVSGGAGPEAGALLLAELVAAEAEQLKPAATHADDPAFWLYSSGSTGRPKGVVHLHADIYWTAELYARNVLGIREDDV 207
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 617 LqcapltsdISVEEIF---G-GAAC------GARLVRSAAMKTgdlAALVDDLVARE--TTIVDLPTAVWQLLCADGdaI 684
Cdd:cd05959 208 C--------FSAAKLFfayGlGNSLtfplsvGATTVLMPERPT---PAAVFKRIRRYrpTVFFGVPTLYAAMLAAPN--L 274
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 685 DAIGRSRLRQIVIGGEAIRCSAVDKWlesAASQGISLLSSYGPTEAtvvatfLPIVCDQTTMDGALLRLGRPIlPNTvfl 764
Cdd:cd05959 275 PSRDLSSLRLCVSAGEALPAEVGERW---KARFGLDILDGIGSTEM------LHIFLSNRPGRVRYGTTGKPV-PGY--- 341
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 765 afgEVVIVGD---LVADGYLG---IDGDGFGTV--TAADGSRRRA----FATGDRVTVDAEGFPVFSGRKDAVVKISGKR 832
Cdd:cd05959 342 ---EVELRDEdggDVADGEPGelyVRGPSSATMywNNRDKTRDTFqgewTRTGDKYVRDDDGFYTYAGRADDMLKVSGIW 418
|
330 340
....*....|....*....|.
gi 489495878 833 VDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd05959 419 VSPFEVESALVQHPAVLEAAV 439
|
|
| PRK08974 |
PRK08974 |
long-chain-fatty-acid--CoA ligase FadD; |
1632-1971 |
1.14e-08 |
|
long-chain-fatty-acid--CoA ligase FadD;
Pssm-ID: 236359 [Multi-domain] Cd Length: 560 Bit Score: 60.45 E-value: 1.14e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1632 NLAYILYTSGTTGEPKGVGITHRN-VTRLFASLPARLSAAQVWSQchsygFDASAWEIWG--AL---------LGGGRLV 1699
Cdd:PRK08974 207 DLAFLQYTGGTTGVAKGAMLTHRNmLANLEQAKAAYGPLLHPGKE-----LVVTALPLYHifALtvncllfieLGGQNLL 281
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1700 IVpesvaaSPNDFHGLlvaehVSVLTQTPAAV---------AMLPTQGLE-----SVALVVAG-EACPAALVDRW--APG 1762
Cdd:PRK08974 282 IT------NPRDIPGF-----VKELKKYPFTAitgvntlfnALLNNEEFQeldfsSLKLSVGGgMAVQQAVAERWvkLTG 350
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1763 RVMLNAYGPTETT-ICAAISAPLRPGSGmpPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTAS- 1840
Cdd:PRK08974 351 QYLLEGYGLTECSpLVSVNPYDLDYYSG--SIGLPVPSTEIKLVDDDGNEVPPGEPGELWVKGPQVMLGYWQRPEATDEv 428
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1841 ---RFVAcpfggsgarmyrTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAredRPGDkr 1917
Cdd:PRK08974 429 ikdGWLA------------TGDIAVMDEEGFLRIVDRKKDMILVSGFNVYPNEIEDVVMLHPKVLEVAAVG---VPSE-- 491
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1918 LVGYATEIAPGAVDPA----GLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK08974 492 VSGEAVKIFVVKKDPSlteeELITHCRRHLTGYKVPKLVEFRDELPKSNVGKILRREL 549
|
|
| LC_FACL_like |
cd05914 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are ... |
1514-1656 |
1.15e-08 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341240 [Multi-domain] Cd Length: 463 Bit Score: 60.15 E-value: 1.15e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1514 GDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAA 1593
Cdd:cd05914 4 GGEPLTYKDLADNIAKFALLLKINGVGTGDRVALMGENRPEWGIAFFAIWTYGAIAVPILAEFTADEVHHILNHSEAKAI 83
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 489495878 1594 VTTaglrsrlaghdlpiiDVVDalaaypgtpppmpaavnLAYILYTSGTTGEPKGVGITHRNV 1656
Cdd:cd05914 84 FVS---------------DEDD-----------------VALINYTSGTTGNSKGVMLTYRNI 114
|
|
| PRK07008 |
PRK07008 |
long-chain-fatty-acid--CoA ligase; Validated |
580-853 |
1.66e-08 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235908 [Multi-domain] Cd Length: 539 Bit Score: 59.72 E-value: 1.66e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 580 TSGTTGQPKLVRISHGS--LAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGdlaALVD 657
Cdd:PRK07008 184 TSGTTGNPKGALYSHRStvLHAYGAALPDAMGLSARDAVLPVVPMFHVNAWGLPYSAPLTGAKLVLPGPDLDG---KSLY 260
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 658 DLVARE--TTIVDLPTaVWQLLCadgDAIDAIGR--SRLRQIVIGGEAirC-SAVDKWLESAasQGISLLSSYGPTEATV 732
Cdd:PRK07008 261 ELIEAErvTFSAGVPT-VWLGLL---NHMREAGLrfSTLRRTVIGGSA--CpPAMIRTFEDE--YGVEVIHAWGMTEMSP 332
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 733 VATFLPIVCDQTTMDGA-----LLRLGRPI--------------LP-NTVflAFGEVVIVGDLVADGYLGIDGDGFgtvt 792
Cdd:PRK07008 333 LGTLCKLKWKHSQLPLDeqrklLEKQGRVIygvdmkivgddgreLPwDGK--AFGDLQVRGPWVIDRYFRGDASPL---- 406
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 489495878 793 aadgsRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK07008 407 -----VDGWFPTGDVATIDADGFMQITDRSKDVIKSGGEWISSIDIENVAVAHPAVAEAAC 462
|
|
| LC-FACS_euk |
cd05927 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are ... |
1624-1663 |
2.97e-08 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are eukaryotic fatty acid CoA synthetases that activate fatty acids with chain lengths of 12 to 20. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells.
Pssm-ID: 341250 [Multi-domain] Cd Length: 545 Bit Score: 59.15 E-value: 2.97e-08
10 20 30 40
....*....|....*....|....*....|....*....|
gi 489495878 1624 PPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASL 1663
Cdd:cd05927 107 PPPPPKPEDLATICYTSGTTGNPKGVMLTHGNIVSNVAGV 146
|
|
| PLN02860 |
PLN02860 |
o-succinylbenzoate-CoA ligase |
1629-1966 |
3.01e-08 |
|
o-succinylbenzoate-CoA ligase
Pssm-ID: 215464 [Multi-domain] Cd Length: 563 Bit Score: 59.04 E-value: 3.01e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1629 AAVNLAYILYTSGTTGEPKGVGITHRNVTrlFASLpARLSAAQVWSQ---------CHSYGFdASAWEIwgaLLGGGRLV 1699
Cdd:PLN02860 170 APDDAVLICFTSGTTGRPKGVTISHSALI--VQSL-AKIAIVGYGEDdvylhtaplCHIGGL-SSALAM---LMVGACHV 242
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1700 IVPEsvaaspndFHGLLVAE-----HVSVLTQTPAAVAMLPT--------QGLESV-ALVVAGEACPAALVD---RWAPG 1762
Cdd:PLN02860 243 LLPK--------FDAKAALQaikqhNVTSMITVPAMMADLISltrksmtwKVFPSVrKILNGGGSLSSRLLPdakKLFPN 314
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1763 RVMLNAYGPTETtiCAAIS-------------------APLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVaGELYIA 1823
Cdd:PLN02860 315 AKLFSAYGMTEA--CSSLTfmtlhdptlespkqtlqtvNQTKSSSVHQPQGVCVGKPAPHVELKIGLDESSRV-GRILTR 391
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1824 GAGVGVGYWrraGLTASRFVACPFGGsgarMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQ 1903
Cdd:PLN02860 392 GPHVMLGYW---GQNSETASVLSNDG----WLDTGDIGWIDKAGNLWLIGRSNDRIKTGGENVYPEEVEAVLSQHPGVAS 464
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1904 AVVIARED-RPGDK-----RL--------VGYATEIAPGAVDPAGLRAQL-AQRLPGYLVPAAVVVI-DALPLTVNGKL 1966
Cdd:PLN02860 465 VVVVGVPDsRLTEMvvacvRLrdgwiwsdNEKENAKKNLTLSSETLRHHCrEKNLSRFKIPKLFVQWrKPFPLTTTGKI 543
|
|
| PRK05851 |
PRK05851 |
long-chain-fatty acid--ACP ligase MbtM; |
580-910 |
3.01e-08 |
|
long-chain-fatty acid--ACP ligase MbtM;
Pssm-ID: 180289 [Multi-domain] Cd Length: 525 Bit Score: 59.01 E-value: 3.01e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 580 TSGTTGQPKLVRISHGS-LAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAamkTGDLAA---- 654
Cdd:PRK05851 160 TAGSTGTPRTAILSPGAvLSNLRGLNARVGLDAATDVGCSWLPLYHDMGLAFLLTAALAGAPLWLAP---TTAFSAspfr 236
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 655 LVDDLVARETTIVDLPTAVWQLLCADGDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLESAASQGI---SLLSSYGPTEAT 731
Cdd:PRK05851 237 WLSWLSDSRATLTAAPNFAYNLIGKYARRVSDVDLGALRVALNGGEPVDCDGFERFATAMAPFGFdagAAAPSYGLAEST 316
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 732 VVATfLPI------VCDQTTMDGALLR----LGRPILPNTVFLA------------FGEVVIVGDLVADGYLGidgdgfg 789
Cdd:PRK05851 317 CAVT-VPVpgiglrVDEVTTDDGSGARrhavLGNPIPGMEVRISpgdgaagvagreIGEIEIRGASMMSGYLG------- 388
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 790 tvtAADGSRRRAFATGDRVTVDAEGFpVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSD---VAVELHSGSL--GVWF 864
Cdd:PRK05851 389 ---QAPIDPDDWFPTGDLGYLVDGGL-VVCGRAKELITVAGRNIFPTEIERVAAQVRGVREgavVAVGTGEGSArpGLVI 464
|
330 340 350 360
....*....|....*....|....*....|....*....|....*...
gi 489495878 865 KSQrTREGEQDAAAATRIRLVLVSLGVSSFFVVGVP--NIPRKPNGKI 910
Cdd:PRK05851 465 AAE-FRGPDEAGARSEVVQRVASECGVVPSDVVFVApgSLPRTSSGKL 511
|
|
| FADD10 |
cd17635 |
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain ... |
574-910 |
3.82e-08 |
|
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain fatty acid CoA ligases, including FadD10 which is involved in the synthesis of a virulence-related lipopeptide. FadD10 is a fatty acyl-AMP ligase (FAAL) that transfers fatty acids to an acyl carrier protein. Structures of FadD10 in apo- and complexed form with dodecanoyl-AMP, show a novel open conformation, facilitated by its unique inter-domain and intermolecular interactions, which is critical for the enzyme to carry out the acyl transfer onto the acyl carrier protein (Rv0100) rather than coenzyme A.
Pssm-ID: 341290 [Multi-domain] Cd Length: 340 Bit Score: 58.04 E-value: 3.82e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSL-AVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEI----FGGAAC---GARLVRSA 645
Cdd:cd17635 3 PLAVIFTSGTTGEPKAVLLANKTFfAVPDILQKEGLNWVVGDVTYLPLPATHIGGLWWIltclIHGGLCvtgGENTTYKS 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 646 AMKTGDLAALvddlvareTTIVDLPTAVWQLLCADGDAIDAIgrSRLRQIVIGGEAIrcsAVDKWLESAASQGISLLSSY 725
Cdd:cd17635 83 LFKILTTNAV--------TTTCLVPTLLSKLVSELKSANATV--PSLRLIGYGGSRA---IAADVRFIEATGLTNTAQVY 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 726 GPTEaTVVATFLPIVCDQTTMDGallrLGRPILPNTVFLA-----------FGEVVIVGDLVADGYLGidgdgfGTVTAA 794
Cdd:cd17635 150 GLSE-TGTALCLPTDDDSIEINA----VGRPYPGVDVYLAatdgiagpsasFGTIWIKSPANMLGYWN------NPERTA 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 795 DGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV-ELHSGSLGVWFKSQRTREGE 873
Cdd:cd17635 219 EVLIDGWVNTGDLGERREDGFLFITGRSSESINCGGVKIAPDEVERIAEGVSGVQECACyEISDEEFGELVGLAVVASAE 298
|
330 340 350 360
....*....|....*....|....*....|....*....|
gi 489495878 874 QDAAAATRIRL-VLVSLGVSSF--FVVGVPNIPRKPNGKI 910
Cdd:cd17635 299 LDENAIRALKHtIRRELEPYARpsTIVIVTDIPRTQSGKV 338
|
|
| PRK07201 |
PRK07201 |
SDR family oxidoreductase; |
2109-2316 |
3.82e-08 |
|
SDR family oxidoreductase;
Pssm-ID: 235962 [Multi-domain] Cd Length: 657 Bit Score: 58.81 E-value: 3.82e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2109 TVLLTGATGFLGRYLVLELLRRlDVDGRLICLVRAESdedaRRRLEktfdsgdpellRHFKELAADRLEVVAGDKSEPDL 2188
Cdd:PRK07201 2 RYFVTGGTGFIGRRLVSRLLDR-RREATVHVLVRRQS----LSRLE-----------ALAAYWGADRVVPLVGDLTEPGL 65
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2189 GLDQPMWRR---------LAETVDLIVDSAAMVNAfpyhelfgpNVAGTAELIRIALTTKLKPFTYVSTADVgAAIEPSA 2259
Cdd:PRK07201 66 GLSEADIAElgdidhvvhLAAIYDLTADEEAQRAA---------NVDGTRNVVELAERLQAATFHHVSSIAV-AGDYEGV 135
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2260 FTE---DADIRVISPtrtvdggwaggYGTSKWAGEVLLREAndlCALPVAVFRCGMILAD 2316
Cdd:PRK07201 136 FREddfDEGQGLPTP-----------YHRTKFEAEKLVREE---CGLPWRVYRPAVVVGD 181
|
|
| FAAL |
cd05931 |
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and ... |
540-910 |
3.99e-08 |
|
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and is homologous to fatty acyl-coenzyme A (CoA) ligases (FACLs). However, FAALs produce only the acyl adenylate and are unable to perform the thioester-forming reaction, while FACLs perform a two-step catalytic reaction; AMP ligation followed by CoA ligation using ATP and CoA as cofactors. FAALs have insertion motifs between the N-terminal and C-terminal subdomains that distinguish them from the FACLs. This insertion motif precludes the binding of CoA, thus preventing CoA ligation. It has been suggested that the acyl adenylates serve as substrates for multifunctional polyketide synthases to permit synthesis of complex lipids such as phthiocerol dimycocerosate, sulfolipids, mycolic acids, and mycobactin.
Pssm-ID: 341254 [Multi-domain] Cd Length: 547 Bit Score: 58.79 E-value: 3.99e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 540 VAATQLAVVGHDELRKVVDERVT-----QVTHDALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHD 614
Cdd:cd05931 112 VRAFAASRPAAGTPRLLVVDLLPdtsaaDWPPPSPDPDDIAYLQYTSGSTGTPKGVVVTHRNLLANVRQIRRAYGLDPGD 191
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 615 TVLQCAPLTSDIS-VEEIFGGAACGARLVRSAAM----KTGDLAALVDDLVAretTIVDLPTAVWQlLCAD---GDAIDA 686
Cdd:cd05931 192 VVVSWLPLYHDMGlIGGLLTPLYSGGPSVLMSPAaflrRPLRWLRLISRYRA---TISAAPNFAYD-LCVRrvrDEDLEG 267
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 687 IGRSRLRQIVIGGEAIRCSAVDKWLESAASQGI---SLLSSYGPTEATVVATFLPI----VCDQTTMDG----------- 748
Cdd:cd05931 268 LDLSSWRVALNGAEPVRPATLRRFAEAFAPFGFrpeAFRPSYGLAEATLFVSGGPPgtgpVVLRVDRDAlagravavaad 347
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 749 -----ALLRLGRPIL--------PNTVFLA----FGEVVIVGDLVADGYLGIDG---DGFGTVTAADGsrRRAFATGDRV 808
Cdd:cd05931 348 dpaarELVSCGRPLPdqevrivdPETGRELpdgeVGEIWVRGPSVASGYWGRPEataETFGALAATDE--GGWLRTGDLG 425
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 809 TVdAEGFPVFSGRKDAVVKISGKRV---DIAEVTRRIAEDPAVSDVAV----ELHSGSLGVWFKSQRTREGEQDAAAATR 881
Cdd:cd05931 426 FL-HDGELYITGRLKDLIIVRGRNHypqDIEATAEEAHPALRPGCVAAfsvpDDGEERLVVVAEVERGADPADLAAIAAA 504
|
410 420 430
....*....|....*....|....*....|..
gi 489495878 882 IR-LVLVSLGVSSFFVVGVPN--IPRKPNGKI 910
Cdd:cd05931 505 IRaAVAREHGVAPADVVLVRPgsIPRTSSGKI 536
|
|
| PRK06334 |
PRK06334 |
long chain fatty acid--[acyl-carrier-protein] ligase; Validated |
1632-1904 |
4.53e-08 |
|
long chain fatty acid--[acyl-carrier-protein] ligase; Validated
Pssm-ID: 180533 [Multi-domain] Cd Length: 539 Bit Score: 58.29 E-value: 4.53e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1632 NLAYILYTSGTTGEPKGVGITHRNvtrLFASLPARLSAAQVWSQ---------CHSYGFDASAweIWGALLGggrLVIVP 1702
Cdd:PRK06334 184 DVAVILFTSGTEKLPKGVPLTHAN---LLANQRACLKFFSPKEDdvmmsflppFHAYGFNSCT--LFPLLSG---VPVVF 255
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1703 ESVAASPNDFHGLLVAEHVSVLTQTPA------AVAMLPTQGLESVALVV-AGEACPAAL---VDRWAPGRVMLNAYGPT 1772
Cdd:PRK06334 256 AYNPLYPKKIVEMIDEAKVTFLGSTPVffdyilKTAKKQESCLPSLRFVViGGDAFKDSLyqeALKTFPHIQLRQGYGTT 335
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1773 ETTICAAISAPLRPGSGmPPIGVPVSGA-ALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWrrAGLTASRFVACpfggSG 1851
Cdd:PRK06334 336 ECSPVITINTVNSPKHE-SCVGMPIRGMdVLIVSEETKVPVSSGETGLVLTRGTSLFSGYL--GEDFGQGFVEL----GG 408
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|...
gi 489495878 1852 ARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQA 1904
Cdd:PRK06334 409 ETWYVTGDLGYVDRHGELFLKGRLSRFVKIGAEMVSLEALESILMEGFGQNAA 461
|
|
| PRK06155 |
PRK06155 |
crotonobetaine/carnitine-CoA ligase; Provisional |
574-853 |
5.91e-08 |
|
crotonobetaine/carnitine-CoA ligase; Provisional
Pssm-ID: 235719 [Multi-domain] Cd Length: 542 Bit Score: 58.23 E-value: 5.91e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLV---RSAAmktg 650
Cdd:PRK06155 182 TAAILYTSGTTGPSKGVCCPHAQFYWWGRNSAEDLEIGADDVLYTTLPLFHTNALNAFFQALLAGATYVlepRFSA---- 257
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 651 dlAALVDDLVARETTIVDLPTAVWQLLCADgDAIDAIGRSRLRQIVIGGEAIRcsAVDKWLESAasqGISLLSSYGPTEA 730
Cdd:PRK06155 258 --SGFWPAVRRHGATVTYLLGAMVSILLSQ-PARESDRAHRVRVALGPGVPAA--LHAAFRERF---GVDLLDGYGSTET 329
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 731 TVVATFLPIVCDQTTM----DGALLRL----GRPILPNTVflafGEVVIVGD---LVADGYlgiDGDGFGTVTAAdgsRR 799
Cdd:PRK06155 330 NFVIAVTHGSQRPGSMgrlaPGFEARVvdehDQELPDGEP----GELLLRADepfAFATGY---FGMPEKTVEAW---RN 399
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*
gi 489495878 800 RAFATGDRVTVDAEGFPVFSGR-KDAvVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK06155 400 LWFHTGDRVVRDADGWFRFVDRiKDA-IRRRGENISSFEVEQVLLSHPAVAAAAV 453
|
|
| PRK06164 |
PRK06164 |
acyl-CoA synthetase; Validated |
580-853 |
5.96e-08 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235722 [Multi-domain] Cd Length: 540 Bit Score: 58.22 E-value: 5.96e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 580 TSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLAALVDDl 659
Cdd:PRK06164 189 TSGTTSGPKLVLHRQATLLRHARAIARAYGYDPGAVLLAALPFCGVFGFSTLLGALAGGAPLVCEPVFDAARTARALRR- 267
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 660 vARETTIVDLPTAVWQLLCADGDAIDAigrSRLRQIvigGEAIRCSAVDKWLESAASQGISLLSSYGPTEatVVATFLpi 739
Cdd:PRK06164 268 -HRVTHTFGNDEMLRRILDTAGERADF---PSARLF---GFASFAPALGELAALARARGVPLTGLYGSSE--VQALVA-- 336
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 740 vCDQTTMDGALLRL--GRPILPNTVFLAF-------------GEVVIVGDLVADGYLGiDGDGFGTVTAADGsrrrAFAT 804
Cdd:PRK06164 337 -LQPATDPVSVRIEggGRPASPEARVRARdpqdgallpdgesGEIEIRAPSLMRGYLD-NPDATARALTDDG----YFRT 410
|
250 260 270 280
....*....|....*....|....*....|....*....|....*....
gi 489495878 805 GDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK06164 411 GDLGYTRGDGQFVYQTRMGDSLRLGGFLVNPAEIEHALEALPGVAAAQV 459
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
574-853 |
6.67e-08 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 57.99 E-value: 6.67e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTsdisveEIFG-GAACGARLVRSAAM---KT 649
Cdd:PRK07656 168 VADILFTSGTTGRPKGAMLTHRQLLSNAADWAEYLGLTEGDRYLAANPFF------HVFGyKAGVNAPLMRGATIlplPV 241
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 650 GDLAALVDDLVARETTIVDLPTAVWQLLCA--DGDAIDAigrSRLRQIVIGGEAIRCSAVDKwLESAASQGIsLLSSYGP 727
Cdd:PRK07656 242 FDPDEVFRLIETERITVLPGPPTMYNSLLQhpDRSAEDL---SSLRLAVTGAASMPVALLER-FESELGVDI-VLTGYGL 316
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 728 TEATVVATFLPIVCDQTT--------MDGALLR----LGRPILPNTVflafGEVVIVGDLVADGYLG--------IDGDG 787
Cdd:PRK07656 317 SEASGVTTFNRLDDDRKTvagtigtaIAGVENKivneLGEEVPVGEV----GELLVRGPNVMKGYYDdpeataaaIDADG 392
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 788 FgtvtaadgsrrraFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK07656 393 W-------------LHTGDLGRLDEEGYLYIVDRKKDMFIVGGFNVYPAEVEEVLYEHPAVAEAAV 445
|
|
| ABCL |
cd05958 |
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate ... |
552-853 |
6.70e-08 |
|
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate aerobic degradation pathway by activating 2-aminobenzoate to 2-aminobenzoyl-CoA. The reaction is carried out via a two-step process; the first step is ATP-dependent and forms a 2-aminobenzoyl-AMP intermediate, and the second step forms the 2-aminobenzoyl-CoA ester and releases the AMP. 2-Aminobenzoyl-CoA is further converted to 2-amino-5-oxo-cyclohex-1-ene-1-carbonyl-CoA catalyzed by 2-aminobenzoyl-CoA monooxygenase/reductase. ABCL has been purified from cells aerobically grown with 2-aminobenzoate as sole carbon, energy, and nitrogen source, and has been characterized as a monomer.
Pssm-ID: 341268 [Multi-domain] Cd Length: 439 Bit Score: 57.49 E-value: 6.70e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 552 ELRKVVDERVTQVTHDALLATktayimpTSGTTGQPKLVRISHGSLAVFCDaisrayGWGAHdtVLQCAPLTSDISVEEI 631
Cdd:cd05958 84 ITVALCAHALTASDDICILAF-------TSGTTGAPKATMHFHRDPLASAD------RYAVN--VLRLREDDRFVGSPPL 148
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 632 FGGAACGARLV------RSAAMKTGDLAALVDDLVARE--TTIVDLPTAvWQLLCADGDAIDAIGrSRLRQIVIGGEAIR 703
Cdd:cd05958 149 AFTFGLGGVLLfpfgvgASGVLLEEATPDLLLSAIARYkpTVLFTAPTA-YRAMLAHPDAAGPDL-SSLRKCVSAGEALP 226
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 704 CSAVDKWLESAasqGISLLSSYGPTEA------------------TVVATFLPIVCDQttmdgallrLGRPILPNTvfla 765
Cdd:cd05958 227 AALHRAWKEAT---GIPIIDGIGSTEMfhifisarpgdarpgatgKPVPGYEAKVVDD---------EGNPVPDGT---- 290
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 766 fgevviVGDLVADGYLGIDGDgfgtvtaADGSRRRAF-----ATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTR 840
Cdd:cd05958 291 ------IGRLAVRGPTGCRYL-------ADKRQRTYVqggwnITGDTYSRDPDGYFRHQGRSDDMIVSGGYNIAPPEVED 357
|
330
....*....|...
gi 489495878 841 RIAEDPAVSDVAV 853
Cdd:cd05958 358 VLLQHPAVAECAV 370
|
|
| PLN02860 |
PLN02860 |
o-succinylbenzoate-CoA ligase |
575-853 |
9.55e-08 |
|
o-succinylbenzoate-CoA ligase
Pssm-ID: 215464 [Multi-domain] Cd Length: 563 Bit Score: 57.50 E-value: 9.55e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTsdisveEIFGGAACGARLVRSAA---MKTGD 651
Cdd:PLN02860 175 VLICFTSGTTGRPKGVTISHSALIVQSLAKIAIVGYGEDDVYLHTAPLC------HIGGLSSALAMLMVGAChvlLPKFD 248
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 652 LAALVDDLVARE-TTIVDLPTAVWQLLCADGDAIDAIGRSRLRQIVIGGEAIRC---SAVDKWLESAAsqgisLLSSYGP 727
Cdd:PLN02860 249 AKAALQAIKQHNvTSMITVPAMMADLISLTRKSMTWKVFPSVRKILNGGGSLSSrllPDAKKLFPNAK-----LFSAYGM 323
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 728 TEATVVATFLPIvcDQTTMDGALLRLGRPILPNTVFLAFGEVVIVGDLVADGYLGIDGDGFGTV---------------- 791
Cdd:PLN02860 324 TEACSSLTFMTL--HDPTLESPKQTLQTVNQTKSSSVHQPQGVCVGKPAPHVELKIGLDESSRVgriltrgphvmlgywg 401
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 792 ----TAADGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PLN02860 402 qnseTASVLSNDGWLDTGDIGWIDKAGNLWLIGRSNDRIKTGGENVYPEEVEAVLSQHPGVASVVV 467
|
|
| PRK12582 |
PRK12582 |
acyl-CoA synthetase; Provisional |
1486-1943 |
1.06e-07 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237144 [Multi-domain] Cd Length: 624 Bit Score: 57.36 E-value: 1.06e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1486 APAPTPVSIPQMLAAQVARIPE----AEAVCCGDA--SMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAM 1559
Cdd:PRK12582 43 PLGPYPRSIPHLLAKWAAEAPDrpwlAQREPGHGQwrKVTYGEAKRAVDALAQALLDLGLDPGRPVMILSGNSIEHALMT 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1560 VAVLKTGAAYLPIDPANP----------------PPRVAFMlGDAVP----VAAVTTAGLRSRLAGHDLPIIDVVdALAA 1619
Cdd:PRK12582 123 LAAMQAGVPAAPVSPAYSlmshdhaklkhlfdlvKPRVVFA-QSGAPfaraLAALDLLDVTVVHVTGPGEGIASI-AFAD 200
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1620 YPGTPPPM----------PAAVnlAYILYTSGTTGEPKGVGITHRNVT-------RLFASLPARLSAAQV----WSqcHS 1678
Cdd:PRK12582 201 LAATPPTAavaaaiaaitPDTV--AKYLFTSGSTGMPKAVINTQRMMCaniamqeQLRPREPDPPPPVSLdwmpWN--HT 276
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1679 YGFDASaweIWGALLGGGRLVIVPESvaASPNDFHGLLVAEH-VS--VLTQTPAAVAMLPT-------------QGLESV 1742
Cdd:PRK12582 277 MGGNAN---FNGLLWGGGTLYIDDGK--PLPGMFEETIRNLReISptVYGNVPAGYAMLAEamekddalrrsffKNLRLM 351
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1743 ALvvAGEACPAALVDRW------APGR--VMLNAYGPTET--TICAAISAPLRPGSgmppIGVPVSGAALFVldswlrpV 1812
Cdd:PRK12582 352 AY--GGATLSDDLYERMqalavrTTGHriPFYTGYGATETapTTTGTHWDTERVGL----IGLPLPGVELKL-------A 418
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1813 PAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFggsgarmYRTGDLVCW----RADGQLEFLGRTDDQVKI-RGYRIE 1887
Cdd:PRK12582 419 PVGDKYEVRVKGPNVTPGYHKDPELTAAAFDEEGF-------YRLGDAARFvdpdDPEKGLIFDGRVAEDFKLsTGTWVS 491
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1888 LGEVAT-ALAELAGVGQAVVIAREDRP-----------GDKRLVGYATEIAPGAVDPAGLRAQLAQRL 1943
Cdd:PRK12582 492 VGTLRPdAVAACSPVIHDAVVAGQDRAfigllawpnpaACRQLAGDPDAAPEDVVKHPAVLAILREGL 559
|
|
| PRK07786 |
PRK07786 |
long-chain-fatty-acid--CoA ligase; Validated |
501-853 |
1.20e-07 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 169098 [Multi-domain] Cd Length: 542 Bit Score: 57.09 E-value: 1.20e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 501 IACHLAGCGYSVCDTADEISVRTNAITEHGDGILVTVVDVAATQLAVVGHDELRKVVDE--RVTQVTHDAllatkTAYIM 578
Cdd:PRK07786 106 IAFLVSDCGAHVVVTEAALAPVATAVRDIVPLLSTVVVAGGSSDDSVLGYEDLLAEAGPahAPVDIPNDS-----PALIM 180
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 579 PTSGTTGQPKLVRISHGSLAvfCDAISRAYGWGA---HDTVLQCAPLTSDISVEEIFGGAACGARLVRSAaMKTGDLAAL 655
Cdd:PRK07786 181 YTSGTTGRPKGAVLTHANLT--GQAMTCLRTNGAdinSDVGFVGVPLFHIAGIGSMLPGLLLGAPTVIYP-LGAFDPGQL 257
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 656 VDDLVARETTIVDLPTAVWQLLCADGDAIdaiGRS-RLRQIVIGGeairCSAVDKWLE--SAASQGISLLSSYGPTEATv 732
Cdd:PRK07786 258 LDVLEAEKVTGIFLVPAQWQAVCAEQQAR---PRDlALRVLSWGA----APASDTLLRqmAATFPEAQILAAFGQTEMS- 329
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 733 vatflPIVCdqtTMDG--ALLRLG---RPI---------------LPNTVflafGEVVIVGDLVADGYLGidgDGFGTVT 792
Cdd:PRK07786 330 -----PVTC---MLLGedAIRKLGsvgKVIptvaarvvdenmndvPVGEV----GEIVYRAPTLMSGYWN---NPEATAE 394
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 489495878 793 AADGSrrrAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK07786 395 AFAGG---WFHSGDLVRQDEEGYVWVVDRKKDMIISGGENIYCAEVENVLASHPDIVEVAV 452
|
|
| UDP_G4E_4_SDR_e |
cd05232 |
UDP-glucose 4 epimerase, subgroup 4, extended (e) SDRs; UDP-glucose 4 epimerase (aka ... |
2109-2331 |
1.23e-07 |
|
UDP-glucose 4 epimerase, subgroup 4, extended (e) SDRs; UDP-glucose 4 epimerase (aka UDP-galactose-4-epimerase), is a homodimeric extended SDR. It catalyzes the NAD-dependent conversion of UDP-galactose to UDP-glucose, the final step in Leloir galactose synthesis. This subgroup is comprised of bacterial proteins, and includes the Staphylococcus aureus capsular polysaccharide Cap5N, which may have a role in the synthesis of UDP-N-acetyl-d-fucosamine. This subgroup has the characteristic active site tetrad and NAD-binding motif of the extended SDRs. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187543 [Multi-domain] Cd Length: 303 Bit Score: 55.82 E-value: 1.23e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2109 TVLLTGATGFLGRYLVLELLrrldvdgrliclvraesdedarrrlektfdsgdpelLRHFKELAADRLEVVAGDKSEPDL 2188
Cdd:cd05232 1 KVLVTGANGFIGRALVDKLL------------------------------------SRGEEVRIAVRNAENAEPSVVLAE 44
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2189 GLDqPMWR-RLAETVDLIVDSAAMVNAF------PYHELFGPNVAGTAELIRIALTTKLKPFTYVSTadVGAAIEPsafT 2261
Cdd:cd05232 45 LPD-IDSFtDLFLGVDAVVHLAARVHVMndqgadPLSDYRKVNTELTRRLARAAARQGVKRFVFLSS--VKVNGEG---T 118
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2262 EDADIRVISPTRTVDGgwaggYGTSKWAGEVLLREANDLCALPVAVFRCGMILADTSYAGQLNMSDWVTR 2331
Cdd:cd05232 119 VGAPFDETDPPAPQDA-----YGRSKLEAERALLELGASDGMEVVILRPPMVYGPGVRGNFARLMRLIDR 183
|
|
| PRK08751 |
PRK08751 |
long-chain fatty acid--CoA ligase; |
563-852 |
1.46e-07 |
|
long-chain fatty acid--CoA ligase;
Pssm-ID: 181546 [Multi-domain] Cd Length: 560 Bit Score: 56.81 E-value: 1.46e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 563 QVTHDALlatktAYIMPTSGTTGQPKLVRISHGSLAVfcdAISRAYGWGA--------HDTVLQCAPLTsdisveEIFGG 634
Cdd:PRK08751 204 QIEPDDI-----AFLQYTGGTTGVAKGAMLTHRNLVA---NMQQAHQWLAgtgkleegCEVVITALPLY------HIFAL 269
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 635 AACGarLVrsaAMKTG----------DLAALVDDLV-ARETTIVDLPTAVWQLLCADGdaIDAIGRSRLRQIVIGGEAIR 703
Cdd:PRK08751 270 TANG--LV---FMKIGgcnhlisnprDMPGFVKELKkTRFTAFTGVNTLFNGLLNTPG--FDQIDFSSLKMTLGGGMAVQ 342
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 704 CSAVDKWLESAasqGISLLSSYGPTEATVVATFLPIVCDQttMDGALlrlGRPIlPNT---------VFLAFGEV---VI 771
Cdd:PRK08751 343 RSVAERWKQVT---GLTLVEAYGLTETSPAACINPLTLKE--YNGSI---GLPI-PSTdacikddagTVLAIGEIgelCI 413
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 772 VGDLVADGYLGiDGDGFGTVTAADGsrrrAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDV 851
Cdd:PRK08751 414 KGPQVMKGYWK-RPEETAKVMDADG----WLHTGDIARMDEQGFVYIVDRKKDMILVSGFNVYPNEIEDVIAMMPGVLEV 488
|
.
gi 489495878 852 A 852
Cdd:PRK08751 489 A 489
|
|
| FACL_like_1 |
cd05910 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
570-852 |
1.80e-07 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341236 [Multi-domain] Cd Length: 457 Bit Score: 56.31 E-value: 1.80e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 570 LATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSdisveeIFG---GAACGARLVRSAA 646
Cdd:cd05910 83 KADEPAAILFTSGSTGTPKGVVYRHGTFAAQIDALRQLYGIRPGEVDLATFPLFA------LFGpalGLTSVIPDMDPTR 156
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 647 MKTGDLAALVDDLVARETTIVDLPTAVWQLLCADGDAIDaIGRSRLRQIVIGGEAIRCSAVDKwLESAASQGISLLSSYG 726
Cdd:cd05910 157 PARADPQKLVGAIRQYGVSIVFGSPALLERVARYCAQHG-ITLPSLRRVLSAGAPVPIALAAR-LRKMLSDEAEILTPYG 234
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 727 PTEATVVATF----LPIVCDQTTMDGALLRLGRPILPNTVFL--------------------AFGEVVIVGDLVADGYLG 782
Cdd:cd05910 235 ATEALPVSSIgsreLLATTTAATSGGAGTCVGRPIPGVRVRIieiddepiaewddtlelprgEIGEITVTGPTVTPTYVN 314
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 489495878 783 -IDGDGFGTVTaaDGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVA 852
Cdd:cd05910 315 rPVATALAKID--DNSEGFWHRMGDLGYLDDEGRLWFCGRKAHRVITTGGTLYTEPVERVFNTHPGVRRSA 383
|
|
| MACS_like_2 |
cd05973 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
561-853 |
1.98e-07 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341277 [Multi-domain] Cd Length: 437 Bit Score: 55.99 E-value: 1.98e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 561 VTQVTHDALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCA-PLTSDISVEEIFGGAACGa 639
Cdd:cd05973 77 VTDAANRHKLDSDPFVMMFTSGTTGLPKGVPVPLRALAAFGAYLRDAVDLRPEDSFWNAAdPGWAYGLYYAITGPLALG- 155
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 640 rlVRSAAMKTGDLAALVDDLVARE--TTIVDLPTAvWQLLCADGDAIDAIGRSRLRQIVIGGEAIRcSAVDKWleSAASQ 717
Cdd:cd05973 156 --HPTILLEGGFSVESTWRVIERLgvTNLAGSPTA-YRLLMAAGAEVPARPKGRLRRVSSAGEPLT-PEVIRW--FDAAL 229
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 718 GISLLSSYGPTEATVVatflpiVCDQTTmdgallrLGRPILPNTVFLAF-GEVVIVGDLVAD-------GYLGIDGDG-- 787
Cdd:cd05973 230 GVPIHDHYGQTELGMV------LANHHA-------LEHPVHAGSAGRAMpGWRVAVLDDDGDelgpgepGRLAIDIANsp 296
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 489495878 788 ---FGTVTAADGSR--RRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd05973 297 lmwFRGYQLPDTPAidGGYYLTGDTVEFDPDGSFSFIGRADDVITMSGYRIGPFDVESALIEHPAVAEAAV 367
|
|
| FACL_like_4 |
cd05944 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
580-862 |
2.53e-07 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341266 [Multi-domain] Cd Length: 359 Bit Score: 55.56 E-value: 2.53e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 580 TSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTS-DISVEEIFGGAACGARLVRSAAMKTGDlAALVDD 658
Cdd:cd05944 10 TGGTTGTPKLAQHTHSNEVYNAWMLALNSLFDPDDVLLCGLPLFHvNGSVVTLLTPLASGAHVVLAGPAGYRN-PGLFDN 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 659 ---LVARE--TTIVDLPTAVWQLLCADGDAidaiGRSRLRQIVIGGEAIRCsAVDKWLESAAsqGISLLSSYGPTEATVV 733
Cdd:cd05944 89 fwkLVERYriTSLSTVPTVYAALLQVPVNA----DISSLRFAMSGAAPLPV-ELRARFEDAT--GLPVVEGYGLTEATCL 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 734 ATF---------------LPIVCDQTTMDGALLRLGRPILPNTVflafGEVVIVGDLVADGYLgiDGDGFGTVTAADGsr 798
Cdd:cd05944 162 VAVnppdgpkrpgsvglrLPYARVRIKVLDGVGRLLRDCAPDEV----GEICVAGPGVFGGYL--YTEGNKNAFVADG-- 233
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 799 rrAFATGDRVTVDAEGFPVFSGR-KDAVVKiSGKRVDIAEVTRRIAEDPAVSDVAV----ELHSGSLGV 862
Cdd:cd05944 234 --WLNTGDLGRLDADGYLFITGRaKDLIIR-GGHNIDPALIEEALLRHPAVAFAGAvgqpDAHAGELPV 299
|
|
| PRK00174 |
PRK00174 |
acetyl-CoA synthetase; Provisional |
1604-1971 |
2.64e-07 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 234677 [Multi-domain] Cd Length: 637 Bit Score: 56.30 E-value: 2.64e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1604 AGHDLPIIDVVDALAAYpGTPPPMPAAVNLaYILYTSGTTGEPKGV-----G------ITHRNV-----------Trlfa 1661
Cdd:PRK00174 220 EGRDLWWHELVAGASDE-CEPEPMDAEDPL-FILYTSGSTGKPKGVlhttgGylvyaaMTMKYVfdykdgdvywcT---- 293
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1662 slparlsaAQV-WSQCHSYGfdasaweIWGALLGGGRLVIVpESVAASPN-DFHGLLVAEH-VSVLTQTPAAVAMLPTQG 1738
Cdd:PRK00174 294 --------ADVgWVTGHSYI-------VYGPLANGATTLMF-EGVPNYPDpGRFWEVIDKHkVTIFYTAPTAIRALMKEG 357
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1739 --------LESVAL------------------VVAGEACPaaLVDRW---APGRVMLnaygpteTTICAAIsaPLRPGSG 1789
Cdd:PRK00174 358 dehpkkydLSSLRLlgsvgepinpeawewyykVVGGERCP--IVDTWwqtETGGIMI-------TPLPGAT--PLKPGSA 426
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1790 MPPI-----------GVPVSGAA---LFVLDSW---LRpvpaGVAG--ELYIAgagvgvGYWrragltaSRFVACPFGGS 1850
Cdd:PRK00174 427 TRPLpgiqpavvdeeGNPLEGGEggnLVIKDPWpgmMR----TIYGdhERFVK------TYF-------STFKGMYFTGD 489
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1851 GARMyrtgDlvcwrADGQLEFLGRTDDQVKIRGYRIELGEVATAL------AELAGV-------GQAV---VIAREDRPG 1914
Cdd:PRK00174 490 GARR----D-----EDGYYWITGRVDDVLNVSGHRLGTAEIESALvahpkvAEAAVVgrpddikGQGIyafVTLKGGEEP 560
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 1915 DKRLvgyATEiapgavdpagLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK00174 561 SDEL---RKE----------LRNWVRKEIGPIAKPDVIQFAPGLPKTRSGKIMRRIL 604
|
|
| PLN02996 |
PLN02996 |
fatty acyl-CoA reductase |
2108-2251 |
3.01e-07 |
|
fatty acyl-CoA reductase
Pssm-ID: 215538 [Multi-domain] Cd Length: 491 Bit Score: 55.87 E-value: 3.01e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2108 RTVLLTGATGFLGRYLVLELLRRLDVDGRLICLVRAESDEDARRRLEKtfDSGDPELLRHFKE--------LAADRLEVV 2179
Cdd:PLN02996 12 KTILVTGATGFLAKIFVEKILRVQPNVKKLYLLLRASDAKSATQRLHD--EVIGKDLFKVLREklgenlnsLISEKVTPV 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2180 AGDKSEPDLG-----LDQPMWRRlaetVDLIVDSAAMVNaFP--YHELFGPNVAGTAELIRIA-LTTKLKPFTYVSTADV 2251
Cdd:PLN02996 90 PGDISYDDLGvkdsnLREEMWKE----IDIVVNLAATTN-FDerYDVALGINTLGALNVLNFAkKCVKVKMLLHVSTAYV 164
|
|
| PRK05850 |
PRK05850 |
acyl-CoA synthetase; Validated |
1580-1883 |
3.07e-07 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235624 [Multi-domain] Cd Length: 578 Bit Score: 55.72 E-value: 3.07e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1580 RVAFMLGDAVPVAAVTTAG----LRSRLAGHDL---PIIDVVDAL--AAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVG 1650
Cdd:PRK05850 100 RVSAVLRDTSPSVVLTTSAvvddVTEYVAPQPGqsaPPVIEVDLLdlDSPRGSDARPRDLPSTAYLQYTSGSTRTPAGVM 179
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1651 ITHRNVT----RLFAS-LPARLSAAQVWSQCHSygfdasaweiW-------GALLGggrlVIVP-----ESVAASPNDFh 1713
Cdd:PRK05850 180 VSHRNVIanfeQLMSDyFGDTGGVPPPDTTVVS----------WlpfyhdmGLVLG----VCAPilggcPAVLTSPVAF- 244
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1714 gL--------LVAEHVSVLTQTP-----AAV-----AMLPTQGLESVALVVAG--EACPAAL---VDRWAP----GRVML 1766
Cdd:PRK05850 245 -LqrparwmqLLASNPHAFSAAPnfafeLAVrktsdDDMAGLDLGGVLGIISGseRVHPATLkrfADRFAPfnlrETAIR 323
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1767 NAYGPTETTICAAISAPLRP---------------------GSGMPPI--GVPVSGAALFVLDSWLRPVPAGVAGELYIA 1823
Cdd:PRK05850 324 PSYGLAEATVYVATREPGQPpesvrfdyeklsaghakrcetGGGTPLVsyGSPRSPTVRIVDPDTCIECPAGTVGEIWVH 403
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 489495878 1824 GAGVGVGYWRRAGLTASRF----VACPFGGSGARMYRTGDL-VCWraDGQLEFLGRTDDQVKIRG 1883
Cdd:PRK05850 404 GDNVAAGYWQKPEETERTFgatlVDPSPGTPEGPWLRTGDLgFIS--EGELFIVGRIKDLLIVDG 466
|
|
| ACLS-CaiC |
cd17637 |
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ... |
577-853 |
3.26e-07 |
|
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized, but may be similar to Carnitine-CoA ligase (CaiC) which catalyzes the transfer of CoA to carnitine. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341292 [Multi-domain] Cd Length: 333 Bit Score: 54.97 E-value: 3.26e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 577 IMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLtsdisveeiFGGAACGARLvrsAAMKTGDLAALV 656
Cdd:cd17637 5 IIHTAAVAGRPRGAVLSHGNLIAANLQLIHAMGLTEADVYLNMLPL---------FHIAGLNLAL---ATFHAGGANVVM 72
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 657 D--------DLVARE--TTIVDLPTAVWQLLcadgDAIDAIGR--SRLRqIVIGGEAIrcSAVDKWLESAASQgisLLSS 724
Cdd:cd17637 73 EkfdpaealELIEEEkvTLMGSFPPILSNLL----DAAEKSGVdlSSLR-HVLGLDAP--ETIQRFEETTGAT---FWSL 142
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 725 YGPTEATVVATFLPIvcdqTTMDGALlrlGRPILPNTVFL-----------AFGEVVIVGDLVADGYLGIDgdgfgTVTA 793
Cdd:cd17637 143 YGQTETSGLVTLSPY----RERPGSA---GRPGPLVRVRIvddndrpvpagETGEIVVRGPLVFQGYWNLP-----ELTA 210
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 794 adgsrrRAFA-----TGDRVTVDAEGFPVFSGRKDA--VVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd17637 211 ------YTFRngwhhTGDLGRFDEDGYLWYAGRKPEkeLIKPGGENVYPAEVEKVILEHPAIAEVCV 271
|
|
| hsFATP2a_ACSVL_like |
cd05938 |
Fatty acid transport proteins (FATP) including hsFATP2, hsFATP5, and hsFATP6, and similar ... |
1514-1680 |
3.51e-07 |
|
Fatty acid transport proteins (FATP) including hsFATP2, hsFATP5, and hsFATP6, and similar proteins; Fatty acid transport proteins (FATP) of this family transport long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes hsFATP2, hsFATP5, and hsFATP6, and similar proteins. Each FATP has unique patterns of tissue distribution. These FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. The hsFATP proteins exist in two splice variants; the b variant, lacking exon 3, has no acyl-CoA synthetase activity. FATPs are key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341261 [Multi-domain] Cd Length: 537 Bit Score: 55.38 E-value: 3.51e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1514 GDASMTYRELDEASNRLAHRL-AGCGAGPGECVALL------------------------------------FERCapav 1556
Cdd:cd05938 2 EGETYTYRDVDRRSNQAARALlAHAGLRPGDTVALLlgnepaflwiwlglaklgcpvaflntnirsksllhcFRCC---- 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1557 vamvavlktGAAYLPIDPAnppprvafmLGDAV-PV-AAVTTAGLRSRLAGHDLP---IIDVVDALAAYPGTPPP--MPA 1629
Cdd:cd05938 78 ---------GAKVLVVAPE---------LQEAVeEVlPALRADGVSVWYLSHTSNtegVISLLDKVDAASDEPVPasLRA 139
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1630 AVNL----AYIlYTSGTTGEPKGVGITHRNVTR---------------LFASLP------------------------AR 1666
Cdd:cd05938 140 HVTIkspaLYI-YTSGTTGLPKAARISHLRVLQcsgflslcgvtaddvIYITLPlyhssgfllgiggcielgatcvlkPK 218
|
250
....*....|....
gi 489495878 1667 LSAAQVWSQCHSYG 1680
Cdd:cd05938 219 FSASQFWDDCRKHN 232
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
517-918 |
3.53e-07 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 55.70 E-value: 3.53e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 517 DEISVRTNAITEHGDGILVTVVDVAATQLAVVGHDELRKVVDERVTQVthdALLATKTA-YIMPTSGTTGQPKLVRISH- 594
Cdd:PRK07788 154 DEFTDLLSALPPDLGRLRAWGGNPDDDEPSGSTDETLDDLIAGSSTAP---LPKPPKPGgIVILTSGTTGTPKGAPRPEp 230
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 595 ---GSLAVFCDAISraygWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVrsaAMKTGDLAALVDDLVA-RETTIVDLP 670
Cdd:PRK07788 231 splAPLAGLLSRVP----FRAGETTLLPAPMFHATGWAHLTLAMALGSTVV---LRRRFDPEATLEDIAKhKATALVVVP 303
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 671 TAVWQLLCADGDAIDAIGRSRLRQIVIGGeaircSAVDKWLESAASQ--GISLLSSYGPTEATV--VATFLPIVCDQTTM 746
Cdd:PRK07788 304 VMLSRILDLGPEVLAKYDTSSLKIIFVSG-----SALSPELATRALEafGPVLYNLYGSTEVAFatIATPEDLAEAPGTV 378
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 747 D----GALLRL----GRPILPNTVflafGEVVIVGDLVADGYLG------IDGdgfgtvtaadgsrrrAFATGDRVTVDA 812
Cdd:PRK07788 379 GrppkGVTVKIldenGNEVPRGVV----GRIFVGNGFPFEGYTDgrdkqiIDG---------------LLSSGDVGYFDE 439
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 813 EGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVelhsgsLGV----WFKSQR----TREGEQDAAAATR--I 882
Cdd:PRK07788 440 DGLLFVDGRDDDMIVSGGENVFPAEVEDLLAGHPDVVEAAV------IGVddeeFGQRLRafvvKAPGAALDEDAIKdyV 513
|
410 420 430
....*....|....*....|....*....|....*.
gi 489495878 883 RLVLVSLGVSSfFVVGVPNIPRKPNGKIdsdnLPRL 918
Cdd:PRK07788 514 RDNLARYKVPR-DVVFLDELPRNPTGKV----LKRE 544
|
|
| UDP_AE_SDR_e |
cd05256 |
UDP-N-acetylglucosamine 4-epimerase, extended (e) SDRs; This subgroup contains ... |
2110-2309 |
3.65e-07 |
|
UDP-N-acetylglucosamine 4-epimerase, extended (e) SDRs; This subgroup contains UDP-N-acetylglucosamine 4-epimerase of Pseudomonas aeruginosa, WbpP, an extended SDR, that catalyzes the NAD+ dependent conversion of UDP-GlcNAc and UDPGalNA to UDP-Glc and UDP-Gal. This subgroup has the characteristic active site tetrad and NAD-binding motif of the extended SDRs. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187566 [Multi-domain] Cd Length: 304 Bit Score: 54.53 E-value: 3.65e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2110 VLLTGATGFLGRYLVLELLRRldvDGRLICLvraesDEdarrrlektFDSGDPELLRHFKelaaDRLEVVAGDKSepdlg 2189
Cdd:cd05256 2 VLVTGGAGFIGSHLVERLLER---GHEVIVL-----DN---------LSTGKKENLPEVK----PNVKFIEGDIR----- 55
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2190 lDQPMWRRLAETVDLIVDSAAM-------VNAFPYHELfgpNVAGTAELIRIALTTKLKPFTYVSTADVGAAIEPSAFTE 2262
Cdd:cd05256 56 -DDELVEFAFEGVDYVFHQAAQasvprsiEDPIKDHEV---NVLGTLNLLEAARKAGVKRFVYASSSSVYGDPPYLPKDE 131
|
170 180 190 200
....*....|....*....|....*....|....*....|....*..
gi 489495878 2263 DADIRVISPtrtvdggwaggYGTSKWAGEVLLREANDLCALPVAVFR 2309
Cdd:cd05256 132 DHPPNPLSP-----------YAVSKYAGELYCQVFARLYGLPTVSLR 167
|
|
| PksD |
COG3321 |
Acyl transferase domain in polyketide synthase (PKS) enzymes [Secondary metabolites ... |
667-1193 |
3.90e-07 |
|
Acyl transferase domain in polyketide synthase (PKS) enzymes [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442550 [Multi-domain] Cd Length: 1386 Bit Score: 56.03 E-value: 3.90e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 667 VDLPTAVWQ---LLCADGDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLESAASQGISLLSSYGPTEATVVATFLPIVCDQ 743
Cdd:COG3321 861 VPLPTYPFQredAAAALLAAALAAALAAAAALGALLLAALAAALAAALLALAAAAAAALALAAAALAALLALVALAAAAA 940
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 744 TTMDGALLRLGRPILPntvfLAFGEVVIVGDLVADGYLGIDGDGFGTVTAADGSRRRAFATGDRVTVDAEGFPVFSGRKD 823
Cdd:COG3321 941 ALLALAAAAAAAAAAL----AAAEAGALLLLAAAAAAAAAAAAAAAAAAAAAAAAAAAALAAAAALALLAAAALLLAAAA 1016
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 824 AVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGVWFKSQRTREGEQDAAAATRIRLVLVSLGVSSFFVVGVPNIP 903
Cdd:COG3321 1017 AAAALLALAALLAAAAAALAAAAAAAAAAAALAALAAAAAAAAALALALAALLLLAALAELALAAAALALAAALAAAALA 1096
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 904 RKPNGKIDSDNLPRLPQWSAAGLNTAETGQRAAGLSQIWSRQLGRAIGPDSSLLGEGIGSLDLIRILPETRRYLGWRLSL 983
Cdd:COG3321 1097 LALAALAAALLLLALLAALALAAAAAALLALAALLAAAAAAAALAAAAAAAAALALAAAAAALAAALAAALLAAAALLLA 1176
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 984 LDLIGADTAANLADYAPTPDAPTGEDRFRPLVAAQRPAAIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALG 1063
Cdd:COG3321 1177 LALALAAALAAALAGLAALLLAALLAALLAALLALALAALAAAAAALLAAAAAAAALALLALAAAAAAVAALAAAAAALL 1256
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1064 AAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADLGCDIVDATAWPADRLQRAIEEAARHSFDLATEIPLRTWLFRIAD 1143
Cdd:COG3321 1257 AALAALALLAAAAGLAALAAAAAAAAAALALAAAAAAAAAALAALLAAAAAAAAAAAAAAAAAALAAALLAAALAALAAA 1336
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|
gi 489495878 1144 DEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAPDWAPLPVQYVD 1193
Cdd:COG3321 1337 VAAALALAAAAAAAAAAAAAAAAAAALAAAAGAAAAAAALALAALAAAVA 1386
|
|
| 4CL |
cd05904 |
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the ... |
515-853 |
4.62e-07 |
|
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the phenylpropanoid metabolic pathway for monolignol and flavonoid biosynthesis. It catalyzes the synthesis of hydroxycinnamate-CoA thioesters in a two-step reaction, involving the formation of hydroxycinnamate-AMP anhydride and the nucleophilic substitution of AMP by CoA. The phenylpropanoid pathway is one of the most important secondary metabolism pathways in plants and hydroxycinnamate-CoA thioesters are the precursors of lignin and other important phenylpropanoids.
Pssm-ID: 341230 [Multi-domain] Cd Length: 505 Bit Score: 54.93 E-value: 4.62e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 515 TADEISvrtNAITEHGDGILVTVVD----VAATQLAVVGHDELRKV---VDERVTQVTHDALLATK-----TAYIMPTSG 582
Cdd:cd05904 92 TPAEIA---KQVKDSGAKLAFTTAElaekLASLALPVVLLDSAEFDslsFSDLLFEADEAEPPVVVikqddVAALLYSSG 168
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 583 TTGQPKLVRISHGSLAVFCDAISRAYG-WGAHDTVLQCA-PLTsdisveEIFG-------GAACGARLVrsaAMKTGDLA 653
Cdd:cd05904 169 TTGRSKGVMLTHRNLIAMVAQFVAGEGsNSDSEDVFLCVlPMF------HIYGlssfalgLLRLGATVV---VMPRFDLE 239
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 654 ALVDDLVARETTIVDL-PTAVWQLlcADGDAIDAIGRSRLRQIVIGGeaircSAVDKWLESAASQ---GISLLSSYGPTE 729
Cdd:cd05904 240 ELLAAIERYKVTHLPVvPPIVLAL--VKSPIVDKYDLSSLRQIMSGA-----APLGKELIEAFRAkfpNVDLGQGYGMTE 312
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 730 ATVVATFLPIVCDQTTMDGALLRL-------------GRPILPNTVflafGEVVIVGDLVADGYLG--------IDGDGF 788
Cdd:cd05904 313 STGVVAMCFAPEKDRAKYGSVGRLvpnveakivdpetGESLPPNQT----GELWIRGPSIMKGYLNnpeataatIDKEGW 388
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 489495878 789 gtvtaadgsrrraFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd05904 389 -------------LHTGDLCYIDEDGYLFIVDRLKELIKYKGFQVAPAELEALLLSHPEILDAAV 440
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
570-910 |
5.23e-07 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 54.75 E-value: 5.23e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 570 LATKTAYIMPTSGTTGQPKLVRISHGSLAvfcdaisraygwgAHDTVLQ----CAPLTSDIsveeiFGGAA----CGARL 641
Cdd:cd05971 86 GSDDPALIIYTSGTTGPPKGALHAHRVLL-------------GHLPGVQfpfnLFPRDGDL-----YWTPAdwawIGGLL 147
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 642 ------------VRSAAMKTGDLAALVDDLVARETTIVDLPTAVWQLLCADGDAIDAIGRsRLRQIVIGGEaircSAVDK 709
Cdd:cd05971 148 dvllpslyfgvpVLAHRMTKFDPKAALDLMSRYGVTTAFLPPTALKMMRQQGEQLKHAQV-KLRAIATGGE----SLGEE 222
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 710 WLESAASQ-GISLLSSYGPTEATVVATFLPIVCDqtTMDGALlrlGRPILPNTVFL--AFGEVVIVGdlvADGYLGI--- 783
Cdd:cd05971 223 LLGWAREQfGVEVNEFYGQTECNLVIGNCSALFP--IKPGSM---GKPIPGHRVAIvdDNGTPLPPG---EVGEIAVelp 294
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 784 DGDGFGTVTAADGSRRRAFA-----TGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV----E 854
Cdd:cd05971 295 DPVAFLGYWNNPSATEKKMAgdwllTGDLGRKDSDGYFWYVGRDDDVITSSGYRIGPAEIEECLLKHPAVLMAAVvgipD 374
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 855 LHSGSLGVWFKSQRTREGEQDAAAATRIRLVLVSLGVSSF--FVVGVPNIPRKPNGKI 910
Cdd:cd05971 375 PIRGEIVKAFVVLNPGETPSDALAREIQELVKTRLAAHEYprEIEFVNELPRTATGKI 432
|
|
| PRK05620 |
PRK05620 |
long-chain fatty-acid--CoA ligase; |
1573-1971 |
6.21e-07 |
|
long-chain fatty-acid--CoA ligase;
Pssm-ID: 180167 [Multi-domain] Cd Length: 576 Bit Score: 54.79 E-value: 6.21e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1573 DPANPPpRVAFMLGDAVPVAAVTTAGLRS--RLAGHDLPIIDVVDALAAYPGTPP----PMPAAVNLAYILYTSGTTGEP 1646
Cdd:PRK05620 118 DPRLAE-QLGEILKECPCVRAVVFIGPSDadSAAAHMPEGIKVYSYEALLDGRSTvydwPELDETTAAAICYSTGTTGAP 196
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1647 KGVGITHRNVTRLFASLPARLSAA----QVWSQC----H--SYGFDASAWEIWGALLGGGRLViVPESVA-----ASPND 1711
Cdd:PRK05620 197 KGVVYSHRSLYLQSLSLRTTDSLAvthgESFLCCvpiyHvlSWGVPLAAFMSGTPLVFPGPDL-SAPTLAkiiatAMPRV 275
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1712 FHGLlvaehVSVLTQTPAAVAMLPTQGLESVALVVAGEACPAALVDRWAP--GRVMLNAYGPTETTICAAISaplRPGSG 1789
Cdd:PRK05620 276 AHGV-----PTLWIQLMVHYLKNPPERMSLQEIYVGGSAVPPILIKAWEEryGVDVVHVWGMTETSPVGTVA---RPPSG 347
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1790 mppigvpVSGAALFVLDSWLRPVPAGV-----------------AGELYIAGAGVGVGYWR----RAGLTASRFVACPFG 1848
Cdd:PRK05620 348 -------VSGEARWAYRVSQGRFPASLeyrivndgqvmestdrnEGEIQVRGNWVTASYYHspteEGGGAASTFRGEDVE 420
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1849 GSGARM-----YRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKR---LVG 1920
Cdd:PRK05620 421 DANDRFtadgwLRTGDVGSVTRDGFLTIHDRARDVIRSGGEWIYSAQLENYIMAAPEVVECAVIGYPDDKWGERplaVTV 500
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|.
gi 489495878 1921 YATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK05620 501 LAPGIEPTRETAERLRDQLRDRLPNWMLPEYWTFVDEIDKTSVGKFDKKDL 551
|
|
| PRK07638 |
PRK07638 |
acyl-CoA synthetase; Validated |
1506-1971 |
7.90e-07 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236071 [Multi-domain] Cd Length: 487 Bit Score: 54.40 E-value: 7.90e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1506 PEAEAVCCGDASMTYRELDEASNRLAHRLaGCGAGPGECVALLFERcapavVAMVAVLKTGAAYL-----PIDPANPPPR 1580
Cdd:PRK07638 15 PNKIAIKENDRVLTYKDWFESVCKVANWL-NEKESKNKTIAILLEN-----RIEFLQLFAGAAMAgwtcvPLDIKWKQDE 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1581 VAFMLGDAVPVAAVTTAGLRSRLAGHDLPIID---VVDALAAYPGTPPPMPAAVNLA-YILYTSGTTGEPKGVGITHRNV 1656
Cdd:PRK07638 89 LKERLAISNADMIVTERYKLNDLPDEEGRVIEideWKRMIEKYLPTYAPIENVQNAPfYMGFTSGSTGKPKAFLRAQQSW 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1657 TRLFaslparlsaaqvwsQCHSYGFDASAWE---IWGALLG-------------GGRLVIVPEsvaASPNDFHGLLVAEH 1720
Cdd:PRK07638 169 LHSF--------------DCNVHDFHMKREDsvlIAGTLVHslflygaistlyvGQTVHLMRK---FIPNQVLDKLETEN 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1721 VSVLTQTPAAV-AMLPTQGL--ESVALVVAGEACPA----ALVDRWaPGRVMLNAYGPTETTICAAIS---APLRPGSgm 1790
Cdd:PRK07638 232 ISVMYTVPTMLeSLYKENRVieNKMKIISSGAKWEAeakeKIKNIF-PYAKLYEFYGASELSFVTALVdeeSERRPNS-- 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1791 ppIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASrfvacpfggSGARMYRT-GDLVCWRADGQL 1869
Cdd:PRK07638 309 --VGRPFHNVQVRICNEAGEEVQKGEIGTVYVKSPQFFMGYIIGGVLARE---------LNADGWMTvRDVGYEDEEGFI 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1870 EFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRpgdkrlvgYATEIA----PGAVDPAGLRAQLAQRLPG 1945
Cdd:PRK07638 378 YIVGREKNMILFGGINIFPEEIESVLHEHPAVDEIVVIGVPDS--------YWGEKPvaiiKGSATKQQLKSFCLQRLSS 449
|
490 500
....*....|....*....|....*.
gi 489495878 1946 YLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK07638 450 FKIPKEWHFVDEIPYTNSGKIARMEA 475
|
|
| AR_FR_like_1_SDR_e |
cd05228 |
uncharacterized subgroup of aldehyde reductase and flavonoid reductase related proteins, ... |
2110-2297 |
9.91e-07 |
|
uncharacterized subgroup of aldehyde reductase and flavonoid reductase related proteins, extended (e) SDRs; This subgroup contains proteins of unknown function related to aldehyde reductase and flavonoid reductase of the extended SDR-type. Aldehyde reductase I (aka carbonyl reductase) is an NADP-binding SDR; it has an NADP-binding motif consensus that is slightly different from the canonical SDR form and lacks the Asn of the extended SDR active site tetrad. Aldehyde reductase I catalyzes the NADP-dependent reduction of ethyl 4-chloro-3-oxobutanoate to ethyl (R)-4-chloro-3-hydroxybutanoate. The related flavonoid reductases act in the NADP-dependent reduction of flavonoids, ketone-containing plant secondary metabolites. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187539 [Multi-domain] Cd Length: 318 Bit Score: 53.44 E-value: 9.91e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2110 VLLTGATGFLGRYLVLELLRRldvDGRLICLVRAESDedarrrlektfdsgdpellrhFKELAADRLEVVAGDKSEPDLG 2189
Cdd:cd05228 1 ILVTGATGFLGSNLVRALLAQ---GYRVRALVRSGSD---------------------AVLLDGLPVEVVEGDLTDAASL 56
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2190 LDQPmwrrlaETVDLIVDSAAMVNAFPYH--ELFGPNVAGTAELIRIALTTKLKPFTYVSTADVGAAIEPSAFTEDADIR 2267
Cdd:cd05228 57 AAAM------KGCDRVFHLAAFTSLWAKDrkELYRTNVEGTRNVLDAALEAGVRRVVHTSSIAALGGPPDGRIDETTPWN 130
|
170 180 190
....*....|....*....|....*....|
gi 489495878 2268 VISPtrtvdggwAGGYGTSKWAGEVLLREA 2297
Cdd:cd05228 131 ERPF--------PNDYYRSKLLAELEVLEA 152
|
|
| PLN02387 |
PLN02387 |
long-chain-fatty-acid-CoA ligase family protein |
1623-1656 |
1.48e-06 |
|
long-chain-fatty-acid-CoA ligase family protein
Pssm-ID: 215217 [Multi-domain] Cd Length: 696 Bit Score: 53.58 E-value: 1.48e-06
10 20 30
....*....|....*....|....*....|....
gi 489495878 1623 TPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNV 1656
Cdd:PLN02387 242 VDPDLPSPNDIAVIMYTSGSTGLPKGVMMTHGNI 275
|
|
| PRK13388 |
PRK13388 |
acyl-CoA synthetase; Provisional |
538-853 |
1.77e-06 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237374 [Multi-domain] Cd Length: 540 Bit Score: 53.11 E-value: 1.77e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 538 VDVAATQLAVVGHDELRKVVDERVTQVTHDALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVL 617
Cdd:PRK13388 116 LDLPGVRVLDVDTPAYAELVAAAGALTPHREVDAMDPFMLIFTSGTTGAPKAVRCSHGRLAFAGRALTERFGLTRDDVCY 195
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 618 QCAPLTSDISVEEIFGGA-ACGARLVRSAAMKTGDLAALVDDLVARETTIVDLPTAVwqLLCADGDAIDAigRSRLRqIV 696
Cdd:PRK13388 196 VSMPLFHSNAVMAGWAPAvASGAAVALPAKFSASGFLDDVRRYGATYFNYVGKPLAY--ILATPERPDDA--DNPLR-VA 270
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 697 IGGEAircSAVDKwLESAASQGISLLSSYGPTEATVVatflpIVCDQTTMDGAllrLGRPIL------PNTV-------F 763
Cdd:PRK13388 271 FGNEA---SPRDI-AEFSRRFGCQVEDGYGSSEGAVI-----VVREPGTPPGS---IGRGAPgvaiynPETLtecavarF 338
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 764 LAFGEVV----IVGDLV----ADGYLGIDGDgfgtvTAADGSRRRA--FATGDRVTVDAEGFPVFSGRKDAVVKISGKRV 833
Cdd:PRK13388 339 DAHGALLnadeAIGELVntagAGFFEGYYNN-----PEATAERMRHgmYWSGDLAYRDADGWIYFAGRTADWMRVDGENL 413
|
330 340
....*....|....*....|
gi 489495878 834 DIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK13388 414 SAAPIERILLRHPAINRVAV 433
|
|
| PrpE |
cd05967 |
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or ... |
569-910 |
2.01e-06 |
|
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or propionate#CoA ligase (PrpE) catalyzes the first step of the 2-methylcitric acid cycle for propionate catabolism. It activates propionate to propionyl-CoA in a two-step reaction, which proceeds through a propionyl-AMP intermediate and requires ATP and Mg2+. In Salmonella enterica, the PrpE protein is required for growth of Salmonella enterica on propionate and can substitute for the acetyl-CoA synthetase (Acs) enzyme during growth on acetate. PrpE can also activate acetate, 3HP, and butyrate to their corresponding CoA-thioesters, although with less efficiency.
Pssm-ID: 341271 [Multi-domain] Cd Length: 617 Bit Score: 53.09 E-value: 2.01e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 569 LLATKTAYIMPTSGTTGQPK-LVRISHGSLAVFCDAISRAYGWGAHDtVLQCApltSDIS--VEE---IFGGAACGARLV 642
Cdd:cd05967 227 VAATDPLYILYTSGTTGKPKgVVRDNGGHAVALNWSMRNIYGIKPGD-VWWAA---SDVGwvVGHsyiVYGPLLHGATTV 302
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 643 RSAAMKTG--DLAA---LVDDlvARETTIVDLPTAVWQLLCAD--GDAIDAIGRSRLRQIVIGGEaiRC-SAVDKWLESA 714
Cdd:cd05967 303 LYEGKPVGtpDPGAfwrVIEK--YQVNALFTAPTAIRAIRKEDpdGKYIKKYDLSSLRTLFLAGE--RLdPPTLEWAENT 378
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 715 AsqGISLLSSYGPTEatvvaTFLPIVCDQTTMDGALLRLGRPILP----NTVFL----------AFGEVVIVGDLVADGY 780
Cdd:cd05967 379 L--GVPVIDHWWQTE-----TGWPITANPVGLEPLPIKAGSPGKPvpgyQVQVLdedgepvgpnELGNIVIKLPLPPGCL 451
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 781 LGIDGDGFGTVTAADGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVelhsgsL 860
Cdd:cd05967 452 LTLWKNDERFKKLYLSKFPGYYDTGDAGYKDEDGYLFIMGRTDDVINVAGHRLSTGEMEESVLSHPAVAECAV------V 525
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 489495878 861 GVW--FKSQRT------REGEQDAAAATR---IRLVLVSLG-VSSF-FVVGVPNIPRKPNGKI 910
Cdd:cd05967 526 GVRdeLKGQVPlglvvlKEGVKITAEELEkelVALVREQIGpVAAFrLVIFVKRLPKTRSGKI 588
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
1993-2057 |
2.05e-06 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 48.02 E-value: 2.05e-06
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 1993 VAGIFARVLGL---ERVGVDDSFFELGGDSLAAMRVIAAINTTLNADLPVRALLHASSTRGLSQLLGR 2057
Cdd:smart00823 17 VREQVAAVLGHaaaEAIDPDRPFRDLGLDSLMAVELRNRLEAATGLRLPATLVFDHPTPAALAEHLAA 84
|
|
| PRK06018 |
PRK06018 |
putative acyl-CoA synthetase; Provisional |
1638-1971 |
2.96e-06 |
|
putative acyl-CoA synthetase; Provisional
Pssm-ID: 235673 [Multi-domain] Cd Length: 542 Bit Score: 52.45 E-value: 2.96e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1638 YTSGTTGEPKGVGITHR-NVTR-LFASLPARLSAAQVWSQCHSYG-FDASAWEI-WGALLGGGRLVIV-PESVAASpndF 1712
Cdd:PRK06018 184 YTSGTTGDPKGVLYSHRsNVLHaLMANNGDALGTSAADTMLPVVPlFHANSWGIaFSAPSMGTKLVMPgAKLDGAS---V 260
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1713 HGLLVAEHVSVLTQTPAAVAMLpTQGLESVAL--------VVAGEACPAALVDRWAPGRV-MLNAYGPTETTICAAISAp 1783
Cdd:PRK06018 261 YELLDTEKVTFTAGVPTVWLML-LQYMEKEGLklphlkmvVCGGSAMPRSMIKAFEDMGVeVRHAWGMTEMSPLGTLAA- 338
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1784 LRPG---------------SGMPPIGVPV-----SGAALfvldswlrPVPAGVAGELYIAGAGVGVGYWRRAG--LTASR 1841
Cdd:PRK06018 339 LKPPfsklpgdarldvlqkQGYPPFGVEMkitddAGKEL--------PWDGKTFGRLKVRGPAVAAAYYRVDGeiLDDDG 410
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1842 FvacpfggsgarmYRTGDLVCWRADGQLEFLGRTDDQVKIRG---YRIELGEVATALAELAgvgQAVVIAREDRPGDKRL 1918
Cdd:PRK06018 411 F------------FDTGDVATIDAYGYMRITDRSKDVIKSGGewiSSIDLENLAVGHPKVA---EAAVIGVYHPKWDERP 475
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 1919 VgYATEIAPGaVDPAglRAQLAQRLPG----YLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK06018 476 L-LIVQLKPG-ETAT--REEILKYMDGkiakWWMPDDVAFVDAIPHTATGKILKTAL 528
|
|
| 3b-HSD_HSDB1_like_SDR_e |
cd09811 |
human 3beta-HSD (hydroxysteroid dehydrogenase) and HSD3B1(delta 5-delta 4-isomerase)-like, ... |
2111-2298 |
3.50e-06 |
|
human 3beta-HSD (hydroxysteroid dehydrogenase) and HSD3B1(delta 5-delta 4-isomerase)-like, extended (e) SDRs; This extended-SDR subgroup includes human 3 beta-HSD/HSD3B1 and C(27) 3beta-HSD/ [3beta-hydroxy-delta(5)-C(27)-steroid oxidoreductase; HSD3B7], and related proteins. These proteins have the characteristic active site tetrad and NAD(P)-binding motif of extended SDRs. 3 beta-HSD catalyzes the oxidative conversion of delta 5-3 beta-hydroxysteroids to the delta 4-3-keto configuration; this activity is essential for the biosynthesis of all classes of hormonal steroids. C(27) 3beta-HSD is a membrane-bound enzyme of the endoplasmic reticulum, it catalyzes the isomerization and oxidation of 7alpha-hydroxylated sterol intermediates, an early step in bile acid biosynthesis. Mutations in the human gene encoding C(27) 3beta-HSD underlie a rare autosomal recessive form of neonatal cholestasis. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid sythase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187671 [Multi-domain] Cd Length: 354 Bit Score: 51.74 E-value: 3.50e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2111 LLTGATGFLGRYLVLELLRRLDVDGRLiclvraesdedarRRLEKTFdsgDPELLRHF-KELAADRLEVVAGDKsepdlg 2189
Cdd:cd09811 3 LVTGGGGFLGQHIIRLLLERKEELKEI-------------RVLDKAF---GPELIEHFeKSQGKTYVTDIEGDI------ 60
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2190 LDQPMWRRLAETVDLIVDSAAMVNAF---PYHELFGPNVAGTAELIRIALTTKLKPFTYVSTADVGA--AIEPSAFTEDA 2264
Cdd:cd09811 61 KDLSFLFRACQGVSVVIHTAAIVDVFgppNYEELEEVNVNGTQAVLEACVQNNVKRLVYTSSIEVAGpnFKGRPIFNGVE 140
|
170 180 190
....*....|....*....|....*....|....
gi 489495878 2265 DirviSPTRTVdggWAGGYGTSKWAGEVLLREAN 2298
Cdd:cd09811 141 D----TPYEDT---STPPYASSKLLAENIVLNAN 167
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
472-853 |
3.80e-06 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 52.13 E-value: 3.80e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 472 VAWLVQRGAAPGDVLVFTDDDTDKTIDLLIACHLAGCGYSVCD---TADEISvrtnAITEHGDGILVTVVDVA----ATQ 544
Cdd:cd05923 42 AARLHARGLRPGQRVAVVLPNSVEAVIALLALHRLGAVPALINprlKAAELA----ELIERGEMTAAVIAVDAqvmdAIF 117
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 545 LAVVGHDELRKVVDERVTQVTHDALLA-----TKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYG--WGAHDTVL 617
Cdd:cd05923 118 QSGVRVLALSDLVGLGEPESAGPLIEDpprepEQPAFVFYTSGTTGLPKGAVIPQRAAESRVLFMSTQAGlrHGRHNVVL 197
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 618 QCAPLTSDISVEEIFGGA-ACGARLVRSAAMKTGDLAALVDDLvaRETTIVDLPTAVWQLLCAdgdaIDAIGR--SRLRQ 694
Cdd:cd05923 198 GLMPLYHVIGFFAVLVAAlALDGTYVVVEEFDPADALKLIEQE--RVTSLFATPTHLDALAAA----AEFAGLklSSLRH 271
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 695 IVIGGEAIRCSAVDKwLESAASqgISLLSSYGPTEATvvaTFLpivCDQTTMDGALLRLGrpilpntvflAFGEVVIVGD 774
Cdd:cd05923 272 VTFAGATMPDAVLER-VNQHLP--GEKVNIYGTTEAM---NSL---YMRDARTGTEMRPG----------FFSEVRIVRI 332
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 775 LVADGYLGIDGDGFGTVTAADGS-----------------RRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAE 837
Cdd:cd05923 333 GGSPDEALANGEEGELIVAAAADaaftgylnqpeatakklQDGWYRTGDVGYVDPSGDVRILGRVDDMIISGGENIHPSE 412
|
410
....*....|....*.
gi 489495878 838 VTRRIAEDPAVSDVAV 853
Cdd:cd05923 413 IERVLSRHPGVTEVVV 428
|
|
| PLN03051 |
PLN03051 |
acyl-activating enzyme; Provisional |
1618-1971 |
5.01e-06 |
|
acyl-activating enzyme; Provisional
Pssm-ID: 215552 [Multi-domain] Cd Length: 499 Bit Score: 51.74 E-value: 5.01e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1618 AAYPGTPPPMP------AAVNLAYILYTSGTTGEPKGVGITH----RNVTRLFASLPARLSAAQVWSQchSYGFDASAWE 1687
Cdd:PLN03051 100 AAAQGSVGGNEyspvyaPVESVTNILFSSGTTGEPKAIPWTHlsplRCASDGWAHMDIQPGDVVCWPT--NLGWMMGPWL 177
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1688 IWGALLGGGRLVIVpeSVAASPNDFHGLLVAEHVSVLTQTPAAVAM------LPTQGLESVALVVAGEACPAALVDR--W 1759
Cdd:PLN03051 178 LYSAFLNGATLALY--GGAPLGRGFGKFVQDAGVTVLGLVPSIVKAwrhtgaFAMEGLDWSKLRVFASTGEASAVDDvlW 255
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1760 -----APGRVMLNAYGPTETTICAAISAPLRPgSGMPPIGVPVSGAALFVLDSWLRPVPAGVA--GELYIAGAGVGVG-Y 1831
Cdd:PLN03051 256 lssvrGYYKPVIEYCGGTELASGYISSTLLQP-QAPGAFSTASLGTRFVLLNDNGVPYPDDQPcvGEVALAPPMLGASdR 334
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1832 WRRAGLTASRFVACP-FGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYR---IELGEVATALAELAGVGQAVVI 1907
Cdd:PLN03051 335 LLNADHDKVYYKGMPmYGSKGMPLRRHGDIMKRTPGGYFCVQGRADDTMNLGGIKtssVEIERACDRAVAGIAETAAVGV 414
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 1908 AREDrPGDKRLVGYAT----EIAPGAVDPAGLRAQLAQRLPGYLVP----AAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PLN03051 415 APPD-GGPELLVIFLVlgeeKKGFDQARPEALQKKFQEAIQTNLNPlfkvSRVKIVPELPRNASNKLLRRVL 485
|
|
| PRK13382 |
PRK13382 |
bile acid CoA ligase; |
562-917 |
6.33e-06 |
|
bile acid CoA ligase;
Pssm-ID: 172019 [Multi-domain] Cd Length: 537 Bit Score: 51.68 E-value: 6.33e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 562 TQVTHDALLAT-----------KTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEE 630
Cdd:PRK13382 175 HDLTVEVLIAAhagqrpeptgrKGRVILLTSGTTGTPKGARRSGPGGIGTLKAILDRTPWRAEEPTVIVAPMFHAWGFSQ 254
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 631 IFGGAACGARLVRSAAMKTGDLAALVDDlvARETTIVDLPTAVWQLLCADGDAIDAIGRSRLRQIVIGGEAIRCSAVDKW 710
Cdd:PRK13382 255 LVLAASLACTIVTRRRFDPEATLDLIDR--HRATGLAVVPVMFDRIMDLPAEVRNRYSGRSLRFAAASGSRMRPDVVIAF 332
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 711 LESAasqGISLLSSYGPTEATVVATFLPivCD-QTTMDGAllrlGRP-------IL-PNTVFLAFGEV---VIVGDLVAD 778
Cdd:PRK13382 333 MDQF---GDVIYNNYNATEAGMIATATP--ADlRAAPDTA----GRPaegteirILdQDFREVPTGEVgtiFVRNDTQFD 403
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 779 GYL-GIDGD---GFgtvtaadgsrrraFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV- 853
Cdd:PRK13382 404 GYTsGSTKDfhdGF-------------MASGDVGYLDENGRLFVVGRDDEMIVSGGENVYPIEVEKTLATHPDVAEAAVi 470
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 854 ----ELHSGSLGVWF----KSQRTREgeqdaAAATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKIDSDNLPR 917
Cdd:PRK13382 471 gvddEQYGQRLAAFVvlkpGASATPE-----TLKQHVRDNLANYKVPRDIVV-LDELPRGATGKILRRELQA 536
|
|
| PRK09192 |
PRK09192 |
fatty acyl-AMP ligase; |
1520-1654 |
9.01e-06 |
|
fatty acyl-AMP ligase;
Pssm-ID: 236403 [Multi-domain] Cd Length: 579 Bit Score: 51.16 E-value: 9.01e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1520 YRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTG--AAYLPIdPANPPPRVAF------MLGDAVPV 1591
Cdd:PRK09192 52 YQTLRARAEAGARRLLALGLKPGDRVALIAETDGDFVEAFFACQYAGlvPVPLPL-PMGFGGRESYiaqlrgMLASAQPA 130
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1592 AAVTTAGLRSRLA----GHDLPII---DVVDALAAyPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHR 1654
Cdd:PRK09192 131 AIITPDELLPWVNeathGNPLLHVlshAWFKALPE-ADVALPRPTPDDIAYLQYSSGSTRFPRGVIITHR 199
|
|
| Arna_like_SDR_e |
cd05257 |
Arna decarboxylase_like, extended (e) SDRs; Decarboxylase domain of ArnA. ArnA, is an enzyme ... |
2109-2309 |
1.26e-05 |
|
Arna decarboxylase_like, extended (e) SDRs; Decarboxylase domain of ArnA. ArnA, is an enzyme involved in the modification of outer membrane protein lipid A of gram-negative bacteria. It is a bifunctional enzyme that catalyzes the NAD-dependent decarboxylation of UDP-glucuronic acid and N-10-formyltetrahydrofolate-dependent formylation of UDP-4-amino-4-deoxy-l-arabinose; its NAD-dependent decaboxylating activity is in the C-terminal 360 residues. This subgroup belongs to the extended SDR family, however the NAD binding motif is not a perfect match and the upstream Asn of the canonical active site tetrad is not conserved. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187567 [Multi-domain] Cd Length: 316 Bit Score: 49.61 E-value: 1.26e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2109 TVLLTGATGFLGRYLVLELLRRldvdGrliCLVRAESDedarrrlektFDSGDPELLRHFKELaaDRLEVVAGDKSEPDL 2188
Cdd:cd05257 1 NVLVTGADGFIGSHLTERLLRE----G---HEVRALDI----------YNSFNSWGLLDNAVH--DRFHFISGDVRDASE 61
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2189 gldqpmWRRLAETVDLIVDSAAMVnAFPY-----HELFGPNVAGTAELIRIALTTKLKPFTYVSTADVGAAIEPSAFTED 2263
Cdd:cd05257 62 ------VEYLVKKCDVVFHLAALI-AIPYsytapLSYVETNVFGTLNVLEAACVLYRKRVVHTSTSEVYGTAQDVPIDED 134
|
170 180 190 200
....*....|....*....|....*....|....*....|....*....
gi 489495878 2264 ADIRVISPTRtvdggWagGYGTSKWAGEvllREANDLCA---LPVAVFR 2309
Cdd:cd05257 135 HPLLYINKPR-----S--PYSASKQGAD---RLAYSYGRsfgLPVTIIR 173
|
|
| PRK08043 |
PRK08043 |
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase; |
1634-1971 |
2.97e-05 |
|
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase;
Pssm-ID: 181207 [Multi-domain] Cd Length: 718 Bit Score: 49.32 E-value: 2.97e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1634 AYILYTSGTTGEPKGVGITHR----NV--TRLFASLPAR---LSAAQVWsqcHSYGFDASaweIWGALLGGGRLVIVPes 1704
Cdd:PRK08043 368 ALILFTSGSEGHPKGVVHSHKsllaNVeqIKTIADFTPNdrfMSALPLF---HSFGLTVG---LFTPLLTGAEVFLYP-- 439
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1705 vaaSPndFHGLLVAEHV-----SVL--TQT----------PAAVAMLptqglesvALVVAG-----EACPAALVDRWapG 1762
Cdd:PRK08043 440 ---SP--LHYRIVPELVydrncTVLfgTSTflgnyarfanPYDFARL--------RYVVAGaeklqESTKQLWQDKF--G 504
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1763 RVMLNAYGPTETTICAAISAPL--RPGSgmppigvpvSGAALFVLDSWLRPVPaGVA--GELYIAGAGVGVGYWR--RAG 1836
Cdd:PRK08043 505 LRILEGYGVTECAPVVSINVPMaaKPGT---------VGRILPGMDARLLSVP-GIEqgGRLQLKGPNIMNGYLRveKPG 574
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1837 LTASRFVACPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDK 1916
Cdd:PRK08043 575 VLEVPTAENARGEMERGWYDTGDIVRFDEQGFVQIQGRAKRFAKIAGEMVSLEMVEQLALGVSPDKQHATAIKSDASKGE 654
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1917 RLVGYATeiapgavDPAGLRAQLAQR-----LPGYLVPAAVVVIDALPLTVNGKLDHRAL 1971
Cdd:PRK08043 655 ALVLFTT-------DSELTREKLQQYarehgVPELAVPRDIRYLKQLPLLGSGKPDFVTL 707
|
|
| PLN02736 |
PLN02736 |
long-chain acyl-CoA synthetase |
1625-1655 |
3.55e-05 |
|
long-chain acyl-CoA synthetase
Pssm-ID: 178337 [Multi-domain] Cd Length: 651 Bit Score: 49.33 E-value: 3.55e-05
10 20 30
....*....|....*....|....*....|.
gi 489495878 1625 PPMPAAVnlAYILYTSGTTGEPKGVGITHRN 1655
Cdd:PLN02736 217 PPKPEDV--ATICYTSGTTGTPKGVVLTHGN 245
|
|
| dTDP_GD_SDR_e |
cd05246 |
dTDP-D-glucose 4,6-dehydratase, extended (e) SDRs; This subgroup contains dTDP-D-glucose 4, ... |
2108-2310 |
3.86e-05 |
|
dTDP-D-glucose 4,6-dehydratase, extended (e) SDRs; This subgroup contains dTDP-D-glucose 4,6-dehydratase and related proteins, members of the extended-SDR family, with the characteristic Rossmann fold core region, active site tetrad and NAD(P)-binding motif. dTDP-D-glucose 4,6-dehydratase is closely related to other sugar epimerases of the SDR family. dTDP-D-dlucose 4,6,-dehydratase catalyzes the second of four steps in the dTDP-L-rhamnose pathway (the dehydration of dTDP-D-glucose to dTDP-4-keto-6-deoxy-D-glucose) in the synthesis of L-rhamnose, a cell wall component of some pathogenic bacteria. In many gram negative bacteria, L-rhamnose is an important constituent of lipopoylsaccharide O-antigen. The larger N-terminal portion of dTDP-D-Glucose 4,6-dehydratase forms a Rossmann fold NAD-binding domain, while the C-terminus binds the sugar substrate. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187557 [Multi-domain] Cd Length: 315 Bit Score: 48.31 E-value: 3.86e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2108 RTVLLTGATGFLGRYLVLELLRRLDVDgRLICLvraesDedarrRLekTFdSGDPELLRHFKElaADRLEVVAGDKSepd 2187
Cdd:cd05246 1 MKILVTGGAGFIGSNFVRYLLNKYPDY-KIINL-----D-----KL--TY-AGNLENLEDVSS--SPRYRFVKGDIC--- 61
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2188 lglDQPMWRRLAET--VDLIVDSAA-------MVNAFPYHELfgpNVAGTAELIRIALTTKLKPFTYVSTADV-GAAIEP 2257
Cdd:cd05246 62 ---DAELVDRLFEEekIDAVIHFAAeshvdrsISDPEPFIRT---NVLGTYTLLEAARKYGVKRFVHISTDEVyGDLLDD 135
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|...
gi 489495878 2258 SAFTEDADIRVISPtrtvdggwaggYGTSKWAGEVLLREANDLCALPVAVFRC 2310
Cdd:cd05246 136 GEFTETSPLAPTSP-----------YSASKAAADLLVRAYHRTYGLPVVITRC 177
|
|
| PTZ00216 |
PTZ00216 |
acyl-CoA synthetase; Provisional |
1587-1668 |
4.48e-05 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240316 [Multi-domain] Cd Length: 700 Bit Score: 48.82 E-value: 4.48e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1587 DAVPvAAVTTAGLRSrlaghdLPIIDVVD----ALAAYPGTPPPmpAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFAS 1662
Cdd:PTZ00216 225 DSLP-ASVDTEGCRL------VAWTDVVAkghsAGSHHPLNIPE--NNDDLALIMYTSGTTGDPKGVMHTHGSLTAGILA 295
|
....*.
gi 489495878 1663 LPARLS 1668
Cdd:PTZ00216 296 LEDRLN 301
|
|
| PRK08043 |
PRK08043 |
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase; |
691-838 |
6.21e-05 |
|
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase;
Pssm-ID: 181207 [Multi-domain] Cd Length: 718 Bit Score: 48.55 E-value: 6.21e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 691 RLRQIVIGGEAIRCSAVDKWLESAasqGISLLSSYGPTE-ATVVATFLPIVCDQTTmdgallrLGRpILPN--TVFLAF- 766
Cdd:PRK08043 480 RLRYVVAGAEKLQESTKQLWQDKF---GLRILEGYGVTEcAPVVSINVPMAAKPGT-------VGR-ILPGmdARLLSVp 548
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 767 -----GEVVIVGDLVADGYLGIDGDGFGTVTAAD---GSRRRA-FATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAE 837
Cdd:PRK08043 549 gieqgGRLQLKGPNIMNGYLRVEKPGVLEVPTAEnarGEMERGwYDTGDIVRFDEQGFVQIQGRAKRFAKIAGEMVSLEM 628
|
.
gi 489495878 838 V 838
Cdd:PRK08043 629 V 629
|
|
| YbjT |
COG0702 |
Uncharacterized conserved protein YbjT, contains NAD(P)-binding and DUF2867 domains [General ... |
2109-2313 |
8.09e-05 |
|
Uncharacterized conserved protein YbjT, contains NAD(P)-binding and DUF2867 domains [General function prediction only];
Pssm-ID: 440466 [Multi-domain] Cd Length: 215 Bit Score: 46.38 E-value: 8.09e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2109 TVLLTGATGFLGRYLVLELLRRldvDGRLICLVRaesdedarrrlektfdsgDPELLRHfkeLAADRLEVVAGDKSEPDl 2188
Cdd:COG0702 1 KILVTGATGFIGRRVVRALLAR---GHPVRALVR------------------DPEKAAA---LAAAGVEVVQGDLDDPE- 55
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2189 gldqpMWRRLAETVDLIVDsaamVNAFPYHELFGPNVAGTAELIRIALTTKLKPFTYVSTADvgaaiepsaftedadirv 2268
Cdd:COG0702 56 -----SLAAALAGVDAVFL----LVPSGPGGDFAVDVEGARNLADAAKAAGVKRIVYLSALG------------------ 108
|
170 180 190 200
....*....|....*....|....*....|....*....|....*
gi 489495878 2269 isptrtVDGGWAGGYGTSKWAGEVLLREAndlcALPVAVFRCGMI 2313
Cdd:COG0702 109 ------ADRDSPSPYLRAKAAVEEALRAS----GLPYTILRPGWF 143
|
|
| 3b-HSD-like_SDR_e |
cd05241 |
3beta-hydroxysteroid dehydrogenases (3b-HSD)-like, extended (e) SDRs; Extended SDR family ... |
2109-2309 |
1.05e-04 |
|
3beta-hydroxysteroid dehydrogenases (3b-HSD)-like, extended (e) SDRs; Extended SDR family domains belonging to this subgroup have the characteristic active site tetrad and a fairly well-conserved NAD(P)-binding motif. 3b-HSD catalyzes the NAD-dependent conversion of various steroids, such as pregnenolone to progesterone, or androstenediol to testosterone. This subgroup includes an unusual bifunctional 3b-HSD/C-4 decarboxylase from Arabidopsis thaliana, and Saccharomyces cerevisiae ERG26, a 3b-HSD/C-4 decarboxylase, involved in the synthesis of ergosterol, the major sterol of yeast. It also includes human 3 beta-HSD/HSD3B1 and C(27) 3beta-HSD/ [3beta-hydroxy-delta(5)-C(27)-steroid oxidoreductase; HSD3B7]. C(27) 3beta-HSD/HSD3B7 is a membrane-bound enzyme of the endoplasmic reticulum, that catalyzes the isomerization and oxidation of 7alpha-hydroxylated sterol intermediates, an early step in bile acid biosynthesis. Mutations in the human NSDHL (NAD(P)H steroid dehydrogenase-like protein) cause CHILD syndrome (congenital hemidysplasia with ichthyosiform nevus and limb defects), an X-linked dominant, male-lethal trait. Mutations in the human gene encoding C(27) 3beta-HSD underlie a rare autosomal recessive form of neonatal cholestasis. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid sythase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187552 [Multi-domain] Cd Length: 331 Bit Score: 47.04 E-value: 1.05e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2109 TVLLTGATGFLGRYLVLELLRRLDVDGRLiclvraesdedarrrlektFDSGDPELlrHFKELAADRLEVVAGDKSEPDl 2188
Cdd:cd05241 1 SVLVTGGSGFFGERLVKQLLERGGTYVRS-------------------FDIAPPGE--ALSAWQHPNIEFLKGDITDRN- 58
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2189 gldqpMWRRLAETVDLIVDSAAMVNAFPYHELFGP-NVAGTAELIRIALTTKLKPFTYVSTADV---GAAIepsaFTEDA 2264
Cdd:cd05241 59 -----DVEQALSGADCVFHTAAIVPLAGPRDLYWEvNVGGTQNVLDACQRCGVQKFVYTSSSSVifgGQNI----HNGDE 129
|
170 180 190 200
....*....|....*....|....*....|....*....|....*
gi 489495878 2265 DIrvisPTRTVDggwAGGYGTSKWAGEVLLREANDLCALPVAVFR 2309
Cdd:cd05241 130 TL----PYPPLD---SDMYAETKAIAEIIVLEANGRDDLLTCALR 167
|
|
| PRK05852 |
PRK05852 |
fatty acid--CoA ligase family protein; |
575-853 |
1.17e-04 |
|
fatty acid--CoA ligase family protein;
Pssm-ID: 235625 [Multi-domain] Cd Length: 534 Bit Score: 47.57 E-value: 1.17e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDIS-VEEIFGGAACGARLVRSAAMKTGDLA 653
Cdd:PRK05852 179 AMIMFTGGTTGLPKMVPWTHANIASSVRAIITGYRLSPRDATVAVMPLYHGHGlIAALLATLASGGAVLLPARGRFSAHT 258
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 654 ALVDDLVARETTIVDLPTAVWQLLCADGDAIDAIGRSRLRQIViggeaiRCSAVdkwLESAASQ------GISLLSSYGP 727
Cdd:PRK05852 259 FWDDIKAVGATWYTAVPTIHQILLERAATEPSGRKPAALRFIR------SCSAP---LTAETAQalqtefAAPVVCAFGM 329
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 728 TEATVVATFLPIVCDQTTMD------------GALLRL----GRPILPNTVflafGEVVIVGDLVADGYLGIDgdgfgTV 791
Cdd:PRK05852 330 TEATHQVTTTQIEGIGQTENpvvstglvgrstGAQIRIvgsdGLPLPAGAV----GEVWLRGTTVVRGYLGDP-----TI 400
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 489495878 792 TAA---DGSRRrafaTGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK05852 401 TAAnftDGWLR----TGDLGSLSAAGDLSIRGRIKELINRGGEKISPERVEGVLASHPNVMEAAV 461
|
|
| RfbD |
COG1091 |
dTDP-4-dehydrorhamnose reductase [Cell wall/membrane/envelope biogenesis]; |
2110-2299 |
1.40e-04 |
|
dTDP-4-dehydrorhamnose reductase [Cell wall/membrane/envelope biogenesis];
Pssm-ID: 440708 [Multi-domain] Cd Length: 279 Bit Score: 46.28 E-value: 1.40e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2110 VLLTGATGFLGRYLVLELLRRldvDGRLICLVRAE---SDEDArrrLEKTFDSGDPELLRHfkeLAAdrleVVAGDK--S 2184
Cdd:COG1091 2 ILVTGANGQLGRALVRLLAER---GYEVVALDRSEldiTDPEA---VAALLEEVRPDVVIN---AAA----YTAVDKaeS 68
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2185 EPDLgldqpmwrrlAETVdlivdsaamvnafpyhelfgpNVAGTAELIRIALTTKLkPFTYVSTADV--GAAIEPsaFTE 2262
Cdd:COG1091 69 EPEL----------AYAV---------------------NATGPANLAEACAELGA-RLIHISTDYVfdGTKGTP--YTE 114
|
170 180 190
....*....|....*....|....*....|....*..
gi 489495878 2263 DADIRVISPtrtvdggwaggYGTSKWAGEVLLREAND 2299
Cdd:COG1091 115 DDPPNPLNV-----------YGRSKLAGEQAVRAAGP 140
|
|
| 3Beta_HSD |
pfam01073 |
3-beta hydroxysteroid dehydrogenase/isomerase family; The enzyme 3 beta-hydroxysteroid ... |
2111-2308 |
1.43e-04 |
|
3-beta hydroxysteroid dehydrogenase/isomerase family; The enzyme 3 beta-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase (3 beta-HSD) catalyzes the oxidation and isomerization of 5-ene-3 beta-hydroxypregnene and 5-ene-hydroxyandrostene steroid precursors into the corresponding 4-ene-ketosteroids necessary for the formation of all classes of steroid hormones.
Pssm-ID: 366449 [Multi-domain] Cd Length: 279 Bit Score: 46.21 E-value: 1.43e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2111 LLTGATGFLGRYLVLELLRRldvdGRLICLvraesdedarRRLEKTFdsgDPELLRHFKELaaDRLEVVAGD-KSEPDLg 2189
Cdd:pfam01073 1 VVTGGGGFLGRHIIKLLVRE----GELKEV----------RVFDLRE---SPELLEDFSKS--NVIKYIQGDvTDKDDL- 60
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2190 ldqpmwRRLAETVDLIVDSAAMVNAF---PYHELFGPNVAGTAELIRIALTTKLKPFTYVSTADVgaaIEPSAFTEdaDI 2266
Cdd:pfam01073 61 ------DNALEGVDVVIHTASAVDVFgkyTFDEIMKVNVKGTQNVLEACVKAGVRVLVYTSSAEV---VGPNSYGQ--PI 129
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|...
gi 489495878 2267 RVISPTRTVDGGWAGGYGTSKWAGEVLLREANDL----------CAL-PVAVF 2308
Cdd:pfam01073 130 LNGDEETPYESTHQDAYPRSKAIAEKLVLKANGRplknggrlytCALrPAGIY 182
|
|
| LC_FACL_like |
cd05914 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are ... |
573-853 |
1.47e-04 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341240 [Multi-domain] Cd Length: 463 Bit Score: 47.05 E-value: 1.47e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 573 KTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLtsdisvEEIFG-------GAACGARLVRSA 645
Cdd:cd05914 90 DVALINYTSGTTGNSKGVMLTYRNIVSNVDGVKEVVLLGKGDKILSILPL------HHIYPltftlllPLLNGAHVVFLD 163
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 646 AMKTgdlaALVDDLVARETTIVDLPTAVWQLL-------------------------------CADGDAIDAIGrSRLRQ 694
Cdd:cd05914 164 KIPS----AKIIALAFAQVTPTLGVPVPLVIEkifkmdiipkltlkkfkfklakkinnrkirkLAFKKVHEAFG-GNIKE 238
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 695 IVIGGEAIRcSAVDKWLESAasqGISLLSSYGPTEATVVATFLP---IVCDQT--TMDGALLRLGRPIlPNTvflAFGEV 769
Cdd:cd05914 239 FVIGGAKIN-PDVEEFLRTI---GFPYTIGYGMTETAPIISYSPpnrIRLGSAgkVIDGVEVRIDSPD-PAT---GEGEI 310
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 770 VIVGDLVADGYLG--------IDGDGFgtvtaadgsrrraFATGDRVTVDAEGFPVFSGR-KDAVVKISGKRVDIAEVTR 840
Cdd:cd05914 311 IVRGPNVMKGYYKnpeataeaFDKDGW-------------FHTGDLGKIDAEGYLYIRGRkKEMIVLSSGKNIYPEEIEA 377
|
330
....*....|....*
gi 489495878 841 RIAEDPAV--SDVAV 853
Cdd:cd05914 378 KINNMPFVleSLVVV 392
|
|
| PRK07824 |
PRK07824 |
o-succinylbenzoate--CoA ligase; |
558-853 |
1.63e-04 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 236108 [Multi-domain] Cd Length: 358 Bit Score: 46.58 E-value: 1.63e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 558 DERVTQVTHDALLATK-----TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYG----W-----GAHDTVLQcaplt 623
Cdd:PRK07824 16 DERRAALLRDALRVGEpidddVALVVATSGTTGTPKGAMLTAAALTASADATHDRLGgpgqWllalpAHHIAGLQ----- 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 624 sdISVEEIFGGAACGARLVrSAAMKTGDLAALVDDLVA--RETTIVdlPTavwQLLCADGD--AIDAIgrSRLRQIVIGG 699
Cdd:PRK07824 91 --VLVRSVIAGSEPVELDV-SAGFDPTALPRAVAELGGgrRYTSLV--PM---QLAKALDDpaATAAL--AELDAVLVGG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 700 EAIRCSAvdkwLESAASQGISLLSSYGPTEatvvaTFLPIVCDQTTMDGALLRLGRpilpntvflafGEVVIVGDLVADG 779
Cdd:PRK07824 161 GPAPAPV----LDAAAAAGINVVRTYGMSE-----TSGGCVYDGVPLDGVRVRVED-----------GRIALGGPTLAKG 220
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 489495878 780 YLGIdgdgfgtVTAADGSRRRAFATGDRVTVDaEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK07824 221 YRNP-------VDPDPFAEPGWFRTDDLGALD-DGVLTVLGRADDAISTGGLTVLPQVVEAALATHPAVADCAV 286
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
576-853 |
1.78e-04 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 46.24 E-value: 1.78e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 576 YIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIF-----GGAACGarlvrsaaMKTG 650
Cdd:cd17633 4 YIGFTSGTTGLPKAYYRSERSWIESFVCNEDLFNISGEDAILAPGPLSHSLFLYGAIsalylGGTFIG--------QRKF 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 651 DLAALVDDLVARETTIVDL-PTAVWQLLcadgdaidaigrsRLRQIVIGGEAIRCSAvDKWLESAASQ------GISLLS 723
Cdd:cd17633 76 NPKSWIRKINQYNATVIYLvPTMLQALA-------------RTLEPESKIKSIFSSG-QKLFESTKKKlknifpKANLIE 141
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 724 SYGPTEATVVaTFLpivCDQTTmdGALLRLGRPI------LPNTVFLAFGEVVIVGDLVADGYLgidgdgFGTVTAADGs 797
Cdd:cd17633 142 FYGTSELSFI-TYN---FNQES--RPPNSVGRPFpnveieIRNADGGEIGKIFVKSEMVFSGYV------RGGFSNPDG- 208
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 798 rrrAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd17633 209 ---WMSVGDIGYVDEEGYLYLVGRESDMIIIGGINIFPTEIESVLKAIPGIEEAIV 261
|
|
| PRK03584 |
PRK03584 |
acetoacetate--CoA ligase; |
1517-1966 |
2.15e-04 |
|
acetoacetate--CoA ligase;
Pssm-ID: 235134 [Multi-domain] Cd Length: 655 Bit Score: 46.71 E-value: 2.15e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1517 SMTYRELDEASNRLAHRLAGCGAGPGECVAllfercapavvamvavlktgaAYLPidpaNPPPRVAFMLG---------- 1586
Cdd:PRK03584 114 ELSWAELRRQVAALAAALRALGVGPGDRVA---------------------AYLP----NIPETVVAMLAtaslgaiwss 168
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1587 -------DAV--------PVAAVTTAG----------------LRSRL-------------AGHDLPIIDVV----DALA 1618
Cdd:PRK03584 169 cspdfgvQGVldrfgqiePKVLIAVDGyryggkafdrrakvaeLRAALpslehvvvvpylgPAAAAAALPGAllweDFLA 248
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1619 AYPGTPP---PMPAAVNLaYILYTSGTTGEPKGV-----GIT---------HRNVT---RLFaslparlsaaqvWsqchs 1678
Cdd:PRK03584 249 PAEAAELefePVPFDHPL-WILYSSGTTGLPKCIvhghgGILlehlkelglHCDLGpgdRFF------------W----- 310
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1679 ygFDASAWEIW----GALLGGGRLVIVPES-VAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLEsvalvvageacpa 1753
Cdd:PRK03584 311 --YTTCGWMMWnwlvSGLLVGATLVLYDGSpFYPDPNVLWDLAAEEGVTVFGTSAKYLDACEKAGLV------------- 375
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1754 alvdrwaPGRVM----LNAYGPTetticaaisaplrpGSGMPPIG--------------VPVSG----AALFVLDSWLRP 1811
Cdd:PRK03584 376 -------PGETHdlsaLRTIGST--------------GSPLPPEGfdwvyehvkadvwlASISGgtdiCSCFVGGNPLLP 434
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1812 VpagVAGELYIAGAGVGVGYWRRAG-----------LTASrFVACPFG----GSGAR-------MY----RTGDLVCWRA 1865
Cdd:PRK03584 435 V---YRGEIQCRGLGMAVEAWDEDGrpvvgevgelvCTKP-FPSMPLGfwndPDGSRyrdayfdTFpgvwRHGDWIEITE 510
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1866 DGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATeIAPGAVDPAGLRAQLAQRLPG 1945
Cdd:PRK03584 511 HGGVVIYGRSDATLNRGGVRIGTAEIYRQVEALPEVLDSLVIGQEWPDGDVRMPLFVV-LAEGVTLDDALRARIRTTIRT 589
|
570 580
....*....|....*....|....*
gi 489495878 1946 YL----VPAAVVVIDALPLTVNGKL 1966
Cdd:PRK03584 590 NLsprhVPDKIIAVPDIPRTLSGKK 614
|
|
| PRK07867 |
PRK07867 |
acyl-CoA synthetase; Validated |
580-853 |
2.16e-04 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236120 [Multi-domain] Cd Length: 529 Bit Score: 46.60 E-value: 2.16e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 580 TSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVeeIFG---GAACGARLVRSAAMKTGDLAALV 656
Cdd:PRK07867 160 TSGTSGDPKAVRCTHRKVASAGVMLAQRFGLGPDDVCYVSMPLFHSNAV--MAGwavALAAGASIALRRKFSASGFLPDV 237
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 657 DDLVARETTIVDLPTAVwqLLCADGDAIDAigRSRLRqIVIGGEAircSAVDKwLESAASQGISLLSSYGPTEATVVATF 736
Cdd:PRK07867 238 RRYGATYANYVGKPLSY--VLATPERPDDA--DNPLR-IVYGNEG---APGDI-ARFARRFGCVVVDGFGSTEGGVAITR 308
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 737 LPivcdqTTMDGALLRLGRPI----------LPNTVFLAFGEV---VIVGDLVadgylGIDG----DGFGTVTAADGSRR 799
Cdd:PRK07867 309 TP-----DTPPGALGPLPPGVaivdpdtgteCPPAEDADGRLLnadEAIGELV-----NTAGpggfEGYYNDPEADAERM 378
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 800 RA--FATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK07867 379 RGgvYWSGDLAYRDADGYAYFAGRLGDWMRVDGENLGTAPIERILLRYPDATEVAV 434
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
472-926 |
3.27e-04 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 45.95 E-value: 3.27e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 472 VAWLVQRGAAPGDVLVFTDDDTDKTIDLLIACHLAGCGYSVCD---TADEIsvrtNAITEHGD-GILVTVVDVAATQLAV 547
Cdd:PRK09088 36 AAVLRRRGCVDGERLAVLARNSVWLVALHFACARVGAIYVPLNwrlSASEL----DALLQDAEpRLLLGDDAVAAGRTDV 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 548 VGHDELRKVVDErVTQVTHDALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDI- 626
Cdd:PRK09088 112 EDLAAFIASADA-LEPADTPSIPPERVSLILFTSGTSGQPKGVMLSERNLQQTAHNFGVLGRVDAHSSFLCDAPMFHIIg 190
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 627 ---SVEEIFggAACGARLVRSAAMKTGDLAALVDDLVAReTTIVDLPTAVWQLlcADGDAIDAIGRSRLRQIVIGGEAIR 703
Cdd:PRK09088 191 litSVRPVL--AVGGSILVSNGFEPKRTLGRLGDPALGI-THYFCVPQMAQAF--RAQPGFDAAALRHLTALFTGGAPHA 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 704 CSAVDKWLEsaasQGISLLSSYGPTEAtvvATFLPIVCDQTTMDGallRLGRPILPN-TVFLAF-------------GEV 769
Cdd:PRK09088 266 AEDILGWLD----DGIPMVDGFGMSEA---GTVFGMSVDCDVIRA---KAGAAGIPTpTVQTRVvddqgndcpagvpGEL 335
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 770 VIVGDLVADGYLGiDGDGFGTVTAADGsrrrAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVS 849
Cdd:PRK09088 336 LLRGPNLSPGYWR-RPQATARAFTGDG----WFRTGDIARRDADGFFWVVDRKKDMFISGGENVYPAEIEAVLADHPGIR 410
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 850 DVAV----ELHSGSLGVWFKSQRTREGEQDAAAATRIRLVLVSLGVSSFFVVgVPNIPRKPNGKIDSdnlPRLPQWSAAG 925
Cdd:PRK09088 411 ECAVvgmaDAQWGEVGYLAIVPADGAPLDLERIRSHLSTRLAKYKVPKHLRL-VDALPRTASGKLQK---ARLRDALAAG 486
|
.
gi 489495878 926 L 926
Cdd:PRK09088 487 R 487
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
577-853 |
3.40e-04 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 45.81 E-value: 3.40e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 577 IMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDIsveeifgGAACGARL--VRSAAMKTGDL-- 652
Cdd:PRK13295 202 LIYTSGTTGEPKGVMHTANTLMANIVPYAERLGLGADDVILMASPMAHQT-------GFMYGLMMpvMLGATAVLQDIwd 274
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 653 AALVDDLVARE---------TTIVDLPTAVwqllcadgdAIDAIGRSRLRQIVIGGEAIRCSAVDKwleSAASQGISLLS 723
Cdd:PRK13295 275 PARAAELIRTEgvtftmastPFLTDLTRAV---------KESGRPVSSLRTFLCAGAPIPGALVER---ARAALGAKIVS 342
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 724 SYGPTEATVVATFLP-------IVCDQTTMDGALLRL----GRPILPNTVflafGEVVIVGDLVADGYLGIDGdgfGTVT 792
Cdd:PRK13295 343 AWGMTENGAVTLTKLddpderaSTTDGCPLPGVEVRVvdadGAPLPAGQI----GRLQVRGCSNFGGYLKRPQ---LNGT 415
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 793 AADGsrrrAFATGDRVTVDAEGFPVFSGR-KDAVVKiSGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK13295 416 DADG----WFDTGDLARIDADGYIRISGRsKDVIIR-GGENIPVVEIEALLYRHPAIAQVAI 472
|
|
| PLN02430 |
PLN02430 |
long-chain-fatty-acid-CoA ligase |
1623-1657 |
3.74e-04 |
|
long-chain-fatty-acid-CoA ligase
Pssm-ID: 178049 [Multi-domain] Cd Length: 660 Bit Score: 45.96 E-value: 3.74e-04
10 20 30
....*....|....*....|....*....|....*
gi 489495878 1623 TPPPMPaaVNLAYILYTSGTTGEPKGVGITHRNVT 1657
Cdd:PLN02430 214 TNPPKP--LDICTIMYTSGTSGDPKGVVLTHEAVA 246
|
|
| PLN02246 |
PLN02246 |
4-coumarate--CoA ligase |
1503-1656 |
4.27e-04 |
|
4-coumarate--CoA ligase
Pssm-ID: 215137 [Multi-domain] Cd Length: 537 Bit Score: 45.74 E-value: 4.27e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1503 ARIPE-AEAVCCGDAS----MTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAylpIDPANP 1577
Cdd:PLN02246 31 ERLSEfSDRPCLIDGAtgrvYTYADVELLSRRVAAGLHKLGIRQGDVVMLLLPNCPEFVLAFLGASRRGAV---TTTANP 107
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1578 ---PPRVAFMLGDAVPVAAVTTAG----LRSRLAGHDLPIIDVVDA----------LAAYPGTPPPMP-AAVNLAYILYT 1639
Cdd:PLN02246 108 fytPAEIAKQAKASGAKLIITQSCyvdkLKGLAEDDGVTVVTIDDPpegclhfselTQADENELPEVEiSPDDVVALPYS 187
|
170
....*....|....*..
gi 489495878 1640 SGTTGEPKGVGITHRNV 1656
Cdd:PLN02246 188 SGTTGLPKGVMLTHKGL 204
|
|
| PaaK |
COG1541 |
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and ... |
1639-1954 |
5.33e-04 |
|
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and metabolism];
Pssm-ID: 441150 [Multi-domain] Cd Length: 423 Bit Score: 45.14 E-value: 5.33e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1639 TSGTTGEPKGVGIThRNVTRLFASLPAR-LSAA--------QVwsqCHSYGFDASAWeiwGALLGGGRL--VIVPESVaa 1707
Cdd:COG1541 91 SSGTTGKPTVVGYT-RKDLDRWAELFARsLRAAgvrpgdrvQN---AFGYGLFTGGL---GLHYGAERLgaTVIPAGG-- 161
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1708 spndfhG-------LLVAEHVSVLTQTP--------AAVAM---LPTQGLEsvALVVAGEACP----AALVDRWapGRVM 1765
Cdd:COG1541 162 ------GnterqlrLMQDFGPTVLVGTPsyllylaeVAEEEgidPRDLSLK--KGIFGGEPWSeemrKEIEERW--GIKA 231
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1766 LNAYGPTETTICAAISAPLRPGSGMPPIGV------PVSGaalfvldswlRPVPAGVAGELYIagagvgvgywrraglTA 1839
Cdd:COG1541 232 YDIYGLTEVGPGVAYECEAQDGLHIWEDHFlveiidPETG----------EPVPEGEEGELVV---------------TT 286
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1840 SRFVACPfggsgarM--YRTGDLVCW------------RADGqleFLGRTDDQVKIRGYRIELGEVATALAELAGVGQA- 1904
Cdd:COG1541 287 LTKEAMP-------LirYRTGDLTRLlpepcpcgrthpRIGR---ILGRADDMLIIRGVNVFPSQIEEVLLRIPEVGPEy 356
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|..
gi 489495878 1905 -VVIAREDRPgDKRLVgyATEIAPGAvDPAGLRAQLAQRLPGYL-VPAAVVV 1954
Cdd:COG1541 357 qIVVDREGGL-DELTV--RVELAPGA-SLEALAEAIAAALKAVLgLRAEVEL 404
|
|
| AFD_CAR-like |
cd17632 |
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation ... |
1597-1659 |
5.87e-04 |
|
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation domain of carboxylic acid reductase enzymes (CARs), and performs an equivalent function to that of the ANL superfamily of adenylating enzymes. It takes a carboxylic acid substrate and ATP, and produces an AMP-acyl phosphoester intermediate, releasing pyrophosphate. Kinetic analysis using various substrates shows that this enzyme has a broad but similar substrate specificity, preferring electron-rich acids. This suggests that attack by the carboxylate on the alpha-phosphate of adenosine triphosphate (ATP) is the step that determines the substrate specificity and reaction kinetics. CAR is an important enzyme for use as a biocatalyst providing regiospecific route to aldehydes from their respective carboxylic acids.
Pssm-ID: 341287 [Multi-domain] Cd Length: 588 Bit Score: 45.14 E-value: 5.87e-04
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 489495878 1597 AGLRSRLAGHDLPIIdVVDALAAYPGTPPPMPAAVN------LAYILYTSGTTGEPKGVGITHRNVTRL 1659
Cdd:cd17632 184 ESARERLAAVGIPVT-TLTLIAVRGRDLPPAPLFRPepdddpLALLIYTSGSTGTPKGAMYTERLVATF 251
|
|
| PLN02657 |
PLN02657 |
3,8-divinyl protochlorophyllide a 8-vinyl reductase |
2091-2186 |
9.11e-04 |
|
3,8-divinyl protochlorophyllide a 8-vinyl reductase
Pssm-ID: 178263 [Multi-domain] Cd Length: 390 Bit Score: 44.37 E-value: 9.11e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2091 ADTLATAVNLPGPSPELRTVLLTGATGFLGRYLVLELLRRldvdG-RLICLVRAESDEDARRRLEKTFDSGDPELLRHFK 2169
Cdd:PLN02657 44 ATAAAAAQSFRSKEPKDVTVLVVGATGYIGKFVVRELVRR----GyNVVAVAREKSGIRGKNGKEDTKKELPGAEVVFGD 119
|
90
....*....|....*..
gi 489495878 2170 ELAADRLEVVAGDKSEP 2186
Cdd:PLN02657 120 VTDADSLRKVLFSEGDP 136
|
|
| PRK04319 |
PRK04319 |
acetyl-CoA synthetase; Provisional |
799-853 |
9.45e-04 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 235279 [Multi-domain] Cd Length: 570 Bit Score: 44.50 E-value: 9.45e-04
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 799 RRAFA-----TGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:PRK04319 426 ESYFAgdwyvSGDSAYMDEDGYFWFQGRVDDVIKTSGERVGPFEVESKLMEHPAVAEAGV 485
|
|
| PaaK |
COG1541 |
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and ... |
580-844 |
9.58e-04 |
|
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and metabolism];
Pssm-ID: 441150 [Multi-domain] Cd Length: 423 Bit Score: 44.37 E-value: 9.58e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 580 TSGTTGQPKLVRISHGSLAVFCDAISRAY---GWGAHDTVLQCAPL---TSDISVEEifGGAACGARLVRSAAMKTGDLA 653
Cdd:COG1541 91 SSGTTGKPTVVGYTRKDLDRWAELFARSLraaGVRPGDRVQNAFGYglfTGGLGLHY--GAERLGATVIPAGGGNTERQL 168
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 654 ALVDDLvaRETTIVDLPTAVWQLlcadGDAIDAIG----RSRLRQIVIGGEAIRCSAVdKWLESAAsqGISLLSSYGPTE 729
Cdd:COG1541 169 RLMQDF--GPTVLVGTPSYLLYL----AEVAEEEGidprDLSLKKGIFGGEPWSEEMR-KEIEERW--GIKAYDIYGLTE 239
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 730 ATV-VAT--------------FLPIVCDQTTmdgallrlGRPilpntvfLAFGEvviVGDLVadgylgidgdgFGTVTaa 794
Cdd:COG1541 240 VGPgVAYeceaqdglhiwedhFLVEIIDPET--------GEP-------VPEGE---EGELV-----------VTTLT-- 288
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 489495878 795 dgsrRRA-----FATGDRVTVDAE------GFPVFS---GRKDAVVKISGKRV---DIAEVTRRIAE 844
Cdd:COG1541 289 ----KEAmplirYRTGDLTRLLPEpcpcgrTHPRIGrilGRADDMLIIRGVNVfpsQIEEVLLRIPE 351
|
|
| RmlD_sub_bind |
pfam04321 |
RmlD substrate binding domain; L-rhamnose is a saccharide required for the virulence of some ... |
2110-2298 |
1.15e-03 |
|
RmlD substrate binding domain; L-rhamnose is a saccharide required for the virulence of some bacteria. Its precursor, dTDP-L-rhamnose, is synthesized by four different enzymes the final one of which is RmlD. The RmlD substrate binding domain is responsible for binding a sugar nucleotide.
Pssm-ID: 427865 [Multi-domain] Cd Length: 284 Bit Score: 43.42 E-value: 1.15e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2110 VLLTGATGFLGRylvlELLRRLDVDGR-LICLVRAESDEDARRRLEKTFDSGDPELLRHfkeLAADRlevvAGDKSEPDl 2188
Cdd:pfam04321 1 ILITGANGQLGT----ELRRLLAERGIeVVALTRAELDLTDPEAVARLLREIKPDVVVN---AAAYT----AVDKAESE- 68
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2189 gldqpmwRRLAETVdlivdsaamvnafpyhelfgpNVAGTAELIRIALTTKLkPFTYVSTADVGAAIEPSAFTEDAdirv 2268
Cdd:pfam04321 69 -------PDLAYAI---------------------NALAPANLAEACAAVGA-PLIHISTDYVFDGTKPRPYEEDD---- 115
|
170 180 190
....*....|....*....|....*....|
gi 489495878 2269 isPTRTVdggwaGGYGTSKWAGEVLLREAN 2298
Cdd:pfam04321 116 --ETNPL-----NVYGRTKLAGEQAVRAAG 138
|
|
| A_NRPS_TubE_like |
cd05906 |
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) ... |
473-622 |
1.66e-03 |
|
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) synthesizing toxins and antitumor agents; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPSs that synthesize toxins and antitumor agents; for example, TubE for Tubulysine, CrpA for cryptophycin, TdiA for terrequinone A, KtzG for kutzneride, and Vlm1/Vlm2 for Valinomycin. Nonribosomal peptide synthetases are large multifunctional enzymes which synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341232 [Multi-domain] Cd Length: 540 Bit Score: 43.81 E-value: 1.66e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 473 AWLVQRGAAPGDVLVFTDDDTDKTIDLLIACHLAG---CGYSVCDTADEISVRTNAItEH-----GDGILVT---VVDVA 541
Cdd:cd05906 54 AGLRQLGLRPGDSVILQFDDNEDFIPAFWACVLAGfvpAPLTVPPTYDEPNARLRKL-RHiwqllGSPVVLTdaeLVAEF 132
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 542 ATQLAVVGHDELRKVVDERVTQVTHDALLATKT----AYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVL 617
Cdd:cd05906 133 AGLETLSGLPGIRVLSIEELLDTAADHDLPQSRpddlALLMLTSGSTGFPKAVPLTHRNILARSAGKIQHNGLTPQDVFL 212
|
....*
gi 489495878 618 QCAPL 622
Cdd:cd05906 213 NWVPL 217
|
|
| AACS_like |
cd05968 |
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This ... |
805-852 |
3.11e-03 |
|
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This uncharacterized acyl-CoA synthetase family (EC 6.2.1.16, or acetoacetate#CoA ligase or acetoacetate:CoA ligase (AMP-forming)) is highly homologous to acetoacetyl-CoA synthetase. However, the proteins in this family exist in only bacteria and archaea. AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms.
Pssm-ID: 341272 [Multi-domain] Cd Length: 610 Bit Score: 42.86 E-value: 3.11e-03
10 20 30 40
....*....|....*....|....*....|....*....|....*...
gi 489495878 805 GDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVA 852
Cdd:cd05968 476 GDFAYYDEEGYFYILGRSDDTINVAGKRVGPAEIESVLNAHPAVLESA 523
|
|
| PRK05851 |
PRK05851 |
long-chain-fatty acid--ACP ligase MbtM; |
1768-1966 |
3.45e-03 |
|
long-chain-fatty acid--ACP ligase MbtM;
Pssm-ID: 180289 [Multi-domain] Cd Length: 525 Bit Score: 42.45 E-value: 3.45e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1768 AYGPTETTiCAaISAPlRPGSG-------MPPIGVP----VSGAALFVLDSWLRPV--PAGVA----GELYIAGAGVGVG 1830
Cdd:PRK05851 309 SYGLAEST-CA-VTVP-VPGIGlrvdevtTDDGSGArrhaVLGNPIPGMEVRISPGdgAAGVAgreiGEIEIRGASMMSG 385
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1831 YWRRAGLTASRFvacpfggsgarmYRTGDLvCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGV--GQAVVIA 1908
Cdd:PRK05851 386 YLGQAPIDPDDW------------FPTGDL-GYLVDGGLVVCGRAKELITVAGRNIFPTEIERVAAQVRGVreGAVVAVG 452
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 1909 REDRPGDKRLVGYATEIAPgavDPAGLRAQLAQRLPGY--LVPAAVVVID--ALPLTVNGKL 1966
Cdd:PRK05851 453 TGEGSARPGLVIAAEFRGP---DEAGARSEVVQRVASEcgVVPSDVVFVApgSLPRTSSGKL 511
|
|
| UDP_invert_4-6DH_SDR_e |
cd05237 |
UDP-Glcnac (UDP-linked N-acetylglucosamine) inverting 4,6-dehydratase, extended (e) SDRs; ... |
2108-2248 |
4.31e-03 |
|
UDP-Glcnac (UDP-linked N-acetylglucosamine) inverting 4,6-dehydratase, extended (e) SDRs; UDP-Glcnac inverting 4,6-dehydratase was identified in Helicobacter pylori as the hexameric flaA1 gene product (FlaA1). FlaA1 is hexameric, possesses UDP-GlcNAc-inverting 4,6-dehydratase activity, and catalyzes the first step in the creation of a pseudaminic acid derivative in protein glycosylation. Although this subgroup has the NADP-binding motif characteristic of extended SDRs, its members tend to have a Met substituted for the active site Tyr found in most SDR families. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187548 [Multi-domain] Cd Length: 287 Bit Score: 41.84 E-value: 4.31e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2108 RTVLLTGATGFLGRYLVLELLRRldVDGRLICLVRAESDEDarrrlektfdsgdpELLRHFKEL-AADRLEVVAGDKSEP 2186
Cdd:cd05237 3 KTILVTGGAGSIGSELVRQILKF--GPKKLIVFDRDENKLH--------------ELVRELRSRfPHDKLRFIIGDVRDK 66
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 2187 DLgldQPMWRRLAEtVDLIVDSAAM--VNA--FPYHELFGPNVAGTAELIRIALTTKLKPFTYVST 2248
Cdd:cd05237 67 ER---LRRAFKERG-PDIVFHAAALkhVPSmeDNPEEAIKTNVLGTKNVIDAAIENGVEKFVCIST 128
|
|
| PRK09192 |
PRK09192 |
fatty acyl-AMP ligase; |
505-739 |
4.52e-03 |
|
fatty acyl-AMP ligase;
Pssm-ID: 236403 [Multi-domain] Cd Length: 579 Bit Score: 42.30 E-value: 4.52e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 505 LAGCGYSVCDTADEISVRTNAITEHGDGilvtVVDVAATQLAvvghdeLRKVVDERVTQVTHDALlatktAYIMPTSGTT 584
Cdd:PRK09192 124 LASAQPAAIITPDELLPWVNEATHGNPL----LHVLSHAWFK------ALPEADVALPRPTPDDI-----AYLQYSSGST 188
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 585 GQPKLVRISHGSLAVFCDAIS----------RAYGWGA--HDTVLQ---CAPLTSDISVEeifggaacgarlvrsaAMKT 649
Cdd:PRK09192 189 RFPRGVIITHRALMANLRAIShdglkvrpgdRCVSWLPfyHDMGLVgflLTPVATQLSVD----------------YLPT 252
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 650 GD-----LAALvdDLVAR-ETTIVDLPTAVWQlLCA---DGDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLESAASQGIS 720
Cdd:PRK09192 253 RDfarrpLQWL--DLISRnRGTISYSPPFGYE-LCArrvNSKDLAELDLSCWRVAGIGADMIRPDVLHQFAEAFAPAGFD 329
|
250 260
....*....|....*....|..
gi 489495878 721 ---LLSSYGPTEATVVATFLPI 739
Cdd:PRK09192 330 dkaFMPSYGLAEATLAVSFSPL 351
|
|
| LC-FACS_euk |
cd05927 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are ... |
575-667 |
4.60e-03 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are eukaryotic fatty acid CoA synthetases that activate fatty acids with chain lengths of 12 to 20. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells.
Pssm-ID: 341250 [Multi-domain] Cd Length: 545 Bit Score: 42.20 E-value: 4.60e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSL----AVFCDAISRAYGWGAHDTVLQCAPLtsdisveeifggAACGARLVRSAAMK-- 648
Cdd:cd05927 117 ATICYTSGTTGNPKGVMLTHGNIvsnvAGVFKILEILNKINPTDVYISYLPL------------AHIFERVVEALFLYhg 184
|
90 100
....*....|....*....|....*
gi 489495878 649 ------TGDLAALVDDLVARETTIV 667
Cdd:cd05927 185 akigfySGDIRLLLDDIKALKPTVF 209
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
690-853 |
5.06e-03 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 42.12 E-value: 5.06e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 690 SRLRQIVIGGEAIRCSAVDKWlesAASQGISLLSSYGPTEATVVATFLPIvcdqttmdGALLRLGR---PIlPNTVF--- 763
Cdd:PRK12492 333 SALKLTNSGGTALVKATAERW---EQLTGCTIVEGYGLTETSPVASTNPY--------GELARLGTvgiPV-PGTALkvi 400
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 764 ------LAFGE---VVIVGDLVADGYLGiDGDGFGTVTAADGsrrrAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVD 834
Cdd:PRK12492 401 dddgneLPLGErgeLCIKGPQVMKGYWQ-QPEATAEALDAEG----WFKTGDIAVIDPDGFVRIVDRKKDLIIVSGFNVY 475
|
170
....*....|....*....
gi 489495878 835 IAEVTRRIAEDPAVSDVAV 853
Cdd:PRK12492 476 PNEIEDVVMAHPKVANCAA 494
|
|
| PTZ00216 |
PTZ00216 |
acyl-CoA synthetase; Provisional |
574-605 |
5.31e-03 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240316 [Multi-domain] Cd Length: 700 Bit Score: 42.27 E-value: 5.31e-03
10 20 30
....*....|....*....|....*....|..
gi 489495878 574 TAYIMPTSGTTGQPKLVRISHGSLAVFCDAIS 605
Cdd:PTZ00216 266 LALIMYTSGTTGDPKGVMHTHGSLTAGILALE 297
|
|
| ArgR-Cyc_NRPS-like |
cd20480 |
Cyc (heterocyclization)-like domain of Vibrio anguillarum AngR and similar proteins; belongs ... |
1217-1360 |
5.74e-03 |
|
Cyc (heterocyclization)-like domain of Vibrio anguillarum AngR and similar proteins; belongs to the Condensation-domain family; Vibrio anguillarum AngR plays a role in regulating the expression of iron transport genes as well as in the production of the siderophore anguibactin. Cyc-domains are a type of Condensation (C) domain. Cyc-domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have a alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. Members of this subfamily have an SxxxD motif at the active site. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to Cyc-domains there are various other subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380470 [Multi-domain] Cd Length: 406 Bit Score: 41.72 E-value: 5.74e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1217 AYWENALAGMPERLRLPTARPyPPVADQRGASL-VVDWPASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAV 1295
Cdd:cd20480 182 AFWNEQILQLPSSANLPTVCE-PEKLRETGITRrTLTLSSDKWQQLVTISKQHNVTPELTLASIFSAVLSLWGNQKDMML 260
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 489495878 1296 GFPIAGRSDPAldNLVGFFVNTLVlrVNLAG-DPSFAELLGQVRARSLAAYENQDVPFEVLVDRLK 1360
Cdd:cd20480 261 RFDLNKKNDVA--GVIGQFTQPLL--VGLSGfGQSFLSLVKENQKHFEQAYPFRQIPIFDLVRQLA 322
|
|
| NDUFA9_like_SDR_a |
cd05271 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, subunit 9, 39 kDa, (NDUFA9) -like, ... |
2109-2437 |
5.88e-03 |
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, subunit 9, 39 kDa, (NDUFA9) -like, atypical (a) SDRs; This subgroup of extended SDR-like proteins are atypical SDRs. They have a glycine-rich NAD(P)-binding motif similar to the typical SDRs, GXXGXXG, and have the YXXXK active site motif (though not the other residues of the SDR tetrad). Members identified include NDUFA9 (mitochondrial) and putative nucleoside-diphosphate-sugar epimerase. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Atypical SDRs include biliverdin IX beta reductase (BVR-B,aka flavin reductase), NMRa (a negative transcriptional regulator of various fungi), progesterone 5-beta-reductase like proteins, phenylcoumaran benzylic ether and pinoresinol-lariciresinol reductases, phenylpropene synthases, eugenol synthase, triphenylmethane reductase, isoflavone reductases, and others. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. In addition to the Rossmann fold core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids, and typically have a TGXXGXXG cofactor binding motif. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187579 [Multi-domain] Cd Length: 273 Bit Score: 41.08 E-value: 5.88e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2109 TVLLTGATGFLGRYLVLELLRRldvdG-RLICLVRaesDEDARRRLEKTFDSGdpellrhfkelaadRLEVVAGDKSEPD 2187
Cdd:cd05271 2 VVTVFGATGFIGRYVVNRLAKR----GsQVIVPYR---CEAYARRLLVMGDLG--------------QVLFVEFDLRDDE 60
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2188 lgldqpMWRRLAETVDLIVDSAAMVNAFPYHELFGPNVAGTAELIRIALTTKLKPFTYVSTAdvGAaiepsafteDADir 2267
Cdd:cd05271 61 ------SIRKALEGSDVVINLVGRLYETKNFSFEDVHVEGPERLAKAAKEAGVERLIHISAL--GA---------DAN-- 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2268 viSPTRtvdggwaggYGTSKWAGEVLLREandlcALPVAV-FRCGMILADTSYagqlnmsdWVTRMVLSLMATGIAPRsf 2346
Cdd:cd05271 122 --SPSK---------YLRSKAEGEEAVRE-----AFPEATiVRPSVVFGREDR--------FLNRFAKLLAFLPFPPL-- 175
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2347 yePDSEGNRQRahfdglPVTF--VAEAIAVLgarVAGSSLAGfATYHVMNPHddGIGLDEYVDWLIEAGYPIRRIDDFAE 2424
Cdd:cd05271 176 --IGGGQTKFQ------PVYVgdVAEAIARA---LKDPETEG-KTYELVGPK--VYTLAELVELLRRLGGRKRRVLPLPL 241
|
330
....*....|...
gi 489495878 2425 WLQRFEASLGALP 2437
Cdd:cd05271 242 WLARLIARVKLLL 254
|
|
| 3b-HSD-NSDHL-like_SDR_e |
cd09813 |
human NSDHL (NAD(P)H steroid dehydrogenase-like protein)-like, extended (e) SDRs; This ... |
2109-2308 |
5.88e-03 |
|
human NSDHL (NAD(P)H steroid dehydrogenase-like protein)-like, extended (e) SDRs; This subgroup includes human NSDHL and related proteins. These proteins have the characteristic active site tetrad of extended SDRs, and also have a close match to their NAD(P)-binding motif. Human NSDHL is a 3beta-hydroxysteroid dehydrogenase (3 beta-HSD) which functions in the cholesterol biosynthetic pathway. 3 beta-HSD catalyzes the oxidative conversion of delta 5-3 beta-hydroxysteroids to the delta 4-3-keto configuration; this activity is essential for the biosynthesis of all classes of hormonal steroids. Mutations in the gene encoding NSDHL cause CHILD syndrome (congenital hemidysplasia with ichthyosiform nevus and limb defects), an X-linked dominant, male-lethal trait. This subgroup also includes an unusual bifunctional [3beta-hydroxysteroid dehydrogenase (3b-HSD)/C-4 decarboxylase from Arabidopsis thaliana, and Saccharomyces cerevisiae ERG26, a 3b-HSD/C-4 decarboxylase, involved in the synthesis of ergosterol, the major sterol of yeast. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid sythase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187673 [Multi-domain] Cd Length: 335 Bit Score: 41.58 E-value: 5.88e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2109 TVLLTGATGFLGRYLVLELLRRLdvdgrlICLVRAesdedarrrlektFDSGDPELLRHFKElaaDRLEVVAGDKSEPDl 2188
Cdd:cd09813 1 SCLVVGGSGFLGRHLVEQLLRRG------NPTVHV-------------FDIRPTFELDPSSS---GRVQFHTGDLTDPQ- 57
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2189 gldQPMWRRLAETVDLIVDSAAMVNAFPYHELFGPNVAGTAELIRIALTTKLKPFTYVSTADVgaaIEPSAFTEDADIRV 2268
Cdd:cd09813 58 ---DLEKAFNEKGPNVVFHTASPDHGSNDDLYYKVNVQGTRNVIEACRKCGVKKLVYTSSASV---VFNGQDIINGDESL 131
|
170 180 190 200
....*....|....*....|....*....|....*....|....*..
gi 489495878 2269 ISPTRTVDggwagGYGTSKWAGEVLLREAND------LCAL-PVAVF 2308
Cdd:cd09813 132 PYPDKHQD-----AYNETKALAEKLVLKANDpesgllTCALrPAGIF 173
|
|
| hsFATP2a_ACSVL_like |
cd05938 |
Fatty acid transport proteins (FATP) including hsFATP2, hsFATP5, and hsFATP6, and similar ... |
551-622 |
6.05e-03 |
|
Fatty acid transport proteins (FATP) including hsFATP2, hsFATP5, and hsFATP6, and similar proteins; Fatty acid transport proteins (FATP) of this family transport long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes hsFATP2, hsFATP5, and hsFATP6, and similar proteins. Each FATP has unique patterns of tissue distribution. These FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. The hsFATP proteins exist in two splice variants; the b variant, lacking exon 3, has no acyl-CoA synthetase activity. FATPs are key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341261 [Multi-domain] Cd Length: 537 Bit Score: 41.89 E-value: 6.05e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 489495878 551 DELRKVVDERVTQVTHDALLATKTAYIMPTSGTTGQPKLVRISHGSLaVFCDAISRAYGWGAHDTVLQCAPL 622
Cdd:cd05938 123 DKVDAASDEPVPASLRAHVTIKSPALYIYTSGTTGLPKAARISHLRV-LQCSGFLSLCGVTADDVIYITLPL 193
|
|
| PRK07445 |
PRK07445 |
O-succinylbenzoic acid--CoA ligase; Reviewed |
1689-1972 |
6.07e-03 |
|
O-succinylbenzoic acid--CoA ligase; Reviewed
Pssm-ID: 236019 [Multi-domain] Cd Length: 452 Bit Score: 41.52 E-value: 6.07e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1689 WGALLGGGRLVIVP-------ESVAASPNDFHGLLVAEHVSVLTQtpaavamLPTQGLESVALVVAGEAcPA--ALVD-- 1757
Cdd:PRK07445 179 MRSFLTGGKLVILPykrlksgQELPPNPSDFFLSLVPTQLQRLLQ-------LRPQWLAQFRTILLGGA-PAwpSLLEqa 250
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1758 -----RWAPgrvmlnAYGPTETticAAISAPLRPG---SGMPPIGVPVSGAALfvldswlrPVPAGVAGELYIAGAGVGV 1829
Cdd:PRK07445 251 rqlqlRLAP------TYGMTET---ASQIATLKPDdflAGNNSSGQVLPHAQI--------TIPANQTGNITIQAQSLAL 313
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 1830 GYWrragltasrfvacPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAR 1909
Cdd:PRK07445 314 GYY-------------PQILDSQGIFETDDLGYLDAQGYLHILGRNSQKIITGGENVYPAEVEAAILATGLVQDVCVLGL 380
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 489495878 1910 EDRPGDKRLVgyATEI-APGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALP 1972
Cdd:PRK07445 381 PDPHWGEVVT--AIYVpKDPSISLEELKTAIKDQLSPFKQPKHWIPVPQLPRNPQGKINRQQLQ 442
|
|
| LC_FACS_euk1 |
cd17639 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The ... |
575-622 |
6.83e-03 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The members of this family are eukaryotic fatty acid CoA synthetases (EC 6.2.1.3) that activate fatty acids with chain lengths of 12 to 20 and includes fungal proteins. They act on a wide range of long-chain saturated and unsaturated fatty acids, but the enzymes from different tissues show some variation in specificity. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. In Schizosaccharomyces pombe, lcf1 gene encodes a new fatty acyl-CoA synthetase that preferentially recognizes myristic acid as a substrate.
Pssm-ID: 341294 [Multi-domain] Cd Length: 507 Bit Score: 41.43 E-value: 6.83e-03
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|
gi 489495878 575 AYIMPTSGTTGQPKLVRISHGSLAVFCDAIS-RAYGW-GAHDTVLQCAPL 622
Cdd:cd17639 91 ACIMYTSGSTGNPKGVMLTHGNLVAGIAGLGdRVPELlGPDDRYLAYLPL 140
|
|
| AR_SDR_e |
cd05227 |
aldehyde reductase, extended (e) SDRs; This subgroup contains aldehyde reductase of the ... |
2109-2257 |
6.83e-03 |
|
aldehyde reductase, extended (e) SDRs; This subgroup contains aldehyde reductase of the extended SDR-type and related proteins. Aldehyde reductase I (aka carbonyl reductase) is an NADP-binding SDR; it has an NADP-binding motif consensus that is slightly different from the canonical SDR form and lacks the Asn of the extended SDR active site tetrad. Aldehyde reductase I catalyzes the NADP-dependent reduction of ethyl 4-chloro-3-oxobutanoate to ethyl (R)-4-chloro-3-hydroxybutanoate. Extended SDRs are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central beta-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
Pssm-ID: 187538 [Multi-domain] Cd Length: 301 Bit Score: 41.10 E-value: 6.83e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2109 TVLLTGATGFLGRYLVLELLRRldvdgrlICLVRAE-SDEDARRRLEKTFDSGDPEllrhfkelaaDRLEVVAgdksepd 2187
Cdd:cd05227 1 LVLVTGATGFIASHIVEQLLKA-------GYKVRGTvRSLSKSAKLKALLKAAGYN----------DRLEFVI------- 56
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 489495878 2188 lgldqpmwrrlaetVDLIVDSAAmvnafpyhelFGPNVAGTAELIRIAlttklKPFTYVSTADVGAAIEP 2257
Cdd:cd05227 57 --------------VDDLTAPNA----------WDEALKGVDYVIHVA-----SPFPFTGPDAEDDVIDP 97
|
|
| ACS |
cd05966 |
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); ... |
802-853 |
7.48e-03 |
|
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); Acetyl-CoA synthetase (ACS, EC 6.2.1.1, acetate#CoA ligase or acetate:CoA ligase (AMP-forming)) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is widely present in all living organisms. The activity of this enzyme is crucial for maintaining the required levels of acetyl-CoA, a key intermediate in many important biosynthetic and catabolic processes. Acetyl-CoA is used in the biosynthesis of glucose, fatty acids, and cholesterol. It can also be used in the production of energy in the citric acid cycle. Eukaryotes typically have two isoforms of acetyl-CoA synthetase, a cytosolic form involved in biosynthetic processes and a mitochondrial form primarily involved in energy generation.
Pssm-ID: 341270 [Multi-domain] Cd Length: 608 Bit Score: 41.39 E-value: 7.48e-03
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|..
gi 489495878 802 FATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAV 853
Cdd:cd05966 471 YFTGDGARRDEDGYYWITGRVDDVINVSGHRLGTAEVESALVAHPAVAEAAV 522
|
|
| LC_FACS_bac1 |
cd17641 |
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial ... |
568-622 |
7.94e-03 |
|
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341296 [Multi-domain] Cd Length: 569 Bit Score: 41.64 E-value: 7.94e-03
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*...
gi 489495878 568 ALLATK---TAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPL 622
Cdd:cd17641 151 EVAAGKgedVAVLCTTSGTTGKPKLAMLSHGNFLGHCAAYLAADPLGPGDEYVSVLPL 208
|
|
|